data_1whu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1whu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.466 -0.132 0 CA-C-O 120.776 0.24 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 50.0 m -76.09 132.47 40.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -73.86 -45.53 50.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.089 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 329' ' ' PHE . 15.6 pt-20 -41.35 -46.29 3.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.464 ' CD1' HG12 ' A' ' 332' ' ' VAL . 7.0 mt -73.33 -59.8 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.419 ' C ' ' O ' ' A' ' 284' ' ' ILE . 85.0 t -34.97 -41.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.077 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -63.67 -48.89 75.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 284' ' ' ILE . 54.1 t80 -69.48 -19.25 63.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.933 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.488 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 9.5 m -72.89 -23.06 60.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.129 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 23.1 mttt -77.05 -43.35 34.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -55.7 -31.74 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.469 HG23 ' CD2' ' A' ' 324' ' ' HIS . 6.7 pt -98.04 -51.49 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.082 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 288' ' ' THR . . . -59.02 -46.87 87.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.086 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 16.9 ttm -55.05 -69.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 293' ' ' MET . 15.7 mt-10 -37.84 -63.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 298' ' ' ALA . 40.9 mttm -53.98 -65.57 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 45.7 mt -38.04 -42.1 0.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.558 ' CE1' HG12 ' A' ' 352' ' ' ILE . 10.8 m-85 -75.98 -36.03 59.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -69.44 -26.71 64.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.072 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 29.9 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.801 0.334 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.33 -61.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.3 t30 -51.87 -47.9 64.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 315' ' ' ASN . 12.2 mmtp -35.98 -53.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.872 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 320' ' ' ASP . 51.1 mt -46.49 -55.59 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -39.1 -32.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.2 mt -89.85 -36.39 15.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.975 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 317' ' ' ILE . 47.3 t0 -66.86 -63.41 1.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 24.2 p -48.65 -44.58 37.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.119 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -50.75 -33.08 21.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.27 -16.54 30.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.852 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . 0.469 ' CD2' HG23 ' A' ' 291' ' ' ILE . 84.3 t60 -91.85 -22.23 20.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 41.9 mt -94.4 -61.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -45.9 -22.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -79.07 -41.64 28.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -69.02 -33.9 74.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 329' ' ' PHE . 2.0 m-85 -116.56 83.0 13.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.678 0.751 . . . . 0.0 110.874 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -22.75 31.56 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 0.0 112.331 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -84.39 -30.53 25.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 333' ' ' ASP . 45.4 t -66.37 157.9 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.164 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . 0.471 ' N ' ' CG1' ' A' ' 332' ' ' VAL . 6.1 t70 -85.57 149.41 25.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . 0.408 ' CD ' HD12 ' A' ' 338' ' ' ILE . 1.0 OUTLIER -59.08 -32.11 69.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.919 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -68.94 -14.29 62.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.47 ' CA ' ' OE1' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -89.49 -21.56 22.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.8 mp -85.31 -26.45 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.12 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.408 HD12 ' CD ' ' A' ' 334' ' ' GLN . 2.7 mp -88.11 -69.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.101 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.473 ' O ' ' CD1' ' A' ' 343' ' ' ILE . 4.8 tp10 -42.83 -34.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 18.8 p -62.8 -50.72 69.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 344' ' ' VAL . 50.1 t80 -49.93 -54.38 20.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 341' ' ' PHE . 7.7 m-80 -36.57 -55.71 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.473 ' CD1' ' O ' ' A' ' 339' ' ' GLU . 5.0 mp -58.45 -38.08 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.14 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 341' ' ' PHE . 52.3 t -65.63 -52.15 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -46.8 -67.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -39.2 6.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -56.83 -49.69 74.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 349' ' ' PHE . 48.2 t -61.44 -60.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 348' ' ' VAL . 11.4 m-85 -34.42 -59.96 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -44.32 -51.93 8.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 10.4 m -58.89 -33.28 70.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.558 HG12 ' CE1' ' A' ' 297' ' ' TYR . 69.8 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.169 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.804 0.252 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.1 t -68.64 130.7 43.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.94 -36.62 82.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -52.0 -38.43 56.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.562 HG12 ' CE2' ' A' ' 329' ' ' PHE . 20.0 mt -76.65 -53.97 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.143 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 82.0 t -39.71 -49.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -55.43 -44.49 76.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -73.51 -26.88 61.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 41.7 m -68.28 -15.95 63.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.177 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 293' ' ' MET . 18.1 mttm -82.99 -40.17 20.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -59.93 -27.14 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.095 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 292' ' ' ALA . 17.1 pt -98.1 -46.96 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.459 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.14 -48.12 68.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.133 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 19.4 ttm -51.89 -60.32 3.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -45.78 -70.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 298' ' ' ALA . 8.4 mmmm -47.27 -62.01 1.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.411 HD22 ' CZ ' ' A' ' 349' ' ' PHE . 49.8 mt -41.67 -48.36 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -75.22 -21.69 58.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -78.29 -26.76 47.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.849 0.356 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 55.7 t -46.83 -29.89 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.147 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -87.31 -41.33 13.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.434 ' N ' ' HD2' ' A' ' 316' ' ' LYS . 3.7 mptt -40.74 -53.87 2.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.418 ' O ' ' C ' ' A' ' 318' ' ' ARG . 52.7 mt -45.41 -57.52 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.123 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 317' ' ' ILE . 16.0 tpp85 -37.22 -44.59 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.8 mt -77.65 -43.75 30.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.76 -69.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.437 HG23 ' CD1' ' A' ' 291' ' ' ILE . 16.5 p -46.27 -51.37 14.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -48.08 -45.19 32.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -80.05 -14.04 58.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . 0.433 ' CD2' HG23 ' A' ' 291' ' ' ILE . 80.9 t60 -91.11 -22.57 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 328' ' ' LYS . 23.0 mt -94.18 -60.3 1.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 325' ' ' LEU . 1.0 OUTLIER -35.86 -44.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -60.26 -46.35 90.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 325' ' ' LEU . 26.8 tptt -60.58 -39.56 88.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.562 ' CE2' HG12 ' A' ' 284' ' ' ILE . 2.8 m-85 -117.43 83.68 17.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.634 0.731 . . . . 0.0 110.851 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 -24.53 29.24 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.24 -30.66 30.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.468 HG12 ' CD1' ' A' ' 284' ' ' ILE . 85.3 t -70.2 144.12 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.194 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . 0.418 ' N ' HG13 ' A' ' 332' ' ' VAL . 6.0 t0 -73.86 150.56 40.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -61.33 -45.56 93.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.1 t80 -51.22 -17.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.891 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.99 -44.13 10.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.6 mp -63.76 -39.99 87.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.96 -58.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -49.02 -52.21 26.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 1.8 p -43.28 -41.63 4.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 344' ' ' VAL . 73.6 t80 -62.16 -56.45 18.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 341' ' ' PHE . 11.2 m-80 -35.72 -36.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 5.2 mp -79.47 -43.03 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.15 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 341' ' ' PHE . 50.8 t -59.94 -41.62 86.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -54.97 -69.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.074 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -53.03 -33.01 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.8 -31.99 73.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 34.7 t -92.12 -57.36 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.411 ' CZ ' HD22 ' A' ' 296' ' ' LEU . 38.1 m-85 -42.3 -55.84 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -51.19 -43.14 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 2.8 t -59.49 -18.93 44.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.816 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 48.2 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.114 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 N--CA 1.466 -0.147 0 CA-C-O 120.818 0.258 . . . . 0.0 112.323 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 2.1 m -71.52 120.52 17.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 283' ' ' GLU . . . -60.09 -56.72 18.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 282' ' ' ALA . 10.7 pt-20 -34.6 -45.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.563 HG12 ' CE2' ' A' ' 329' ' ' PHE . 27.3 mt -68.99 -57.73 7.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 87.3 t -38.13 -57.04 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -52.1 -40.84 61.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -73.83 -27.03 60.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.438 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 17.5 m -67.6 -19.08 65.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.174 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 293' ' ' MET . 28.4 mttt -79.57 -41.79 26.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -58.47 -29.85 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.479 HG23 ' CD2' ' A' ' 324' ' ' HIS . 7.6 pt -97.53 -49.55 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 288' ' ' THR . . . -62.06 -48.04 82.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.478 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 11.9 ttm -54.94 -52.27 63.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -51.79 -68.65 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -50.35 -58.65 5.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.954 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 42.6 mt -42.6 -58.23 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -61.56 -29.64 70.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.964 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.33 -48.92 66.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.986 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.786 0.327 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 46.0 t -57.54 -28.37 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 317' ' ' ILE . 0.5 OUTLIER -80.79 -44.04 19.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.93 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -40.52 -24.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 320' ' ' ASP . 94.8 mt -58.96 -67.16 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.148 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' A' ' 319' ' ' LEU . 7.3 ptp180 -37.97 -32.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.451 ' N ' ' HG3' ' A' ' 318' ' ' ARG . 18.8 mt -76.58 -42.69 41.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 317' ' ' ILE . 15.7 t0 -74.41 -62.86 1.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 324' ' ' HIS . 7.5 p -42.04 -54.73 3.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -45.02 -49.33 11.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -68.9 -21.34 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . 0.479 ' CD2' HG23 ' A' ' 291' ' ' ILE . 78.7 t60 -86.63 -23.06 25.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.828 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.45 ' HB2' ' CG2' ' A' ' 337' ' ' ILE . 42.8 mt -88.71 -58.02 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.935 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 325' ' ' LEU . 0.2 OUTLIER -37.14 -48.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -53.27 -54.53 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.434 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 26.2 tptt -53.4 -47.52 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.563 ' CE2' HG12 ' A' ' 284' ' ' ILE . 0.4 OUTLIER -113.05 86.72 9.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.651 0.739 . . . . 0.0 110.886 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -38.63 7.54 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 2.24 . . . . 0.0 112.359 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.78 -26.82 66.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 284' ' ' ILE . 96.0 t -73.06 141.99 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.087 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -79.57 147.49 32.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.851 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -51.41 -49.14 62.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.3 t80 -46.51 -21.28 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.419 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 7.5 mm-40 -88.71 -38.82 14.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.45 ' CG2' ' HB2' ' A' ' 325' ' ' LEU . 2.6 mp -70.81 -30.17 40.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 79.7 mt -77.13 -66.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -43.53 -49.19 7.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 7.4 p -43.16 -47.18 6.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.44 ' O ' ' C ' ' A' ' 342' ' ' ASN . 61.2 t80 -52.32 -56.08 17.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.828 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 341' ' ' PHE . 21.1 m-80 -35.07 -57.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 5.2 mp -56.24 -51.57 61.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 21.6 t -51.0 -66.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -38.92 -58.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -37.72 -52.14 1.25 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -56.87 -65.78 0.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 46.9 t -42.66 -42.44 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.087 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' A' ' 350' ' ' ARG . 4.9 m-85 -57.83 -65.01 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 349' ' ' PHE . 13.0 tpp85 -37.39 -65.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 68.5 p -41.23 -59.51 1.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 48.8 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.16 179.934 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.16 0 CA-C-O 120.786 0.244 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.2 t -68.26 121.37 16.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.844 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.63 82.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.099 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -50.9 -37.83 46.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.566 HG12 ' CE2' ' A' ' 329' ' ' PHE . 59.2 mt -76.52 -44.04 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 47.3 t -50.34 -60.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.151 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -40.19 -47.01 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -72.23 -39.85 68.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.467 ' HA ' ' CD1' ' A' ' 291' ' ' ILE . 4.1 m -54.73 -17.94 4.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.182 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 293' ' ' MET . 42.1 mttt -79.47 -46.43 17.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.4 mp -58.4 -22.65 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.095 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 288' ' ' THR . 7.3 pt -98.17 -51.92 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.457 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -66.88 -48.22 69.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 29.8 ttm -49.44 -71.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -41.45 -69.35 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 298' ' ' ALA . 0.0 OUTLIER -42.44 -63.88 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 39.7 mt -43.97 -43.02 6.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.555 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.9 m-85 -70.69 -30.76 67.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -70.2 -65.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 7.0 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.121 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.849 0.357 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 60.2 t -52.47 -44.18 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.9 t30 -70.26 -47.77 59.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 315' ' ' ASN . 10.8 mmtm -35.86 -51.98 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.441 ' O ' ' N ' ' A' ' 320' ' ' ASP . 42.0 mt -45.12 -54.07 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.112 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -39.22 -33.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.55 -34.19 15.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 317' ' ' ILE . 6.5 t0 -67.63 -68.15 0.41 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.439 ' CG2' HG13 ' A' ' 291' ' ' ILE . 17.1 p -42.91 -44.2 4.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -50.2 -46.57 54.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.13 -17.66 60.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.835 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -87.84 -28.3 21.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 328' ' ' LYS . 19.0 mt -90.62 -59.07 2.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 325' ' ' LEU . 7.3 tmtt? -38.22 -45.53 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.54 -39.62 94.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.887 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 325' ' ' LEU . 22.1 tptt -65.01 -44.9 87.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.566 ' CE2' HG12 ' A' ' 284' ' ' ILE . 0.5 OUTLIER -113.72 86.17 10.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.638 0.733 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -22.08 32.64 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.73 2.287 . . . . 0.0 112.346 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -84.06 -26.08 29.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 329' ' ' PHE . 48.7 t -75.89 138.73 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.124 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . 0.418 ' N ' HG12 ' A' ' 332' ' ' VAL . 6.6 t0 -72.08 142.86 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.812 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -51.57 -47.92 63.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.597 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 1.5 t80 -47.45 -20.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -88.09 -45.57 10.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.4 mp -60.3 -26.21 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 340' ' ' SER . 76.7 mt -89.34 -64.95 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -41.88 -26.11 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.919 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 338' ' ' ILE . 2.4 p -65.77 -46.57 78.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.44 ' O ' ' C ' ' A' ' 342' ' ' ASN . 23.3 t80 -53.92 -52.74 59.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 341' ' ' PHE . 28.2 m-80 -34.53 -48.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 4.7 mp -73.46 -41.75 56.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.15 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 341' ' ' PHE . 25.2 t -58.25 -59.97 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -38.17 -64.9 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -46.34 -60.72 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.943 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -39.86 -34.99 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.21 -53.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.158 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.0 m-85 -52.5 -64.48 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 349' ' ' PHE . 23.9 ptt85 -37.77 -28.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.866 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 349' ' ' PHE . 15.8 t -84.17 -41.74 16.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.555 HG12 ' CE1' ' A' ' 297' ' ' TYR . 83.6 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.867 0.278 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 2.1 m -74.58 137.17 42.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.07 -48.44 62.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -42.66 -45.56 4.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.554 HG12 ' CZ ' ' A' ' 329' ' ' PHE . 25.1 mt -74.45 -54.03 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.404 ' CG2' ' CB ' ' A' ' 340' ' ' SER . 95.4 t -45.16 -43.11 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -61.94 -36.14 80.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -80.3 -30.69 38.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.464 ' HA ' ' CD1' ' A' ' 291' ' ' ILE . 9.9 m -60.49 -19.92 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 293' ' ' MET . 42.0 mttt -80.54 -48.94 12.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -54.78 -22.74 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 288' ' ' THR . 5.2 pt -98.71 -52.2 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.45 ' N ' ' CG1' ' A' ' 291' ' ' ILE . . . -68.76 -49.19 60.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.498 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 20.0 ttm -43.1 -65.22 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -46.63 -63.07 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.856 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 298' ' ' ALA . 47.1 mmtt -46.39 -65.46 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.432 ' O ' ' CG2' ' A' ' 299' ' ' VAL . 31.5 mt -42.85 -53.85 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.533 ' CE2' HG13 ' A' ' 348' ' ' VAL . 11.2 m-85 -64.94 -23.53 67.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.96 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -76.05 -32.98 59.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.126 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 296' ' ' LEU . 28.2 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.822 0.344 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.0 -61.08 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.129 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.98 -46.47 61.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -38.9 -58.24 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 320' ' ' ASP . 32.2 mt -41.17 -59.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 317' ' ' ILE . 56.1 ttt180 -34.87 -39.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.6 mt -81.82 -41.15 21.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 317' ' ' ILE . 3.7 t70 -60.14 -69.14 0.23 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 69.7 p -47.85 -42.21 25.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.5 ' C ' ' CD ' ' A' ' 322' ' ' GLU . 4.2 tm-20 -53.62 -40.66 65.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -87.37 -15.5 37.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -86.49 -27.15 24.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.795 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 326' ' ' LYS . 35.4 mt -88.21 -58.07 2.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 325' ' ' LEU . 1.4 tmmm? -35.92 -60.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -47.38 -50.24 22.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.481 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 22.3 tttp -55.78 -48.96 74.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.916 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.554 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 4.7 m-85 -110.89 82.42 3.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.64 0.733 . . . . 0.0 110.897 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -31.79 19.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.642 2.228 . . . . 0.0 112.318 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.56 -24.0 53.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.463 HG12 ' CD1' ' A' ' 284' ' ' ILE . 68.8 t -74.58 146.42 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -67.44 147.13 53.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . 0.422 ' O ' ' CD1' ' A' ' 338' ' ' ILE . 11.2 tt0 -61.88 -33.32 73.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.941 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -68.9 -14.98 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -84.13 -25.22 29.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.2 mp -83.64 -25.02 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.422 ' CD1' ' O ' ' A' ' 334' ' ' GLN . 2.0 mp -80.93 -49.75 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.165 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 340' ' ' SER . 19.0 mt-10 -57.33 -62.55 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 339' ' ' GLU . 75.2 p -35.78 -43.99 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.841 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 344' ' ' VAL . 77.6 t80 -63.68 -55.94 19.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 341' ' ' PHE . 26.7 m-80 -38.19 -42.0 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 4.0 mp -67.72 -43.11 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 341' ' ' PHE . 70.0 t -58.7 -60.56 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.114 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -41.0 -49.27 3.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -65.75 -34.59 78.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.05 -67.09 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.533 HG13 ' CE2' ' A' ' 297' ' ' TYR . 42.5 t -51.43 -37.25 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.403 ' O ' ' N ' ' A' ' 352' ' ' ILE . 3.2 m-30 -60.57 -66.55 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -40.25 -31.04 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 4.2 t -68.3 -46.57 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 349' ' ' PHE . 11.3 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.125 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.466 -0.138 0 CA-C-O 120.798 0.249 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 13.2 m -73.82 122.7 22.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.74 81.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.099 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -41.61 -46.66 3.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.48 HG12 ' CE1' ' A' ' 329' ' ' PHE . 13.6 mt -72.68 -52.08 24.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 89.8 t -46.15 -38.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.093 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -61.83 -47.57 84.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -73.87 -26.55 60.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.967 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 97.5 m -65.38 -17.67 64.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 31.7 mttt -80.17 -44.21 20.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.899 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.71 -24.03 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.131 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.461 HG13 ' N ' ' A' ' 292' ' ' ALA . 10.7 pt -98.31 -49.81 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.461 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.7 -48.54 66.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.074 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 12.3 ttm -49.42 -61.4 2.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -46.87 -72.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 16.8 mtmm -43.78 -61.86 1.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 56.7 mt -44.09 -46.5 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -69.56 -28.22 65.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.73 -48.3 66.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 33.5 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.112 179.996 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.823 0.344 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.38 -64.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.113 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -48.76 -24.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 15.3 mmtp -64.99 -37.64 88.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.11 -55.69 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.409 ' HG2' ' CE2' ' A' ' 341' ' ' PHE . 17.9 mmm-85 -39.36 -30.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.0 mt -90.42 -40.58 11.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.7 -60.87 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.2 p -52.24 -40.47 61.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.462 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 17.7 tt0 -53.41 -41.1 65.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -84.44 -15.26 46.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -87.27 -22.18 25.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 326' ' ' LYS . 32.5 mt -94.15 -59.66 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 325' ' ' LEU . 1.3 mmmp? -34.12 -53.19 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -48.26 -51.39 25.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -56.7 -40.33 75.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.48 ' CE1' HG12 ' A' ' 284' ' ' ILE . 6.4 m-85 -118.7 84.27 24.43 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.611 0.719 . . . . 0.0 110.879 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -28.79 25.14 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.72 2.28 . . . . 0.0 112.362 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.24 -25.21 42.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.469 HG12 ' CD1' ' A' ' 284' ' ' ILE . 41.6 t -71.08 151.37 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . 0.419 ' N ' HG13 ' A' ' 332' ' ' VAL . 8.4 t0 -81.86 150.22 27.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . 0.431 ' O ' ' CD1' ' A' ' 338' ' ' ILE . 20.1 tt0 -58.45 -33.88 70.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.588 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.0 t80 -63.76 -17.34 62.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.467 ' N ' ' OE1' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -87.37 -35.25 18.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.462 ' CG2' ' HA ' ' A' ' 322' ' ' GLU . 2.1 mp -71.61 -37.27 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.431 ' CD1' ' O ' ' A' ' 334' ' ' GLN . 2.8 mp -74.29 -71.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.111 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -38.19 -50.49 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 9.5 p -45.17 -43.67 10.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.858 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 344' ' ' VAL . 46.4 t80 -58.94 -55.35 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.903 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 341' ' ' PHE . 33.5 m-80 -36.23 -55.23 0.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 5.4 mp -56.28 -41.3 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 341' ' ' PHE . 68.0 t -64.35 -59.18 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -40.83 -61.16 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -44.71 -51.5 9.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.949 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.72 -70.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 99.2 t -38.06 -62.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.158 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' A' ' 350' ' ' ARG . 10.5 m-85 -44.82 -66.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.852 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 349' ' ' PHE . 12.1 tpt180 -35.58 -56.25 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 1.3 t -49.46 -46.79 48.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 64.8 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.163 179.899 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . 0.411 ' HD3' ' CD ' ' A' ' 339' ' ' GLU . 54.0 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 CA-C-O 120.757 0.232 . . . . 0.0 112.369 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' SER . . . . . 0.444 ' O ' ' CG2' ' A' ' 285' ' ' VAL . 5.1 t -73.3 142.23 47.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -76.09 -40.35 53.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.17 -39.34 63.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.554 HG12 ' CE1' ' A' ' 329' ' ' PHE . 18.3 mt -77.1 -49.35 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 281' ' ' SER . 48.2 t -51.26 -33.93 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.145 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -68.84 -40.64 79.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -73.79 -27.83 61.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 42.2 m -63.23 -19.66 64.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.134 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 293' ' ' MET . 2.7 mptm? -75.56 -44.54 42.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.3 mp -55.74 -27.87 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 292' ' ' ALA . 6.2 pt -98.25 -51.99 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.132 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.449 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -63.82 -48.45 76.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 25.2 ttm -56.33 -64.2 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -45.55 -56.97 4.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.881 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 298' ' ' ALA . 17.4 mmtp -58.5 -69.32 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 295' ' ' LYS . 86.5 mt -37.04 -42.54 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.96 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -74.33 -38.71 63.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -59.22 -28.89 67.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.133 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.9 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 179.99 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.816 0.341 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.17 -56.46 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -47.47 -39.78 16.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -54.15 -55.29 29.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 320' ' ' ASP . 87.6 mt -42.32 -60.8 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 317' ' ' ILE . 8.8 mtp-105 -36.56 -34.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.826 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 11.6 mt -86.16 -39.5 16.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.4 t70 -63.94 -63.93 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 68.9 p -53.29 -40.85 65.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.444 ' C ' ' OE1' ' A' ' 322' ' ' GLU . 0.0 OUTLIER -54.01 -37.36 63.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -92.59 -13.07 30.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -86.89 -28.06 23.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 17.3 mt -89.8 -54.37 4.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.427 ' N ' HG12 ' A' ' 337' ' ' ILE . 25.4 tttm -44.06 -39.97 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.7 -39.76 91.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.494 ' HB3' ' CE1' ' A' ' 329' ' ' PHE . 47.0 tttp -57.16 -42.64 81.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.554 ' CE1' HG12 ' A' ' 284' ' ' ILE . 0.2 OUTLIER -129.99 91.91 38.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.607 0.718 . . . . 0.0 110.895 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -20.78 34.34 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.698 2.266 . . . . 0.0 112.358 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -78.69 -33.07 47.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 1.5 p -65.79 150.27 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -70.53 156.04 39.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . 0.446 ' HG3' ' CD1' ' A' ' 338' ' ' ILE . 2.5 tp-100 -68.08 -41.86 81.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -58.69 -13.94 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -82.63 -31.33 28.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.427 HG12 ' N ' ' A' ' 326' ' ' LYS . 1.9 mp -81.16 -28.87 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.446 ' CD1' ' HG3' ' A' ' 334' ' ' GLN . 2.6 mp -77.17 -53.58 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.459 ' O ' ' CD1' ' A' ' 343' ' ' ILE . 10.0 tt0 -60.95 -44.41 97.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 96.3 p -47.49 -49.44 25.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 344' ' ' VAL . 71.5 t80 -58.35 -56.83 17.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 341' ' ' PHE . 17.9 m-80 -35.09 -43.96 0.22 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.459 ' CD1' ' O ' ' A' ' 339' ' ' GLU . 4.1 mp -66.96 -46.86 83.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' A' ' 341' ' ' PHE . 71.6 t -55.65 -66.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -37.41 -64.3 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -42.99 -43.24 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -67.63 -70.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 88.8 t -40.89 -50.64 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.145 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -52.51 -61.34 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 -44.98 -43.33 9.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 3.3 t -51.29 -34.78 34.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.932 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.163 0 CA-C-O 120.813 0.255 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 21.2 m -73.08 119.99 18.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.837 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 284' ' ' ILE . . . -57.17 -55.44 34.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 282' ' ' ALA . 13.7 pt-20 -36.44 -33.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.549 HG12 ' CE1' ' A' ' 329' ' ' PHE . 47.1 mt -83.46 -54.35 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 49.6 t -38.83 -53.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.414 ' NZ ' ' HB2' ' A' ' 282' ' ' ALA . 18.6 mtmt -57.1 -55.75 30.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -59.65 -20.9 59.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 49.2 m -75.15 -25.36 58.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.158 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 293' ' ' MET . 14.4 mttp -77.13 -41.08 43.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.6 mp -56.65 -30.13 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.463 HG13 ' N ' ' A' ' 292' ' ' ALA . 10.4 pt -97.76 -49.81 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.463 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -61.87 -48.02 82.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.473 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 13.9 ttm -51.9 -60.24 3.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -47.82 -53.32 15.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 298' ' ' ALA . 29.1 mtpt -60.42 -67.99 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.438 ' CD2' HD13 ' A' ' 317' ' ' ILE . 90.9 mt -38.6 -38.55 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.459 ' CE1' HG12 ' A' ' 352' ' ' ILE . 8.6 m-85 -77.99 -37.06 48.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -67.23 -34.58 77.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.116 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.829 0.347 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 55.0 t -66.89 -69.38 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.118 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -41.19 -42.92 2.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -40.86 -60.45 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.443 ' O ' ' N ' ' A' ' 320' ' ' ASP . 29.8 mt -41.4 -63.43 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.141 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.43 ' HB2' ' NH1' ' A' ' 318' ' ' ARG . 23.8 ttm105 -36.43 -39.1 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.856 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.2 mt -83.51 -39.63 20.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.95 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.2 t0 -62.51 -63.87 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 72.9 p -51.84 -52.77 46.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -47.05 -36.6 8.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -85.88 -18.93 31.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -89.43 -19.7 24.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 47.9 mt -93.31 -60.06 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -44.16 -35.3 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.33 -38.36 87.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.413 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 26.2 tptt -72.42 -42.59 64.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.549 ' CE1' HG12 ' A' ' 284' ' ' ILE . 3.2 m-85 -110.46 85.03 4.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -35.41 12.65 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.335 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.84 -31.53 66.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.463 HG11 ' CD1' ' A' ' 284' ' ' ILE . 74.9 t -67.94 149.73 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -79.71 144.35 33.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . 0.455 ' HG2' ' CD1' ' A' ' 338' ' ' ILE . 25.6 tt0 -53.46 -38.29 63.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.443 ' CD2' ' OE1' ' A' ' 336' ' ' GLU . 7.2 t80 -59.7 -21.16 60.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.443 ' OE1' ' CD2' ' A' ' 335' ' ' PHE . 0.0 OUTLIER -86.92 -18.52 30.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.886 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.4 mp -88.32 -27.41 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.455 ' CD1' ' HG2' ' A' ' 334' ' ' GLN . 3.5 mp -89.75 -51.99 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -51.52 -31.47 24.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 2.1 p -66.37 -36.1 82.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 345' ' ' ALA . 39.1 t80 -68.35 -31.05 70.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.847 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -56.42 -32.01 64.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 5.0 mp -88.13 -37.92 11.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 81.0 t -64.23 -51.3 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 341' ' ' PHE . . . -51.12 -66.78 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.062 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . 0.404 ' C ' ' HD3' ' A' ' 346' ' ' LYS . 0.0 OUTLIER -50.39 -31.29 14.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -67.68 -66.94 0.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 98.2 t -45.71 -44.2 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 352' ' ' ILE . 4.1 m-85 -45.6 -60.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 349' ' ' PHE . 3.4 tpm_? -37.3 -62.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 28.1 m -47.55 -33.29 6.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.459 HG12 ' CE1' ' A' ' 297' ' ' TYR . 93.6 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.153 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.203 0 CA-C-O 120.769 0.237 . . . . 0.0 112.386 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' SER . . . . . 0.406 ' HB2' ' CD1' ' A' ' 284' ' ' ILE . 72.7 m -68.56 134.37 49.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.874 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -72.57 -40.74 66.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -55.26 -36.24 65.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.899 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.562 HG12 ' CE2' ' A' ' 329' ' ' PHE . 22.8 mt -78.33 -41.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 77.7 t -58.46 -46.42 89.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -60.65 -37.02 80.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -73.78 -34.22 64.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 92.0 m -56.38 -19.29 14.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.162 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 293' ' ' MET . 7.2 mptt -77.13 -49.23 15.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.9 mp -53.74 -24.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.162 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.466 HG13 ' N ' ' A' ' 292' ' ' ALA . 7.0 pt -98.83 -52.4 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.148 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.466 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.94 -49.29 62.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.061 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.517 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 19.1 ttm -45.42 -62.26 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -52.29 -72.56 0.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 298' ' ' ALA . 35.1 mtmt -42.14 -63.83 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 81.7 mt -42.3 -52.33 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.472 ' CE1' ' CG1' ' A' ' 352' ' ' ILE . 7.7 m-85 -62.2 -26.54 68.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.975 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -72.18 -51.1 22.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.092 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.108 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.806 0.336 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.3 t -79.84 -38.58 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.118 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.9 OUTLIER -59.75 -54.23 48.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.931 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 315' ' ' ASN . 22.7 mtmt -35.15 -62.74 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.93 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 320' ' ' ASP . 31.8 mt -36.63 -58.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 317' ' ' ILE . 0.0 OUTLIER -35.19 -42.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.5 mt -80.68 -39.31 27.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 317' ' ' ILE . 19.8 t0 -60.96 -70.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 68.1 p -45.77 -45.84 14.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.158 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -51.29 -36.21 41.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.34 -20.99 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -85.6 -18.93 31.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 42.8 mt -93.18 -59.54 2.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -41.47 -36.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.7 -52.58 50.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.487 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 30.4 tttp -54.59 -41.82 70.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.562 ' CE2' HG12 ' A' ' 284' ' ' ILE . 1.3 m-85 -116.12 83.95 13.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.661 0.743 . . . . 0.0 110.823 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -30.24 22.54 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.348 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -77.92 -18.46 56.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.458 HG13 ' CD1' ' A' ' 284' ' ' ILE . 53.4 t -80.39 152.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -82.9 151.72 25.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -60.55 -41.04 93.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -53.85 -26.27 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.42 -30.45 33.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 337' ' ' ILE . 1.8 mp -84.62 -14.43 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.145 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 36.5 mt -87.33 -52.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -59.83 -48.36 81.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 40.3 m -39.76 -50.82 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 344' ' ' VAL . 42.7 t80 -56.03 -57.92 10.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 341' ' ' PHE . 67.4 m-20 -37.47 -46.47 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 4.4 mp -68.41 -40.08 81.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 341' ' ' PHE . 81.1 t -61.36 -64.18 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.08 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -42.71 -55.96 3.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -48.62 -30.16 5.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -83.73 -64.37 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 56.5 t -43.89 -27.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -74.02 -62.75 1.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 350' ' ' ARG . 21.0 ttm105 -41.5 -44.78 3.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 25.6 p -60.39 -50.83 72.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.472 ' CG1' ' CE1' ' A' ' 297' ' ' TYR . 50.1 mt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . 0.418 ' HD3' ' CD ' ' A' ' 339' ' ' GLU . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.838 0.266 . . . . 0.0 112.308 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.8 t -69.78 120.96 16.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.04 96.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -49.77 -41.15 43.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.555 HG12 ' CE2' ' A' ' 329' ' ' PHE . 22.1 mt -75.95 -42.32 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 75.3 t -54.5 -42.68 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . 0.402 ' O ' ' CD1' ' A' ' 290' ' ' ILE . 0.4 OUTLIER -62.53 -36.43 82.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.462 ' CD2' ' HD3' ' A' ' 328' ' ' LYS . 31.5 t80 -76.87 -31.36 56.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 33.2 m -64.01 -23.73 67.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 293' ' ' MET . 30.7 mttt -76.19 -39.57 54.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . 0.402 ' CD1' ' O ' ' A' ' 286' ' ' LYS . 2.6 mp -61.7 -28.49 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.515 HG21 ' CD2' ' A' ' 324' ' ' HIS . 23.6 pt -97.77 -43.4 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.122 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.434 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -69.25 -47.8 63.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.485 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 9.5 ttm -52.53 -71.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.889 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 293' ' ' MET . 18.3 mt-10 -36.94 -60.01 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -53.92 -66.21 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 75.8 mt -39.11 -49.79 1.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -65.34 -40.27 93.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.93 -50.43 73.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.803 0.335 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 66.1 t -68.76 -36.89 76.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.7 -12.33 60.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -82.55 -17.58 44.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 320' ' ' ASP . 72.9 mt -67.55 -56.7 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' A' ' 322' ' ' GLU . 7.3 ptm180 -41.2 -35.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.8 mt -76.08 -37.78 57.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 27.3 t70 -73.97 -69.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.853 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.464 HG22 ' CD1' ' A' ' 291' ' ' ILE . 14.5 p -41.3 -47.6 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 318' ' ' ARG . 33.0 mt-10 -45.73 -49.99 14.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.85 -18.47 60.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . 0.515 ' CD2' HG21 ' A' ' 291' ' ' ILE . 79.3 t60 -84.88 -23.96 28.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 19.3 mt -93.77 -54.49 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.928 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.34 -26.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.95 -35.62 37.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.472 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 37.6 tttp -69.84 -39.34 76.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.555 ' CE2' HG12 ' A' ' 284' ' ' ILE . 2.8 m-85 -117.06 87.44 22.91 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.678 0.751 . . . . 0.0 110.875 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -40.71 5.01 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.685 2.257 . . . . 0.0 112.316 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.53 -24.46 65.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.459 HG12 ' CD1' ' A' ' 284' ' ' ILE . 41.5 t -73.47 154.14 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . 0.413 ' N ' ' CG1' ' A' ' 332' ' ' VAL . 5.7 t70 -83.35 147.28 28.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.38 -37.08 74.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.495 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 7.3 t80 -61.98 -13.32 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -90.61 -26.66 19.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.9 mp -82.54 -24.55 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.428 ' O ' ' ND2' ' A' ' 342' ' ' ASN . 3.2 mp -89.77 -35.5 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.418 ' CD ' ' HD3' ' A' ' 280' ' ' PRO . 11.5 tt0 -72.67 -22.51 60.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 341' ' ' PHE . 10.9 m -74.55 -65.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.423 ' C ' ' O ' ' A' ' 340' ' ' SER . 73.8 t80 -36.6 -41.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 338' ' ' ILE . 4.0 m-80 -49.1 -51.95 28.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 3.9 mp -68.84 -33.58 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.153 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 345' ' ' ALA . 32.8 t -62.57 -63.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -35.72 -66.67 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.123 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -40.66 -53.55 2.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -44.38 -39.25 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 39.9 t -76.49 -43.49 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.412 ' C ' ' N ' ' A' ' 351' ' ' SER . 3.3 m-85 -49.56 -70.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 31.1 ptt85 -43.09 -23.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.851 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 349' ' ' PHE . 3.2 t -78.89 -52.29 8.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.812 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.136 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.142 0 CA-C-O 120.79 0.246 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' SER . . . . . 0.408 ' O ' ' CG2' ' A' ' 285' ' ' VAL . 1.0 OUTLIER -75.84 133.04 40.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.869 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -77.98 -42.23 33.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.136 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -51.49 -39.04 56.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.553 HG23 ' CE1' ' A' ' 329' ' ' PHE . 12.1 mt -79.11 -44.09 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.119 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 281' ' ' SER . 74.7 t -54.61 -37.69 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.085 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -64.24 -35.74 81.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -79.87 -24.46 41.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.424 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 8.9 m -66.49 -18.22 65.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.123 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 293' ' ' MET . 1.0 OUTLIER -77.27 -44.91 28.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.02 -29.18 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.156 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.46 HG13 ' N ' ' A' ' 292' ' ' ALA . 8.7 pt -98.31 -50.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.46 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -63.93 -48.28 77.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.493 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 10.6 ttm -58.88 -67.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -43.31 -58.8 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -55.3 -65.78 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.444 ' O ' ' CG2' ' A' ' 299' ' ' VAL . 49.4 mt -40.61 -58.49 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -54.98 -38.56 67.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.03 -49.49 72.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.147 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 296' ' ' LEU . 16.7 m . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.875 0.369 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 74.8 t -58.95 -34.96 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -83.14 -41.35 18.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -43.03 -30.24 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 318' ' ' ARG . 49.2 mt -61.75 -60.21 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 317' ' ' ILE . 3.3 tmt_? -34.28 -70.91 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 319' ' ' LEU . 0.0 OUTLIER -44.58 -43.13 7.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -66.02 -70.48 0.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.445 HG22 ' CD1' ' A' ' 291' ' ' ILE . 37.5 p -44.83 -55.49 5.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.153 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -45.6 -49.47 14.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -77.65 -12.41 59.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -90.74 -25.54 19.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 328' ' ' LYS . 23.3 mt -94.37 -56.73 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -45.91 -24.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -81.82 -32.77 31.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 325' ' ' LEU . 26.5 tttp -69.23 -36.72 77.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.553 ' CE1' HG23 ' A' ' 284' ' ' ILE . 0.5 OUTLIER -122.38 90.94 49.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.688 0.756 . . . . 0.0 110.892 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -20.45 34.75 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.715 2.277 . . . . 0.0 112.337 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.31 -40.78 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.448 HG11 ' CD1' ' A' ' 284' ' ' ILE . 0.8 OUTLIER -62.98 161.57 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.114 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -93.39 160.06 14.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -67.07 -38.42 85.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -57.36 -15.42 6.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -90.51 -26.07 19.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.437 ' CD1' HG13 ' A' ' 332' ' ' VAL . 3.0 mp -86.69 -45.25 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.31 -52.15 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -62.3 -55.23 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 16.1 p -38.8 -39.27 0.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 344' ' ' VAL . 35.3 t80 -64.15 -53.39 50.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 341' ' ' PHE . 17.5 m-80 -36.5 -37.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 5.3 mp -78.55 -41.22 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 341' ' ' PHE . 50.4 t -57.72 -47.84 84.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -54.74 -63.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -54.2 -23.37 14.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -78.16 -31.24 49.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 89.7 t -86.04 -32.72 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.085 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 351' ' ' SER . 5.5 m-85 -59.9 -67.04 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 349' ' ' PHE . 30.8 ptt180 -37.73 -28.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 349' ' ' PHE . 8.0 t -78.86 -45.19 21.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 349' ' ' PHE . 65.2 mt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.797 0.249 . . . . 0.0 112.323 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.2 t -72.96 120.53 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.72 -49.4 70.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.117 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -43.04 -43.05 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.525 HG12 ' CE1' ' A' ' 329' ' ' PHE . 30.4 mt -73.52 -48.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.146 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 98.1 t -47.19 -36.11 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.129 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -68.5 -57.26 6.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -55.75 -24.83 37.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 32.1 m -68.97 -26.24 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.092 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -75.13 -43.59 51.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.1 mp -54.75 -29.62 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.114 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 292' ' ' ALA . 8.5 pt -98.12 -51.22 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.457 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -58.4 -48.15 81.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 19.7 ttm -53.88 -60.18 3.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -45.4 -60.2 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 298' ' ' ALA . 29.4 mtpt -58.04 -67.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.832 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 295' ' ' LYS . 86.2 mt -37.93 -33.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -84.63 -37.48 21.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -64.76 -31.95 73.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.053 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.144 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.826 0.345 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.2 -68.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' A' ' 316' ' ' LYS . 3.8 t30 -43.17 -50.34 6.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 315' ' ' ASN . 11.3 mmmt -34.64 -58.3 0.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 318' ' ' ARG . 63.9 mt -38.22 -61.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 317' ' ' ILE . 3.6 tmt_? -35.19 -49.72 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 6.8 mt -69.92 -44.21 70.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -61.67 -68.86 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.888 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.2 p -45.5 -47.25 14.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -49.24 -50.59 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -71.18 -16.07 62.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -90.15 -21.92 21.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 45.0 mt -93.45 -54.9 3.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 25.7 tttm -49.61 -26.71 3.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 328' ' ' LYS . 10.8 pt-20 -78.01 -39.27 42.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 27.4 tptt -59.58 -48.62 80.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.525 ' CE1' HG12 ' A' ' 284' ' ' ILE . 0.2 OUTLIER -114.86 89.97 21.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -18.65 37.32 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.71 2.273 . . . . 0.0 112.399 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.91 -24.31 30.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.424 HG13 ' CD1' ' A' ' 337' ' ' ILE . 0.8 OUTLIER -77.05 154.93 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -82.83 155.0 24.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . 0.46 ' HG2' ' CD1' ' A' ' 338' ' ' ILE . 35.7 tt0 -63.93 -49.58 72.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -47.41 -19.85 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -81.65 -39.32 24.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.424 ' CD1' HG13 ' A' ' 332' ' ' VAL . 1.8 mp -71.24 -22.24 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.46 ' CD1' ' HG2' ' A' ' 334' ' ' GLN . 2.5 mp -81.81 -55.25 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.158 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.432 ' O ' ' CD1' ' A' ' 343' ' ' ILE . 0.6 OUTLIER -60.38 -37.22 80.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 96.5 p -55.73 -54.89 38.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 342' ' ' ASN . 48.6 t80 -53.35 -52.45 59.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 341' ' ' PHE . 5.6 m-80 -36.01 -47.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 339' ' ' GLU . 4.0 mp -64.2 -47.74 88.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 90.0 t -47.81 -56.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.151 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -44.5 -53.89 6.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.049 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -51.82 -38.52 56.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.69 -66.21 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.9 t -47.6 -55.89 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.105 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.449 ' O ' ' C ' ' A' ' 350' ' ' ARG . 6.1 m-85 -46.88 -60.31 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 349' ' ' PHE . 17.7 tpp85 -34.53 -52.86 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 70.9 m -61.32 -57.51 12.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 89.1 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.148 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.755 0.231 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.9 t -78.1 120.86 23.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.82 -48.01 83.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.099 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -45.95 -41.34 11.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.531 HG12 ' CE1' ' A' ' 329' ' ' PHE . 24.5 mt -77.08 -43.95 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 43.5 t -53.9 -40.48 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -63.82 -42.81 97.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -72.66 -32.85 66.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 28.2 m -59.48 -22.54 61.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 293' ' ' MET . 51.2 mttt -76.31 -46.55 27.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -54.8 -27.55 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.465 HG13 ' N ' ' A' ' 292' ' ' ALA . 7.0 pt -98.48 -52.19 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.465 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -63.83 -48.78 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.089 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.498 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 30.9 ttm -51.97 -64.78 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -40.18 -56.38 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 298' ' ' ALA . 16.6 mmmt -59.15 -66.09 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.457 HD12 ' CG2' ' A' ' 348' ' ' VAL . 91.6 mt -38.68 -42.09 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.557 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.9 m-85 -73.54 -35.65 65.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -68.98 -54.02 17.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.13 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.821 0.343 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 60.1 t -82.54 -54.98 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.6 OUTLIER -48.87 -48.98 41.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 317' ' ' ILE . 16.9 mtmm -38.2 -58.1 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 320' ' ' ASP . 68.3 mt -33.95 -57.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.089 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 317' ' ' ILE . 50.8 ttt180 -34.53 -59.07 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.6 mt -58.9 -39.57 81.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.5 t70 -66.05 -69.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.431 HG23 ' CG2' ' A' ' 317' ' ' ILE . 27.1 p -47.12 -47.3 23.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.181 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.36 -39.11 60.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -84.61 -12.93 53.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -92.97 -26.3 17.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 328' ' ' LYS . 18.8 mt -92.63 -59.37 2.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -39.57 -34.15 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.26 -39.1 55.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.527 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 32.5 tptt -54.18 -49.94 68.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.531 ' CE1' HG12 ' A' ' 284' ' ' ILE . 0.1 OUTLIER -117.14 91.14 35.73 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 110.901 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.66 -18.62 37.35 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.706 2.271 . . . . 0.0 112.34 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.3 -0.16 57.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.02 148.96 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -72.53 154.47 40.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -67.19 -45.43 76.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -54.19 -15.31 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -81.85 -31.62 31.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.54 -32.33 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.143 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 46.5 mt -69.75 -41.06 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 340' ' ' SER . 6.0 tt0 -74.52 -56.56 4.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 339' ' ' GLU . 57.2 p -34.71 -45.48 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 344' ' ' VAL . 56.9 t80 -59.9 -60.39 3.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 341' ' ' PHE . 14.5 m-80 -37.03 -47.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 4.8 mp -66.5 -41.86 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 341' ' ' PHE . 61.5 t -60.79 -50.86 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -44.16 -67.32 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . 0.44 ' HG3' ' N ' ' A' ' 347' ' ' GLU . 32.9 pttt -48.53 -44.77 36.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . 0.44 ' N ' ' HG3' ' A' ' 346' ' ' LYS . 16.1 mt-10 -55.61 -50.42 70.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.457 ' CG2' HD12 ' A' ' 296' ' ' LEU . 57.7 t -59.93 -48.06 89.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.126 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.5 m-85 -54.93 -55.11 34.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -44.49 -33.47 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 6.3 m -82.87 -30.63 28.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.841 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.557 HG12 ' CE1' ' A' ' 297' ' ' TYR . 86.0 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.131 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.781 0.242 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.3 t -69.98 121.92 18.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.829 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.93 -48.12 77.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -46.08 -42.19 13.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.563 HG12 ' CZ ' ' A' ' 329' ' ' PHE . 22.7 mt -73.77 -40.18 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 90.7 t -57.12 -46.36 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -60.87 -40.89 94.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -74.89 -30.86 61.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 42.9 m -62.91 -22.34 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 293' ' ' MET . 30.3 mttt -77.76 -43.57 30.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -55.72 -28.56 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.446 ' CG1' ' N ' ' A' ' 292' ' ' ALA . 5.8 pt -98.13 -51.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.446 ' N ' ' CG1' ' A' ' 291' ' ' ILE . . . -62.76 -48.21 80.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.493 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 32.4 ttm -55.51 -70.25 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -40.27 -54.61 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 298' ' ' ALA . 26.8 mttp -58.75 -69.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 295' ' ' LYS . 86.4 mt -37.92 -43.39 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.567 ' CE1' HG12 ' A' ' 352' ' ' ILE . 10.4 m-85 -71.61 -38.95 70.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -62.12 -46.68 87.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.101 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 26.4 m . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.126 179.996 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.799 0.333 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.45 -53.96 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.22 -36.83 61.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -57.2 -32.08 66.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 320' ' ' ASP . 8.7 mm -48.12 -71.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 317' ' ' ILE . 31.2 ttt180 -33.95 -45.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 13.6 mt -69.56 -44.3 71.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.93 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 317' ' ' ILE . 32.1 t0 -67.06 -66.19 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.411 ' CG2' HG13 ' A' ' 291' ' ' ILE . 16.9 p -47.21 -51.74 17.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -49.4 -43.92 44.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -82.31 -11.99 58.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -89.39 -27.9 20.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 328' ' ' LYS . 20.0 mt -90.19 -52.62 4.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 325' ' ' LEU . 0.4 OUTLIER -36.81 -44.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -64.44 -46.65 82.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 21.1 tptt -55.33 -42.49 73.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.563 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 0.2 OUTLIER -120.62 89.87 45.24 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.686 0.755 . . . . 0.0 110.873 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.94 2.4 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.242 . . . . 0.0 112.362 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -61.98 -25.65 67.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.467 HG11 ' CD1' ' A' ' 284' ' ' ILE . 97.2 t -73.75 148.81 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . 0.463 ' N ' HG12 ' A' ' 332' ' ' VAL . 8.8 t0 -84.65 147.84 26.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -53.57 -45.14 69.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.6 t80 -51.98 -18.79 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -88.92 -41.15 12.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.5 mp -69.31 -31.72 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.183 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 39.6 mt -76.22 -66.64 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.118 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.423 ' O ' ' CD1' ' A' ' 343' ' ' ILE . 8.5 tp10 -42.1 -53.86 3.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 2.2 p -40.5 -41.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.837 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.443 ' CE1' HG22 ' A' ' 317' ' ' ILE . 75.7 t80 -62.43 -53.03 60.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.851 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -42.53 -43.33 3.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.423 ' CD1' ' O ' ' A' ' 339' ' ' GLU . 4.7 mp -65.94 -34.14 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 341' ' ' PHE . 73.9 t -70.66 -58.74 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.129 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -37.18 -61.74 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.074 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -45.5 -51.25 11.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -55.81 -59.67 4.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 88.5 t -48.98 -62.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.114 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.1 m-85 -44.5 -69.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 349' ' ' PHE . 20.9 ttp180 -34.3 -54.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 41.9 m -56.5 -42.67 78.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.567 HG12 ' CE1' ' A' ' 297' ' ' TYR . 61.8 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 120.827 0.261 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 66.5 m -68.91 127.5 33.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.85 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 284' ' ' ILE . . . -70.98 -52.18 21.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -39.86 -27.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.557 HG12 ' CZ ' ' A' ' 329' ' ' PHE . 22.0 mt -92.27 -43.25 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 77.6 t -53.65 -35.93 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -66.01 -34.69 78.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.906 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -76.95 -27.21 54.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.863 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.487 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 2.7 m -65.64 -20.68 66.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 293' ' ' MET . 0.7 OUTLIER -76.5 -45.71 29.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.2 mp -52.58 -32.1 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.458 HG13 ' N ' ' A' ' 292' ' ' ALA . 6.9 pt -98.49 -52.08 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 288' ' ' THR . . . -60.78 -48.56 81.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.07 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 33.8 ttm -55.36 -69.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 293' ' ' MET . 16.2 mt-10 -37.91 -67.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.867 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 298' ' ' ALA . 45.5 mmtt -50.37 -63.44 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 72.6 mt -42.96 -30.38 0.41 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.559 ' CE1' HG12 ' A' ' 352' ' ' ILE . 10.1 m-85 -88.84 -31.25 18.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -69.79 -48.99 57.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.076 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.165 179.944 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.825 0.345 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 23.8 t -54.98 -41.9 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.6 -44.67 85.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -44.24 -57.09 3.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 320' ' ' ASP . 58.8 mt -41.49 -55.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -39.75 -35.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.0 mt -88.62 -32.29 18.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 24.8 t70 -67.48 -65.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 71.8 p -51.77 -44.46 63.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -44.69 -54.4 6.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -76.81 -13.1 60.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.836 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -85.96 -26.19 25.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 328' ' ' LYS . 26.6 mt -91.62 -62.22 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -39.83 -43.78 1.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -62.86 -38.15 89.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 325' ' ' LEU . 44.2 tttp -60.33 -45.74 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.557 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 0.9 OUTLIER -117.97 94.71 46.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.688 0.756 . . . . 0.0 110.863 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -20.63 34.47 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.652 2.235 . . . . 0.0 112.327 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.02 -40.22 28.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.46 HG12 ' CD1' ' A' ' 337' ' ' ILE . 0.9 OUTLIER -63.93 156.16 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -90.98 156.49 17.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -62.94 -42.9 99.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.6 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 4.3 t80 -54.03 -15.96 1.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -88.18 -27.58 21.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.46 ' CD1' HG12 ' A' ' 332' ' ' VAL . 2.6 mp -85.67 -56.83 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . 0.41 ' O ' ' ND2' ' A' ' 342' ' ' ASN . 72.8 mt -48.56 -33.12 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.123 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -79.22 -42.4 26.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 73.8 m -52.23 -53.07 48.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.406 ' CE1' HG23 ' A' ' 317' ' ' ILE . 56.0 t80 -46.61 -53.03 12.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 338' ' ' ILE . 37.6 m-80 -42.55 -52.49 4.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 3.7 mp -56.3 -40.04 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.161 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 345' ' ' ALA . 91.3 t -63.89 -62.11 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.131 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.1 -66.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -46.44 -58.13 4.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -42.69 -62.34 1.02 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.538 HG12 ' CE2' ' A' ' 297' ' ' TYR . 37.0 t -50.33 -66.13 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.144 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 351' ' ' SER . 8.0 m-85 -39.01 -69.49 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 349' ' ' PHE . 35.8 ttm180 -36.33 -32.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 349' ' ' PHE . 1.6 t -76.89 -56.37 4.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.559 HG12 ' CE1' ' A' ' 297' ' ' TYR . 80.2 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.102 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.466 -0.125 0 CA-C-O 120.815 0.256 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 14.1 m -77.6 124.67 28.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.5 76.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.12 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -46.78 -29.67 2.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.447 ' CD1' HG23 ' A' ' 332' ' ' VAL . 17.4 mt -89.18 -52.4 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.112 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 40.2 t -44.22 -35.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -66.0 -35.56 80.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.441 ' CD2' ' HD3' ' A' ' 328' ' ' LYS . 28.4 t80 -81.5 -18.77 43.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 28.3 m -70.38 -26.09 63.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 293' ' ' MET . 0.0 OUTLIER -75.79 -43.35 46.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.889 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.6 mp -54.58 -31.25 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.559 HG21 ' CD2' ' A' ' 324' ' ' HIS . 6.3 pt -98.09 -51.83 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.443 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -60.45 -48.1 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.1 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 11.9 ttm -55.9 -62.26 1.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -39.75 -72.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 298' ' ' ALA . 13.7 mptt -50.23 -63.61 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 45.1 mt -37.66 -43.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -78.67 -33.36 47.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -65.67 -36.56 84.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.095 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.809 0.338 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 58.4 t -55.61 -42.29 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.5 OUTLIER -59.95 -55.54 32.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 315' ' ' ASN . 9.6 mmmt -35.53 -43.71 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.422 ' CG2' HG22 ' A' ' 321' ' ' THR . 50.5 mt -47.49 -52.43 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.44 ' HG2' ' CE2' ' A' ' 341' ' ' PHE . 14.6 mmm-85 -40.01 -39.22 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.0 mt -82.98 -44.83 14.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.73 -69.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.85 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.422 HG22 ' CG2' ' A' ' 317' ' ' ILE . 37.6 p -46.04 -47.95 16.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.47 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 60.5 tt0 -45.22 -52.3 9.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.92 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -78.66 -14.54 59.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . 0.559 ' CD2' HG21 ' A' ' 291' ' ' ILE . 44.5 t60 -82.1 -29.71 31.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.867 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 328' ' ' LYS . 15.9 mt -92.39 -59.78 2.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.407 ' NZ ' ' HB2' ' A' ' 334' ' ' GLN . 39.8 tttp -43.14 -29.67 0.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.88 -35.36 50.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 37.9 tttp -58.51 -55.66 32.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.511 ' CZ ' ' HG2' ' A' ' 328' ' ' LYS . 0.1 OUTLIER -117.89 107.64 43.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.663 0.744 . . . . 0.0 110.866 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -21.9 32.77 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.679 2.253 . . . . 0.0 112.344 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.57 -35.72 70.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 337' ' ' ILE . 7.1 p -63.8 146.0 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . 0.415 ' O ' ' CD1' ' A' ' 337' ' ' ILE . 1.4 t70 -87.17 157.9 19.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 326' ' ' LYS . 9.7 tt0 -65.16 -35.92 82.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.465 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 9.5 t80 -63.55 -9.77 14.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -93.38 -41.35 9.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.47 ' CG2' ' HA ' ' A' ' 322' ' ' GLU . 4.9 mp -69.64 -45.57 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.11 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.81 -41.05 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.414 ' O ' ' CD1' ' A' ' 343' ' ' ILE . 16.6 tt0 -73.61 -42.77 61.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 341' ' ' PHE . 37.1 m -51.11 -62.35 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 344' ' ' VAL . 68.6 t80 -37.78 -59.39 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 341' ' ' PHE . 2.4 m-80 -36.63 -54.56 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.414 ' CD1' ' O ' ' A' ' 339' ' ' GLU . 4.7 mp -57.75 -36.6 55.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 341' ' ' PHE . 97.1 t -72.14 -59.12 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -36.26 -66.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -49.62 -36.51 24.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 344' ' ' VAL . 1.5 tp10 -57.33 -40.09 77.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.09 -40.09 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.145 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 350' ' ' ARG . 6.1 m-85 -51.94 -70.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 349' ' ' PHE . 10.1 ptt85 -35.33 -42.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 23.4 m -64.11 -49.0 73.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 349' ' ' PHE . 97.3 mt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.111 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.817 0.257 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 2.3 t -69.99 125.71 27.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.38 -30.92 70.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.66 -40.08 74.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.569 HG12 ' CE2' ' A' ' 329' ' ' PHE . 17.4 mt -76.79 -45.85 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 91.5 t -48.94 -39.19 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -65.06 -44.29 89.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.495 ' CE1' ' NZ ' ' A' ' 328' ' ' LYS . 49.4 t80 -72.17 -26.36 62.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 110.978 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 49.4 m -69.37 -20.94 63.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.163 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 27.9 mttt -78.84 -43.55 24.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.25 -31.09 31.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.466 ' CG1' ' N ' ' A' ' 292' ' ' ALA . 6.1 pt -97.77 -51.33 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 288' ' ' THR . . . -59.82 -46.96 87.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.111 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 33.3 ttm -55.93 -68.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.865 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 293' ' ' MET . 49.2 mt-10 -35.92 -59.91 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 298' ' ' ALA . 31.3 mmtt -60.06 -64.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 295' ' ' LYS . 48.4 mt -36.03 -37.88 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.894 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.489 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.8 m-85 -78.48 -44.25 24.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -59.36 -40.16 85.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.063 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.969 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.806 0.336 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.56 -62.87 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -50.47 -41.67 53.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -41.61 -64.77 0.52 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 320' ' ' ASP . 41.5 mt -42.29 -61.88 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.123 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.456 ' CD ' ' CD1' ' A' ' 341' ' ' PHE . 15.8 mmm180 -36.82 -33.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 317' ' ' ILE . 10.0 mt -88.11 -41.49 13.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 317' ' ' ILE . 41.2 m-20 -61.28 -61.8 2.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.436 ' CG2' HG13 ' A' ' 291' ' ' ILE . 36.2 p -54.16 -46.47 72.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -49.33 -40.13 34.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -85.46 -19.75 30.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . 0.401 ' CD2' HG21 ' A' ' 291' ' ' ILE . 74.7 t60 -82.46 -25.79 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 328' ' ' LYS . 32.5 mt -89.76 -56.47 3.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.93 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.4 ' N ' HG12 ' A' ' 337' ' ' ILE . 2.2 tmmm? -38.2 -45.74 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.63 -37.8 85.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.583 ' HG2' ' CE2' ' A' ' 329' ' ' PHE . 9.9 tptm -57.95 -49.2 77.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.583 ' CE2' ' HG2' ' A' ' 328' ' ' LYS . 9.5 m-85 -124.26 94.66 44.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.629 0.728 . . . . 0.0 110.848 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -41.99 3.8 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.668 2.245 . . . . 0.0 112.341 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -63.71 -25.71 68.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 284' ' ' ILE . 53.0 t -69.17 148.77 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . 0.453 ' N ' HG11 ' A' ' 332' ' ' VAL . 3.3 t70 -72.53 150.51 43.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -62.48 -40.05 95.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.93 -11.09 16.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -87.26 -34.26 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.466 ' CG2' ' HB2' ' A' ' 325' ' ' LEU . 2.5 mp -75.04 -35.63 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.88 -64.62 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -44.9 -53.9 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 46.9 m -41.03 -34.96 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.456 ' CD1' ' CD ' ' A' ' 318' ' ' ARG . 48.0 t80 -70.01 -53.05 19.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -40.77 -40.19 1.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 5.1 mp -73.67 -42.87 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 20.1 t -60.91 -62.64 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.116 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -40.28 -67.03 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -39.22 -51.74 1.96 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -56.08 -68.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 38.3 t -44.44 -30.95 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.139 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -73.98 -64.38 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.02 -19.53 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 6.3 p -87.07 -32.02 20.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.489 HG12 ' CE1' ' A' ' 297' ' ' TYR . 54.3 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.806 0.252 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 9.9 m -68.61 125.89 27.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.77 87.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -38.78 -35.29 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.501 ' CD1' ' CG2' ' A' ' 332' ' ' VAL . 22.0 mt -86.72 -56.99 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.113 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 91.9 t -40.84 -36.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -64.65 -41.98 95.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 284' ' ' ILE . 55.1 t80 -74.26 -31.44 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.455 ' CG2' HD13 ' A' ' 325' ' ' LEU . 22.8 m -60.34 -20.98 61.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 293' ' ' MET . 21.4 mttt -77.98 -43.79 28.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.4 mp -58.88 -27.2 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.476 ' CG1' ' N ' ' A' ' 292' ' ' ALA . 5.5 pt -98.1 -51.13 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.476 ' N ' ' CG1' ' A' ' 291' ' ' ILE . . . -61.92 -46.28 90.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.094 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.492 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 8.0 ttm -52.19 -63.46 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 293' ' ' MET . 14.9 mt-10 -37.53 -73.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 296' ' ' LEU . 1.1 mptm? -46.59 -64.14 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 295' ' ' LYS . 51.1 mt -36.04 -55.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.561 ' CE1' HG12 ' A' ' 352' ' ' ILE . 11.5 m-85 -60.82 -41.95 96.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.935 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -58.83 -52.75 64.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.083 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 27.7 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.992 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.821 0.343 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 96.0 t -61.15 -66.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.9 t30 -43.25 -49.65 6.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.919 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 315' ' ' ASN . 20.5 mmtt -37.8 -55.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 320' ' ' ASP . 54.2 mt -43.08 -62.81 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 317' ' ' ILE . 4.4 tmt_? -34.41 -38.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 8.4 mt -79.82 -43.09 23.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 317' ' ' ILE . 1.5 t70 -61.32 -65.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 71.7 p -50.79 -46.46 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.413 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 0.3 OUTLIER -48.08 -35.64 11.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -93.18 -20.22 20.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -81.29 -21.6 39.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 328' ' ' LYS . 22.8 mt -94.22 -65.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -39.93 -29.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 328' ' ' LYS . 4.9 pt-20 -75.08 -43.01 55.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.532 ' HE3' ' CZ ' ' A' ' 329' ' ' PHE . 45.3 tttp -53.54 -45.52 69.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.532 ' CZ ' ' HE3' ' A' ' 328' ' ' LYS . 0.1 OUTLIER -123.1 107.94 32.59 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.642 0.734 . . . . 0.0 110.926 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -22.5 32.13 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.657 2.238 . . . . 0.0 112.352 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -72.3 -39.45 68.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.501 ' CG2' ' CD1' ' A' ' 284' ' ' ILE . 7.3 p -57.03 147.98 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . 0.438 ' N ' HG23 ' A' ' 332' ' ' VAL . 1.5 t70 -96.56 154.33 17.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -61.81 -21.67 64.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.593 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.5 t80 -76.44 -9.67 58.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -96.31 -46.87 6.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.467 ' CD1' HG11 ' A' ' 332' ' ' VAL . 5.4 mp -62.15 -37.69 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 48.4 mt -71.18 -59.35 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -62.32 -12.29 20.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 341' ' ' PHE . 3.5 m -80.19 -68.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.821 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 340' ' ' SER . 40.0 t80 -34.82 -44.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -42.61 -49.99 5.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 4.1 mp -63.42 -47.51 91.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.131 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 345' ' ' ALA . 53.9 t -48.89 -67.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.18 -66.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.133 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -38.45 -44.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 348' ' ' VAL . 15.6 tt0 -62.37 -68.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 349' ' ' PHE . 96.1 t -35.18 -68.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 352' ' ' ILE . 9.5 m-85 -34.72 -68.86 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 349' ' ' PHE . 17.2 ttt180 -34.24 -50.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 3.5 m -67.07 -40.38 87.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.875 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.561 HG12 ' CE1' ' A' ' 297' ' ' TYR . 70.7 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.165 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.807 0.253 . . . . 0.0 112.322 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.4 p -72.95 122.88 22.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.04 -49.14 77.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.077 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -44.53 -42.79 7.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.569 HG12 ' CE1' ' A' ' 329' ' ' PHE . 8.8 mt -77.16 -44.21 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 40.5 t -52.13 -43.75 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.109 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -30.52 70.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . 0.56 ' CE2' ' HD2' ' A' ' 328' ' ' LYS . 47.6 t80 -84.47 -22.94 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.933 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 30.0 m -66.31 -22.96 66.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 2.1 mptm? -75.75 -44.1 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.9 mp -53.64 -30.87 19.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.108 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.521 HG21 ' CD2' ' A' ' 324' ' ' HIS . 5.4 pt -98.37 -51.99 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.44 ' N ' ' CG1' ' A' ' 291' ' ' ILE . . . -61.49 -48.61 80.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.096 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 15.4 ttm -55.11 -62.28 1.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -47.72 -64.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -51.34 -63.7 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 51.3 mt -40.59 -57.43 1.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . 0.505 ' CE1' ' CG1' ' A' ' 352' ' ' ILE . 9.2 m-85 -55.58 -34.53 64.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -66.64 -53.07 37.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.058 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 35.9 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 -179.994 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.832 0.348 . . . . 0.0 111.125 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.65 -45.77 72.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.7 t30 -67.81 -51.02 53.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.937 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 315' ' ' ASN . 18.4 mmtt -36.61 -59.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 318' ' ' ARG . 92.8 mt -42.17 -54.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.157 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 317' ' ' ILE . 76.4 mtt-85 -38.09 -35.84 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.7 mt -83.87 -43.95 14.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.91 -69.24 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 68.3 p -49.15 -46.79 45.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.096 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.469 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 7.3 tm-20 -46.76 -43.67 18.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -87.59 -10.14 52.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . 0.521 ' CD2' HG21 ' A' ' 291' ' ' ILE . 44.8 t60 -89.34 -26.18 21.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 19.5 mt -93.59 -53.32 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -50.62 -27.93 7.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -84.5 -27.71 27.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.568 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 42.0 tttp -62.26 -55.19 30.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.569 ' CE1' HG12 ' A' ' 284' ' ' ILE . 0.1 OUTLIER -123.31 108.39 31.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.642 0.734 . . . . 0.0 110.86 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -21.08 34.02 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.691 2.261 . . . . 0.0 112.328 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.43 -35.5 75.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.455 HG12 ' CD1' ' A' ' 337' ' ' ILE . 9.9 p -71.7 153.47 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.173 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -93.47 161.42 14.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -61.97 -47.04 86.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . 0.597 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.4 t80 -51.41 -16.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -89.09 -34.54 16.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.915 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.469 ' CG2' ' HA ' ' A' ' 322' ' ' GLU . 2.8 mp -73.81 -30.33 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 28.1 mt -77.84 -61.83 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . 0.429 ' O ' ' CD1' ' A' ' 343' ' ' ILE . 6.9 tp10 -52.67 -35.7 55.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 4.4 p -57.02 -47.79 80.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -56.85 -50.47 72.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -40.42 -51.48 2.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . 0.429 ' CD1' ' O ' ' A' ' 339' ' ' GLU . 4.9 mp -65.1 -38.07 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.169 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 347' ' ' GLU . 77.8 t -60.85 -63.64 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -37.69 -51.99 1.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.079 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -54.84 -42.73 72.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 344' ' ' VAL . 20.0 tp10 -60.31 -54.74 42.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.947 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 349' ' ' PHE . 49.2 t -57.56 -69.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.116 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.461 ' O ' ' N ' ' A' ' 352' ' ' ILE . 13.0 m-85 -35.32 -55.6 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 349' ' ' PHE . 15.4 tpt180 -36.85 -57.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 47.3 t -65.31 -31.25 72.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . 0.505 ' CG1' ' CE1' ' A' ' 297' ' ' TYR . 51.0 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.113 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.151 0 CA-C-O 120.822 0.259 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.57 121.28 26.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 283' ' ' GLU . . . -53.24 -57.46 10.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.066 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 282' ' ' ALA . 4.5 pt-20 -38.1 -44.46 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' ILE . . . . . 0.554 HG12 ' CE1' ' A' ' 329' ' ' PHE . 74.6 mt -69.82 -55.98 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 88.0 t -37.81 -46.1 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.162 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -58.1 -55.94 28.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -60.23 -26.72 66.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 16.9 m -69.31 -20.17 63.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 293' ' ' MET . 25.6 mttt -80.69 -38.26 29.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.1 mp -60.23 -32.31 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ILE . . . . . 0.461 ' CD1' HG21 ' A' ' 321' ' ' THR . 16.9 pt -95.37 -46.84 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.126 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . 0.458 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -62.79 -47.68 82.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' MET . . . . . 0.446 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 10.5 ttm -57.04 -60.97 2.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -48.77 -60.89 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 298' ' ' ALA . 27.0 mtmt -55.41 -62.94 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 67.0 mt -41.71 -49.05 4.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -67.59 -28.78 68.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -70.59 -40.4 73.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.078 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' VAL . . . . . 0.459 HG11 ' CB ' ' A' ' 313' ' ' ALA . 30.6 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' ALA . . . . . 0.459 ' CB ' HG11 ' A' ' 299' ' ' VAL . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.849 0.356 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.4 t -77.44 -54.8 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.141 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.7 OUTLIER -51.54 -53.04 42.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 315' ' ' ASN . 15.9 mmmt -34.58 -51.66 0.48 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 318' ' ' ARG . 82.5 mt -41.69 -58.85 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 317' ' ' ILE . 25.5 mtp180 -37.11 -43.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.2 mt -80.5 -44.26 19.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -56.57 -62.02 2.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.481 ' O ' ' N ' ' A' ' 324' ' ' HIS . 25.3 p -54.51 -57.51 11.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 17.0 tt0 -40.77 -34.92 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.89 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -87.84 -28.58 21.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 321' ' ' THR . 71.4 t60 -75.0 -21.26 59.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.832 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 328' ' ' LYS . 14.8 mt -93.2 -63.03 1.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 325' ' ' LEU . 8.4 tmtt? -35.98 -52.67 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -53.71 -44.85 70.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.869 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 325' ' ' LEU . 33.7 tttp -59.53 -44.08 93.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' PHE . . . . . 0.554 ' CE1' HG12 ' A' ' 284' ' ' ILE . 0.3 OUTLIER -115.97 89.19 23.81 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.676 0.751 . . . . 0.0 110.918 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -26.64 27.29 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.696 2.264 . . . . 0.0 112.308 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.89 -29.03 55.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 336' ' ' GLU . 39.8 t -70.72 153.28 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.15 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' ASP . . . . . 0.413 ' N ' HG13 ' A' ' 332' ' ' VAL . 7.9 t0 -88.45 154.25 20.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -57.61 -47.97 80.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.67 -23.83 4.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' GLU . . . . . 0.469 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 7.7 mt-10 -79.83 -29.05 40.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' ILE . . . . . 0.419 ' CG2' ' HA ' ' A' ' 322' ' ' GLU . 1.5 mp -89.23 -23.73 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 64.6 mt -74.15 -53.94 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -64.06 -45.97 86.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 90.8 p -39.77 -50.73 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -59.09 -56.56 20.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -38.24 -44.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.45 -42.4 80.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 345' ' ' ALA . 53.7 t -58.94 -63.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.113 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.34 -55.59 0.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -47.92 -53.8 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -48.65 -61.37 2.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 349' ' ' PHE . 41.1 t -55.46 -62.03 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.201 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 348' ' ' VAL . 6.6 m-85 -34.68 -63.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -39.29 -62.15 0.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 42.5 t -46.11 -45.26 16.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 77.9 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.933 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.0 m -152.08 161.41 42.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.376 . . . . 0.0 110.871 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 34.2 p -157.73 162.51 38.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 90.24 131.28 4.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.474 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.8 m -91.83 126.92 37.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 0.0 110.877 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 17.9 p -174.99 124.53 0.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.842 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 89.75 -166.8 33.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.468 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 2.83 3.17 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.688 2.259 . . . . 0.0 112.31 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -65.99 116.16 6.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -69.71 168.96 13.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.477 ' CG2' ' N ' ' A' ' 278' ' ' PHE . 10.8 mt -104.69 158.27 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.477 ' N ' ' CG2' ' A' ' 277' ' ' ILE . 6.1 m-85 -75.62 148.36 38.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 22.3 p -90.03 154.25 47.3 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.575 0.702 . . . . 0.0 111.168 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -168.95 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.639 2.226 . . . . 0.0 112.366 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 50.0 m -76.09 132.47 40.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -73.86 -45.53 50.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.089 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 329' ' ' PHE . 15.6 pt-20 -41.35 -46.29 3.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.464 ' CD1' HG12 ' A' ' 332' ' ' VAL . 7.0 mt -73.33 -59.8 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.419 ' C ' ' O ' ' A' ' 284' ' ' ILE . 85.0 t -34.97 -41.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.077 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -63.67 -48.89 75.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 284' ' ' ILE . 54.1 t80 -69.48 -19.25 63.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.933 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.488 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 9.5 m -72.89 -23.06 60.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.129 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 23.1 mttt -77.05 -43.35 34.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -55.7 -31.74 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.469 HG23 ' CD2' ' A' ' 324' ' ' HIS . 6.7 pt -98.04 -51.49 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.082 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 288' ' ' THR . . . -59.02 -46.87 87.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.086 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 16.9 ttm -55.05 -69.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 293' ' ' MET . 15.7 mt-10 -37.84 -63.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 298' ' ' ALA . 40.9 mttm -53.98 -65.57 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 45.7 mt -38.04 -42.1 0.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.558 ' CE1' HG12 ' A' ' 352' ' ' ILE . 10.8 m-85 -75.98 -36.03 59.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -69.44 -26.71 64.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.072 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 29.9 m -89.23 -34.63 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.582 ' CZ ' ' OE2' ' A' ' 356' ' ' GLU . 0.4 OUTLIER -67.14 -51.26 56.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 89.5 m -52.05 -35.37 47.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -109.25 -177.31 3.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 68.28 35.39 3.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -79.79 -54.02 6.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.884 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -52.2 -50.52 61.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.462 ' CB ' ' HB2' ' A' ' 309' ' ' SER . 0.9 OUTLIER -84.33 140.5 31.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -90.95 -39.49 12.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 61.3 t -81.55 -37.67 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.462 ' HB2' ' CB ' ' A' ' 306' ' ' ASP . 3.8 t -46.05 -36.63 5.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 16.4 ptm180 -84.53 -27.27 27.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -58.37 -43.63 88.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -78.63 -35.17 45.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -58.18 -43.83 87.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.33 -61.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.3 t30 -51.87 -47.9 64.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 315' ' ' ASN . 12.2 mmtp -35.98 -53.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.872 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.438 ' O ' ' N ' ' A' ' 320' ' ' ASP . 51.1 mt -46.49 -55.59 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -39.1 -32.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.2 mt -89.85 -36.39 15.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.975 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 317' ' ' ILE . 47.3 t0 -66.86 -63.41 1.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 24.2 p -48.65 -44.58 37.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.119 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -50.75 -33.08 21.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.27 -16.54 30.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.852 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . 0.469 ' CD2' HG23 ' A' ' 291' ' ' ILE . 84.3 t60 -91.85 -22.23 20.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 41.9 mt -94.4 -61.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -45.9 -22.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -79.07 -41.64 28.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -69.02 -33.9 74.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 329' ' ' PHE . 2.0 m-85 -116.56 83.0 13.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.678 0.751 . . . . 0.0 110.874 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -22.75 31.56 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 0.0 112.331 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -84.39 -30.53 25.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.471 ' CG1' ' N ' ' A' ' 333' ' ' ASP . 45.4 t -66.37 157.9 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.164 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . 0.471 ' N ' ' CG1' ' A' ' 332' ' ' VAL . 6.1 t70 -85.57 149.41 25.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . 0.408 ' CD ' HD12 ' A' ' 338' ' ' ILE . 1.0 OUTLIER -59.08 -32.11 69.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.919 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -68.94 -14.29 62.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.47 ' CA ' ' OE1' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -89.49 -21.56 22.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.8 mp -85.31 -26.45 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.12 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.408 HD12 ' CD ' ' A' ' 334' ' ' GLN . 2.7 mp -88.11 -69.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.101 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.473 ' O ' ' CD1' ' A' ' 343' ' ' ILE . 4.8 tp10 -42.83 -34.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 18.8 p -62.8 -50.72 69.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 344' ' ' VAL . 50.1 t80 -49.93 -54.38 20.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 341' ' ' PHE . 7.7 m-80 -36.57 -55.71 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.473 ' CD1' ' O ' ' A' ' 339' ' ' GLU . 5.0 mp -58.45 -38.08 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.14 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 341' ' ' PHE . 52.3 t -65.63 -52.15 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -46.8 -67.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -39.2 6.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -56.83 -49.69 74.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.43 ' O ' ' C ' ' A' ' 349' ' ' PHE . 48.2 t -61.44 -60.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 348' ' ' VAL . 11.4 m-85 -34.42 -59.96 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -44.32 -51.93 8.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 10.4 m -58.89 -33.28 70.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.558 HG12 ' CE1' ' A' ' 297' ' ' TYR . 69.8 mt -73.76 -29.18 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.169 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 16.8 mm -70.96 -12.73 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 7.3 mp -79.15 -11.27 59.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.95 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -123.19 25.82 8.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . 0.582 ' OE2' ' CZ ' ' A' ' 300' ' ' PHE . 23.9 pt-20 -175.14 133.7 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.444 ' CG ' ' O ' ' A' ' 357' ' ' TYR . 16.5 t80 65.2 37.11 6.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -130.54 177.57 7.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -146.99 134.37 20.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 1.9 t 54.0 44.14 29.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -48.39 -49.85 33.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 154.14 90.7 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.519 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -41.19 155.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.771 0.32 . . . . 0.0 110.887 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -131.61 146.37 52.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.846 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 29.3 t -103.38 -38.12 7.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -100.98 -157.74 27.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.486 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 130.7 19.81 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.658 2.239 . . . . 0.0 112.329 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.1 m -84.06 -52.73 6.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.2 t -107.42 95.29 5.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 86.1 p -113.88 42.11 2.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.883 0.373 . . . . 0.0 110.84 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 35.0 m -154.38 176.38 12.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.843 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 169.79 83.99 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.477 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.2 m -68.59 121.02 15.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.839 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 25.1 p -87.21 167.17 14.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.812 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 170.96 -158.12 29.48 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -3.09 11.28 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.711 2.274 . . . . 0.0 112.332 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -71.18 143.85 50.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 147.92 50.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.97 163.05 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.136 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -126.19 141.19 52.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 29.6 p -79.68 153.08 75.67 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.562 0.696 . . . . 0.0 111.192 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 171.24 14.74 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.731 2.287 . . . . 0.0 112.337 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.1 t -68.64 130.7 43.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.94 -36.62 82.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -52.0 -38.43 56.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.562 HG12 ' CE2' ' A' ' 329' ' ' PHE . 20.0 mt -76.65 -53.97 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.143 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 82.0 t -39.71 -49.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -55.43 -44.49 76.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -73.51 -26.88 61.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 41.7 m -68.28 -15.95 63.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.177 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 293' ' ' MET . 18.1 mttm -82.99 -40.17 20.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -59.93 -27.14 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.095 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 292' ' ' ALA . 17.1 pt -98.1 -46.96 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.459 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.14 -48.12 68.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.133 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 19.4 ttm -51.89 -60.32 3.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -45.78 -70.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 298' ' ' ALA . 8.4 mmmm -47.27 -62.01 1.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.411 HD22 ' CZ ' ' A' ' 349' ' ' PHE . 49.8 mt -41.67 -48.36 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -75.22 -21.69 58.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -78.29 -26.76 47.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 28.4 m -90.26 -30.97 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.482 ' CG ' HG23 ' A' ' 352' ' ' ILE . 1.5 t80 -72.15 -44.7 62.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 8.0 t -74.96 2.17 11.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.118 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -117.49 -66.63 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.834 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.506 ' CZ ' ' HG2' ' A' ' 310' ' ' ARG . 0.4 OUTLIER -79.61 62.87 4.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -88.8 -64.92 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -55.77 -50.9 69.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -109.26 84.06 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 309' ' ' SER . 3.6 tmtt? -83.48 -66.53 0.88 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 2.1 p -38.98 -25.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 307' ' ' LYS . 36.9 m -71.84 -60.37 2.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.506 ' HG2' ' CZ ' ' A' ' 303' ' ' TYR . 9.7 tpt180 -92.05 37.6 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -68.33 -29.14 67.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -54.3 -36.3 63.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -50.91 -53.21 34.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.081 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 55.7 t -46.83 -29.89 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.147 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -87.31 -41.33 13.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.434 ' N ' ' HD2' ' A' ' 316' ' ' LYS . 3.7 mptt -40.74 -53.87 2.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.418 ' O ' ' C ' ' A' ' 318' ' ' ARG . 52.7 mt -45.41 -57.52 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.123 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 317' ' ' ILE . 16.0 tpp85 -37.22 -44.59 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.8 mt -77.65 -43.75 30.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.76 -69.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.437 HG23 ' CD1' ' A' ' 291' ' ' ILE . 16.5 p -46.27 -51.37 14.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -48.08 -45.19 32.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -80.05 -14.04 58.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . 0.433 ' CD2' HG23 ' A' ' 291' ' ' ILE . 80.9 t60 -91.11 -22.57 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 328' ' ' LYS . 23.0 mt -94.18 -60.3 1.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 325' ' ' LEU . 1.0 OUTLIER -35.86 -44.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -60.26 -46.35 90.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 325' ' ' LEU . 26.8 tptt -60.58 -39.56 88.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.562 ' CE2' HG12 ' A' ' 284' ' ' ILE . 2.8 m-85 -117.43 83.68 17.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.634 0.731 . . . . 0.0 110.851 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 -24.53 29.24 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.24 -30.66 30.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.468 HG12 ' CD1' ' A' ' 284' ' ' ILE . 85.3 t -70.2 144.12 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.194 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . 0.418 ' N ' HG13 ' A' ' 332' ' ' VAL . 6.0 t0 -73.86 150.56 40.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -61.33 -45.56 93.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.1 t80 -51.22 -17.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.891 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.99 -44.13 10.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.6 mp -63.76 -39.99 87.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.96 -58.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -49.02 -52.21 26.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 1.8 p -43.28 -41.63 4.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 344' ' ' VAL . 73.6 t80 -62.16 -56.45 18.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 341' ' ' PHE . 11.2 m-80 -35.72 -36.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 5.2 mp -79.47 -43.03 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.15 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 341' ' ' PHE . 50.8 t -59.94 -41.62 86.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -54.97 -69.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.074 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -53.03 -33.01 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.8 -31.99 73.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 34.7 t -92.12 -57.36 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.411 ' CZ ' HD22 ' A' ' 296' ' ' LEU . 38.1 m-85 -42.3 -55.84 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -51.19 -43.14 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.468 ' HA ' ' CD2' ' A' ' 354' ' ' LEU . 2.8 t -59.49 -18.93 44.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.816 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.482 HG23 ' CG ' ' A' ' 300' ' ' PHE . 48.2 mt -95.27 -49.77 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.114 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . 0.471 ' N ' HD12 ' A' ' 353' ' ' ILE . 1.7 mp -55.23 -36.89 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.468 ' CD2' ' HA ' ' A' ' 351' ' ' SER . 1.4 pp -48.32 -24.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . 0.466 ' N ' HD13 ' A' ' 354' ' ' LEU . 28.6 m-20 -47.54 -39.55 16.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -48.51 -47.78 38.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -104.83 105.56 15.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -112.63 156.56 22.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.14 174.09 14.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 21.4 p -74.01 152.73 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.15 142.91 51.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -80.01 -90.13 0.48 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.462 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 364' ' ' ASP . 41.2 mtp180 -143.2 122.6 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.862 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 363' ' ' ARG . 6.3 t70 -36.91 141.49 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 45.5 t -79.78 -60.6 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.843 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -174.3 171.33 44.46 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 119.72 6.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.248 . . . . 0.0 112.369 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 4.2 t -150.6 156.79 42.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.54 -3.94 56.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.858 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.476 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.6 t -116.9 44.59 2.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 0.0 110.891 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.3 t -82.15 85.69 6.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 154.82 -102.0 0.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.496 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 47.2 m 43.1 51.69 5.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.869 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 14.5 t -82.06 142.91 31.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 170.41 -158.18 29.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.498 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -1.08 7.83 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.741 2.294 . . . . 0.0 112.352 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -71.69 158.81 35.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -73.4 164.23 26.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 2.6 pp -97.71 162.14 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.092 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -126.39 139.85 52.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 34.9 p -86.44 153.52 56.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.584 0.707 . . . . 0.0 111.171 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 177.33 5.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.716 2.277 . . . . 0.0 112.323 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 2.1 m -71.52 120.52 17.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 283' ' ' GLU . . . -60.09 -56.72 18.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 282' ' ' ALA . 10.7 pt-20 -34.6 -45.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.563 HG12 ' CE2' ' A' ' 329' ' ' PHE . 27.3 mt -68.99 -57.73 7.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 87.3 t -38.13 -57.04 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -52.1 -40.84 61.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -73.83 -27.03 60.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.438 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 17.5 m -67.6 -19.08 65.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.174 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 293' ' ' MET . 28.4 mttt -79.57 -41.79 26.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -58.47 -29.85 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.479 HG23 ' CD2' ' A' ' 324' ' ' HIS . 7.6 pt -97.53 -49.55 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.438 ' CB ' ' O ' ' A' ' 288' ' ' THR . . . -62.06 -48.04 82.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.478 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 11.9 ttm -54.94 -52.27 63.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -51.79 -68.65 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -50.35 -58.65 5.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.954 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 42.6 mt -42.6 -58.23 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -61.56 -29.64 70.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.964 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.33 -48.92 66.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 24.0 m -74.8 -26.96 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -79.32 -33.14 43.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 27.3 p -76.87 -34.4 57.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -83.02 -46.41 12.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -87.07 75.53 9.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -83.09 -67.88 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -65.62 -48.95 70.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.52 63.43 7.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -76.72 -60.6 2.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 6.2 p -70.0 -16.69 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 2.5 m -82.63 -34.29 27.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.803 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -106.79 30.19 6.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.83 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.38 -27.31 68.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 7.4 pm0 -61.82 -32.73 73.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -64.78 -48.34 74.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.081 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 46.0 t -57.54 -28.37 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 317' ' ' ILE . 0.5 OUTLIER -80.79 -44.04 19.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.93 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 25.6 mttt -40.52 -24.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.486 ' O ' ' N ' ' A' ' 320' ' ' ASP . 94.8 mt -58.96 -67.16 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.148 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' A' ' 319' ' ' LEU . 7.3 ptp180 -37.97 -32.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.451 ' N ' ' HG3' ' A' ' 318' ' ' ARG . 18.8 mt -76.58 -42.69 41.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 317' ' ' ILE . 15.7 t0 -74.41 -62.86 1.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 324' ' ' HIS . 7.5 p -42.04 -54.73 3.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -45.02 -49.33 11.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -68.9 -21.34 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . 0.479 ' CD2' HG23 ' A' ' 291' ' ' ILE . 78.7 t60 -86.63 -23.06 25.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.828 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.45 ' HB2' ' CG2' ' A' ' 337' ' ' ILE . 42.8 mt -88.71 -58.02 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.935 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 325' ' ' LEU . 0.2 OUTLIER -37.14 -48.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -53.27 -54.53 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.434 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 26.2 tptt -53.4 -47.52 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.563 ' CE2' HG12 ' A' ' 284' ' ' ILE . 0.4 OUTLIER -113.05 86.72 9.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.651 0.739 . . . . 0.0 110.886 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -38.63 7.54 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 2.24 . . . . 0.0 112.359 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.78 -26.82 66.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 284' ' ' ILE . 96.0 t -73.06 141.99 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.087 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -79.57 147.49 32.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.851 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -51.41 -49.14 62.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.3 t80 -46.51 -21.28 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.419 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 7.5 mm-40 -88.71 -38.82 14.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.45 ' CG2' ' HB2' ' A' ' 325' ' ' LEU . 2.6 mp -70.81 -30.17 40.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 79.7 mt -77.13 -66.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -43.53 -49.19 7.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 7.4 p -43.16 -47.18 6.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.44 ' O ' ' C ' ' A' ' 342' ' ' ASN . 61.2 t80 -52.32 -56.08 17.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.828 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 341' ' ' PHE . 21.1 m-80 -35.07 -57.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 5.2 mp -56.24 -51.57 61.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 21.6 t -51.0 -66.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -38.92 -58.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -37.72 -52.14 1.25 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -56.87 -65.78 0.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 46.9 t -42.66 -42.44 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.087 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' A' ' 350' ' ' ARG . 4.9 m-85 -57.83 -65.01 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 349' ' ' PHE . 13.0 tpp85 -37.39 -65.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 68.5 p -41.23 -59.51 1.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 48.8 mt -55.59 -63.08 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.16 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 30.8 mm -40.91 -47.03 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.136 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.461 HD22 ' N ' ' A' ' 354' ' ' LEU . 4.4 mm? -71.0 -37.14 72.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -61.94 -40.07 94.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -58.52 -55.44 35.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -152.19 116.52 4.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -84.85 144.96 28.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -134.36 156.9 47.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 72.2 m -46.36 100.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.05 150.97 17.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -122.09 141.53 14.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.5 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -129.53 148.63 51.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.811 0.339 . . . . 0.0 110.884 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -123.46 172.96 8.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 7.5 t -57.69 158.28 6.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -119.31 159.88 14.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.479 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 169.08 19.71 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.341 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 74.7 m -118.98 161.06 20.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 29.2 t -47.88 158.48 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.483 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 10.1 t -66.63 166.13 13.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.946 0.403 . . . . 0.0 110.818 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.7 m -107.25 107.91 19.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -83.42 -143.77 5.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.485 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 41.7 t -107.93 -45.03 4.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.886 0.374 . . . . 0.0 110.833 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 4.7 m -92.18 109.41 20.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.857 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -143.64 146.18 16.59 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -14.48 36.12 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.658 2.239 . . . . 0.0 112.353 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -74.84 163.6 27.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.434 ' HG3' ' N ' ' A' ' 277' ' ' ILE . 27.5 tptt -82.98 148.94 27.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.434 ' N ' ' HG3' ' A' ' 276' ' ' LYS . 51.2 mm -95.66 154.23 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -129.93 143.64 50.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 70.4 p -75.93 151.68 84.33 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.574 0.702 . . . . 0.0 111.132 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 166.6 27.0 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.667 2.245 . . . . 0.0 112.35 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.2 t -68.26 121.37 16.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.844 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.63 82.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.099 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -50.9 -37.83 46.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.566 HG12 ' CE2' ' A' ' 329' ' ' PHE . 59.2 mt -76.52 -44.04 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 47.3 t -50.34 -60.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.151 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -40.19 -47.01 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -72.23 -39.85 68.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.467 ' HA ' ' CD1' ' A' ' 291' ' ' ILE . 4.1 m -54.73 -17.94 4.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.182 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 293' ' ' MET . 42.1 mttt -79.47 -46.43 17.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.4 mp -58.4 -22.65 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.095 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 288' ' ' THR . 7.3 pt -98.17 -51.92 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.457 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -66.88 -48.22 69.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 29.8 ttm -49.44 -71.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -41.45 -69.35 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 298' ' ' ALA . 0.0 OUTLIER -42.44 -63.88 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 39.7 mt -43.97 -43.02 6.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.555 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.9 m-85 -70.69 -30.76 67.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -70.2 -65.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 7.0 m -47.54 -27.39 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.121 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.509 ' CD2' HG23 ' A' ' 352' ' ' ILE . 2.7 t80 -76.73 -49.5 15.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 45.1 m -54.17 -35.69 62.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -83.68 -61.98 1.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 303' ' ' TYR . 0.3 OUTLIER -88.26 87.04 7.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -94.19 -50.99 5.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.843 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -78.36 -41.2 34.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.845 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.31 50.44 1.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.847 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -60.4 -58.03 10.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 309' ' ' SER . 30.2 m -71.55 -48.88 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.113 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.435 ' N ' HG22 ' A' ' 308' ' ' VAL . 3.5 m -49.95 -44.12 50.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -108.44 37.01 2.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -70.65 -17.48 62.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -53.68 -24.42 14.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -72.55 -55.17 7.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 60.2 t -52.47 -44.18 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.9 t30 -70.26 -47.77 59.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 315' ' ' ASN . 10.8 mmtm -35.86 -51.98 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.441 ' O ' ' N ' ' A' ' 320' ' ' ASP . 42.0 mt -45.12 -54.07 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.112 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -39.22 -33.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.55 -34.19 15.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 317' ' ' ILE . 6.5 t0 -67.63 -68.15 0.41 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.439 ' CG2' HG13 ' A' ' 291' ' ' ILE . 17.1 p -42.91 -44.2 4.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -50.2 -46.57 54.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.13 -17.66 60.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.835 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -87.84 -28.3 21.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.475 ' O ' ' N ' ' A' ' 328' ' ' LYS . 19.0 mt -90.62 -59.07 2.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 325' ' ' LEU . 7.3 tmtt? -38.22 -45.53 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.54 -39.62 94.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.887 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 325' ' ' LEU . 22.1 tptt -65.01 -44.9 87.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.566 ' CE2' HG12 ' A' ' 284' ' ' ILE . 0.5 OUTLIER -113.72 86.17 10.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.638 0.733 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -22.08 32.64 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.73 2.287 . . . . 0.0 112.346 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -84.06 -26.08 29.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 329' ' ' PHE . 48.7 t -75.89 138.73 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.124 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . 0.418 ' N ' HG12 ' A' ' 332' ' ' VAL . 6.6 t0 -72.08 142.86 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.812 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -51.57 -47.92 63.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.597 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 1.5 t80 -47.45 -20.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -88.09 -45.57 10.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.4 mp -60.3 -26.21 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 340' ' ' SER . 76.7 mt -89.34 -64.95 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -41.88 -26.11 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.919 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 338' ' ' ILE . 2.4 p -65.77 -46.57 78.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.44 ' O ' ' C ' ' A' ' 342' ' ' ASN . 23.3 t80 -53.92 -52.74 59.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 341' ' ' PHE . 28.2 m-80 -34.53 -48.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 4.7 mp -73.46 -41.75 56.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.15 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.422 ' N ' ' O ' ' A' ' 341' ' ' PHE . 25.2 t -58.25 -59.97 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -38.17 -64.9 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.104 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -46.34 -60.72 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.943 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -39.86 -34.99 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.21 -53.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.158 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.0 m-85 -52.5 -64.48 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 349' ' ' PHE . 23.9 ptt85 -37.77 -28.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.866 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 349' ' ' PHE . 15.8 t -84.17 -41.74 16.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.555 HG12 ' CE1' ' A' ' 297' ' ' TYR . 83.6 mt -63.68 -17.1 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 18.7 mm -64.93 -22.28 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.176 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 354' ' ' LEU . 1.3 pt? -54.58 -24.17 19.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -95.63 -13.26 24.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 357' ' ' TYR . 52.4 mm-40 -91.53 87.33 6.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 356' ' ' GLU . 1.1 p90 36.75 53.47 1.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -143.24 128.13 18.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.69 159.73 33.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.89 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 31.8 p -162.13 174.49 12.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.855 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -78.76 99.79 6.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -148.76 127.69 2.59 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.518 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' A' ' 364' ' ' ASP . 22.8 ptt180 -46.76 -46.47 20.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.801 0.334 . . . . 0.0 110.919 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.406 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 2.8 t70 -112.06 139.78 47.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.809 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 29.8 p -77.62 -53.57 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 170.16 148.19 5.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.496 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 153.36 68.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.611 2.207 . . . . 0.0 112.348 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 11.5 t -98.43 117.31 32.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.7 t -129.68 166.7 19.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.831 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.475 -179.969 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 58.0 m -100.35 -56.13 2.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.891 0.377 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.7 t -77.18 130.52 37.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.791 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -171.69 161.88 34.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.471 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 83.8 p -161.43 135.87 7.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 110.828 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 45.1 t -50.88 -66.26 0.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 104.27 83.83 1.72 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -21.57 33.43 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.733 2.289 . . . . 0.0 112.352 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -68.2 158.44 33.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -73.31 115.53 12.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.856 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.473 ' CG2' ' N ' ' A' ' 278' ' ' PHE . 14.4 mt -94.18 163.0 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.473 ' N ' ' CG2' ' A' ' 277' ' ' ILE . 5.7 m-85 -78.82 150.73 32.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 18.3 p -72.61 152.83 91.66 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.615 0.721 . . . . 0.0 111.122 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 173.32 11.14 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 0.0 112.31 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 2.1 m -74.58 137.17 42.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.07 -48.44 62.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -42.66 -45.56 4.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.554 HG12 ' CZ ' ' A' ' 329' ' ' PHE . 25.1 mt -74.45 -54.03 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.404 ' CG2' ' CB ' ' A' ' 340' ' ' SER . 95.4 t -45.16 -43.11 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -61.94 -36.14 80.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -80.3 -30.69 38.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.464 ' HA ' ' CD1' ' A' ' 291' ' ' ILE . 9.9 m -60.49 -19.92 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 293' ' ' MET . 42.0 mttt -80.54 -48.94 12.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -54.78 -22.74 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.464 ' CD1' ' HA ' ' A' ' 288' ' ' THR . 5.2 pt -98.71 -52.2 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.45 ' N ' ' CG1' ' A' ' 291' ' ' ILE . . . -68.76 -49.19 60.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.498 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 20.0 ttm -43.1 -65.22 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -46.63 -63.07 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.856 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 298' ' ' ALA . 47.1 mmtt -46.39 -65.46 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.432 ' O ' ' CG2' ' A' ' 299' ' ' VAL . 31.5 mt -42.85 -53.85 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.533 ' CE2' HG13 ' A' ' 348' ' ' VAL . 11.2 m-85 -64.94 -23.53 67.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.96 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -76.05 -32.98 59.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.126 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' A' ' 296' ' ' LEU . 28.2 m -82.08 -27.74 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -83.63 -31.88 25.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 5.4 t -70.44 -20.23 62.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.28 -58.69 1.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.65 88.3 4.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -94.06 -44.48 8.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.556 ' CE1' ' OD1' ' A' ' 306' ' ' ASP . 9.3 p80 -89.64 -49.08 6.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.556 ' OD1' ' CE1' ' A' ' 305' ' ' HIS . 5.0 m-20 -84.03 77.55 9.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -80.8 -69.73 0.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 28.9 m -66.1 -34.65 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.138 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.5 m -46.93 -44.98 20.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.878 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -116.26 49.44 1.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.854 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.27 -11.61 33.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -63.1 -34.04 76.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -57.87 -42.21 84.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.1 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.0 -61.08 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.129 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.98 -46.47 61.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -38.9 -58.24 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 320' ' ' ASP . 32.2 mt -41.17 -59.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 317' ' ' ILE . 56.1 ttt180 -34.87 -39.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.6 mt -81.82 -41.15 21.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 317' ' ' ILE . 3.7 t70 -60.14 -69.14 0.23 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 69.7 p -47.85 -42.21 25.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.5 ' C ' ' CD ' ' A' ' 322' ' ' GLU . 4.2 tm-20 -53.62 -40.66 65.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -87.37 -15.5 37.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -86.49 -27.15 24.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.795 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 326' ' ' LYS . 35.4 mt -88.21 -58.07 2.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 325' ' ' LEU . 1.4 tmmm? -35.92 -60.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -47.38 -50.24 22.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.481 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 22.3 tttp -55.78 -48.96 74.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.916 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.554 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 4.7 m-85 -110.89 82.42 3.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.64 0.733 . . . . 0.0 110.897 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -31.79 19.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.642 2.228 . . . . 0.0 112.318 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.56 -24.0 53.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.463 HG12 ' CD1' ' A' ' 284' ' ' ILE . 68.8 t -74.58 146.42 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -67.44 147.13 53.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . 0.422 ' O ' ' CD1' ' A' ' 338' ' ' ILE . 11.2 tt0 -61.88 -33.32 73.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.941 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -68.9 -14.98 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -84.13 -25.22 29.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.2 mp -83.64 -25.02 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.422 ' CD1' ' O ' ' A' ' 334' ' ' GLN . 2.0 mp -80.93 -49.75 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.165 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 340' ' ' SER . 19.0 mt-10 -57.33 -62.55 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 339' ' ' GLU . 75.2 p -35.78 -43.99 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.841 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 344' ' ' VAL . 77.6 t80 -63.68 -55.94 19.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 341' ' ' PHE . 26.7 m-80 -38.19 -42.0 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 4.0 mp -67.72 -43.11 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.427 ' N ' ' O ' ' A' ' 341' ' ' PHE . 70.0 t -58.7 -60.56 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.114 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -41.0 -49.27 3.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -65.75 -34.59 78.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.05 -67.09 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.533 HG13 ' CE2' ' A' ' 297' ' ' TYR . 42.5 t -51.43 -37.25 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.412 ' C ' HD12 ' A' ' 353' ' ' ILE . 3.2 m-30 -60.57 -66.55 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -40.25 -31.04 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.5 ' O ' ' CD1' ' A' ' 354' ' ' LEU . 4.2 t -68.3 -46.57 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 349' ' ' PHE . 11.3 mt -72.37 -40.85 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.125 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . 0.412 HD12 ' C ' ' A' ' 349' ' ' PHE . 5.3 mp -76.28 -14.65 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.075 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.538 ' CD2' ' C ' ' A' ' 354' ' ' LEU . 0.0 OUTLIER -42.99 -23.56 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . 0.505 ' N ' ' CD1' ' A' ' 354' ' ' LEU . 16.7 m-80 -48.49 -38.65 20.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.833 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -65.67 -69.68 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -61.9 150.54 37.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 358' ' ' LYS . 1.4 mppt? -101.6 89.22 3.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.909 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 -109.39 124.97 51.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 28.3 p -102.1 41.32 1.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -142.98 146.54 34.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 81.11 168.5 40.04 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.488 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -123.68 149.89 44.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.347 . . . . 0.0 110.878 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -132.22 145.22 51.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 21.1 p -148.53 172.49 14.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.821 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -159.58 83.78 0.13 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.523 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 170.34 16.75 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.689 2.259 . . . . 0.0 112.375 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 30.4 m -62.39 156.68 21.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.841 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.6 m -122.9 127.49 49.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 -179.976 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 44.0 p -120.43 175.41 5.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.939 0.399 . . . . 0.0 110.801 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.2 t -96.23 169.74 9.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -92.03 -98.48 1.33 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.501 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 77.3 p -168.61 177.78 5.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.829 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 26.9 t -109.76 171.89 7.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.845 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -84.33 142.5 20.47 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.484 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -174.47 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.686 2.257 . . . . 0.0 112.347 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 4.0 tp60 -103.79 150.67 23.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -83.57 113.94 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.948 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 277' ' ' ILE . 4.3 mp -90.71 151.21 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.141 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -124.92 137.59 54.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.4 p -125.93 153.18 73.64 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.538 0.685 . . . . 0.0 111.145 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -170.71 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.628 2.219 . . . . 0.0 112.363 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 13.2 m -73.82 122.7 22.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.74 81.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.099 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -41.61 -46.66 3.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.48 HG12 ' CE1' ' A' ' 329' ' ' PHE . 13.6 mt -72.68 -52.08 24.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 89.8 t -46.15 -38.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.093 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -61.83 -47.57 84.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -73.87 -26.55 60.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.967 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 97.5 m -65.38 -17.67 64.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 31.7 mttt -80.17 -44.21 20.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.899 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.71 -24.03 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.131 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.461 HG13 ' N ' ' A' ' 292' ' ' ALA . 10.7 pt -98.31 -49.81 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.461 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.7 -48.54 66.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.074 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 12.3 ttm -49.42 -61.4 2.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -46.87 -72.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 16.8 mtmm -43.78 -61.86 1.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 56.7 mt -44.09 -46.5 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -69.56 -28.22 65.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.73 -48.3 66.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 33.5 m -73.21 -23.7 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.112 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.462 ' CD1' HG23 ' A' ' 352' ' ' ILE . 0.8 OUTLIER -53.95 -64.15 0.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.848 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 24.8 m -47.83 -49.99 27.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.166 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -84.42 179.69 7.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 303' ' ' TYR . 1.6 m-30 55.98 48.6 17.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.954 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -92.13 -56.06 3.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -84.65 -39.19 18.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 -38.42 129.85 1.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.96 -33.51 70.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 13.0 m -44.93 -29.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 310' ' ' ARG . 3.4 m 49.73 49.47 20.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 309' ' ' SER . 28.5 ptt-85 35.82 53.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -89.2 -31.02 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.845 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 313' ' ' ALA . 15.1 pt-20 -94.83 -47.73 6.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . 0.452 ' N ' ' HG3' ' A' ' 312' ' ' GLU . . . -49.38 -44.89 45.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.134 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.38 -64.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.113 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -48.76 -24.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 15.3 mmtp -64.99 -37.64 88.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.11 -55.69 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.409 ' HG2' ' CE2' ' A' ' 341' ' ' PHE . 17.9 mmm-85 -39.36 -30.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.0 mt -90.42 -40.58 11.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.7 -60.87 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 3.2 p -52.24 -40.47 61.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.462 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 17.7 tt0 -53.41 -41.1 65.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -84.44 -15.26 46.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 77.8 t60 -87.27 -22.18 25.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 326' ' ' LYS . 32.5 mt -94.15 -59.66 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 325' ' ' LEU . 1.3 mmmp? -34.12 -53.19 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -48.26 -51.39 25.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -56.7 -40.33 75.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.48 ' CE1' HG12 ' A' ' 284' ' ' ILE . 6.4 m-85 -118.7 84.27 24.43 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.611 0.719 . . . . 0.0 110.879 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -28.79 25.14 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.72 2.28 . . . . 0.0 112.362 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.24 -25.21 42.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.469 HG12 ' CD1' ' A' ' 284' ' ' ILE . 41.6 t -71.08 151.37 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . 0.419 ' N ' HG13 ' A' ' 332' ' ' VAL . 8.4 t0 -81.86 150.22 27.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . 0.431 ' O ' ' CD1' ' A' ' 338' ' ' ILE . 20.1 tt0 -58.45 -33.88 70.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.588 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.0 t80 -63.76 -17.34 62.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -87.37 -35.25 18.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.462 ' CG2' ' HA ' ' A' ' 322' ' ' GLU . 2.1 mp -71.61 -37.27 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.431 ' CD1' ' O ' ' A' ' 334' ' ' GLN . 2.8 mp -74.29 -71.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.111 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -38.19 -50.49 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 9.5 p -45.17 -43.67 10.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.858 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 344' ' ' VAL . 46.4 t80 -58.94 -55.35 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.903 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 341' ' ' PHE . 33.5 m-80 -36.23 -55.23 0.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 5.4 mp -56.28 -41.3 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 341' ' ' PHE . 68.0 t -64.35 -59.18 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -40.83 -61.16 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -44.71 -51.5 9.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.949 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.72 -70.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 99.2 t -38.06 -62.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.158 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.432 ' O ' ' C ' ' A' ' 350' ' ' ARG . 10.5 m-85 -44.82 -66.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.852 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 349' ' ' PHE . 12.1 tpt180 -35.58 -56.25 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 1.3 t -49.46 -46.79 48.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.462 HG23 ' CD1' ' A' ' 300' ' ' PHE . 64.8 mt -55.26 -60.26 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.163 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 4.4 mp -44.33 -49.41 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.109 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 14.3 mt -60.62 -48.59 81.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -43.16 -42.22 4.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -40.52 -43.87 1.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -44.61 152.68 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.946 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -39.61 126.83 1.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -119.12 173.05 7.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.859 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 26.2 p -64.38 118.1 8.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.49 -64.33 0.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 65.55 -114.4 6.63 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -114.1 147.25 39.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 0.0 110.925 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -141.12 116.88 10.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.6 t -94.73 -62.4 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 102.02 146.51 18.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.485 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 176.85 6.19 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.67 2.247 . . . . 0.0 112.374 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 75.7 p -116.04 171.99 7.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.883 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 18.2 m -112.54 146.58 38.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.465 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 68.9 m -131.24 154.15 48.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.899 0.38 . . . . 0.0 110.836 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 2.1 m -106.21 117.8 34.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.854 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 121.78 113.62 2.25 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.5 t -165.78 155.88 12.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.86 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 38.4 t -62.53 121.07 12.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.835 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 164.57 -89.72 0.1 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.478 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -174.01 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.667 2.245 . . . . 0.0 112.332 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -74.93 160.59 30.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -87.42 138.0 31.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 2.6 pp -104.74 149.29 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.1 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -95.38 138.93 32.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.883 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 81.2 p -74.52 151.17 87.24 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.555 0.693 . . . . 0.0 111.11 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . 0.411 ' HD3' ' CD ' ' A' ' 339' ' ' GLU . 54.0 Cg_endo -69.75 172.25 12.97 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.728 2.285 . . . . 0.0 112.369 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' SER . . . . . 0.444 ' O ' ' CG2' ' A' ' 285' ' ' VAL . 5.1 t -73.3 142.23 47.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -76.09 -40.35 53.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.17 -39.34 63.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.554 HG12 ' CE1' ' A' ' 329' ' ' PHE . 18.3 mt -77.1 -49.35 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 281' ' ' SER . 48.2 t -51.26 -33.93 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.145 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -68.84 -40.64 79.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -73.79 -27.83 61.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 42.2 m -63.23 -19.66 64.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.134 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 293' ' ' MET . 2.7 mptm? -75.56 -44.54 42.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.3 mp -55.74 -27.87 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.449 HG13 ' N ' ' A' ' 292' ' ' ALA . 6.2 pt -98.25 -51.99 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.132 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.449 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -63.82 -48.45 76.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 25.2 ttm -56.33 -64.2 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -45.55 -56.97 4.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.881 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 298' ' ' ALA . 17.4 mmtp -58.5 -69.32 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 295' ' ' LYS . 86.5 mt -37.04 -42.54 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.96 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -74.33 -38.71 63.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -59.22 -28.89 67.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.133 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.9 m -90.73 -36.18 7.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 300' ' ' PHE . 0.2 OUTLIER -38.83 -64.36 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 22.2 m -51.67 -51.97 51.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -47.78 -73.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -88.18 86.83 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.958 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 305' ' ' HIS . 18.1 mt-10 -95.79 -48.87 5.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.451 ' CD2' ' OD1' ' A' ' 306' ' ' ASP . 13.6 t60 -34.45 -65.97 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.451 ' OD1' ' CD2' ' A' ' 305' ' ' HIS . 3.8 m-20 -140.94 166.53 24.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -48.9 11.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 18.3 m -49.21 -32.9 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.072 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 1.9 m -50.78 117.07 2.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 51.97 43.24 30.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -47.08 -27.63 1.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -47.23 -28.82 2.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -59.73 -59.23 5.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.101 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.17 -56.46 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -47.47 -39.78 16.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -54.15 -55.29 29.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 320' ' ' ASP . 87.6 mt -42.32 -60.8 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 317' ' ' ILE . 8.8 mtp-105 -36.56 -34.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.826 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 11.6 mt -86.16 -39.5 16.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.4 t70 -63.94 -63.93 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 68.9 p -53.29 -40.85 65.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.444 ' C ' ' OE1' ' A' ' 322' ' ' GLU . 0.0 OUTLIER -54.01 -37.36 63.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -92.59 -13.07 30.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -86.89 -28.06 23.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 17.3 mt -89.8 -54.37 4.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.427 ' N ' HG12 ' A' ' 337' ' ' ILE . 25.4 tttm -44.06 -39.97 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.7 -39.76 91.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.494 ' HB3' ' CE1' ' A' ' 329' ' ' PHE . 47.0 tttp -57.16 -42.64 81.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.554 ' CE1' HG12 ' A' ' 284' ' ' ILE . 0.2 OUTLIER -129.99 91.91 38.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.607 0.718 . . . . 0.0 110.895 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -20.78 34.34 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.698 2.266 . . . . 0.0 112.358 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -78.69 -33.07 47.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 1.5 p -65.79 150.27 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -70.53 156.04 39.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . 0.446 ' HG3' ' CD1' ' A' ' 338' ' ' ILE . 2.5 tp-100 -68.08 -41.86 81.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -58.69 -13.94 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -82.63 -31.33 28.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.427 HG12 ' N ' ' A' ' 326' ' ' LYS . 1.9 mp -81.16 -28.87 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.446 ' CD1' ' HG3' ' A' ' 334' ' ' GLN . 2.6 mp -77.17 -53.58 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.459 ' O ' ' CD1' ' A' ' 343' ' ' ILE . 10.0 tt0 -60.95 -44.41 97.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 96.3 p -47.49 -49.44 25.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 344' ' ' VAL . 71.5 t80 -58.35 -56.83 17.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 341' ' ' PHE . 17.9 m-80 -35.09 -43.96 0.22 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.459 ' CD1' ' O ' ' A' ' 339' ' ' GLU . 4.1 mp -66.96 -46.86 83.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' A' ' 341' ' ' PHE . 71.6 t -55.65 -66.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -37.41 -64.3 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -42.99 -43.24 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -67.63 -70.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 88.8 t -40.89 -50.64 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.145 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -52.51 -61.34 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 -44.98 -43.33 9.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 3.3 t -51.29 -34.78 34.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.419 HG22 ' CD1' ' A' ' 300' ' ' PHE . 14.8 mt -93.73 -32.33 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 355' ' ' ASN . 44.9 mm -58.39 -42.8 85.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.093 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -43.19 -23.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . 0.418 ' N ' ' O ' ' A' ' 353' ' ' ILE . 11.8 t-20 -61.59 -43.17 99.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -95.66 -52.04 4.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.437 ' CE1' ' HG2' ' A' ' 359' ' ' ARG . 6.8 t80 -90.08 89.11 7.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -118.81 89.04 3.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . 0.437 ' HG2' ' CE1' ' A' ' 357' ' ' TYR . 20.7 ptt180 -171.46 115.92 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.832 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 43.0 t -78.95 112.63 16.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -162.4 166.95 24.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 175.05 -52.97 0.13 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.49 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -81.95 159.25 23.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.834 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.2 160.07 39.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 16.8 t -91.55 162.88 14.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -85.58 -156.64 27.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.479 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -36.45 10.73 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.706 2.271 . . . . 0.0 112.326 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 35.9 p -59.15 100.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 92.1 p -166.66 176.94 6.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.503 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.9 m -98.94 174.07 6.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.87 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 45.4 p -163.63 174.32 11.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.874 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -125.05 -135.82 4.44 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 2.1 t -167.32 134.6 2.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.902 0.382 . . . . 0.0 110.803 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 95.4 p -156.52 154.02 29.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.861 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 131.35 160.13 9.75 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -4.91 14.94 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.705 2.27 . . . . 0.0 112.367 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -68.13 143.72 55.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -87.75 115.61 25.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.41 HG22 ' N ' ' A' ' 278' ' ' PHE . 3.8 mt -113.65 151.48 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.119 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.41 ' N ' HG22 ' A' ' 277' ' ' ILE . 5.9 m-85 -75.71 147.61 39.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 33.5 p -102.18 153.58 37.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.553 0.692 . . . . 0.0 111.156 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -174.06 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.66 2.24 . . . . 0.0 112.358 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 21.2 m -73.08 119.99 18.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.837 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 284' ' ' ILE . . . -57.17 -55.44 34.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 282' ' ' ALA . 13.7 pt-20 -36.44 -33.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.549 HG12 ' CE1' ' A' ' 329' ' ' PHE . 47.1 mt -83.46 -54.35 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 49.6 t -38.83 -53.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.414 ' NZ ' ' HB2' ' A' ' 282' ' ' ALA . 18.6 mtmt -57.1 -55.75 30.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -59.65 -20.9 59.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 49.2 m -75.15 -25.36 58.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.158 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.473 ' O ' ' CB ' ' A' ' 293' ' ' MET . 14.4 mttp -77.13 -41.08 43.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.6 mp -56.65 -30.13 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.463 HG13 ' N ' ' A' ' 292' ' ' ALA . 10.4 pt -97.76 -49.81 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.463 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -61.87 -48.02 82.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.473 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 13.9 ttm -51.9 -60.24 3.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -47.82 -53.32 15.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 298' ' ' ALA . 29.1 mtpt -60.42 -67.99 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.438 ' CD2' HD13 ' A' ' 317' ' ' ILE . 90.9 mt -38.6 -38.55 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.459 ' CE1' HG12 ' A' ' 352' ' ' ILE . 8.6 m-85 -77.99 -37.06 48.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -67.23 -34.58 77.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.116 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.427 HG21 ' N ' ' A' ' 300' ' ' PHE . 29.4 m -87.49 -24.11 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.458 ' CG ' HG22 ' A' ' 352' ' ' ILE . 2.0 t80 -54.53 -54.86 35.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 9.4 t -77.37 -17.89 57.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.146 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -62.99 -71.91 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.418 ' HA ' ' NE2' ' A' ' 305' ' ' HIS . 12.4 p90 -85.61 17.43 3.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.961 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 305' ' ' HIS . 15.5 tm-20 -38.15 -56.53 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 304' ' ' GLU . 8.9 p80 -34.8 -46.06 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -159.56 136.91 9.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -70.29 -62.14 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.858 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 9.6 p -41.01 -30.63 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.168 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 10.5 t -78.79 114.58 17.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 73.59 34.67 0.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -51.14 -25.25 4.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 6.0 pt-20 -55.36 -27.35 46.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -57.62 -50.42 73.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 55.0 t -66.89 -69.38 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.118 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -41.19 -42.92 2.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.494 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 0.9 OUTLIER -40.86 -60.45 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.443 ' O ' ' N ' ' A' ' 320' ' ' ASP . 29.8 mt -41.4 -63.43 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.141 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.43 ' HB2' ' NH1' ' A' ' 318' ' ' ARG . 23.8 ttm105 -36.43 -39.1 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.856 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.2 mt -83.51 -39.63 20.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.95 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.2 t0 -62.51 -63.87 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 72.9 p -51.84 -52.77 46.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -47.05 -36.6 8.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -85.88 -18.93 31.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -89.43 -19.7 24.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 47.9 mt -93.31 -60.06 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -44.16 -35.3 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.33 -38.36 87.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.413 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 26.2 tptt -72.42 -42.59 64.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.549 ' CE1' HG12 ' A' ' 284' ' ' ILE . 3.2 m-85 -110.46 85.03 4.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -35.41 12.65 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.335 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.84 -31.53 66.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.463 HG11 ' CD1' ' A' ' 284' ' ' ILE . 74.9 t -67.94 149.73 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -79.71 144.35 33.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . 0.455 ' HG2' ' CD1' ' A' ' 338' ' ' ILE . 25.6 tt0 -53.46 -38.29 63.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.443 ' CD2' ' OE1' ' A' ' 336' ' ' GLU . 7.2 t80 -59.7 -21.16 60.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.443 ' OE1' ' CD2' ' A' ' 335' ' ' PHE . 0.0 OUTLIER -86.92 -18.52 30.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.886 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.4 mp -88.32 -27.41 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.455 ' CD1' ' HG2' ' A' ' 334' ' ' GLN . 3.5 mp -89.75 -51.99 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -51.52 -31.47 24.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 2.1 p -66.37 -36.1 82.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.432 ' CE1' ' HB2' ' A' ' 345' ' ' ALA . 39.1 t80 -68.35 -31.05 70.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.847 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -56.42 -32.01 64.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 5.0 mp -88.13 -37.92 11.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 81.0 t -64.23 -51.3 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . 0.432 ' HB2' ' CE1' ' A' ' 341' ' ' PHE . . . -51.12 -66.78 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.062 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . 0.404 ' C ' ' HD3' ' A' ' 346' ' ' LYS . 0.0 OUTLIER -50.39 -31.29 14.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -67.68 -66.94 0.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 98.2 t -45.71 -44.2 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 352' ' ' ILE . 4.1 m-85 -45.6 -60.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 349' ' ' PHE . 3.4 tpm_? -37.3 -62.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 28.1 m -47.55 -33.29 6.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.459 HG12 ' CE1' ' A' ' 297' ' ' TYR . 93.6 mt -79.7 -34.81 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.153 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 5.0 mm -60.77 -23.06 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 10.1 mp -47.61 -20.53 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -117.8 102.72 9.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -61.27 83.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -40.95 109.25 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.953 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 12.9 pttp -166.35 137.18 3.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 70.1 mmt-85 -40.88 133.6 2.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 4.8 p -104.92 -33.04 8.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 40.79 45.76 2.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -166.84 132.78 2.71 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.45 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -114.31 95.76 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 110.847 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 63.97 31.09 13.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 7.5 m -118.02 136.0 53.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 83.53 147.33 7.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.489 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 89.8 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.674 2.25 . . . . 0.0 112.335 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 13.1 t -131.81 98.75 4.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 37.5 m -37.37 -53.09 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.464 -179.976 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 26.1 m -115.46 85.07 2.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.933 0.397 . . . . 0.0 110.856 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 57.4 m -85.56 92.79 8.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.886 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -101.85 -145.15 15.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.469 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 42.5 t -111.06 -43.9 3.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 0.0 110.833 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 32.1 m -62.72 97.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 120.93 178.98 16.07 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.498 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 178.88 4.13 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.677 2.251 . . . . 0.0 112.332 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -100.12 151.32 21.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.73 139.41 41.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 2.7 pp -114.54 151.52 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -122.83 133.71 54.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 67.2 p -103.24 152.2 38.63 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.605 0.717 . . . . 0.0 111.125 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -178.59 2.4 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.701 2.268 . . . . 0.0 112.386 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' SER . . . . . 0.406 ' HB2' ' CD1' ' A' ' 284' ' ' ILE . 72.7 m -68.56 134.37 49.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.874 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -72.57 -40.74 66.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -55.26 -36.24 65.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.899 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.562 HG12 ' CE2' ' A' ' 329' ' ' PHE . 22.8 mt -78.33 -41.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 77.7 t -58.46 -46.42 89.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -60.65 -37.02 80.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -73.78 -34.22 64.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 92.0 m -56.38 -19.29 14.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.162 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.517 ' O ' ' CB ' ' A' ' 293' ' ' MET . 7.2 mptt -77.13 -49.23 15.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.9 mp -53.74 -24.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.162 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.466 HG13 ' N ' ' A' ' 292' ' ' ALA . 7.0 pt -98.83 -52.4 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.148 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.466 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.94 -49.29 62.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.061 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.517 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 19.1 ttm -45.42 -62.26 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -52.29 -72.56 0.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 298' ' ' ALA . 35.1 mtmt -42.14 -63.83 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 81.7 mt -42.3 -52.33 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.472 ' CE1' ' CG1' ' A' ' 352' ' ' ILE . 7.7 m-85 -62.2 -26.54 68.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.975 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -72.18 -51.1 22.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.092 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.518 ' O ' ' CE2' ' A' ' 303' ' ' TYR . 18.8 m -75.02 -24.32 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.108 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.534 ' CD1' ' C ' ' A' ' 300' ' ' PHE . 0.2 OUTLIER -40.26 -68.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 28.1 m -63.61 -9.63 14.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.177 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 304' ' ' GLU . 1.7 t70 -80.25 179.63 7.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.854 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.518 ' CE2' ' O ' ' A' ' 299' ' ' VAL . 46.0 p90 37.56 28.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 302' ' ' ASP . 17.5 tt0 -37.26 -45.59 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.85 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.431 ' C ' ' O ' ' A' ' 304' ' ' GLU . 77.6 t60 -36.15 -60.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -166.71 135.47 2.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 311' ' ' ASP . 12.9 ttmt -57.35 -58.26 9.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 32.9 m -55.11 -40.82 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.08 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 31.4 t -48.42 -54.13 15.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -124.75 42.31 3.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 307' ' ' LYS . 4.0 p30 -49.28 -25.53 2.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -41.39 -32.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.943 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -56.96 -52.89 63.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.3 t -79.84 -38.58 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.118 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.9 OUTLIER -59.75 -54.23 48.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.931 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 315' ' ' ASN . 22.7 mtmt -35.15 -62.74 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.93 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.464 ' O ' ' N ' ' A' ' 320' ' ' ASP . 31.8 mt -36.63 -58.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 317' ' ' ILE . 0.0 OUTLIER -35.19 -42.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.5 mt -80.68 -39.31 27.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 317' ' ' ILE . 19.8 t0 -60.96 -70.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 68.1 p -45.77 -45.84 14.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.158 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -51.29 -36.21 41.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.34 -20.99 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -85.6 -18.93 31.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 42.8 mt -93.18 -59.54 2.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -41.47 -36.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.7 -52.58 50.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.487 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 30.4 tttp -54.59 -41.82 70.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.562 ' CE2' HG12 ' A' ' 284' ' ' ILE . 1.3 m-85 -116.12 83.95 13.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.661 0.743 . . . . 0.0 110.823 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -30.24 22.54 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.348 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -77.92 -18.46 56.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.458 HG13 ' CD1' ' A' ' 284' ' ' ILE . 53.4 t -80.39 152.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -82.9 151.72 25.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -60.55 -41.04 93.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -53.85 -26.27 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.42 -30.45 33.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 337' ' ' ILE . 1.8 mp -84.62 -14.43 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.145 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 36.5 mt -87.33 -52.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -59.83 -48.36 81.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 40.3 m -39.76 -50.82 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 344' ' ' VAL . 42.7 t80 -56.03 -57.92 10.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 341' ' ' PHE . 67.4 m-20 -37.47 -46.47 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 4.4 mp -68.41 -40.08 81.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.449 ' N ' ' O ' ' A' ' 341' ' ' PHE . 81.1 t -61.36 -64.18 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.08 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -42.71 -55.96 3.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -48.62 -30.16 5.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -83.73 -64.37 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 56.5 t -43.89 -27.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -74.02 -62.75 1.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 350' ' ' ARG . 21.0 ttm105 -41.5 -44.78 3.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 25.6 p -60.39 -50.83 72.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.478 HG22 ' CG ' ' A' ' 300' ' ' PHE . 50.1 mt -51.14 -52.22 19.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mp -59.96 -53.04 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.489 ' O ' ' N ' ' A' ' 356' ' ' GLU . 7.0 mp -49.43 -49.41 45.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.92 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 354' ' ' LEU . 51.1 t-20 -37.33 -28.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 354' ' ' LEU . 5.2 tp10 -82.17 -67.71 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.859 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.411 ' C ' ' O ' ' A' ' 356' ' ' GLU . 15.4 m-85 -35.7 -53.63 0.71 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.44 89.97 3.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.848 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -60.03 165.05 3.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 31.0 p -145.91 151.91 38.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -86.59 103.88 15.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.847 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 174.22 86.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 17.3 mmm-85 -74.71 160.62 30.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.829 0.347 . . . . 0.0 110.888 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.86 -56.02 2.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 58.2 p 39.1 41.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -137.39 83.66 0.25 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.452 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 151.98 69.27 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.267 . . . . 0.0 112.343 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.6 m -114.46 134.41 55.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.816 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 53.5 p -162.97 163.12 26.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.838 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 -179.97 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.7 m -43.92 136.78 3.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 110.815 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 99.3 p -149.06 145.19 27.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 106.58 62.99 0.6 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 5.3 p -80.13 124.28 28.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 0.0 110.863 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 77.6 p -173.77 132.7 0.44 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -170.73 -175.98 39.74 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.48 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -33.95 15.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -78.56 162.03 26.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -70.09 116.14 10.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.441 HG22 ' N ' ' A' ' 278' ' ' PHE . 45.6 mm -94.5 158.28 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.441 ' N ' HG22 ' A' ' 277' ' ' ILE . 5.8 m-85 -87.57 140.0 29.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 55.0 p -99.28 151.66 37.5 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.599 0.714 . . . . 0.0 111.148 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . 0.418 ' HD3' ' CD ' ' A' ' 339' ' ' GLU . 53.9 Cg_endo -69.74 179.62 3.56 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.725 2.283 . . . . 0.0 112.308 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.8 t -69.78 120.96 16.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.04 96.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -49.77 -41.15 43.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.555 HG12 ' CE2' ' A' ' 329' ' ' PHE . 22.1 mt -75.95 -42.32 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 75.3 t -54.5 -42.68 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . 0.402 ' O ' ' CD1' ' A' ' 290' ' ' ILE . 0.4 OUTLIER -62.53 -36.43 82.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.462 ' CD2' ' HD3' ' A' ' 328' ' ' LYS . 31.5 t80 -76.87 -31.36 56.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 33.2 m -64.01 -23.73 67.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.485 ' O ' ' CB ' ' A' ' 293' ' ' MET . 30.7 mttt -76.19 -39.57 54.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . 0.402 ' CD1' ' O ' ' A' ' 286' ' ' LYS . 2.6 mp -61.7 -28.49 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.515 HG21 ' CD2' ' A' ' 324' ' ' HIS . 23.6 pt -97.77 -43.4 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.122 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.434 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -69.25 -47.8 63.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.485 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 9.5 ttm -52.53 -71.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.889 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 293' ' ' MET . 18.3 mt-10 -36.94 -60.01 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -53.92 -66.21 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 75.8 mt -39.11 -49.79 1.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -65.34 -40.27 93.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.93 -50.43 73.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 27.9 m -64.92 -28.8 45.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.517 ' CZ ' HG21 ' A' ' 352' ' ' ILE . 4.4 t80 -69.45 -57.02 5.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 8.5 t -67.85 -18.53 64.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.148 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -83.4 -63.07 1.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -86.72 95.13 9.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -93.59 -52.7 4.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.922 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -86.34 -71.11 0.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -44.88 103.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -84.31 -36.76 22.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 1.6 p -54.82 -29.54 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.2 m -89.62 -36.66 15.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 24.0 ttp180 -67.67 -17.07 64.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -85.41 -45.4 11.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 15.3 pt-20 -77.7 -17.71 57.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -75.2 -49.4 19.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.055 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 66.1 t -68.76 -36.89 76.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.7 -12.33 60.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.492 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 22.3 mmtt -82.55 -17.58 44.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 320' ' ' ASP . 72.9 mt -67.55 -56.7 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' A' ' 322' ' ' GLU . 7.3 ptm180 -41.2 -35.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.8 mt -76.08 -37.78 57.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 27.3 t70 -73.97 -69.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.853 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.464 HG22 ' CD1' ' A' ' 291' ' ' ILE . 14.5 p -41.3 -47.6 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 318' ' ' ARG . 33.0 mt-10 -45.73 -49.99 14.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.85 -18.47 60.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . 0.515 ' CD2' HG21 ' A' ' 291' ' ' ILE . 79.3 t60 -84.88 -23.96 28.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 19.3 mt -93.77 -54.49 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.928 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.34 -26.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.95 -35.62 37.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.472 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 37.6 tttp -69.84 -39.34 76.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.555 ' CE2' HG12 ' A' ' 284' ' ' ILE . 2.8 m-85 -117.06 87.44 22.91 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.678 0.751 . . . . 0.0 110.875 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -40.71 5.01 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.685 2.257 . . . . 0.0 112.316 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.53 -24.46 65.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.459 HG12 ' CD1' ' A' ' 284' ' ' ILE . 41.5 t -73.47 154.14 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . 0.413 ' N ' ' CG1' ' A' ' 332' ' ' VAL . 5.7 t70 -83.35 147.28 28.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.38 -37.08 74.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.495 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 7.3 t80 -61.98 -13.32 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -90.61 -26.66 19.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.9 mp -82.54 -24.55 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.428 ' O ' ' ND2' ' A' ' 342' ' ' ASN . 3.2 mp -89.77 -35.5 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.418 ' CD ' ' HD3' ' A' ' 280' ' ' PRO . 11.5 tt0 -72.67 -22.51 60.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 341' ' ' PHE . 10.9 m -74.55 -65.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.423 ' C ' ' O ' ' A' ' 340' ' ' SER . 73.8 t80 -36.6 -41.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 338' ' ' ILE . 4.0 m-80 -49.1 -51.95 28.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 3.9 mp -68.84 -33.58 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.153 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.423 ' O ' ' C ' ' A' ' 345' ' ' ALA . 32.8 t -62.57 -63.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -35.72 -66.67 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.123 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -40.66 -53.55 2.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -44.38 -39.25 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 39.9 t -76.49 -43.49 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.412 ' C ' ' N ' ' A' ' 351' ' ' SER . 3.3 m-85 -49.56 -70.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 31.1 ptt85 -43.09 -23.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.851 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 349' ' ' PHE . 3.2 t -78.89 -52.29 8.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.812 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.517 HG21 ' CZ ' ' A' ' 300' ' ' PHE . 44.8 mt -70.64 -57.42 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.136 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 1.7 mt -43.63 -39.95 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -75.6 -58.77 3.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -37.55 -39.03 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -86.68 -59.87 2.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -115.56 89.05 3.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -50.14 151.36 2.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -159.23 147.09 17.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 31.5 p -130.92 120.91 24.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -134.69 173.82 11.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -97.86 -123.43 4.7 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.527 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 27.8 mmt-85 -125.64 55.23 1.44 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.896 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 364' ' ' ASP . 4.2 p-10 -93.69 49.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 8.2 t -153.15 -179.93 8.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -122.66 83.42 0.36 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 164.66 33.76 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.688 2.259 . . . . 0.0 112.33 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 33.4 t -89.93 -54.23 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 30.7 t -63.29 -47.6 81.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 60.2 p -166.77 148.91 6.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.914 0.388 . . . . 0.0 110.85 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.4 t -75.77 -62.32 1.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.844 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -65.79 -151.39 0.12 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.474 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 59.6 p -40.13 100.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 110.825 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.2 t -52.18 -53.51 42.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -158.1 85.21 0.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.53 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -35.41 12.69 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.708 2.272 . . . . 0.0 112.314 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -81.55 162.96 22.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.923 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -87.93 127.72 35.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.408 HD11 ' C ' ' A' ' 277' ' ' ILE . 2.7 pp -104.93 162.95 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.08 150.63 23.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.8 p -74.0 154.92 88.73 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.613 0.721 . . . . 0.0 111.134 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -170.29 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.743 2.295 . . . . 0.0 112.349 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' SER . . . . . 0.408 ' O ' ' CG2' ' A' ' 285' ' ' VAL . 1.0 OUTLIER -75.84 133.04 40.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.869 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -77.98 -42.23 33.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.136 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -51.49 -39.04 56.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.553 HG23 ' CE1' ' A' ' 329' ' ' PHE . 12.1 mt -79.11 -44.09 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.119 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 281' ' ' SER . 74.7 t -54.61 -37.69 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.085 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -64.24 -35.74 81.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -79.87 -24.46 41.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.424 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 8.9 m -66.49 -18.22 65.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.123 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 293' ' ' MET . 1.0 OUTLIER -77.27 -44.91 28.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.02 -29.18 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.156 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.46 HG13 ' N ' ' A' ' 292' ' ' ALA . 8.7 pt -98.31 -50.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.46 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -63.93 -48.28 77.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.493 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 10.6 ttm -58.88 -67.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -43.31 -58.8 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -55.3 -65.78 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.444 ' O ' ' CG2' ' A' ' 299' ' ' VAL . 49.4 mt -40.61 -58.49 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -54.98 -38.56 67.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.03 -49.49 72.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.147 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.444 ' CG2' ' O ' ' A' ' 296' ' ' LEU . 16.7 m -66.46 -35.21 74.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.454 ' CD2' ' CD1' ' A' ' 352' ' ' ILE . 10.2 m-85 -71.79 -38.1 70.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 59.4 m -68.41 -40.71 81.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.181 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.62 -56.88 4.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -79.9 71.22 6.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 305' ' ' HIS . 13.7 pt-20 -89.96 -37.66 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.909 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 304' ' ' GLU . 14.2 m80 -35.98 -42.79 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.856 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -173.5 154.97 2.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -50.27 30.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.5 -31.26 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.144 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 310' ' ' ARG . 26.4 t -59.29 135.77 57.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' A' ' 309' ' ' SER . 5.5 mpt_? 37.08 48.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -62.65 -30.42 71.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -45.49 -22.51 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -68.82 -47.18 66.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 74.8 t -58.95 -34.96 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -83.14 -41.35 18.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 13.5 mmtp -43.03 -30.24 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 318' ' ' ARG . 49.2 mt -61.75 -60.21 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.435 ' C ' ' O ' ' A' ' 317' ' ' ILE . 3.3 tmt_? -34.28 -70.91 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.47 ' CD1' ' N ' ' A' ' 319' ' ' LEU . 0.0 OUTLIER -44.58 -43.13 7.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -66.02 -70.48 0.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.445 HG22 ' CD1' ' A' ' 291' ' ' ILE . 37.5 p -44.83 -55.49 5.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.153 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -45.6 -49.47 14.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -77.65 -12.41 59.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -90.74 -25.54 19.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.422 ' O ' ' N ' ' A' ' 328' ' ' LYS . 23.3 mt -94.37 -56.73 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -45.91 -24.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -81.82 -32.77 31.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 325' ' ' LEU . 26.5 tttp -69.23 -36.72 77.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.553 ' CE1' HG23 ' A' ' 284' ' ' ILE . 0.5 OUTLIER -122.38 90.94 49.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.688 0.756 . . . . 0.0 110.892 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -20.45 34.75 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.715 2.277 . . . . 0.0 112.337 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.31 -40.78 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.448 HG11 ' CD1' ' A' ' 284' ' ' ILE . 0.8 OUTLIER -62.98 161.57 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.114 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -93.39 160.06 14.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -67.07 -38.42 85.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -57.36 -15.42 6.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -90.51 -26.07 19.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.437 ' CD1' HG13 ' A' ' 332' ' ' VAL . 3.0 mp -86.69 -45.25 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.31 -52.15 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -62.3 -55.23 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 16.1 p -38.8 -39.27 0.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 344' ' ' VAL . 35.3 t80 -64.15 -53.39 50.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 341' ' ' PHE . 17.5 m-80 -36.5 -37.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 5.3 mp -78.55 -41.22 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 341' ' ' PHE . 50.4 t -57.72 -47.84 84.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -54.74 -63.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -54.2 -23.37 14.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -78.16 -31.24 49.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 89.7 t -86.04 -32.72 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.085 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 351' ' ' SER . 5.5 m-85 -59.9 -67.04 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.497 ' O ' ' CD1' ' A' ' 354' ' ' LEU . 30.8 ptt180 -37.73 -28.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 349' ' ' PHE . 8.0 t -78.86 -45.19 21.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 349' ' ' PHE . 65.2 mt -70.42 -21.76 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 31.2 mm -70.18 -27.17 31.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 350' ' ' ARG . 5.6 mp -83.39 -51.48 7.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 354' ' ' LEU . 28.8 m-20 -35.57 -49.97 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -54.37 -54.47 40.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.911 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.505 ' CG ' ' O ' ' A' ' 357' ' ' TYR . 8.6 p90 -143.36 114.31 7.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.917 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -92.37 140.34 29.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.88 -31.75 6.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.823 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 2.1 t -99.71 83.97 2.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -56.21 136.06 53.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 174.63 -139.68 4.99 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.456 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -106.12 175.38 5.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.853 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -104.19 115.01 29.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 49.6 m -93.31 113.92 26.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -148.23 141.97 9.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.5 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 368' ' ' SER . 54.2 Cg_endo -69.73 -6.52 18.78 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.68 2.253 . . . . 0.0 112.361 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 367' ' ' PRO . 77.9 p -37.04 104.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 51.3 m -89.7 149.02 22.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.489 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 7.8 t -172.55 147.34 1.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.942 0.401 . . . . 0.0 110.833 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 53.3 p -83.87 81.45 8.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.822 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -161.75 -104.49 0.19 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 93.4 p -99.27 132.99 44.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.841 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 29.2 t -88.3 -51.05 5.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -136.74 -157.46 7.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.497 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 93.79 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.712 2.274 . . . . 0.0 112.337 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -117.77 146.06 44.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -86.81 148.91 25.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.903 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.54 161.55 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -128.51 146.99 50.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 74.7 p -72.02 151.21 92.74 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.592 0.711 . . . . 0.0 111.143 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 175.87 7.5 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.674 2.249 . . . . 0.0 112.323 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.2 t -72.96 120.53 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.72 -49.4 70.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.117 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -43.04 -43.05 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.525 HG12 ' CE1' ' A' ' 329' ' ' PHE . 30.4 mt -73.52 -48.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.146 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 98.1 t -47.19 -36.11 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.129 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -68.5 -57.26 6.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -55.75 -24.83 37.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 32.1 m -68.97 -26.24 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.092 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -75.13 -43.59 51.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.1 mp -54.75 -29.62 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.114 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.457 HG13 ' N ' ' A' ' 292' ' ' ALA . 8.5 pt -98.12 -51.22 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.457 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -58.4 -48.15 81.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 19.7 ttm -53.88 -60.18 3.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -45.4 -60.2 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 298' ' ' ALA . 29.4 mtpt -58.04 -67.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.832 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.401 ' C ' ' O ' ' A' ' 295' ' ' LYS . 86.2 mt -37.93 -33.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -84.63 -37.48 21.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -64.76 -31.95 73.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.053 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 35.1 m -85.27 -23.56 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.557 ' CZ ' ' OE1' ' A' ' 304' ' ' GLU . 5.3 t80 -75.2 -47.26 29.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 79.4 p -53.07 -40.87 64.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.102 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.71 -60.89 2.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.816 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -82.86 44.14 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.557 ' OE1' ' CZ ' ' A' ' 300' ' ' PHE . 14.9 tp10 -64.33 -42.69 96.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 304' ' ' GLU . 7.4 m170 -34.45 -50.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -166.1 174.22 9.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -80.7 -50.54 9.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.835 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 28.4 m -45.68 -42.28 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.141 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 10.0 t -48.12 104.14 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.42 37.83 22.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.849 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -40.27 -40.0 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -39.77 -42.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -47.07 -45.96 22.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.068 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.2 -68.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' A' ' 316' ' ' LYS . 3.8 t30 -43.17 -50.34 6.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 315' ' ' ASN . 11.3 mmmt -34.64 -58.3 0.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 318' ' ' ARG . 63.9 mt -38.22 -61.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 317' ' ' ILE . 3.6 tmt_? -35.19 -49.72 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 6.8 mt -69.92 -44.21 70.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -61.67 -68.86 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.888 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 14.2 p -45.5 -47.25 14.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -49.24 -50.59 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -71.18 -16.07 62.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -90.15 -21.92 21.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 45.0 mt -93.45 -54.9 3.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 25.7 tttm -49.61 -26.71 3.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 328' ' ' LYS . 10.8 pt-20 -78.01 -39.27 42.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 27.4 tptt -59.58 -48.62 80.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.525 ' CE1' HG12 ' A' ' 284' ' ' ILE . 0.2 OUTLIER -114.86 89.97 21.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -18.65 37.32 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.71 2.273 . . . . 0.0 112.399 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.91 -24.31 30.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.424 HG13 ' CD1' ' A' ' 337' ' ' ILE . 0.8 OUTLIER -77.05 154.93 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -82.83 155.0 24.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . 0.46 ' HG2' ' CD1' ' A' ' 338' ' ' ILE . 35.7 tt0 -63.93 -49.58 72.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -47.41 -19.85 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -81.65 -39.32 24.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.424 ' CD1' HG13 ' A' ' 332' ' ' VAL . 1.8 mp -71.24 -22.24 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.46 ' CD1' ' HG2' ' A' ' 334' ' ' GLN . 2.5 mp -81.81 -55.25 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.158 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.432 ' O ' ' CD1' ' A' ' 343' ' ' ILE . 0.6 OUTLIER -60.38 -37.22 80.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 96.5 p -55.73 -54.89 38.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 342' ' ' ASN . 48.6 t80 -53.35 -52.45 59.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 341' ' ' PHE . 5.6 m-80 -36.01 -47.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.432 ' CD1' ' O ' ' A' ' 339' ' ' GLU . 4.0 mp -64.2 -47.74 88.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 90.0 t -47.81 -56.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.151 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -44.5 -53.89 6.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.049 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -51.82 -38.52 56.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.69 -66.21 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 14.9 t -47.6 -55.89 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.105 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.449 ' O ' ' C ' ' A' ' 350' ' ' ARG . 6.1 m-85 -46.88 -60.31 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 349' ' ' PHE . 17.7 tpp85 -34.53 -52.86 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 70.9 m -61.32 -57.51 12.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 89.1 mt -47.41 -40.57 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 6.4 mm -62.45 -41.88 93.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.117 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -63.53 -44.85 93.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -39.26 -39.8 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -88.51 -53.14 4.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -53.45 137.23 36.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -94.74 117.53 30.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.909 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -136.69 127.07 26.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 6.8 t -78.88 128.68 33.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.62 121.24 44.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -156.51 -122.35 0.74 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.48 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 13.7 ptt85 -50.1 -44.01 51.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.799 0.333 . . . . 0.0 110.908 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 364' ' ' ASP . 19.6 p-10 -53.64 97.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.1 t 73.05 41.18 0.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.818 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -92.72 -81.61 1.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.537 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 -6.86 19.64 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.698 2.265 . . . . 0.0 112.325 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 73.1 p -69.87 122.34 19.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.815 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 19.5 p -108.48 43.17 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.467 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.1 t -142.7 149.5 38.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.839 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.8 t -85.88 131.56 34.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 150.97 -171.02 30.72 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 17.1 m -95.09 90.89 6.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.858 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 86.6 p -168.57 136.37 2.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 81.03 163.18 29.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 98.97 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.648 2.232 . . . . 0.0 112.36 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -108.8 164.66 12.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 277' ' ' ILE . 0.2 OUTLIER -86.55 156.51 20.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.415 ' N ' ' HG3' ' A' ' 276' ' ' LYS . 0.2 OUTLIER -114.62 145.88 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.115 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -109.58 143.09 39.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.0 p -118.78 154.96 53.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.59 0.709 . . . . 0.0 111.137 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -166.73 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.672 2.248 . . . . 0.0 112.377 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.9 t -78.1 120.86 23.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.82 -48.01 83.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.099 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -45.95 -41.34 11.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.531 HG12 ' CE1' ' A' ' 329' ' ' PHE . 24.5 mt -77.08 -43.95 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 43.5 t -53.9 -40.48 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -63.82 -42.81 97.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -72.66 -32.85 66.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 28.2 m -59.48 -22.54 61.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 293' ' ' MET . 51.2 mttt -76.31 -46.55 27.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -54.8 -27.55 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.465 HG13 ' N ' ' A' ' 292' ' ' ALA . 7.0 pt -98.48 -52.19 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.465 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -63.83 -48.78 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.089 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.498 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 30.9 ttm -51.97 -64.78 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -40.18 -56.38 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 298' ' ' ALA . 16.6 mmmt -59.15 -66.09 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.457 HD12 ' CG2' ' A' ' 348' ' ' VAL . 91.6 mt -38.68 -42.09 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.557 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.9 m-85 -73.54 -35.65 65.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -68.98 -54.02 17.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.13 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 34.3 m -56.53 -40.4 68.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -55.04 -57.46 11.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 26.1 m -46.99 -40.16 13.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.89 -175.76 3.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.541 ' CE2' ' HB1' ' A' ' 313' ' ' ALA . 2.1 m-85 60.24 44.34 12.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -89.38 -53.88 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -69.05 -43.16 75.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -43.2 153.22 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 309' ' ' SER . 4.1 ttpm? -77.41 -41.42 40.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 307' ' ' LYS . 10.9 m -36.86 -30.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 307' ' ' LYS . 18.2 m 54.96 47.02 23.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? 60.34 40.5 17.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' ' 311' ' ' ASP . 9.9 t0 -86.93 -62.93 1.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 313' ' ' ALA . 12.5 pt-20 -75.43 -37.31 60.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . 0.541 ' HB1' ' CE2' ' A' ' 303' ' ' TYR . . . -55.11 -36.45 65.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.093 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 60.1 t -82.54 -54.98 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.6 OUTLIER -48.87 -48.98 41.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 317' ' ' ILE . 16.9 mtmm -38.2 -58.1 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 320' ' ' ASP . 68.3 mt -33.95 -57.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.089 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 317' ' ' ILE . 50.8 ttt180 -34.53 -59.07 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.6 mt -58.9 -39.57 81.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.5 t70 -66.05 -69.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.431 HG23 ' CG2' ' A' ' 317' ' ' ILE . 27.1 p -47.12 -47.3 23.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.181 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.36 -39.11 60.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -84.61 -12.93 53.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 70.4 t60 -92.97 -26.3 17.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.49 ' O ' ' N ' ' A' ' 328' ' ' LYS . 18.8 mt -92.63 -59.37 2.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -39.57 -34.15 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.26 -39.1 55.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.527 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 32.5 tptt -54.18 -49.94 68.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.531 ' CE1' HG12 ' A' ' 284' ' ' ILE . 0.1 OUTLIER -117.14 91.14 35.73 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 110.901 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.66 -18.62 37.35 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.706 2.271 . . . . 0.0 112.34 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.3 -0.16 57.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.02 148.96 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -72.53 154.47 40.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -67.19 -45.43 76.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -54.19 -15.31 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -81.85 -31.62 31.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 1.7 mp -85.54 -32.33 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.143 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 46.5 mt -69.75 -41.06 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 340' ' ' SER . 6.0 tt0 -74.52 -56.56 4.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.445 ' C ' ' O ' ' A' ' 339' ' ' GLU . 57.2 p -34.71 -45.48 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 344' ' ' VAL . 56.9 t80 -59.9 -60.39 3.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 341' ' ' PHE . 14.5 m-80 -37.03 -47.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 4.8 mp -66.5 -41.86 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.428 ' N ' ' O ' ' A' ' 341' ' ' PHE . 61.5 t -60.79 -50.86 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -44.16 -67.32 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . 0.44 ' HG3' ' N ' ' A' ' 347' ' ' GLU . 32.9 pttt -48.53 -44.77 36.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . 0.44 ' N ' ' HG3' ' A' ' 346' ' ' LYS . 16.1 mt-10 -55.61 -50.42 70.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.457 ' CG2' HD12 ' A' ' 296' ' ' LEU . 57.7 t -59.93 -48.06 89.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.126 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.5 m-85 -54.93 -55.11 34.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -44.49 -33.47 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 6.3 m -82.87 -30.63 28.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.841 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.557 HG12 ' CE1' ' A' ' 297' ' ' TYR . 86.0 mt -79.82 -17.19 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.131 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 9.5 mm -60.52 -18.99 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.11 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -57.07 -23.88 49.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . 0.428 ' C ' ' CD ' ' A' ' 356' ' ' GLU . 8.9 t30 -89.42 22.13 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . 0.428 ' CD ' ' C ' ' A' ' 355' ' ' ASN . 39.5 mp0 -144.5 116.58 8.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 72.64 45.28 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -41.68 113.07 0.38 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.92 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -128.58 179.79 5.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 75.6 m -70.18 102.59 2.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -136.85 167.77 20.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -91.66 -124.02 3.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -107.4 140.75 39.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 110.89 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -141.25 158.77 43.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 5.8 t -43.26 131.03 4.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.831 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 66.35 82.05 0.13 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.485 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 95.63 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.742 2.294 . . . . 0.0 112.35 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 369' ' ' SER . 13.2 t -76.67 -48.84 17.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.836 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 368' ' ' SER . 87.9 p 36.19 41.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.485 -179.959 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.0 m 38.7 48.51 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.392 . . . . 0.0 110.874 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 80.2 p -118.42 -32.92 4.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.865 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 52.56 -124.62 26.88 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.497 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -43.0 156.04 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.884 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 98.3 p -149.03 145.6 27.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.871 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -101.28 -83.26 1.72 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.455 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 142.9 49.34 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.686 2.258 . . . . 0.0 112.317 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -67.39 121.4 15.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -104.59 141.73 35.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.404 ' H ' ' CD1' ' A' ' 277' ' ' ILE . 0.2 OUTLIER -92.99 159.06 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -130.28 139.82 50.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 41.2 p -106.0 151.77 40.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.583 0.706 . . . . 0.0 111.137 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -174.06 0.83 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.702 2.268 . . . . 0.0 112.366 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.3 t -69.98 121.92 18.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.829 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.93 -48.12 77.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -46.08 -42.19 13.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.563 HG12 ' CZ ' ' A' ' 329' ' ' PHE . 22.7 mt -73.77 -40.18 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 90.7 t -57.12 -46.36 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 35.0 mttm -60.87 -40.89 94.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -74.89 -30.86 61.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 42.9 m -62.91 -22.34 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 293' ' ' MET . 30.3 mttt -77.76 -43.57 30.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -55.72 -28.56 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.446 ' CG1' ' N ' ' A' ' 292' ' ' ALA . 5.8 pt -98.13 -51.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.446 ' N ' ' CG1' ' A' ' 291' ' ' ILE . . . -62.76 -48.21 80.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.493 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 32.4 ttm -55.51 -70.25 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -40.27 -54.61 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 298' ' ' ALA . 26.8 mttp -58.75 -69.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.403 ' C ' ' O ' ' A' ' 295' ' ' LYS . 86.4 mt -37.92 -43.39 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.567 ' CE1' HG12 ' A' ' 352' ' ' ILE . 10.4 m-85 -71.61 -38.95 70.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -62.12 -46.68 87.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.101 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 26.4 m -70.74 -27.02 29.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.433 ' CZ ' HG22 ' A' ' 352' ' ' ILE . 3.2 t80 -76.39 -48.1 20.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 3.5 m -56.53 -20.51 20.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.091 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.535 ' OD2' ' CE1' ' A' ' 303' ' ' TYR . 17.9 t0 -99.29 -64.3 1.05 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.871 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.535 ' CE1' ' OD2' ' A' ' 302' ' ' ASP . 5.0 m-85 -77.51 66.01 3.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 305' ' ' HIS . 34.4 mt-10 -88.7 -50.61 6.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.433 ' O ' ' CG ' ' A' ' 306' ' ' ASP . 34.6 p-80 -35.76 -36.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.834 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 305' ' ' HIS . 15.8 m-20 -162.29 150.25 14.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.41 -26.11 20.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.954 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 310' ' ' ARG . 2.8 m -76.83 -34.41 22.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.3 m -52.03 86.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 308' ' ' VAL . 14.9 ttp180 73.84 48.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -56.63 -25.73 54.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -39.29 -34.1 0.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -55.17 -60.29 3.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.45 -53.96 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.22 -36.83 61.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp -57.2 -32.08 66.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.495 ' O ' ' N ' ' A' ' 320' ' ' ASP . 8.7 mm -48.12 -71.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 317' ' ' ILE . 31.2 ttt180 -33.95 -45.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 13.6 mt -69.56 -44.3 71.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.93 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 317' ' ' ILE . 32.1 t0 -67.06 -66.19 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.411 ' CG2' HG13 ' A' ' 291' ' ' ILE . 16.9 p -47.21 -51.74 17.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -49.4 -43.92 44.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -82.31 -11.99 58.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -89.39 -27.9 20.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 328' ' ' LYS . 20.0 mt -90.19 -52.62 4.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 325' ' ' LEU . 0.4 OUTLIER -36.81 -44.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -64.44 -46.65 82.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.451 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 21.1 tptt -55.33 -42.49 73.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.563 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 0.2 OUTLIER -120.62 89.87 45.24 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.686 0.755 . . . . 0.0 110.873 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.94 2.4 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.242 . . . . 0.0 112.362 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -61.98 -25.65 67.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.467 HG11 ' CD1' ' A' ' 284' ' ' ILE . 97.2 t -73.75 148.81 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . 0.463 ' N ' HG12 ' A' ' 332' ' ' VAL . 8.8 t0 -84.65 147.84 26.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -53.57 -45.14 69.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.6 t80 -51.98 -18.79 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -88.92 -41.15 12.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.5 mp -69.31 -31.72 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.183 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 39.6 mt -76.22 -66.64 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.118 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.423 ' O ' ' CD1' ' A' ' 343' ' ' ILE . 8.5 tp10 -42.1 -53.86 3.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 2.2 p -40.5 -41.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.837 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.443 ' CE1' HG22 ' A' ' 317' ' ' ILE . 75.7 t80 -62.43 -53.03 60.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.851 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -42.53 -43.33 3.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.423 ' CD1' ' O ' ' A' ' 339' ' ' GLU . 4.7 mp -65.94 -34.14 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 341' ' ' PHE . 73.9 t -70.66 -58.74 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.129 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -37.18 -61.74 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.074 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -45.5 -51.25 11.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -55.81 -59.67 4.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 88.5 t -48.98 -62.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.114 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.1 m-85 -44.5 -69.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 349' ' ' PHE . 20.9 ttp180 -34.3 -54.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 41.9 m -56.5 -42.67 78.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.567 HG12 ' CE1' ' A' ' 297' ' ' TYR . 61.8 mt -68.31 -21.76 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 10.8 mm -70.08 -11.99 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.172 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 356' ' ' GLU . 2.4 mm? -83.66 -1.59 54.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 355' ' ' ASN . 2.9 p-10 -52.84 85.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 354' ' ' LEU . 6.1 mm-40 64.0 40.52 7.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -122.03 120.8 35.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -100.81 131.47 46.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.891 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -129.36 153.28 48.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.873 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 361' ' ' ASP . 13.0 t -99.12 -43.31 6.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.929 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 360' ' ' CYS . 68.7 m-20 -37.14 140.11 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -147.13 -91.89 0.11 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.491 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -73.94 108.75 6.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -49.51 171.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.3 t -69.41 -57.58 5.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -158.76 146.81 13.68 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.474 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 87.07 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.699 2.266 . . . . 0.0 112.342 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 88.5 p -66.08 143.1 57.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.855 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 20.1 m -113.51 -54.69 2.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.846 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 -179.966 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.2 t 49.68 41.64 22.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.915 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.3 t -100.37 121.51 41.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 124.04 128.07 3.27 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.453 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 17.3 m -124.82 103.1 7.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.391 . . . . 0.0 110.875 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 64.4 p -106.66 129.72 54.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.884 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 73.19 -176.74 43.81 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 95.36 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.696 2.264 . . . . 0.0 112.321 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -119.99 127.45 52.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.56 119.91 13.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.907 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 7.5 mm -96.93 146.6 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.155 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -124.66 142.95 51.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 43.6 p -74.73 151.63 86.9 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.583 0.706 . . . . 0.0 111.15 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.99 6.04 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.664 2.243 . . . . 0.0 112.339 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 66.5 m -68.91 127.5 33.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.85 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 284' ' ' ILE . . . -70.98 -52.18 21.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -39.86 -27.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.557 HG12 ' CZ ' ' A' ' 329' ' ' PHE . 22.0 mt -92.27 -43.25 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 77.6 t -53.65 -35.93 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -66.01 -34.69 78.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.906 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -76.95 -27.21 54.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.863 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.487 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 2.7 m -65.64 -20.68 66.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 293' ' ' MET . 0.7 OUTLIER -76.5 -45.71 29.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.2 mp -52.58 -32.1 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.458 HG13 ' N ' ' A' ' 292' ' ' ALA . 6.9 pt -98.49 -52.08 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' A' ' 288' ' ' THR . . . -60.78 -48.56 81.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.07 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 33.8 ttm -55.36 -69.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 293' ' ' MET . 16.2 mt-10 -37.91 -67.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.867 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 298' ' ' ALA . 45.5 mmtt -50.37 -63.44 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 72.6 mt -42.96 -30.38 0.41 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.559 ' CE1' HG12 ' A' ' 352' ' ' ILE . 10.1 m-85 -88.84 -31.25 18.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -69.79 -48.99 57.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.076 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.469 HG21 ' N ' ' A' ' 300' ' ' PHE . 19.5 m -64.55 -34.64 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.165 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.594 ' CZ ' ' CG2' ' A' ' 352' ' ' ILE . 3.6 t80 -57.05 -59.88 4.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.6 m -67.5 -37.0 82.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -64.86 -69.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -85.77 82.53 8.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -86.67 -49.11 7.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 50.5 p-80 -91.85 -50.39 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.86 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -44.01 121.37 2.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.845 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -90.82 -67.73 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 8.0 p -44.82 -49.87 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 14.6 m -56.56 -41.91 77.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.453 ' NH2' ' CD2' ' A' ' 300' ' ' PHE . 7.3 tpt85 -59.01 -52.48 65.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -49.5 -64.19 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.816 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.1 -31.27 65.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -64.48 -65.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 23.8 t -54.98 -41.9 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.6 -44.67 85.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -44.24 -57.09 3.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.445 ' O ' ' N ' ' A' ' 320' ' ' ASP . 58.8 mt -41.49 -55.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -39.75 -35.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.0 mt -88.62 -32.29 18.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 24.8 t70 -67.48 -65.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 71.8 p -51.77 -44.46 63.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -44.69 -54.4 6.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -76.81 -13.1 60.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.836 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -85.96 -26.19 25.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.456 ' O ' ' N ' ' A' ' 328' ' ' LYS . 26.6 mt -91.62 -62.22 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -39.83 -43.78 1.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -62.86 -38.15 89.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 325' ' ' LEU . 44.2 tttp -60.33 -45.74 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.557 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 0.9 OUTLIER -117.97 94.71 46.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.688 0.756 . . . . 0.0 110.863 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -20.63 34.47 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.652 2.235 . . . . 0.0 112.327 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.02 -40.22 28.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.46 HG12 ' CD1' ' A' ' 337' ' ' ILE . 0.9 OUTLIER -63.93 156.16 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -90.98 156.49 17.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -62.94 -42.9 99.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.6 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 4.3 t80 -54.03 -15.96 1.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -88.18 -27.58 21.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.46 ' CD1' HG12 ' A' ' 332' ' ' VAL . 2.6 mp -85.67 -56.83 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . 0.41 ' O ' ' ND2' ' A' ' 342' ' ' ASN . 72.8 mt -48.56 -33.12 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.123 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -79.22 -42.4 26.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 73.8 m -52.23 -53.07 48.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.406 ' CE1' HG23 ' A' ' 317' ' ' ILE . 56.0 t80 -46.61 -53.03 12.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 338' ' ' ILE . 37.6 m-80 -42.55 -52.49 4.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 3.7 mp -56.3 -40.04 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.161 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.448 ' O ' ' C ' ' A' ' 345' ' ' ALA . 91.3 t -63.89 -62.11 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.131 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.1 -66.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -46.44 -58.13 4.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -42.69 -62.34 1.02 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.538 HG12 ' CE2' ' A' ' 297' ' ' TYR . 37.0 t -50.33 -66.13 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.144 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 351' ' ' SER . 8.0 m-85 -39.01 -69.49 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 349' ' ' PHE . 35.8 ttm180 -36.33 -32.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 355' ' ' ASN . 1.6 t -76.89 -56.37 4.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.594 ' CG2' ' CZ ' ' A' ' 300' ' ' PHE . 80.2 mt -47.51 -51.37 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.102 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.7 mp -55.95 -32.22 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 77.5 mt -100.83 -0.49 36.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 351' ' ' SER . 41.6 t30 -102.06 96.86 7.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.851 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' ' 355' ' ' ASN . 7.8 pt-20 43.62 42.02 3.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.445 ' C ' ' CD1' ' A' ' 357' ' ' TYR . 5.5 t80 -127.08 -56.72 1.34 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.973 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -136.6 139.97 42.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 7.0 mtm-85 -87.11 94.1 9.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 30.1 t -74.74 135.18 41.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -75.89 102.51 5.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 155.12 108.15 0.29 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.446 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -82.67 44.57 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.808 0.337 . . . . 0.0 110.858 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -117.21 -57.79 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 61.5 m -74.49 114.61 13.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -117.16 -157.84 10.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.472 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -25.25 29.14 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.744 2.296 . . . . 0.0 112.343 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 32.2 m -40.8 117.62 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 370' ' ' GLY . 69.6 m -150.83 158.87 44.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.834 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 369' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.541 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.6 t -171.5 121.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 0.0 110.911 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 25.9 p -173.28 166.49 4.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -167.77 141.82 7.09 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.461 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -167.43 160.18 13.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 110.877 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.4 m -171.09 148.71 2.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.879 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 127.33 -93.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.477 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 1.22 4.61 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.677 2.251 . . . . 0.0 112.356 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -66.06 163.78 16.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -93.12 137.83 32.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 3.1 mm -108.81 110.49 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.148 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -108.74 147.47 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 72.6 p -75.68 151.18 84.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.562 0.696 . . . . 0.0 111.142 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -176.02 1.35 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.641 2.228 . . . . 0.0 112.339 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 14.1 m -77.6 124.67 28.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.5 76.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.12 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -46.78 -29.67 2.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.447 ' CD1' HG23 ' A' ' 332' ' ' VAL . 17.4 mt -89.18 -52.4 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.112 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 40.2 t -44.22 -35.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -66.0 -35.56 80.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.441 ' CD2' ' HD3' ' A' ' 328' ' ' LYS . 28.4 t80 -81.5 -18.77 43.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 28.3 m -70.38 -26.09 63.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 293' ' ' MET . 0.0 OUTLIER -75.79 -43.35 46.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.889 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.6 mp -54.58 -31.25 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.559 HG21 ' CD2' ' A' ' 324' ' ' HIS . 6.3 pt -98.09 -51.83 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.443 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -60.45 -48.1 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.1 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 11.9 ttm -55.9 -62.26 1.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -39.75 -72.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 298' ' ' ALA . 13.7 mptt -50.23 -63.61 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 45.1 mt -37.66 -43.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -78.67 -33.36 47.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -65.67 -36.56 84.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.095 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 24.0 m -80.8 -27.09 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.503 ' CZ ' HG21 ' A' ' 352' ' ' ILE . 3.6 t80 -69.0 -50.81 45.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 33.3 p -53.36 -53.66 47.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.153 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -58.74 -74.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -76.56 54.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 305' ' ' HIS . 10.2 tm-20 -66.77 -58.35 5.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.447 ' C ' ' O ' ' A' ' 304' ' ' GLU . 6.3 t-80 -34.82 -58.12 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -139.59 128.0 22.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.96 -52.65 4.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 13.8 m -54.65 -22.05 8.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.138 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 51.9 p -60.97 -27.52 68.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.791 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -133.55 49.71 2.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.33 -30.07 17.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 9.6 pt-20 -51.4 -25.45 6.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -75.11 -68.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.07 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 58.4 t -55.61 -42.29 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.5 OUTLIER -59.95 -55.54 32.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 9.6 mmmt -35.53 -43.71 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.422 ' CG2' HG22 ' A' ' 321' ' ' THR . 50.5 mt -47.49 -52.43 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.44 ' HG2' ' CE2' ' A' ' 341' ' ' PHE . 14.6 mmm-85 -40.01 -39.22 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.0 mt -82.98 -44.83 14.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.73 -69.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.85 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.422 HG22 ' CG2' ' A' ' 317' ' ' ILE . 37.6 p -46.04 -47.95 16.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.47 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 60.5 tt0 -45.22 -52.3 9.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.92 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -78.66 -14.54 59.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . 0.559 ' CD2' HG21 ' A' ' 291' ' ' ILE . 44.5 t60 -82.1 -29.71 31.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.867 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 328' ' ' LYS . 15.9 mt -92.39 -59.78 2.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.407 ' NZ ' ' HB2' ' A' ' 334' ' ' GLN . 39.8 tttp -43.14 -29.67 0.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.88 -35.36 50.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.511 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 37.9 tttp -58.51 -55.66 32.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.511 ' CZ ' ' HG2' ' A' ' 328' ' ' LYS . 0.1 OUTLIER -117.89 107.64 43.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.663 0.744 . . . . 0.0 110.866 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -21.9 32.77 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.679 2.253 . . . . 0.0 112.344 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.57 -35.72 70.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 337' ' ' ILE . 7.1 p -63.8 146.0 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . 0.415 ' O ' ' CD1' ' A' ' 337' ' ' ILE . 1.4 t70 -87.17 157.9 19.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . 0.407 ' HB2' ' NZ ' ' A' ' 326' ' ' LYS . 9.7 tt0 -65.16 -35.92 82.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.465 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 9.5 t80 -63.55 -9.77 14.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -93.38 -41.35 9.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.47 ' CG2' ' HA ' ' A' ' 322' ' ' GLU . 4.9 mp -69.64 -45.57 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.11 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.81 -41.05 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.414 ' O ' ' CD1' ' A' ' 343' ' ' ILE . 16.6 tt0 -73.61 -42.77 61.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 341' ' ' PHE . 37.1 m -51.11 -62.35 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 344' ' ' VAL . 68.6 t80 -37.78 -59.39 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 341' ' ' PHE . 2.4 m-80 -36.63 -54.56 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.414 ' CD1' ' O ' ' A' ' 339' ' ' GLU . 4.7 mp -57.75 -36.6 55.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 341' ' ' PHE . 97.1 t -72.14 -59.12 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -36.26 -66.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -49.62 -36.51 24.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 344' ' ' VAL . 1.5 tp10 -57.33 -40.09 77.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.09 -40.09 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.145 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 350' ' ' ARG . 6.1 m-85 -51.94 -70.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 349' ' ' PHE . 10.1 ptt85 -35.33 -42.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 23.4 m -64.11 -49.0 73.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.503 HG21 ' CZ ' ' A' ' 300' ' ' PHE . 97.3 mt -63.91 -43.57 97.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.111 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 4.4 mm -49.27 -38.32 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.162 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 3.5 mp -90.32 -12.74 36.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.78 -7.87 54.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . 0.504 ' O ' ' CD2' ' A' ' 357' ' ' TYR . 8.2 pt-20 -114.83 56.61 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 356' ' ' GLU . 43.3 m-85 -165.52 124.46 1.68 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -63.7 93.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -141.57 122.12 14.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 57.3 m -93.34 129.68 39.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -92.92 -50.04 5.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 159.17 -107.87 0.34 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.477 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -80.26 88.41 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -87.76 158.15 18.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 46.1 t -130.08 106.48 8.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.852 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -108.78 -82.99 1.46 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.508 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 112.2 3.01 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.71 2.273 . . . . 0.0 112.331 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 24.8 p -90.89 41.19 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.856 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 74.4 m 62.87 41.97 8.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.488 -179.992 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.481 -0.247 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 19.6 t -118.21 -55.84 2.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.887 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 27.6 p 46.78 42.17 11.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.868 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -132.26 106.96 0.68 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.502 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.0 m -115.77 174.03 6.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.353 . . . . 0.0 110.868 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 16.5 m -152.46 151.12 30.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -134.96 169.22 23.36 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.435 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 102.13 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.656 2.237 . . . . 0.0 112.325 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . 0.413 ' HG3' ' N ' ' A' ' 276' ' ' LYS . 3.7 tp-100 -113.69 152.03 31.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . 0.413 ' N ' ' HG3' ' A' ' 275' ' ' GLN . 21.4 mttp -83.45 109.36 17.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -107.69 158.56 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.179 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' A' ' 278' ' ' PHE . 0.1 OUTLIER -74.86 147.3 41.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 68.3 p -74.18 152.21 88.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.556 0.693 . . . . 0.0 111.201 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -176.57 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.673 2.249 . . . . 0.0 112.341 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 2.3 t -69.99 125.71 27.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.38 -30.92 70.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.66 -40.08 74.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.569 HG12 ' CE2' ' A' ' 329' ' ' PHE . 17.4 mt -76.79 -45.85 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 91.5 t -48.94 -39.19 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -65.06 -44.29 89.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.495 ' CE1' ' NZ ' ' A' ' 328' ' ' LYS . 49.4 t80 -72.17 -26.36 62.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 110.978 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 49.4 m -69.37 -20.94 63.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.163 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 27.9 mttt -78.84 -43.55 24.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.25 -31.09 31.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.466 ' CG1' ' N ' ' A' ' 292' ' ' ALA . 6.1 pt -97.77 -51.33 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 288' ' ' THR . . . -59.82 -46.96 87.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.111 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 33.3 ttm -55.93 -68.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.865 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 293' ' ' MET . 49.2 mt-10 -35.92 -59.91 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 298' ' ' ALA . 31.3 mmtt -60.06 -64.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 295' ' ' LYS . 48.4 mt -36.03 -37.88 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.894 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.489 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.8 m-85 -78.48 -44.25 24.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -59.36 -40.16 85.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.063 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 302' ' ' ASP . 28.1 m -77.64 -38.21 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.557 ' CZ ' ' CG2' ' A' ' 352' ' ' ILE . 15.8 t80 -42.37 -46.37 4.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 11.1 m -77.28 -23.6 51.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.149 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 299' ' ' VAL . 26.1 t0 -64.08 -60.68 2.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.501 ' CZ ' ' CG2' ' A' ' 314' ' ' VAL . 37.9 p90 -100.53 20.38 15.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.89 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.423 ' OE2' ' CG ' ' A' ' 305' ' ' HIS . 2.1 pp20? -44.72 -42.42 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.423 ' CG ' ' OE2' ' A' ' 304' ' ' GLU . 8.6 m-70 -50.26 -71.81 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -124.8 154.01 41.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -67.57 -51.7 47.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.3 m -55.36 -52.78 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.153 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 93.1 p -45.62 114.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? 61.7 35.62 16.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.912 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -53.42 -28.69 31.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 21.6 pm0 -56.16 -27.77 55.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -56.95 -42.95 81.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . 0.501 ' CG2' ' CZ ' ' A' ' 303' ' ' TYR . 54.5 t -72.56 -62.87 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -50.47 -41.67 53.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 8.4 mmtp -41.61 -64.77 0.52 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.423 ' O ' ' N ' ' A' ' 320' ' ' ASP . 41.5 mt -42.29 -61.88 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.123 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.456 ' CD ' ' CD1' ' A' ' 341' ' ' PHE . 15.8 mmm180 -36.82 -33.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 317' ' ' ILE . 10.0 mt -88.11 -41.49 13.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 317' ' ' ILE . 41.2 m-20 -61.28 -61.8 2.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.436 ' CG2' HG13 ' A' ' 291' ' ' ILE . 36.2 p -54.16 -46.47 72.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -49.33 -40.13 34.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -85.46 -19.75 30.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . 0.401 ' CD2' HG21 ' A' ' 291' ' ' ILE . 74.7 t60 -82.46 -25.79 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.488 ' O ' ' N ' ' A' ' 328' ' ' LYS . 32.5 mt -89.76 -56.47 3.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.93 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.4 ' N ' HG12 ' A' ' 337' ' ' ILE . 2.2 tmmm? -38.2 -45.74 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.63 -37.8 85.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.583 ' HG2' ' CE2' ' A' ' 329' ' ' PHE . 9.9 tptm -57.95 -49.2 77.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.583 ' CE2' ' HG2' ' A' ' 328' ' ' LYS . 9.5 m-85 -124.26 94.66 44.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.629 0.728 . . . . 0.0 110.848 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -41.99 3.8 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.668 2.245 . . . . 0.0 112.341 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -63.71 -25.71 68.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 284' ' ' ILE . 53.0 t -69.17 148.77 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . 0.453 ' N ' HG11 ' A' ' 332' ' ' VAL . 3.3 t70 -72.53 150.51 43.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -62.48 -40.05 95.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.93 -11.09 16.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -87.26 -34.26 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.466 ' CG2' ' HB2' ' A' ' 325' ' ' LEU . 2.5 mp -75.04 -35.63 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.88 -64.62 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -44.9 -53.9 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 46.9 m -41.03 -34.96 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.456 ' CD1' ' CD ' ' A' ' 318' ' ' ARG . 48.0 t80 -70.01 -53.05 19.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -40.77 -40.19 1.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 5.1 mp -73.67 -42.87 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 20.1 t -60.91 -62.64 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.116 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -40.28 -67.03 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -39.22 -51.74 1.96 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -56.08 -68.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 38.3 t -44.44 -30.95 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.139 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -73.98 -64.38 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.02 -19.53 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 6.3 p -87.07 -32.02 20.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.557 ' CG2' ' CZ ' ' A' ' 300' ' ' PHE . 54.3 mt -70.97 -54.52 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.146 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 5.0 mp -50.95 -29.28 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.151 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 55.7 mt -94.67 -27.8 15.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -46.3 -43.19 15.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -45.57 -43.49 12.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -99.55 102.91 14.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.444 ' HD3' ' N ' ' A' ' 358' ' ' LYS . 0.1 OUTLIER -74.05 107.87 6.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.909 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -112.49 36.79 3.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 57.2 m -145.61 155.52 43.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -56.97 -59.21 5.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 363' ' ' ARG . . . 156.44 45.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 362' ' ' GLY . 11.3 ttp85 -35.54 101.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 110.856 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -95.15 -57.34 2.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.4 t 57.92 34.66 24.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -137.93 85.96 0.23 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.521 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 368' ' ' SER . 53.9 Cg_endo -69.73 -42.5 3.37 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.67 2.247 . . . . 0.0 112.372 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 367' ' ' PRO . 49.1 m -35.55 122.71 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 15.1 p -65.13 -9.57 23.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.89 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.515 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.6 t -173.13 149.47 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 110.861 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 12.4 p -98.31 23.24 8.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 61.55 174.33 1.55 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 82.9 p -157.87 169.02 25.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.375 . . . . 0.0 110.842 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 57.7 p -125.44 137.26 53.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.864 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 170.94 -160.31 32.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.526 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 2.16 3.77 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.658 2.239 . . . . 0.0 112.319 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -65.99 133.8 51.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -66.04 168.91 7.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 2.5 pp -105.16 160.69 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.149 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -122.29 148.09 45.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 53.0 p -73.07 151.58 90.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.543 0.687 . . . . 0.0 111.128 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 170.28 16.91 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.663 2.242 . . . . 0.0 112.35 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 9.9 m -68.61 125.89 27.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.77 87.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -38.78 -35.29 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.501 ' CD1' ' CG2' ' A' ' 332' ' ' VAL . 22.0 mt -86.72 -56.99 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.113 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 91.9 t -40.84 -36.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -64.65 -41.98 95.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 284' ' ' ILE . 55.1 t80 -74.26 -31.44 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.455 ' CG2' HD13 ' A' ' 325' ' ' LEU . 22.8 m -60.34 -20.98 61.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 293' ' ' MET . 21.4 mttt -77.98 -43.79 28.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.4 mp -58.88 -27.2 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.476 ' CG1' ' N ' ' A' ' 292' ' ' ALA . 5.5 pt -98.1 -51.13 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.476 ' N ' ' CG1' ' A' ' 291' ' ' ILE . . . -61.92 -46.28 90.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.094 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.492 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 8.0 ttm -52.19 -63.46 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 293' ' ' MET . 14.9 mt-10 -37.53 -73.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 296' ' ' LEU . 1.1 mptm? -46.59 -64.14 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 295' ' ' LYS . 51.1 mt -36.04 -55.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.561 ' CE1' HG12 ' A' ' 352' ' ' ILE . 11.5 m-85 -60.82 -41.95 96.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.935 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -58.83 -52.75 64.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.083 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.425 HG21 ' N ' ' A' ' 300' ' ' PHE . 27.7 m -65.44 -25.31 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.553 ' CD2' HG21 ' A' ' 352' ' ' ILE . 16.0 t80 -69.64 -62.37 1.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 14.6 t -58.09 -18.15 22.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.133 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -86.06 -65.09 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -89.39 48.6 1.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 305' ' ' HIS . 10.0 tp10 -64.67 -48.74 73.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.894 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 304' ' ' GLU . 34.9 t60 -35.9 -45.25 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.851 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -167.43 130.64 1.73 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -59.78 -53.35 58.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 2.7 m -41.41 -33.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 7.5 t -53.22 111.57 0.71 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 46.96 42.0 11.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 313' ' ' ALA . 1.0 OUTLIER -43.15 -25.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.834 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.469 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 7.8 pt-20 -39.29 -29.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 311' ' ' ASP . . . -62.0 -53.71 51.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 96.0 t -61.15 -66.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.9 t30 -43.25 -49.65 6.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.919 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.469 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 20.5 mmtt -37.8 -55.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 320' ' ' ASP . 54.2 mt -43.08 -62.81 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 317' ' ' ILE . 4.4 tmt_? -34.41 -38.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 8.4 mt -79.82 -43.09 23.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 317' ' ' ILE . 1.5 t70 -61.32 -65.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 71.7 p -50.79 -46.46 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.413 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 0.3 OUTLIER -48.08 -35.64 11.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -93.18 -20.22 20.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -81.29 -21.6 39.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.462 ' O ' ' N ' ' A' ' 328' ' ' LYS . 22.8 mt -94.22 -65.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -39.93 -29.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . 0.443 ' HG3' ' N ' ' A' ' 328' ' ' LYS . 4.9 pt-20 -75.08 -43.01 55.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.532 ' HE3' ' CZ ' ' A' ' 329' ' ' PHE . 45.3 tttp -53.54 -45.52 69.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.532 ' CZ ' ' HE3' ' A' ' 328' ' ' LYS . 0.1 OUTLIER -123.1 107.94 32.59 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.642 0.734 . . . . 0.0 110.926 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -22.5 32.13 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.657 2.238 . . . . 0.0 112.352 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -72.3 -39.45 68.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.501 ' CG2' ' CD1' ' A' ' 284' ' ' ILE . 7.3 p -57.03 147.98 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . 0.438 ' N ' HG23 ' A' ' 332' ' ' VAL . 1.5 t70 -96.56 154.33 17.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -61.81 -21.67 64.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.593 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.5 t80 -76.44 -9.67 58.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -96.31 -46.87 6.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.467 ' CD1' HG11 ' A' ' 332' ' ' VAL . 5.4 mp -62.15 -37.69 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 48.4 mt -71.18 -59.35 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -62.32 -12.29 20.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 341' ' ' PHE . 3.5 m -80.19 -68.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.821 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 340' ' ' SER . 40.0 t80 -34.82 -44.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -42.61 -49.99 5.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 4.1 mp -63.42 -47.51 91.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.131 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 345' ' ' ALA . 53.9 t -48.89 -67.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.18 -66.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.133 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -38.45 -44.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 348' ' ' VAL . 15.6 tt0 -62.37 -68.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.436 ' O ' ' C ' ' A' ' 349' ' ' PHE . 96.1 t -35.18 -68.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 352' ' ' ILE . 9.5 m-85 -34.72 -68.86 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 349' ' ' PHE . 17.2 ttt180 -34.24 -50.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 3.5 m -67.07 -40.38 87.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.875 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.561 HG12 ' CE1' ' A' ' 297' ' ' TYR . 70.7 mt -59.71 -21.42 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.165 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . 0.431 ' CG2' ' HB2' ' A' ' 357' ' ' TYR . 23.5 mm -68.82 -24.78 29.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.149 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -57.31 -16.9 9.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.947 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -84.77 58.17 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 357' ' ' TYR . 23.5 mt-10 41.38 51.17 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.431 ' HB2' ' CG2' ' A' ' 353' ' ' ILE . 32.9 t80 -37.17 142.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 357' ' ' TYR . 1.1 pptp? -38.17 149.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.914 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 67.68 46.17 1.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 8.2 t -108.73 166.08 11.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -138.99 171.44 14.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 105.57 69.49 0.75 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.515 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -84.92 41.71 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.806 0.336 . . . . 0.0 110.878 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -131.82 113.98 14.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 17.0 m -132.25 123.17 26.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 88.43 146.6 12.55 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 368' ' ' SER . 54.0 Cg_endo -69.74 2.73 3.26 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.698 2.266 . . . . 0.0 112.35 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 367' ' ' PRO . 22.9 t -34.63 124.86 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 368' ' ' SER . 75.4 m -37.63 144.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.848 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.455 179.979 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.0 m 50.06 42.43 24.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 110.897 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 39.7 m -59.47 120.13 8.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.852 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 129.98 78.29 0.19 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.495 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 3.3 m -68.78 124.74 24.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 0.0 110.825 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 56.2 p -73.99 -41.16 62.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.84 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -127.77 -174.03 13.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.486 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 106.91 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.736 2.291 . . . . 0.0 112.361 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -67.34 157.27 34.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.41 155.19 36.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . 0.421 ' C ' HD12 ' A' ' 277' ' ' ILE . 2.7 pp -96.01 148.33 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -132.15 137.74 47.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 17.0 p -95.79 153.59 39.29 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.591 0.71 . . . . 0.0 111.104 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 167.14 25.36 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.705 2.27 . . . . 0.0 112.322 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.4 p -72.95 122.88 22.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.04 -49.14 77.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.077 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -44.53 -42.79 7.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.569 HG12 ' CE1' ' A' ' 329' ' ' PHE . 8.8 mt -77.16 -44.21 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 40.5 t -52.13 -43.75 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.109 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -30.52 70.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . 0.56 ' CE2' ' HD2' ' A' ' 328' ' ' LYS . 47.6 t80 -84.47 -22.94 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.933 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 30.0 m -66.31 -22.96 66.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 2.1 mptm? -75.75 -44.1 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.9 mp -53.64 -30.87 19.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.108 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.521 HG21 ' CD2' ' A' ' 324' ' ' HIS . 5.4 pt -98.37 -51.99 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.44 ' N ' ' CG1' ' A' ' 291' ' ' ILE . . . -61.49 -48.61 80.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.096 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 15.4 ttm -55.11 -62.28 1.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -47.72 -64.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -51.34 -63.7 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 51.3 mt -40.59 -57.43 1.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . 0.505 ' CE1' ' CG1' ' A' ' 352' ' ' ILE . 9.2 m-85 -55.58 -34.53 64.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -66.64 -53.07 37.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.058 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.42 -25.82 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -50.57 -56.46 11.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 69.0 p -73.13 -11.53 60.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.14 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -77.46 -55.68 5.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -100.25 13.18 35.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -37.36 -34.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -41.77 -55.76 2.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -163.09 171.26 16.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.2 -62.25 1.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 38.4 t -48.25 -35.32 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 10.3 m -55.22 120.97 7.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 42.93 35.95 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -50.83 -20.76 1.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.843 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 6.7 pt-20 -57.56 -19.9 28.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -67.91 -58.9 3.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.125 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.65 -45.77 72.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.7 t30 -67.81 -51.02 53.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.937 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.472 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 18.4 mmtt -36.61 -59.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 318' ' ' ARG . 92.8 mt -42.17 -54.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.157 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 317' ' ' ILE . 76.4 mtt-85 -38.09 -35.84 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.7 mt -83.87 -43.95 14.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.91 -69.24 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 68.3 p -49.15 -46.79 45.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.096 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.469 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 7.3 tm-20 -46.76 -43.67 18.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -87.59 -10.14 52.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . 0.521 ' CD2' HG21 ' A' ' 291' ' ' ILE . 44.8 t60 -89.34 -26.18 21.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 19.5 mt -93.59 -53.32 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -50.62 -27.93 7.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -84.5 -27.71 27.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.568 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 42.0 tttp -62.26 -55.19 30.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.569 ' CE1' HG12 ' A' ' 284' ' ' ILE . 0.1 OUTLIER -123.31 108.39 31.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.642 0.734 . . . . 0.0 110.86 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -21.08 34.02 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.691 2.261 . . . . 0.0 112.328 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.43 -35.5 75.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.455 HG12 ' CD1' ' A' ' 337' ' ' ILE . 9.9 p -71.7 153.47 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.173 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -93.47 161.42 14.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -61.97 -47.04 86.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . 0.597 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.4 t80 -51.41 -16.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -89.09 -34.54 16.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.915 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.469 ' CG2' ' HA ' ' A' ' 322' ' ' GLU . 2.8 mp -73.81 -30.33 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 28.1 mt -77.84 -61.83 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.429 ' O ' ' CD1' ' A' ' 343' ' ' ILE . 6.9 tp10 -52.67 -35.7 55.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 4.4 p -57.02 -47.79 80.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -56.85 -50.47 72.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -40.42 -51.48 2.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . 0.429 ' CD1' ' O ' ' A' ' 339' ' ' GLU . 4.9 mp -65.1 -38.07 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.169 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.409 ' O ' ' N ' ' A' ' 347' ' ' GLU . 77.8 t -60.85 -63.64 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -37.69 -51.99 1.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.079 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -54.84 -42.73 72.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 344' ' ' VAL . 20.0 tp10 -60.31 -54.74 42.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.947 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.438 ' O ' ' C ' ' A' ' 349' ' ' PHE . 49.2 t -57.56 -69.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.116 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.461 ' O ' ' N ' ' A' ' 352' ' ' ILE . 13.0 m-85 -35.32 -55.6 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 349' ' ' PHE . 15.4 tpt180 -36.85 -57.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 47.3 t -65.31 -31.25 72.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . 0.505 ' CG1' ' CE1' ' A' ' 297' ' ' TYR . 51.0 mt -76.39 -11.2 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.113 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 12.0 mm -69.87 -15.88 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -53.44 -27.39 24.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -95.3 -63.5 1.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -63.77 80.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -97.17 56.77 1.4 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp 50.89 45.0 28.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -106.0 36.45 2.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 31.4 p -39.63 154.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -86.23 -47.56 9.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 100.99 -125.37 8.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.48 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -105.1 153.5 21.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 110.87 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -154.61 173.15 16.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.828 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 29.8 t -75.95 158.91 31.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 139.1 146.4 4.93 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -24.82 29.22 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.649 2.232 . . . . 0.0 112.368 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 4.1 t -54.34 127.75 28.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.6 t -163.78 159.75 21.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.866 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.5 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 31.4 t -96.93 87.58 4.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 0.0 110.873 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.0 m 51.53 42.13 29.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -96.05 174.2 31.15 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 10.0 t -93.35 155.21 17.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.83 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 60.5 p -87.26 145.62 26.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.817 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 126.5 -72.78 0.45 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 156.97 61.94 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.704 2.269 . . . . 0.0 112.326 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -98.61 131.58 44.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.56 120.29 36.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 24.5 mm -94.37 142.36 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.108 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -108.4 143.04 37.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.1 p -82.61 152.49 66.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.567 0.699 . . . . 0.0 111.11 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 178.85 4.18 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.678 2.252 . . . . 0.0 112.308 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.57 121.28 26.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 283' ' ' GLU . . . -53.24 -57.46 10.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.066 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 282' ' ' ALA . 4.5 pt-20 -38.1 -44.46 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' ILE . . . . . 0.554 HG12 ' CE1' ' A' ' 329' ' ' PHE . 74.6 mt -69.82 -55.98 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 88.0 t -37.81 -46.1 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.162 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -58.1 -55.94 28.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -60.23 -26.72 66.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 16.9 m -69.31 -20.17 63.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 293' ' ' MET . 25.6 mttt -80.69 -38.26 29.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.1 mp -60.23 -32.31 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ILE . . . . . 0.461 ' CD1' HG21 ' A' ' 321' ' ' THR . 16.9 pt -95.37 -46.84 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.126 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . 0.458 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -62.79 -47.68 82.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' MET . . . . . 0.446 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 10.5 ttm -57.04 -60.97 2.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -48.77 -60.89 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 298' ' ' ALA . 27.0 mtmt -55.41 -62.94 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 67.0 mt -41.71 -49.05 4.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -67.59 -28.78 68.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -70.59 -40.4 73.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.078 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . 0.53 ' O ' ' CD2' ' A' ' 303' ' ' TYR . 30.6 m -78.79 -46.64 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' PHE . . . . . 0.47 ' N ' HG23 ' A' ' 299' ' ' VAL . 12.1 m-85 -63.54 -56.69 13.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 89.7 m -48.17 -48.48 34.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.15 -45.27 70.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 299' ' ' VAL . 15.9 m-85 -97.82 76.62 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 305' ' ' HIS . 11.6 pt-20 -95.05 -41.35 9.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 304' ' ' GLU . 52.3 m80 -34.96 -58.15 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -152.45 154.78 36.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -69.93 -48.07 59.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.931 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.3 m -52.24 -22.52 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.5 t -69.22 103.67 2.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.815 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 62.49 37.66 13.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -50.02 -42.44 49.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -45.09 -36.54 3.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . 0.459 ' CB ' HG11 ' A' ' 299' ' ' VAL . . . -51.28 -37.89 49.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.047 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.4 t -77.44 -54.8 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.141 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.7 OUTLIER -51.54 -53.04 42.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 315' ' ' ASN . 15.9 mmmt -34.58 -51.66 0.48 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.419 ' O ' ' C ' ' A' ' 318' ' ' ARG . 82.5 mt -41.69 -58.85 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 317' ' ' ILE . 25.5 mtp180 -37.11 -43.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.2 mt -80.5 -44.26 19.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -56.57 -62.02 2.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.481 ' O ' ' N ' ' A' ' 324' ' ' HIS . 25.3 p -54.51 -57.51 11.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.419 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 17.0 tt0 -40.77 -34.92 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.89 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -87.84 -28.58 21.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 321' ' ' THR . 71.4 t60 -75.0 -21.26 59.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.832 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' A' ' 328' ' ' LYS . 14.8 mt -93.2 -63.03 1.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 325' ' ' LEU . 8.4 tmtt? -35.98 -52.67 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -53.71 -44.85 70.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.869 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 325' ' ' LEU . 33.7 tttp -59.53 -44.08 93.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' PHE . . . . . 0.554 ' CE1' HG12 ' A' ' 284' ' ' ILE . 0.3 OUTLIER -115.97 89.19 23.81 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.676 0.751 . . . . 0.0 110.918 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -26.64 27.29 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.696 2.264 . . . . 0.0 112.308 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.89 -29.03 55.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' VAL . . . . . 0.469 ' CG1' ' HB2' ' A' ' 336' ' ' GLU . 39.8 t -70.72 153.28 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.15 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . 0.413 ' N ' HG13 ' A' ' 332' ' ' VAL . 7.9 t0 -88.45 154.25 20.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -57.61 -47.97 80.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.67 -23.83 4.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' GLU . . . . . 0.469 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 7.7 mt-10 -79.83 -29.05 40.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' ILE . . . . . 0.419 ' CG2' ' HA ' ' A' ' 322' ' ' GLU . 1.5 mp -89.23 -23.73 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 64.6 mt -74.15 -53.94 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -64.06 -45.97 86.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 90.8 p -39.77 -50.73 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -59.09 -56.56 20.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.911 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -38.24 -44.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' ILE . . . . . . . . . . . . . 4.2 mp -69.45 -42.4 80.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 345' ' ' ALA . 53.7 t -58.94 -63.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.113 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.34 -55.59 0.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -47.92 -53.8 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -48.65 -61.37 2.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 349' ' ' PHE . 41.1 t -55.46 -62.03 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.201 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 348' ' ' VAL . 6.6 m-85 -34.68 -63.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -39.29 -62.15 0.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 42.5 t -46.11 -45.26 16.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 77.9 mt -56.79 -47.75 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 3.2 mp -61.95 -36.42 73.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.107 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.69 -31.49 71.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 357' ' ' TYR . 35.1 m-20 -70.37 85.23 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 355' ' ' ASN . 58.3 mt-10 -32.58 92.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' A' ' 355' ' ' ASN . 73.7 m-85 -38.22 151.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 357' ' ' TYR . 0.6 OUTLIER -34.97 -64.33 0.27 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -91.71 98.92 11.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 4.1 t -87.14 168.89 12.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -133.63 42.47 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 140.15 104.16 0.57 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.497 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -88.82 175.64 7.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.896 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -146.31 118.22 8.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 83.7 p 42.28 44.27 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 58.64 -156.82 21.83 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.482 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 145.28 56.35 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 2.24 . . . . 0.0 112.343 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.4 t -173.53 156.03 2.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 31.4 t -131.34 140.02 49.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.908 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.483 -179.979 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.466 -0.132 0 CA-C-O 120.776 0.24 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.688 ' O ' HG23 ' A' ' 285' ' ' VAL . 50.0 m -76.09 132.47 40.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -73.86 -45.53 50.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.089 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 329' ' ' PHE . 15.6 pt-20 -41.35 -46.29 3.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.538 HD11 HG21 ' A' ' 332' ' ' VAL . 7.0 mt -73.33 -59.8 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 281' ' ' SER . 85.0 t -34.97 -41.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.077 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -63.67 -48.89 75.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 284' ' ' ILE . 54.1 t80 -69.48 -19.25 63.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.933 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.768 ' HB ' HG21 ' A' ' 344' ' ' VAL . 9.5 m -72.89 -23.06 60.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.129 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 23.1 mttt -77.05 -43.35 34.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -55.7 -31.74 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.563 HG21 ' CD2' ' A' ' 324' ' ' HIS . 6.7 pt -98.04 -51.49 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.082 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 288' ' ' THR . . . -59.02 -46.87 87.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.086 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 16.9 ttm -55.05 -69.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 293' ' ' MET . 15.7 mt-10 -37.84 -63.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 298' ' ' ALA . 40.9 mttm -53.98 -65.57 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 45.7 mt -38.04 -42.1 0.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.585 ' CE2' HG13 ' A' ' 348' ' ' VAL . 10.8 m-85 -75.98 -36.03 59.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -69.44 -26.71 64.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.072 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 29.9 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.801 0.334 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.33 -61.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.3 t30 -51.87 -47.9 64.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 315' ' ' ASN . 12.2 mmtp -35.98 -53.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.872 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 321' ' ' THR . 51.1 mt -46.49 -55.59 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -39.1 -32.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.2 mt -89.85 -36.39 15.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.975 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 317' ' ' ILE . 47.3 t0 -66.86 -63.41 1.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.449 HG23 HG23 ' A' ' 317' ' ' ILE . 24.2 p -48.65 -44.58 37.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.119 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -50.75 -33.08 21.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.27 -16.54 30.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.852 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' HIS . . . . . 0.563 ' CD2' HG21 ' A' ' 291' ' ' ILE . 84.3 t60 -91.85 -22.23 20.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.46 HD11 HG23 ' A' ' 288' ' ' THR . 41.9 mt -94.4 -61.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -45.9 -22.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -79.07 -41.64 28.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -69.02 -33.9 74.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 329' ' ' PHE . 2.0 m-85 -116.56 83.0 13.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.678 0.751 . . . . 0.0 110.874 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -22.75 31.56 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 0.0 112.331 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -84.39 -30.53 25.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.538 HG21 HD11 ' A' ' 284' ' ' ILE . 45.4 t -66.37 157.9 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.164 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' ASP . . . . . 0.471 ' N ' ' CG1' ' A' ' 332' ' ' VAL . 6.1 t70 -85.57 149.41 25.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 334' ' ' GLN . . . . . 0.403 ' C ' ' OE1' ' A' ' 334' ' ' GLN . 1.0 OUTLIER -59.08 -32.11 69.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.919 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -68.94 -14.29 62.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.47 ' CA ' ' OE1' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -89.49 -21.56 22.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.413 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.8 mp -85.31 -26.45 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.12 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 339' ' ' GLU . 2.7 mp -88.11 -69.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.101 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.602 ' O ' HD12 ' A' ' 343' ' ' ILE . 4.8 tp10 -42.83 -34.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.572 ' HB2' HG22 ' A' ' 285' ' ' VAL . 18.8 p -62.8 -50.72 69.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 344' ' ' VAL . 50.1 t80 -49.93 -54.38 20.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 341' ' ' PHE . 7.7 m-80 -36.57 -55.71 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.602 HD12 ' O ' ' A' ' 339' ' ' GLU . 5.0 mp -58.45 -38.08 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.14 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.768 HG21 ' HB ' ' A' ' 288' ' ' THR . 52.3 t -65.63 -52.15 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -46.8 -67.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -39.2 6.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -56.83 -49.69 74.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.585 HG13 ' CE2' ' A' ' 297' ' ' TYR . 48.2 t -61.44 -60.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 348' ' ' VAL . 11.4 m-85 -34.42 -59.96 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -44.32 -51.93 8.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 10.4 m -58.89 -33.28 70.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.58 HG12 ' CE1' ' A' ' 297' ' ' TYR . 69.8 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.169 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.804 0.252 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.1 t -68.64 130.7 43.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.94 -36.62 82.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -52.0 -38.43 56.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.711 HD11 HG21 ' A' ' 332' ' ' VAL . 20.0 mt -76.65 -53.97 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.143 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 281' ' ' SER . 82.0 t -39.71 -49.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -55.43 -44.49 76.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -73.51 -26.88 61.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.498 HG23 HD11 ' A' ' 325' ' ' LEU . 41.7 m -68.28 -15.95 63.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.177 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 293' ' ' MET . 18.1 mttm -82.99 -40.17 20.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -59.93 -27.14 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.095 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.679 ' CD1' HG22 ' A' ' 321' ' ' THR . 17.1 pt -98.1 -46.96 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.482 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.14 -48.12 68.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.133 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 19.4 ttm -51.89 -60.32 3.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -45.78 -70.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 298' ' ' ALA . 8.4 mmmm -47.27 -62.01 1.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.419 HD22 ' CZ ' ' A' ' 349' ' ' PHE . 49.8 mt -41.67 -48.36 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.484 ' CE2' HG13 ' A' ' 348' ' ' VAL . 13.5 m-85 -75.22 -21.69 58.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -78.29 -26.76 47.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.849 0.356 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 314' ' ' VAL . . . . . 0.442 HG13 ' HZ ' ' A' ' 349' ' ' PHE . 55.7 t -46.83 -29.89 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.147 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -87.31 -41.33 13.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.449 ' N ' ' HD2' ' A' ' 316' ' ' LYS . 3.7 mptt -40.74 -53.87 2.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.418 ' O ' ' C ' ' A' ' 318' ' ' ARG . 52.7 mt -45.41 -57.52 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.123 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 317' ' ' ILE . 16.0 tpp85 -37.22 -44.59 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.8 mt -77.65 -43.75 30.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.76 -69.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.679 HG22 ' CD1' ' A' ' 291' ' ' ILE . 16.5 p -46.27 -51.37 14.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -48.08 -45.19 32.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -80.05 -14.04 58.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' HIS . . . . . 0.504 ' ND1' HG21 ' A' ' 291' ' ' ILE . 40.6 t-80 -91.11 -22.57 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.498 HD11 HG23 ' A' ' 288' ' ' THR . 23.0 mt -94.18 -60.3 1.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 325' ' ' LEU . 1.0 OUTLIER -35.86 -44.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -60.26 -46.35 90.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.454 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 26.8 tptt -60.58 -39.56 88.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.585 ' CE2' HG12 ' A' ' 284' ' ' ILE . 2.8 m-85 -117.43 83.68 17.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.634 0.731 . . . . 0.0 110.851 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 -24.53 29.24 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.24 -30.66 30.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.711 HG21 HD11 ' A' ' 284' ' ' ILE . 85.3 t -70.2 144.12 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.194 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -73.86 150.56 40.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -61.33 -45.56 93.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.1 t80 -51.22 -17.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.891 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.99 -44.13 10.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.6 mp -63.76 -39.99 87.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.96 -58.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.636 ' OE2' HD11 ' A' ' 343' ' ' ILE . 7.5 tm-20 -49.02 -52.21 26.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.406 ' CB ' HG22 ' A' ' 285' ' ' VAL . 1.8 p -43.28 -41.63 4.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 344' ' ' VAL . 73.6 t80 -62.16 -56.45 18.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 341' ' ' PHE . 11.2 m-80 -35.72 -36.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.636 HD11 ' OE2' ' A' ' 339' ' ' GLU . 5.2 mp -79.47 -43.03 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.15 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 341' ' ' PHE . 50.8 t -59.94 -41.62 86.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -54.97 -69.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.074 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -53.03 -33.01 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.8 -31.99 73.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.484 HG13 ' CE2' ' A' ' 297' ' ' TYR . 34.7 t -92.12 -57.36 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.442 ' HZ ' HG13 ' A' ' 314' ' ' VAL . 38.1 m-85 -42.3 -55.84 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -51.19 -43.14 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 2.8 t -59.49 -18.93 44.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.816 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 48.2 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.114 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 N--CA 1.466 -0.147 0 CA-C-O 120.818 0.258 . . . . 0.0 112.323 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 2.1 m -71.52 120.52 17.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 283' ' ' GLU . . . -60.09 -56.72 18.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 282' ' ' ALA . 10.7 pt-20 -34.6 -45.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.646 HD11 HG21 ' A' ' 332' ' ' VAL . 27.3 mt -68.99 -57.73 7.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 87.3 t -38.13 -57.04 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -52.1 -40.84 61.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -73.83 -27.03 60.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.801 ' HB ' HG21 ' A' ' 344' ' ' VAL . 17.5 m -67.6 -19.08 65.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.174 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 293' ' ' MET . 28.4 mttt -79.57 -41.79 26.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -58.47 -29.85 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.627 HG13 HG22 ' A' ' 321' ' ' THR . 7.6 pt -97.53 -49.55 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.452 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -62.06 -48.04 82.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.478 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 11.9 ttm -54.94 -52.27 63.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -51.79 -68.65 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 298' ' ' ALA . 69.8 mttt -50.35 -58.65 5.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.954 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.659 ' HG ' HD13 ' A' ' 317' ' ' ILE . 42.6 mt -42.6 -58.23 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.419 ' CE2' HG13 ' A' ' 348' ' ' VAL . 11.0 m-85 -61.56 -29.64 70.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.964 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 295' ' ' LYS . . . -67.33 -48.92 66.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.986 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.786 0.327 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 46.0 t -57.54 -28.37 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 317' ' ' ILE . 7.0 t-20 -80.79 -44.04 19.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.93 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.645 ' HA ' HD12 ' A' ' 319' ' ' LEU . 25.6 mttt -40.52 -24.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.659 HD13 ' HG ' ' A' ' 296' ' ' LEU . 94.8 mt -58.96 -67.16 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.148 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 319' ' ' LEU . 7.3 ptp180 -37.97 -32.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 316' ' ' LYS . 18.8 mt -76.58 -42.69 41.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 317' ' ' ILE . 15.7 t0 -74.41 -62.86 1.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.627 HG22 HG13 ' A' ' 291' ' ' ILE . 7.5 p -42.04 -54.73 3.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -45.02 -49.33 11.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -68.9 -21.34 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' HIS . . . . . 0.532 ' ND1' HG21 ' A' ' 291' ' ' ILE . 25.5 t-80 -86.63 -23.06 25.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.828 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.55 ' HB2' HG23 ' A' ' 337' ' ' ILE . 42.8 mt -88.71 -58.02 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.935 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 325' ' ' LEU . 0.2 OUTLIER -37.14 -48.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -53.27 -54.53 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.453 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 26.2 tptt -53.4 -47.52 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.584 ' CE2' HG12 ' A' ' 284' ' ' ILE . 0.4 OUTLIER -113.05 86.72 9.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.651 0.739 . . . . 0.0 110.886 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -38.63 7.54 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 2.24 . . . . 0.0 112.359 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.78 -26.82 66.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 284' ' ' ILE . 96.0 t -73.06 141.99 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.087 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -79.57 147.49 32.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.851 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -51.41 -49.14 62.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.3 t80 -46.51 -21.28 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.434 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 7.5 mm-40 -88.71 -38.82 14.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.6 mp -70.81 -30.17 40.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 79.7 mt -77.13 -66.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.575 ' OE1' HD11 ' A' ' 343' ' ' ILE . 3.2 tm-20 -43.53 -49.19 7.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 7.4 p -43.16 -47.18 6.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.602 ' CE1' HG22 ' A' ' 317' ' ' ILE . 61.2 t80 -52.32 -56.08 17.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.828 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 341' ' ' PHE . 12.1 m120 -35.07 -57.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.632 ' H ' HD12 ' A' ' 343' ' ' ILE . 5.2 mp -56.24 -51.57 61.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.801 HG21 ' HB ' ' A' ' 288' ' ' THR . 21.6 t -51.0 -66.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -38.92 -58.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -37.72 -52.14 1.25 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -56.87 -65.78 0.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 297' ' ' TYR . 46.9 t -42.66 -42.44 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.087 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' A' ' 350' ' ' ARG . 4.9 m-85 -57.83 -65.01 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 349' ' ' PHE . 13.0 tpp85 -37.39 -65.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 68.5 p -41.23 -59.51 1.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.402 HG12 ' CE1' ' A' ' 297' ' ' TYR . 48.8 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.16 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.16 0 CA-C-O 120.786 0.244 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.418 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.2 t -68.26 121.37 16.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.844 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.63 82.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.099 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -50.9 -37.83 46.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.91 HD11 HG21 ' A' ' 332' ' ' VAL . 59.2 mt -76.52 -44.04 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 281' ' ' SER . 47.3 t -50.34 -60.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -40.19 -47.01 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -72.23 -39.85 68.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.778 HG23 HD11 ' A' ' 325' ' ' LEU . 4.1 m -54.73 -17.94 4.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.182 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 293' ' ' MET . 42.1 mttt -79.47 -46.43 17.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 290' ' ' ILE . 2.4 mp -58.4 -22.65 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.095 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.516 HD11 ' HA ' ' A' ' 288' ' ' THR . 7.3 pt -98.17 -51.92 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.481 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -66.88 -48.22 69.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 29.8 ttm -49.44 -71.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -41.45 -69.35 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 298' ' ' ALA . 0.0 OUTLIER -42.44 -63.88 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 39.7 mt -43.97 -43.02 6.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.576 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.9 m-85 -70.69 -30.76 67.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -70.2 -65.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 7.0 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.121 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.849 0.357 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 314' ' ' VAL . . . . . 0.421 HG11 ' HZ ' ' A' ' 349' ' ' PHE . 60.2 t -52.47 -44.18 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.9 t30 -70.26 -47.77 59.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 315' ' ' ASN . 10.8 mmtm -35.86 -51.98 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.441 ' O ' ' N ' ' A' ' 320' ' ' ASP . 42.0 mt -45.12 -54.07 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.112 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -39.22 -33.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.55 -34.19 15.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 317' ' ' ILE . 6.5 t0 -67.63 -68.15 0.41 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.51 HG22 HD12 ' A' ' 291' ' ' ILE . 17.1 p -42.91 -44.2 4.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -50.2 -46.57 54.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.13 -17.66 60.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.835 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -87.84 -28.3 21.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.778 HD11 HG23 ' A' ' 288' ' ' THR . 19.0 mt -90.62 -59.07 2.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 325' ' ' LEU . 7.3 tmtt? -38.22 -45.53 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.54 -39.62 94.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.887 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 325' ' ' LEU . 22.1 tptt -65.01 -44.9 87.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.59 ' CE2' HG12 ' A' ' 284' ' ' ILE . 0.5 OUTLIER -113.72 86.17 10.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.638 0.733 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -22.08 32.64 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.73 2.287 . . . . 0.0 112.346 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -84.06 -26.08 29.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.91 HG21 HD11 ' A' ' 284' ' ' ILE . 48.7 t -75.89 138.73 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.124 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -72.08 142.86 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.812 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -51.57 -47.92 63.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.597 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 1.5 t80 -47.45 -20.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.408 ' HB2' HG12 ' A' ' 332' ' ' VAL . 20.8 mt-10 -88.09 -45.57 10.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.4 mp -60.3 -26.21 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.134 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 340' ' ' SER . 76.7 mt -89.34 -64.95 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -41.88 -26.11 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.919 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 338' ' ' ILE . 2.4 p -65.77 -46.57 78.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.44 ' CE2' HG22 ' A' ' 317' ' ' ILE . 23.3 t80 -53.92 -52.74 59.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 341' ' ' PHE . 28.2 m-80 -34.53 -48.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.507 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.7 mp -73.46 -41.75 56.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.15 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.48 HG11 ' HB3' ' A' ' 292' ' ' ALA . 25.2 t -58.25 -59.97 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' ALA . . . . . 0.412 ' HB2' ' CE1' ' A' ' 341' ' ' PHE . . . -38.17 -64.9 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.104 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -46.34 -60.72 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.943 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -39.86 -34.99 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 344' ' ' VAL . 22.0 t -81.21 -53.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.158 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.0 m-85 -52.5 -64.48 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 349' ' ' PHE . 23.9 ptt85 -37.77 -28.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.866 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 349' ' ' PHE . 15.8 t -84.17 -41.74 16.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.576 HG12 ' CE1' ' A' ' 297' ' ' TYR . 83.6 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.867 0.278 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.837 ' O ' HG23 ' A' ' 285' ' ' VAL . 2.1 m -74.58 137.17 42.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.07 -48.44 62.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -42.66 -45.56 4.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.79 HD11 HG21 ' A' ' 332' ' ' VAL . 25.1 mt -74.45 -54.03 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.853 HG22 ' CB ' ' A' ' 340' ' ' SER . 95.4 t -45.16 -43.11 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -61.94 -36.14 80.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -80.3 -30.69 38.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.546 ' HA ' HD11 ' A' ' 291' ' ' ILE . 9.9 m -60.49 -19.92 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.508 ' HG3' HG22 ' A' ' 344' ' ' VAL . 42.0 mttt -80.54 -48.94 12.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.419 ' H ' HD12 ' A' ' 290' ' ' ILE . 3.0 mp -54.78 -22.74 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.546 HD11 ' HA ' ' A' ' 288' ' ' THR . 5.2 pt -98.71 -52.2 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.594 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -68.76 -49.19 60.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.498 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 20.0 ttm -43.1 -65.22 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -46.63 -63.07 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.856 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 298' ' ' ALA . 47.1 mmtt -46.39 -65.46 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.641 ' O ' HG22 ' A' ' 299' ' ' VAL . 31.5 mt -42.85 -53.85 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.813 ' CE2' HG13 ' A' ' 348' ' ' VAL . 11.2 m-85 -64.94 -23.53 67.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.96 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -76.05 -32.98 59.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.126 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 296' ' ' LEU . 28.2 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.611 ' HB1' ' CG1' ' A' ' 299' ' ' VAL . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.822 0.344 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.0 -61.08 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.129 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -50.98 -46.47 61.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -38.9 -58.24 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 320' ' ' ASP . 32.2 mt -41.17 -59.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 317' ' ' ILE . 56.1 ttt180 -34.87 -39.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.6 mt -81.82 -41.15 21.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 317' ' ' ILE . 3.7 t70 -60.14 -69.14 0.23 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.436 HG22 HG13 ' A' ' 291' ' ' ILE . 69.7 p -47.85 -42.21 25.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.5 ' C ' ' CD ' ' A' ' 322' ' ' GLU . 4.2 tm-20 -53.62 -40.66 65.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -87.37 -15.5 37.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -86.49 -27.15 24.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.795 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.531 HD11 HG23 ' A' ' 288' ' ' THR . 35.4 mt -88.21 -58.07 2.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 325' ' ' LEU . 1.4 tmmm? -35.92 -60.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -47.38 -50.24 22.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.471 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 22.3 tttp -55.78 -48.96 74.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.916 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.569 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 4.7 m-85 -110.89 82.42 3.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.64 0.733 . . . . 0.0 110.897 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -31.79 19.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.642 2.228 . . . . 0.0 112.318 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.56 -24.0 53.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.79 HG21 HD11 ' A' ' 284' ' ' ILE . 68.8 t -74.58 146.42 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -67.44 147.13 53.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' GLN . . . . . 0.548 ' O ' HD12 ' A' ' 338' ' ' ILE . 11.2 tt0 -61.88 -33.32 73.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.941 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -68.9 -14.98 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -84.13 -25.22 29.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.446 HG23 HD12 ' A' ' 325' ' ' LEU . 2.2 mp -83.64 -25.02 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 334' ' ' GLN . 2.0 mp -80.93 -49.75 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.165 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 340' ' ' SER . 19.0 mt-10 -57.33 -62.55 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.853 ' CB ' HG22 ' A' ' 285' ' ' VAL . 75.2 p -35.78 -43.99 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.841 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 344' ' ' VAL . 77.6 t80 -63.68 -55.94 19.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 341' ' ' PHE . 8.1 m120 -38.19 -42.0 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.0 mp -67.72 -43.11 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' A' ' 292' ' ' ALA . 70.0 t -58.7 -60.56 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.114 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -41.0 -49.27 3.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -65.75 -34.59 78.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.05 -67.09 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.813 HG13 ' CE2' ' A' ' 297' ' ' TYR . 42.5 t -51.43 -37.25 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.439 ' HE1' HD22 ' A' ' 296' ' ' LEU . 3.2 m-30 -60.57 -66.55 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -40.25 -31.04 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 4.2 t -68.3 -46.57 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 349' ' ' PHE . 11.3 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.125 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.466 -0.138 0 CA-C-O 120.798 0.249 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.583 ' O ' HG23 ' A' ' 285' ' ' VAL . 13.2 m -73.82 122.7 22.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.74 81.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.099 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -41.61 -46.66 3.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.738 HD11 HG21 ' A' ' 332' ' ' VAL . 13.6 mt -72.68 -52.08 24.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.668 HG22 ' HB2' ' A' ' 340' ' ' SER . 89.8 t -46.15 -38.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.093 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -61.83 -47.57 84.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -73.87 -26.55 60.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.967 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 97.5 m -65.38 -17.67 64.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 31.7 mttt -80.17 -44.21 20.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.899 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.71 -24.03 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.131 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.677 HG21 ' CD2' ' A' ' 324' ' ' HIS . 10.7 pt -98.31 -49.81 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.485 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.7 -48.54 66.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.074 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 12.3 ttm -49.42 -61.4 2.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -46.87 -72.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 16.8 mtmm -43.78 -61.86 1.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 56.7 mt -44.09 -46.5 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -69.56 -28.22 65.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.73 -48.3 66.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.515 HG11 ' HB1' ' A' ' 313' ' ' ALA . 33.5 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.112 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.515 ' HB1' HG11 ' A' ' 299' ' ' VAL . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.823 0.344 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.38 -64.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.113 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -48.76 -24.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 15.3 mmtp -64.99 -37.64 88.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.11 -55.69 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.413 ' HG2' ' CE2' ' A' ' 341' ' ' PHE . 17.9 mmm-85 -39.36 -30.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.0 mt -90.42 -40.58 11.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.7 -60.87 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.605 HG22 HD12 ' A' ' 291' ' ' ILE . 3.2 p -52.24 -40.47 61.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.472 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 17.7 tt0 -53.41 -41.1 65.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -84.44 -15.26 46.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' HIS . . . . . 0.677 ' CD2' HG21 ' A' ' 291' ' ' ILE . 77.8 t60 -87.27 -22.18 25.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.441 HD12 HG23 ' A' ' 337' ' ' ILE . 32.5 mt -94.15 -59.66 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.463 ' HD3' HD13 ' A' ' 337' ' ' ILE . 1.3 mmmp? -34.12 -53.19 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -48.26 -51.39 25.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -56.7 -40.33 75.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.491 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 6.4 m-85 -118.7 84.27 24.43 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.611 0.719 . . . . 0.0 110.879 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -28.79 25.14 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.72 2.28 . . . . 0.0 112.362 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.24 -25.21 42.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.738 HG21 HD11 ' A' ' 284' ' ' ILE . 41.6 t -71.08 151.37 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -81.86 150.22 27.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' GLN . . . . . 0.477 ' O ' HD12 ' A' ' 338' ' ' ILE . 20.1 tt0 -58.45 -33.88 70.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.588 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.0 t80 -63.76 -17.34 62.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -87.37 -35.25 18.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.472 ' CG2' ' HA ' ' A' ' 322' ' ' GLU . 2.1 mp -71.61 -37.27 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.477 HD12 ' O ' ' A' ' 334' ' ' GLN . 2.8 mp -74.29 -71.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.111 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.621 ' O ' HD12 ' A' ' 343' ' ' ILE . 6.8 tp10 -38.19 -50.49 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.668 ' HB2' HG22 ' A' ' 285' ' ' VAL . 9.5 p -45.17 -43.67 10.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.858 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 344' ' ' VAL . 46.4 t80 -58.94 -55.35 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.903 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 341' ' ' PHE . 11.2 m120 -36.23 -55.23 0.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.702 ' H ' HD12 ' A' ' 343' ' ' ILE . 5.4 mp -56.28 -41.3 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 341' ' ' PHE . 68.0 t -64.35 -59.18 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -40.83 -61.16 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -44.71 -51.5 9.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.949 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.72 -70.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 99.2 t -38.06 -62.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.158 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.592 ' HA ' HD12 ' A' ' 352' ' ' ILE . 10.5 m-85 -44.82 -66.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.852 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 349' ' ' PHE . 12.1 tpt180 -35.58 -56.25 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 1.3 t -49.46 -46.79 48.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 349' ' ' PHE . 64.8 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.163 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' PRO . . . . . 0.424 ' HD3' ' CD ' ' A' ' 339' ' ' GLU . 54.0 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 CA-C-O 120.757 0.232 . . . . 0.0 112.369 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.948 ' O ' HG23 ' A' ' 285' ' ' VAL . 5.1 t -73.3 142.23 47.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -76.09 -40.35 53.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.17 -39.34 63.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.555 HG12 ' CE1' ' A' ' 329' ' ' PHE . 18.3 mt -77.1 -49.35 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.948 HG23 ' O ' ' A' ' 281' ' ' SER . 48.2 t -51.26 -33.93 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.145 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -68.84 -40.64 79.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.414 ' HA ' HD13 ' A' ' 290' ' ' ILE . 54.7 t80 -73.79 -27.83 61.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 42.2 m -63.23 -19.66 64.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.134 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 293' ' ' MET . 2.7 mptm? -75.56 -44.54 42.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.472 ' H ' HD12 ' A' ' 290' ' ' ILE . 3.3 mp -55.74 -27.87 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.521 HG21 ' CD2' ' A' ' 324' ' ' HIS . 6.2 pt -98.25 -51.99 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.132 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.71 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -63.82 -48.45 76.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 25.2 ttm -56.33 -64.2 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -45.55 -56.97 4.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.881 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 298' ' ' ALA . 17.4 mmtp -58.5 -69.32 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.43 ' HB2' HG11 ' A' ' 348' ' ' VAL . 86.5 mt -37.04 -42.54 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.96 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -74.33 -38.71 63.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -59.22 -28.89 67.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.133 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 296' ' ' LEU . 30.9 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.816 0.341 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.17 -56.46 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -47.47 -39.78 16.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -54.15 -55.29 29.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 320' ' ' ASP . 87.6 mt -42.32 -60.8 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.432 ' HB3' ' NH1' ' A' ' 318' ' ' ARG . 8.8 mtp-105 -36.56 -34.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.826 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 11.6 mt -86.16 -39.5 16.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.4 t70 -63.94 -63.93 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.456 HG22 ' CG1' ' A' ' 291' ' ' ILE . 68.9 p -53.29 -40.85 65.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.444 ' C ' ' OE1' ' A' ' 322' ' ' GLU . 0.0 OUTLIER -54.01 -37.36 63.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -92.59 -13.07 30.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' HIS . . . . . 0.521 ' CD2' HG21 ' A' ' 291' ' ' ILE . 54.3 t60 -86.89 -28.06 23.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.5 HD12 HG23 ' A' ' 337' ' ' ILE . 17.3 mt -89.8 -54.37 4.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.439 ' N ' HG12 ' A' ' 337' ' ' ILE . 25.4 tttm -44.06 -39.97 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.7 -39.76 91.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.495 ' HB3' ' CE1' ' A' ' 329' ' ' PHE . 47.0 tttp -57.16 -42.64 81.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.701 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.2 OUTLIER -129.99 91.91 38.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.607 0.718 . . . . 0.0 110.895 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 329' ' ' PHE . 53.6 Cg_endo -69.77 -20.78 34.34 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.698 2.266 . . . . 0.0 112.358 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -78.69 -33.07 47.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 329' ' ' PHE . 1.5 p -65.79 150.27 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -70.53 156.04 39.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' GLN . . . . . 0.465 ' HG3' ' CD1' ' A' ' 338' ' ' ILE . 2.5 tp-100 -68.08 -41.86 81.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -58.69 -13.94 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -82.63 -31.33 28.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.5 HG23 HD12 ' A' ' 325' ' ' LEU . 1.9 mp -81.16 -28.87 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.465 ' CD1' ' HG3' ' A' ' 334' ' ' GLN . 2.6 mp -77.17 -53.58 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.625 ' O ' HD12 ' A' ' 343' ' ' ILE . 10.0 tt0 -60.95 -44.41 97.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.533 ' HB2' HG22 ' A' ' 285' ' ' VAL . 96.3 p -47.49 -49.44 25.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 344' ' ' VAL . 71.5 t80 -58.35 -56.83 17.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 341' ' ' PHE . 17.9 m-80 -35.09 -43.96 0.22 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.625 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.1 mp -66.96 -46.86 83.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.71 HG11 ' HB3' ' A' ' 292' ' ' ALA . 71.6 t -55.65 -66.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -37.41 -64.3 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -42.99 -43.24 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -67.63 -70.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 296' ' ' LEU . 88.8 t -40.89 -50.64 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.145 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -52.51 -61.34 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 -44.98 -43.33 9.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 3.3 t -51.29 -34.78 34.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.932 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.163 0 CA-C-O 120.813 0.255 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.542 ' HB2' HD12 ' A' ' 284' ' ' ILE . 21.2 m -73.08 119.99 18.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.837 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 284' ' ' ILE . . . -57.17 -55.44 34.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 282' ' ' ALA . 13.7 pt-20 -36.44 -33.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.62 HD11 HG21 ' A' ' 332' ' ' VAL . 47.1 mt -83.46 -54.35 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.672 HG12 ' NZ ' ' A' ' 289' ' ' LYS . 49.6 t -38.83 -53.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -57.1 -55.75 30.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -59.65 -20.9 59.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.483 HG23 HD11 ' A' ' 325' ' ' LEU . 49.2 m -75.15 -25.36 58.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.158 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.672 ' NZ ' HG12 ' A' ' 285' ' ' VAL . 14.4 mttp -77.13 -41.08 43.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.6 mp -56.65 -30.13 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 292' ' ' ALA . 10.4 pt -97.76 -49.81 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.487 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -61.87 -48.02 82.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.473 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 13.9 ttm -51.9 -60.24 3.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -47.82 -53.32 15.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 298' ' ' ALA . 29.1 mtpt -60.42 -67.99 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.462 HD23 ' CD1' ' A' ' 317' ' ' ILE . 90.9 mt -38.6 -38.55 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.475 ' CE1' HG12 ' A' ' 352' ' ' ILE . 8.6 m-85 -77.99 -37.06 48.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -67.23 -34.58 77.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.116 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.829 0.347 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 55.0 t -66.89 -69.38 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.118 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -41.19 -42.92 2.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -40.86 -60.45 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.53 HG22 ' CE2' ' A' ' 341' ' ' PHE . 29.8 mt -41.4 -63.43 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.141 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.444 ' HB2' ' NH1' ' A' ' 318' ' ' ARG . 23.8 ttm105 -36.43 -39.1 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.856 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.2 mt -83.51 -39.63 20.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.95 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.2 t0 -62.51 -63.87 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.453 HG22 HG13 ' A' ' 291' ' ' ILE . 72.9 p -51.84 -52.77 46.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -47.05 -36.6 8.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -85.88 -18.93 31.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -89.43 -19.7 24.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.521 ' HB2' HG23 ' A' ' 337' ' ' ILE . 47.9 mt -93.31 -60.06 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -44.16 -35.3 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.33 -38.36 87.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.43 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 26.2 tptt -72.42 -42.59 64.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.566 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 3.2 m-85 -110.46 85.03 4.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -35.41 12.65 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.335 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.84 -31.53 66.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.62 HG21 HD11 ' A' ' 284' ' ' ILE . 74.9 t -67.94 149.73 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -79.71 144.35 33.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' GLN . . . . . 0.47 ' O ' HD12 ' A' ' 338' ' ' ILE . 25.6 tt0 -53.46 -38.29 63.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.443 ' CD2' ' OE1' ' A' ' 336' ' ' GLU . 7.2 t80 -59.7 -21.16 60.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.443 ' OE1' ' CD2' ' A' ' 335' ' ' PHE . 0.0 OUTLIER -86.92 -18.52 30.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.886 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.4 mp -88.32 -27.41 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 334' ' ' GLN . 3.5 mp -89.75 -51.99 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.56 ' O ' HD12 ' A' ' 343' ' ' ILE . 7.7 tt0 -51.52 -31.47 24.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 2.1 p -66.37 -36.1 82.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.53 ' CE2' HG22 ' A' ' 317' ' ' ILE . 39.1 t80 -68.35 -31.05 70.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.847 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -56.42 -32.01 64.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.56 HD12 ' O ' ' A' ' 339' ' ' GLU . 5.0 mp -88.13 -37.92 11.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 81.0 t -64.23 -51.3 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 345' ' ' ALA . . . . . 0.5 ' HB2' ' CE1' ' A' ' 341' ' ' PHE . . . -51.12 -66.78 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.062 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' LYS . . . . . 0.403 ' C ' ' HD3' ' A' ' 346' ' ' LYS . 0.0 OUTLIER -50.39 -31.29 14.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -67.68 -66.94 0.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 98.2 t -45.71 -44.2 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 352' ' ' ILE . 4.1 m-85 -45.6 -60.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 349' ' ' PHE . 3.4 tpm_? -37.3 -62.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 28.1 m -47.55 -33.29 6.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.475 HG12 ' CE1' ' A' ' 297' ' ' TYR . 93.6 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.153 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.203 0 CA-C-O 120.769 0.237 . . . . 0.0 112.386 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 285' ' ' VAL . 72.7 m -68.56 134.37 49.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.874 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -72.57 -40.74 66.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -55.26 -36.24 65.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.899 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.852 HD11 HG21 ' A' ' 332' ' ' VAL . 22.8 mt -78.33 -41.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 281' ' ' SER . 77.7 t -58.46 -46.42 89.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -60.65 -37.02 80.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -73.78 -34.22 64.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.507 ' CG2' HG21 ' A' ' 344' ' ' VAL . 92.0 m -56.38 -19.29 14.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.162 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.543 ' NZ ' HG22 ' A' ' 344' ' ' VAL . 7.2 mptt -77.13 -49.23 15.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 290' ' ' ILE . 2.9 mp -53.74 -24.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.162 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.491 HG13 ' N ' ' A' ' 292' ' ' ALA . 7.0 pt -98.83 -52.4 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.148 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.491 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.94 -49.29 62.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.061 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.517 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 19.1 ttm -45.42 -62.26 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -52.29 -72.56 0.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 298' ' ' ALA . 35.1 mtmt -42.14 -63.83 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.516 HD23 ' CD1' ' A' ' 317' ' ' ILE . 81.7 mt -42.3 -52.33 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.472 ' CE1' ' CG1' ' A' ' 352' ' ' ILE . 7.7 m-85 -62.2 -26.54 68.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.975 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -72.18 -51.1 22.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.092 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.854 ' HB ' ' HB1' ' A' ' 313' ' ' ALA . 18.8 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.854 ' HB1' ' HB ' ' A' ' 299' ' ' VAL . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.806 0.336 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.3 t -79.84 -38.58 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.118 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.9 OUTLIER -59.75 -54.23 48.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.931 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 315' ' ' ASN . 22.7 mtmt -35.15 -62.74 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.93 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.516 ' CD1' HD23 ' A' ' 296' ' ' LEU . 31.8 mt -36.63 -58.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 317' ' ' ILE . 0.0 OUTLIER -35.19 -42.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.5 mt -80.68 -39.31 27.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 317' ' ' ILE . 19.8 t0 -60.96 -70.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.457 HG23 HG23 ' A' ' 317' ' ' ILE . 68.1 p -45.77 -45.84 14.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.158 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -51.29 -36.21 41.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.34 -20.99 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -85.6 -18.93 31.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 42.8 mt -93.18 -59.54 2.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -41.47 -36.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.7 -52.58 50.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.476 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 30.4 tttp -54.59 -41.82 70.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.586 ' CE2' HG12 ' A' ' 284' ' ' ILE . 1.3 m-85 -116.12 83.95 13.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.661 0.743 . . . . 0.0 110.823 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -30.24 22.54 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.348 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -77.92 -18.46 56.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.852 HG21 HD11 ' A' ' 284' ' ' ILE . 53.4 t -80.39 152.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -82.9 151.72 25.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -60.55 -41.04 93.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -53.85 -26.27 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.42 -30.45 33.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 337' ' ' ILE . 1.8 mp -84.62 -14.43 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.145 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 36.5 mt -87.33 -52.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' ' 343' ' ' ILE . 4.7 tt0 -59.83 -48.36 81.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.545 ' O ' HG23 ' A' ' 344' ' ' VAL . 40.3 m -39.76 -50.82 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.51 ' CE1' HG22 ' A' ' 317' ' ' ILE . 42.7 t80 -56.03 -57.92 10.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 341' ' ' PHE . 67.4 m-20 -37.47 -46.47 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.52 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.4 mp -68.41 -40.08 81.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 340' ' ' SER . 81.1 t -61.36 -64.18 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.08 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -42.71 -55.96 3.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -48.62 -30.16 5.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -83.73 -64.37 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 56.5 t -43.89 -27.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -74.02 -62.75 1.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 350' ' ' ARG . 21.0 ttm105 -41.5 -44.78 3.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 25.6 p -60.39 -50.83 72.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.472 ' CG1' ' CE1' ' A' ' 297' ' ' TYR . 50.1 mt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' PRO . . . . . 0.409 ' HD3' ' CD ' ' A' ' 339' ' ' GLU . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.838 0.266 . . . . 0.0 112.308 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.552 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.8 t -69.78 120.96 16.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.04 96.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -49.77 -41.15 43.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.808 HD11 HG21 ' A' ' 332' ' ' VAL . 22.1 mt -75.95 -42.32 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 281' ' ' SER . 75.3 t -54.5 -42.68 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 286' ' ' LYS . 0.4 OUTLIER -62.53 -36.43 82.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.478 ' CD2' ' HD3' ' A' ' 328' ' ' LYS . 31.5 t80 -76.87 -31.36 56.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.836 ' HB ' HG21 ' A' ' 344' ' ' VAL . 33.2 m -64.01 -23.73 67.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.606 ' HG3' HG13 ' A' ' 344' ' ' VAL . 30.7 mttt -76.19 -39.57 54.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.402 ' CD1' ' O ' ' A' ' 286' ' ' LYS . 2.6 mp -61.7 -28.49 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.838 HG21 ' CD2' ' A' ' 324' ' ' HIS . 23.6 pt -97.77 -43.4 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.122 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.454 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -69.25 -47.8 63.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.485 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 9.5 ttm -52.53 -71.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.889 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 293' ' ' MET . 18.3 mt-10 -36.94 -60.01 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -53.92 -66.21 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.648 ' CD2' HG13 ' A' ' 314' ' ' VAL . 75.8 mt -39.11 -49.79 1.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.671 ' CE2' HG13 ' A' ' 348' ' ' VAL . 11.8 m-85 -65.34 -40.27 93.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.93 -50.43 73.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 296' ' ' LEU . 27.9 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.803 0.335 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 314' ' ' VAL . . . . . 0.648 HG13 ' CD2' ' A' ' 296' ' ' LEU . 66.1 t -68.76 -36.89 76.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.7 -12.33 60.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.472 ' HA ' HD12 ' A' ' 319' ' ' LEU . 22.3 mmtt -82.55 -17.58 44.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.553 HD12 ' CD2' ' A' ' 296' ' ' LEU . 72.9 mt -67.55 -56.7 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' A' ' 322' ' ' GLU . 7.3 ptm180 -41.2 -35.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 316' ' ' LYS . 4.8 mt -76.08 -37.78 57.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 27.3 t70 -73.97 -69.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.853 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.715 HG22 HD12 ' A' ' 291' ' ' ILE . 14.5 p -41.3 -47.6 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 318' ' ' ARG . 33.0 mt-10 -45.73 -49.99 14.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.85 -18.47 60.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' HIS . . . . . 0.838 ' CD2' HG21 ' A' ' 291' ' ' ILE . 79.3 t60 -84.88 -23.96 28.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.467 ' HB2' HG23 ' A' ' 337' ' ' ILE . 19.3 mt -93.77 -54.49 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.928 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.34 -26.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.95 -35.62 37.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.478 ' HD3' ' CD2' ' A' ' 287' ' ' TYR . 37.6 tttp -69.84 -39.34 76.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.587 ' CE1' HG23 ' A' ' 284' ' ' ILE . 2.8 m-85 -117.06 87.44 22.91 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.678 0.751 . . . . 0.0 110.875 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -40.71 5.01 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.685 2.257 . . . . 0.0 112.316 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.53 -24.46 65.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.808 HG21 HD11 ' A' ' 284' ' ' ILE . 41.5 t -73.47 154.14 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' ASP . . . . . 0.413 ' N ' ' CG1' ' A' ' 332' ' ' VAL . 5.7 t70 -83.35 147.28 28.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.38 -37.08 74.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.495 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 7.3 t80 -61.98 -13.32 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -90.61 -26.66 19.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.467 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.9 mp -82.54 -24.55 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.428 ' O ' ' ND2' ' A' ' 342' ' ' ASN . 3.2 mp -89.77 -35.5 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.409 ' CD ' ' HD3' ' A' ' 280' ' ' PRO . 11.5 tt0 -72.67 -22.51 60.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 341' ' ' PHE . 10.9 m -74.55 -65.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.484 ' CE1' HG22 ' A' ' 317' ' ' ILE . 73.8 t80 -36.6 -41.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 338' ' ' ILE . 4.0 m-80 -49.1 -51.95 28.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.497 ' H ' HD12 ' A' ' 343' ' ' ILE . 3.9 mp -68.84 -33.58 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.153 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.836 HG21 ' HB ' ' A' ' 288' ' ' THR . 32.8 t -62.57 -63.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -35.72 -66.67 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.123 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -40.66 -53.55 2.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -44.38 -39.25 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.671 HG13 ' CE2' ' A' ' 297' ' ' TYR . 39.9 t -76.49 -43.49 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.412 ' C ' ' N ' ' A' ' 351' ' ' SER . 3.3 m-85 -49.56 -70.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 31.1 ptt85 -43.09 -23.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.851 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 349' ' ' PHE . 3.2 t -78.89 -52.29 8.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.812 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.136 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.142 0 CA-C-O 120.79 0.246 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.87 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.0 OUTLIER -75.84 133.04 40.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.869 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -77.98 -42.23 33.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.136 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -51.49 -39.04 56.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.562 HG12 ' CZ ' ' A' ' 329' ' ' PHE . 12.1 mt -79.11 -44.09 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.119 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.891 HG22 ' HB2' ' A' ' 340' ' ' SER . 74.7 t -54.61 -37.69 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.085 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -64.24 -35.74 81.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -79.87 -24.46 41.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.486 ' HB ' HG21 ' A' ' 344' ' ' VAL . 8.9 m -66.49 -18.22 65.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.123 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 293' ' ' MET . 1.0 OUTLIER -77.27 -44.91 28.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.02 -29.18 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.156 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.583 HD12 HG22 ' A' ' 321' ' ' THR . 8.7 pt -98.31 -50.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.541 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -63.93 -48.28 77.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.493 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 10.6 ttm -58.88 -67.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -43.31 -58.8 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -55.3 -65.78 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.476 ' O ' HG22 ' A' ' 299' ' ' VAL . 49.4 mt -40.61 -58.49 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -54.98 -38.56 67.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.03 -49.49 72.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.147 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 296' ' ' LEU . 16.7 m . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.875 0.369 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 74.8 t -58.95 -34.96 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' ASN . . . . . 0.413 ' O ' HD22 ' A' ' 319' ' ' LEU . 10.7 t30 -83.14 -41.35 18.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.451 ' HA ' HD23 ' A' ' 319' ' ' LEU . 13.5 mmtp -43.03 -30.24 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 318' ' ' ARG . 49.2 mt -61.75 -60.21 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.486 ' HD2' HD13 ' A' ' 319' ' ' LEU . 3.3 tmt_? -34.28 -70.91 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.709 ' N ' HD13 ' A' ' 319' ' ' LEU . 0.0 OUTLIER -44.58 -43.13 7.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -66.02 -70.48 0.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.583 HG22 HD12 ' A' ' 291' ' ' ILE . 37.5 p -44.83 -55.49 5.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.153 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -45.6 -49.47 14.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -77.65 -12.41 59.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -90.74 -25.54 19.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.609 HD12 HG23 ' A' ' 337' ' ' ILE . 23.3 mt -94.37 -56.73 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -45.91 -24.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -81.82 -32.77 31.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 325' ' ' LEU . 26.5 tttp -69.23 -36.72 77.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.562 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 0.5 OUTLIER -122.38 90.94 49.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.688 0.756 . . . . 0.0 110.892 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -20.45 34.75 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.715 2.277 . . . . 0.0 112.337 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.31 -40.78 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.657 ' CG1' HD11 ' A' ' 337' ' ' ILE . 0.8 OUTLIER -62.98 161.57 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.114 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -93.39 160.06 14.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -67.07 -38.42 85.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -57.36 -15.42 6.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -90.51 -26.07 19.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.657 HD11 ' CG1' ' A' ' 332' ' ' VAL . 3.0 mp -86.69 -45.25 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.31 -52.15 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -62.3 -55.23 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.891 ' HB2' HG22 ' A' ' 285' ' ' VAL . 16.1 p -38.8 -39.27 0.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 344' ' ' VAL . 35.3 t80 -64.15 -53.39 50.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 341' ' ' PHE . 5.4 m120 -36.5 -37.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 343' ' ' ILE . 5.3 mp -78.55 -41.22 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.541 HG11 ' HB3' ' A' ' 292' ' ' ALA . 50.4 t -57.72 -47.84 84.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -54.74 -63.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -54.2 -23.37 14.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -78.16 -31.24 49.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 344' ' ' VAL . 89.7 t -86.04 -32.72 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.085 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 351' ' ' SER . 5.5 m-85 -59.9 -67.04 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 349' ' ' PHE . 30.8 ptt180 -37.73 -28.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 349' ' ' PHE . 8.0 t -78.86 -45.19 21.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 349' ' ' PHE . 65.2 mt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.797 0.249 . . . . 0.0 112.323 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.2 t -72.96 120.53 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.72 -49.4 70.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.117 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -43.04 -43.05 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.535 HG12 ' CE1' ' A' ' 329' ' ' PHE . 30.4 mt -73.52 -48.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.146 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.49 HG22 ' HB2' ' A' ' 340' ' ' SER . 98.1 t -47.19 -36.11 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -68.5 -57.26 6.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.43 ' HA ' HD13 ' A' ' 290' ' ' ILE . 43.0 t80 -55.75 -24.83 37.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.486 ' CG2' HG21 ' A' ' 344' ' ' VAL . 32.1 m -68.97 -26.24 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.092 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -75.13 -43.59 51.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 287' ' ' TYR . 3.1 mp -54.75 -29.62 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.114 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.521 HG13 HG22 ' A' ' 321' ' ' THR . 8.5 pt -98.12 -51.22 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.607 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -58.4 -48.15 81.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 19.7 ttm -53.88 -60.18 3.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -45.4 -60.2 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 298' ' ' ALA . 29.4 mtpt -58.04 -67.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.832 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.612 HD12 HG21 ' A' ' 348' ' ' VAL . 86.2 mt -37.93 -33.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -84.63 -37.48 21.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -64.76 -31.95 73.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.053 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.144 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.826 0.345 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.2 -68.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' A' ' 316' ' ' LYS . 3.8 t30 -43.17 -50.34 6.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 315' ' ' ASN . 11.3 mmmt -34.64 -58.3 0.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 318' ' ' ARG . 63.9 mt -38.22 -61.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 317' ' ' ILE . 3.6 tmt_? -35.19 -49.72 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 6.8 mt -69.92 -44.21 70.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -61.67 -68.86 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.888 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.521 HG22 HG13 ' A' ' 291' ' ' ILE . 14.2 p -45.5 -47.25 14.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -49.24 -50.59 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -71.18 -16.07 62.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -90.15 -21.92 21.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.463 HD11 HG23 ' A' ' 288' ' ' THR . 45.0 mt -93.45 -54.9 3.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 25.7 tttm -49.61 -26.71 3.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 328' ' ' LYS . 10.8 pt-20 -78.01 -39.27 42.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.492 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 27.4 tptt -59.58 -48.62 80.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.616 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.2 OUTLIER -114.86 89.97 21.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -18.65 37.32 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.71 2.273 . . . . 0.0 112.399 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.91 -24.31 30.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 329' ' ' PHE . 0.8 OUTLIER -77.05 154.93 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -82.83 155.0 24.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' GLN . . . . . 0.472 ' HG2' ' CD1' ' A' ' 338' ' ' ILE . 35.7 tt0 -63.93 -49.58 72.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -47.41 -19.85 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -81.65 -39.32 24.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.572 HD11 ' CG1' ' A' ' 332' ' ' VAL . 1.8 mp -71.24 -22.24 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.472 ' CD1' ' HG2' ' A' ' 334' ' ' GLN . 2.5 mp -81.81 -55.25 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.158 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.624 ' O ' HD12 ' A' ' 343' ' ' ILE . 0.6 OUTLIER -60.38 -37.22 80.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.49 ' HB2' HG22 ' A' ' 285' ' ' VAL . 96.5 p -55.73 -54.89 38.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 342' ' ' ASN . 48.6 t80 -53.35 -52.45 59.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 341' ' ' PHE . 5.6 m-80 -36.01 -47.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.624 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.0 mp -64.2 -47.74 88.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.607 HG11 ' HB3' ' A' ' 292' ' ' ALA . 90.0 t -47.81 -56.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -44.5 -53.89 6.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.049 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -51.82 -38.52 56.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.69 -66.21 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.612 HG21 HD12 ' A' ' 296' ' ' LEU . 14.9 t -47.6 -55.89 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.105 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.449 ' O ' ' C ' ' A' ' 350' ' ' ARG . 6.1 m-85 -46.88 -60.31 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 349' ' ' PHE . 17.7 tpp85 -34.53 -52.86 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 70.9 m -61.32 -57.51 12.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 89.1 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.148 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.755 0.231 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.843 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.9 t -78.1 120.86 23.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.82 -48.01 83.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.099 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -45.95 -41.34 11.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.754 HD11 HG21 ' A' ' 332' ' ' VAL . 24.5 mt -77.08 -43.95 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 281' ' ' SER . 43.5 t -53.9 -40.48 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -63.82 -42.81 97.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -72.66 -32.85 66.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.616 HG23 HD11 ' A' ' 325' ' ' LEU . 28.2 m -59.48 -22.54 61.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 293' ' ' MET . 51.2 mttt -76.31 -46.55 27.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -54.8 -27.55 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 292' ' ' ALA . 7.0 pt -98.48 -52.19 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.488 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -63.83 -48.78 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.089 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.498 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 30.9 ttm -51.97 -64.78 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -40.18 -56.38 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 298' ' ' ALA . 16.6 mmmt -59.15 -66.09 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.768 HD12 HG21 ' A' ' 348' ' ' VAL . 91.6 mt -38.68 -42.09 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.572 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.9 m-85 -73.54 -35.65 65.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -68.98 -54.02 17.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.13 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.821 0.343 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 60.1 t -82.54 -54.98 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.6 OUTLIER -48.87 -48.98 41.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 317' ' ' ILE . 16.9 mtmm -38.2 -58.1 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 320' ' ' ASP . 68.3 mt -33.95 -57.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.089 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 317' ' ' ILE . 50.8 ttt180 -34.53 -59.07 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.6 mt -58.9 -39.57 81.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.5 t70 -66.05 -69.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.468 HG22 HG13 ' A' ' 291' ' ' ILE . 27.1 p -47.12 -47.3 23.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.181 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.36 -39.11 60.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -84.61 -12.93 53.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' HIS . . . . . 0.421 ' CD2' HG21 ' A' ' 291' ' ' ILE . 70.4 t60 -92.97 -26.3 17.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.616 HD11 HG23 ' A' ' 288' ' ' THR . 18.8 mt -92.63 -59.37 2.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -39.57 -34.15 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.26 -39.1 55.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.541 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 32.5 tptt -54.18 -49.94 68.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.643 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.1 OUTLIER -117.14 91.14 35.73 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 110.901 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.66 -18.62 37.35 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.706 2.271 . . . . 0.0 112.34 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.3 -0.16 57.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.754 HG21 HD11 ' A' ' 284' ' ' ILE . 0.8 OUTLIER -98.02 148.96 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -72.53 154.47 40.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -67.19 -45.43 76.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -54.19 -15.31 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -81.85 -31.62 31.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.58 HD11 HG11 ' A' ' 332' ' ' VAL . 1.7 mp -85.54 -32.33 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.143 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 46.5 mt -69.75 -41.06 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.449 ' O ' HD12 ' A' ' 343' ' ' ILE . 6.0 tt0 -74.52 -56.56 4.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 344' ' ' VAL . 57.2 p -34.71 -45.48 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 344' ' ' VAL . 56.9 t80 -59.9 -60.39 3.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 341' ' ' PHE . 14.5 m-80 -37.03 -47.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.591 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.8 mp -66.5 -41.86 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 340' ' ' SER . 61.5 t -60.79 -50.86 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -44.16 -67.32 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 346' ' ' LYS . . . . . 0.529 ' HE2' HG23 ' A' ' 343' ' ' ILE . 32.9 pttt -48.53 -44.77 36.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 347' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 346' ' ' LYS . 16.1 mt-10 -55.61 -50.42 70.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.768 HG21 HD12 ' A' ' 296' ' ' LEU . 57.7 t -59.93 -48.06 89.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.126 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.5 m-85 -54.93 -55.11 34.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -44.49 -33.47 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 6.3 m -82.87 -30.63 28.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.841 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.572 HG12 ' CE1' ' A' ' 297' ' ' TYR . 86.0 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.131 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.781 0.242 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.69 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.3 t -69.98 121.92 18.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.829 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.93 -48.12 77.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -46.08 -42.19 13.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.715 HD11 HG21 ' A' ' 332' ' ' VAL . 22.7 mt -73.77 -40.18 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 281' ' ' SER . 90.7 t -57.12 -46.36 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.409 ' O ' HD12 ' A' ' 290' ' ' ILE . 35.0 mttm -60.87 -40.89 94.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.418 ' HA ' HD13 ' A' ' 290' ' ' ILE . 49.5 t80 -74.89 -30.86 61.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.406 HG23 HD11 ' A' ' 325' ' ' LEU . 42.9 m -62.91 -22.34 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 293' ' ' MET . 30.3 mttt -77.76 -43.57 30.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 287' ' ' TYR . 3.0 mp -55.72 -28.56 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.591 HG13 HG22 ' A' ' 321' ' ' THR . 5.8 pt -98.13 -51.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.455 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -62.76 -48.21 80.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.493 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 32.4 ttm -55.51 -70.25 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -40.27 -54.61 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.495 ' HB3' HD11 ' A' ' 317' ' ' ILE . 26.8 mttp -58.75 -69.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.427 HD12 HG21 ' A' ' 348' ' ' VAL . 86.4 mt -37.92 -43.39 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.584 ' CE1' HG12 ' A' ' 352' ' ' ILE . 10.4 m-85 -71.61 -38.95 70.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -62.12 -46.68 87.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.101 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 26.4 m . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.126 179.996 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.799 0.333 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.45 -53.96 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -53.22 -36.83 61.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.453 ' HA ' HD12 ' A' ' 319' ' ' LEU . 13.3 mmtp -57.2 -32.08 66.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.552 HG22 ' CE1' ' A' ' 341' ' ' PHE . 8.7 mm -48.12 -71.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 317' ' ' ILE . 31.2 ttt180 -33.95 -45.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 316' ' ' LYS . 13.6 mt -69.56 -44.3 71.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 317' ' ' ILE . 32.1 t0 -67.06 -66.19 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.591 HG22 HG13 ' A' ' 291' ' ' ILE . 16.9 p -47.21 -51.74 17.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -49.4 -43.92 44.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -82.31 -11.99 58.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -89.39 -27.9 20.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.568 ' HB2' HG23 ' A' ' 337' ' ' ILE . 20.0 mt -90.19 -52.62 4.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 325' ' ' LEU . 0.4 OUTLIER -36.81 -44.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -64.44 -46.65 82.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 21.1 tptt -55.33 -42.49 73.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.577 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 0.2 OUTLIER -120.62 89.87 45.24 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.686 0.755 . . . . 0.0 110.873 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.94 2.4 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.242 . . . . 0.0 112.362 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -61.98 -25.65 67.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.715 HG21 HD11 ' A' ' 284' ' ' ILE . 97.2 t -73.75 148.81 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -84.65 147.84 26.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -53.57 -45.14 69.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.6 t80 -51.98 -18.79 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.401 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 47.5 mt-10 -88.92 -41.15 12.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.568 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.5 mp -69.31 -31.72 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.183 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 39.6 mt -76.22 -66.64 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.118 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.619 ' O ' HD12 ' A' ' 343' ' ' ILE . 8.5 tp10 -42.1 -53.86 3.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.54 ' CB ' HG22 ' A' ' 285' ' ' VAL . 2.2 p -40.5 -41.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.837 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 317' ' ' ILE . 75.7 t80 -62.43 -53.03 60.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.851 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -42.53 -43.33 3.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.642 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.7 mp -65.94 -34.14 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 341' ' ' PHE . 73.9 t -70.66 -58.74 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.129 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -37.18 -61.74 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.074 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -45.5 -51.25 11.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -55.81 -59.67 4.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 352' ' ' ILE . 88.5 t -48.98 -62.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.114 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.1 m-85 -44.5 -69.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 349' ' ' PHE . 20.9 ttp180 -34.3 -54.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 41.9 m -56.5 -42.67 78.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.584 HG12 ' CE1' ' A' ' 297' ' ' TYR . 61.8 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 120.827 0.261 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.635 ' HB2' HD12 ' A' ' 284' ' ' ILE . 66.5 m -68.91 127.5 33.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.85 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 284' ' ' ILE . . . -70.98 -52.18 21.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -39.86 -27.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.881 HG23 ' CE1' ' A' ' 329' ' ' PHE . 22.0 mt -92.27 -43.25 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 281' ' ' SER . 77.6 t -53.65 -35.93 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -66.01 -34.69 78.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.906 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.407 ' HA ' HD13 ' A' ' 290' ' ' ILE . 50.3 t80 -76.95 -27.21 54.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.654 HG23 HD11 ' A' ' 325' ' ' LEU . 2.7 m -65.64 -20.68 66.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 293' ' ' MET . 0.7 OUTLIER -76.5 -45.71 29.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.451 ' H ' HD12 ' A' ' 290' ' ' ILE . 3.2 mp -52.58 -32.1 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.501 ' CD1' HG22 ' A' ' 321' ' ' THR . 6.9 pt -98.49 -52.08 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.68 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -60.78 -48.56 81.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.07 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 33.8 ttm -55.36 -69.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 293' ' ' MET . 16.2 mt-10 -37.91 -67.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.867 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 298' ' ' ALA . 45.5 mmtt -50.37 -63.44 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 72.6 mt -42.96 -30.38 0.41 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.589 ' CE2' HG13 ' A' ' 348' ' ' VAL . 10.1 m-85 -88.84 -31.25 18.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -69.79 -48.99 57.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.076 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.165 179.944 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.825 0.345 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 23.8 t -54.98 -41.9 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.6 -44.67 85.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -44.24 -57.09 3.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.643 HG22 ' CE1' ' A' ' 341' ' ' PHE . 58.8 mt -41.49 -55.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -39.75 -35.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.0 mt -88.62 -32.29 18.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 24.8 t70 -67.48 -65.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.501 HG22 ' CD1' ' A' ' 291' ' ' ILE . 71.8 p -51.77 -44.46 63.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -44.69 -54.4 6.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -76.81 -13.1 60.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.836 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -85.96 -26.19 25.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.654 HD11 HG23 ' A' ' 288' ' ' THR . 26.6 mt -91.62 -62.22 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -39.83 -43.78 1.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -62.86 -38.15 89.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 325' ' ' LEU . 44.2 tttp -60.33 -45.74 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.881 ' CE1' HG23 ' A' ' 284' ' ' ILE . 0.9 OUTLIER -117.97 94.71 46.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.688 0.756 . . . . 0.0 110.863 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -20.63 34.47 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.652 2.235 . . . . 0.0 112.327 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.02 -40.22 28.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.597 HG11 HD11 ' A' ' 337' ' ' ILE . 0.9 OUTLIER -63.93 156.16 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -90.98 156.49 17.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -62.94 -42.9 99.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.6 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 4.3 t80 -54.03 -15.96 1.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -88.18 -27.58 21.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.641 HG23 HD12 ' A' ' 325' ' ' LEU . 2.6 mp -85.67 -56.83 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 338' ' ' ILE . . . . . 0.41 ' O ' ' ND2' ' A' ' 342' ' ' ASN . 72.8 mt -48.56 -33.12 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.123 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.421 ' O ' HD12 ' A' ' 343' ' ' ILE . 17.0 tt0 -79.22 -42.4 26.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.407 ' HB3' HG22 ' A' ' 285' ' ' VAL . 73.8 m -52.23 -53.07 48.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.643 ' CE1' HG22 ' A' ' 317' ' ' ILE . 56.0 t80 -46.61 -53.03 12.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 338' ' ' ILE . 37.6 m-80 -42.55 -52.49 4.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 343' ' ' ILE . 3.7 mp -56.3 -40.04 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.161 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.68 HG11 ' HB3' ' A' ' 292' ' ' ALA . 91.3 t -63.89 -62.11 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.131 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.1 -66.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -46.44 -58.13 4.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -42.69 -62.34 1.02 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.589 HG13 ' CE2' ' A' ' 297' ' ' TYR . 37.0 t -50.33 -66.13 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.144 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 351' ' ' SER . 8.0 m-85 -39.01 -69.49 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 349' ' ' PHE . 35.8 ttm180 -36.33 -32.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 349' ' ' PHE . 1.6 t -76.89 -56.37 4.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.575 HG12 ' CE1' ' A' ' 297' ' ' TYR . 80.2 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.102 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.466 -0.125 0 CA-C-O 120.815 0.256 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.685 ' O ' HG23 ' A' ' 285' ' ' VAL . 14.1 m -77.6 124.67 28.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.5 76.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.12 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -46.78 -29.67 2.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.756 ' CD1' HG21 ' A' ' 332' ' ' VAL . 17.4 mt -89.18 -52.4 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.112 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 281' ' ' SER . 40.2 t -44.22 -35.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -66.0 -35.56 80.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.461 ' CD2' ' HD3' ' A' ' 328' ' ' LYS . 28.4 t80 -81.5 -18.77 43.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.412 HG23 HD11 ' A' ' 325' ' ' LEU . 28.3 m -70.38 -26.09 63.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.563 ' HD2' HG22 ' A' ' 344' ' ' VAL . 0.0 OUTLIER -75.79 -43.35 46.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.889 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.6 mp -54.58 -31.25 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.767 HG21 ' CD2' ' A' ' 324' ' ' HIS . 6.3 pt -98.09 -51.83 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.466 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -60.45 -48.1 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.1 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 11.9 ttm -55.9 -62.26 1.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -39.75 -72.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 298' ' ' ALA . 13.7 mptt -50.23 -63.61 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.456 ' CD2' HG13 ' A' ' 314' ' ' VAL . 45.1 mt -37.66 -43.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -78.67 -33.36 47.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -65.67 -36.56 84.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.095 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.809 0.338 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 314' ' ' VAL . . . . . 0.456 HG13 ' CD2' ' A' ' 296' ' ' LEU . 58.4 t -55.61 -42.29 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.5 OUTLIER -59.95 -55.54 32.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 315' ' ' ASN . 9.6 mmmt -35.53 -43.71 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.44 HD12 HD23 ' A' ' 296' ' ' LEU . 50.5 mt -47.49 -52.43 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.436 ' HG2' ' CE2' ' A' ' 341' ' ' PHE . 14.6 mmm-85 -40.01 -39.22 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.0 mt -82.98 -44.83 14.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.73 -69.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.85 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.527 HG22 HG13 ' A' ' 291' ' ' ILE . 37.6 p -46.04 -47.95 16.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.482 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 60.5 tt0 -45.22 -52.3 9.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.92 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -78.66 -14.54 59.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' HIS . . . . . 0.767 ' CD2' HG21 ' A' ' 291' ' ' ILE . 44.5 t60 -82.1 -29.71 31.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.867 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.607 HD12 HG23 ' A' ' 337' ' ' ILE . 15.9 mt -92.39 -59.78 2.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.4 ' NZ ' ' HB2' ' A' ' 334' ' ' GLN . 39.8 tttp -43.14 -29.67 0.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.88 -35.36 50.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.504 ' HE3' ' CZ ' ' A' ' 329' ' ' PHE . 37.9 tttp -58.51 -55.66 32.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.982 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.1 OUTLIER -117.89 107.64 43.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.663 0.744 . . . . 0.0 110.866 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 329' ' ' PHE . 53.6 Cg_endo -69.77 -21.9 32.77 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.679 2.253 . . . . 0.0 112.344 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.57 -35.72 70.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.982 HG12 ' O ' ' A' ' 329' ' ' PHE . 7.1 p -63.8 146.0 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 333' ' ' ASP . . . . . 0.627 ' O ' HD12 ' A' ' 337' ' ' ILE . 1.4 t70 -87.17 157.9 19.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 334' ' ' GLN . . . . . 0.4 ' HB2' ' NZ ' ' A' ' 326' ' ' LYS . 9.7 tt0 -65.16 -35.92 82.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.465 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 9.5 t80 -63.55 -9.77 14.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -93.38 -41.35 9.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 333' ' ' ASP . 4.9 mp -69.64 -45.57 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.11 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.81 -41.05 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.662 ' O ' HD12 ' A' ' 343' ' ' ILE . 16.6 tt0 -73.61 -42.77 61.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 341' ' ' PHE . 37.1 m -51.11 -62.35 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 344' ' ' VAL . 68.6 t80 -37.78 -59.39 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 341' ' ' PHE . 2.4 m-80 -36.63 -54.56 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.7 mp -57.75 -36.6 55.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.563 HG22 ' HD2' ' A' ' 289' ' ' LYS . 97.1 t -72.14 -59.12 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 345' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -36.26 -66.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -49.62 -36.51 24.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 344' ' ' VAL . 1.5 tp10 -57.33 -40.09 77.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.09 -40.09 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.145 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 350' ' ' ARG . 6.1 m-85 -51.94 -70.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 349' ' ' PHE . 10.1 ptt85 -35.33 -42.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 23.4 m -64.11 -49.0 73.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 349' ' ' PHE . 97.3 mt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.111 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.817 0.257 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 285' ' ' VAL . 2.3 t -69.99 125.71 27.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.38 -30.92 70.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.66 -40.08 74.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.682 HD11 HG21 ' A' ' 332' ' ' VAL . 17.4 mt -76.79 -45.85 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 281' ' ' SER . 91.5 t -48.94 -39.19 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -65.06 -44.29 89.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.495 ' CE1' ' NZ ' ' A' ' 328' ' ' LYS . 49.4 t80 -72.17 -26.36 62.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 110.978 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 49.4 m -69.37 -20.94 63.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.163 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 27.9 mttt -78.84 -43.55 24.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.25 -31.09 31.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.65 HG13 HG22 ' A' ' 321' ' ' THR . 6.1 pt -97.77 -51.33 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.538 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -59.82 -46.96 87.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.111 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 33.3 ttm -55.93 -68.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.865 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 293' ' ' MET . 49.2 mt-10 -35.92 -59.91 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 298' ' ' ALA . 31.3 mmtt -60.06 -64.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.474 HD13 ' HB ' ' A' ' 348' ' ' VAL . 48.4 mt -36.03 -37.88 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.894 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.503 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.8 m-85 -78.48 -44.25 24.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -59.36 -40.16 85.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.063 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.442 ' HB ' ' HB1' ' A' ' 313' ' ' ALA . 28.1 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.442 ' HB1' ' HB ' ' A' ' 299' ' ' VAL . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.806 0.336 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.56 -62.87 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -50.47 -41.67 53.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -41.61 -64.77 0.52 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.567 HG22 ' CE2' ' A' ' 341' ' ' PHE . 41.5 mt -42.29 -61.88 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.123 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.464 ' HD2' ' CD1' ' A' ' 341' ' ' PHE . 15.8 mmm180 -36.82 -33.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 319' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 317' ' ' ILE . 10.0 mt -88.11 -41.49 13.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 317' ' ' ILE . 41.2 m-20 -61.28 -61.8 2.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.65 HG22 HG13 ' A' ' 291' ' ' ILE . 36.2 p -54.16 -46.47 72.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -49.33 -40.13 34.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -85.46 -19.75 30.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' HIS . . . . . 0.544 ' CD2' HG21 ' A' ' 291' ' ' ILE . 74.7 t60 -82.46 -25.79 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.674 ' HB2' HG23 ' A' ' 337' ' ' ILE . 32.5 mt -89.76 -56.47 3.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.93 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.416 ' N ' HG12 ' A' ' 337' ' ' ILE . 2.2 tmmm? -38.2 -45.74 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.63 -37.8 85.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.608 ' HG2' ' CE2' ' A' ' 329' ' ' PHE . 9.9 tptm -57.95 -49.2 77.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.608 ' CE2' ' HG2' ' A' ' 328' ' ' LYS . 9.5 m-85 -124.26 94.66 44.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.629 0.728 . . . . 0.0 110.848 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 329' ' ' PHE . 53.7 Cg_endo -69.75 -41.99 3.8 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.668 2.245 . . . . 0.0 112.341 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -63.71 -25.71 68.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.682 HG21 HD11 ' A' ' 284' ' ' ILE . 53.0 t -69.17 148.77 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -72.53 150.51 43.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -62.48 -40.05 95.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.93 -11.09 16.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.409 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 6.6 mm-40 -87.26 -34.26 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.674 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.5 mp -75.04 -35.63 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.88 -64.62 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.458 ' O ' HD12 ' A' ' 343' ' ' ILE . 1.8 tp10 -44.9 -53.9 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 46.9 m -41.03 -34.96 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.567 ' CE2' HG22 ' A' ' 317' ' ' ILE . 48.0 t80 -70.01 -53.05 19.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -40.77 -40.19 1.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.458 HD12 ' O ' ' A' ' 339' ' ' GLU . 5.1 mp -73.67 -42.87 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.538 HG11 ' HB3' ' A' ' 292' ' ' ALA . 20.1 t -60.91 -62.64 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.116 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -40.28 -67.03 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -39.22 -51.74 1.96 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -56.08 -68.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 296' ' ' LEU . 38.3 t -44.44 -30.95 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -73.98 -64.38 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.02 -19.53 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 6.3 p -87.07 -32.02 20.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.503 HG12 ' CE1' ' A' ' 297' ' ' TYR . 54.3 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.806 0.252 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 9.9 m -68.61 125.89 27.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.77 87.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -38.78 -35.29 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.755 ' CD1' HG21 ' A' ' 332' ' ' VAL . 22.0 mt -86.72 -56.99 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.113 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 91.9 t -40.84 -36.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -64.65 -41.98 95.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 284' ' ' ILE . 55.1 t80 -74.26 -31.44 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.62 HG23 HD11 ' A' ' 325' ' ' LEU . 22.8 m -60.34 -20.98 61.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 293' ' ' MET . 21.4 mttt -77.98 -43.79 28.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.4 mp -58.88 -27.2 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.484 HG13 HG22 ' A' ' 321' ' ' THR . 5.5 pt -98.1 -51.13 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.476 ' N ' ' CG1' ' A' ' 291' ' ' ILE . . . -61.92 -46.28 90.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.094 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.519 ' HE2' ' HB2' ' A' ' 293' ' ' MET . 8.0 ttm -52.19 -63.46 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 293' ' ' MET . 14.9 mt-10 -37.53 -73.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 296' ' ' LEU . 1.1 mptm? -46.59 -64.14 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.606 HD12 HG21 ' A' ' 348' ' ' VAL . 51.1 mt -36.04 -55.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.587 ' CE1' HG12 ' A' ' 352' ' ' ILE . 11.5 m-85 -60.82 -41.95 96.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.935 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -58.83 -52.75 64.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.083 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 296' ' ' LEU . 27.7 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.821 0.343 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 96.0 t -61.15 -66.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.9 t30 -43.25 -49.65 6.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.919 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 315' ' ' ASN . 20.5 mmtt -37.8 -55.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 320' ' ' ASP . 54.2 mt -43.08 -62.81 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 317' ' ' ILE . 4.4 tmt_? -34.41 -38.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 8.4 mt -79.82 -43.09 23.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 317' ' ' ILE . 1.5 t70 -61.32 -65.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.484 HG22 HG13 ' A' ' 291' ' ' ILE . 71.7 p -50.79 -46.46 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.424 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 0.3 OUTLIER -48.08 -35.64 11.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -93.18 -20.22 20.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -81.29 -21.6 39.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.62 HD11 HG23 ' A' ' 288' ' ' THR . 22.8 mt -94.22 -65.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -39.93 -29.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 328' ' ' LYS . 4.9 pt-20 -75.08 -43.01 55.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.538 ' HE3' ' CZ ' ' A' ' 329' ' ' PHE . 45.3 tttp -53.54 -45.52 69.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.986 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.1 OUTLIER -123.1 107.94 32.59 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.642 0.734 . . . . 0.0 110.926 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -22.5 32.13 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.657 2.238 . . . . 0.0 112.352 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -72.3 -39.45 68.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.986 HG12 ' O ' ' A' ' 329' ' ' PHE . 7.3 p -57.03 147.98 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' ASP . . . . . 0.688 ' O ' HD12 ' A' ' 337' ' ' ILE . 1.5 t70 -96.56 154.33 17.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -61.81 -21.67 64.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.593 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.5 t80 -76.44 -9.67 58.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -96.31 -46.87 6.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 333' ' ' ASP . 5.4 mp -62.15 -37.69 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 48.4 mt -71.18 -59.35 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -62.32 -12.29 20.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 341' ' ' PHE . 3.5 m -80.19 -68.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.821 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 340' ' ' SER . 40.0 t80 -34.82 -44.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -42.61 -49.99 5.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.1 mp -63.42 -47.51 91.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.131 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 345' ' ' ALA . 53.9 t -48.89 -67.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.18 -66.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.133 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -38.45 -44.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 347' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 348' ' ' VAL . 15.6 tt0 -62.37 -68.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.606 HG21 HD12 ' A' ' 296' ' ' LEU . 96.1 t -35.18 -68.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 352' ' ' ILE . 9.5 m-85 -34.72 -68.86 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 349' ' ' PHE . 17.2 ttt180 -34.24 -50.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 3.5 m -67.07 -40.38 87.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.875 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.587 HG12 ' CE1' ' A' ' 297' ' ' TYR . 70.7 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.165 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' PRO . . . . . 0.425 ' HA ' ' OE1' ' A' ' 336' ' ' GLU . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.807 0.253 . . . . 0.0 112.322 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.4 p -72.95 122.88 22.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.537 ' HB1' ' HE2' ' A' ' 286' ' ' LYS . . . -62.04 -49.14 77.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.077 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -44.53 -42.79 7.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.737 HD12 HG21 ' A' ' 332' ' ' VAL . 8.8 mt -77.16 -44.21 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 281' ' ' SER . 40.5 t -52.13 -43.75 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 286' ' ' LYS . . . . . 0.537 ' HE2' ' HB1' ' A' ' 282' ' ' ALA . 0.0 OUTLIER -61.25 -30.52 70.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.58 ' CE2' ' HD2' ' A' ' 328' ' ' LYS . 47.6 t80 -84.47 -22.94 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.933 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.536 ' CG2' HG21 ' A' ' 344' ' ' VAL . 30.0 m -66.31 -22.96 66.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 2.1 mptm? -75.75 -44.1 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 287' ' ' TYR . 2.9 mp -53.64 -30.87 19.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.108 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.669 HG21 ' CD2' ' A' ' 324' ' ' HIS . 5.4 pt -98.37 -51.99 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.455 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -61.49 -48.61 80.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.096 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 15.4 ttm -55.11 -62.28 1.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -47.72 -64.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 298' ' ' ALA . 85.0 mttt -51.34 -63.7 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.463 HD12 HG21 ' A' ' 348' ' ' VAL . 51.3 mt -40.59 -57.43 1.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' TYR . . . . . 0.505 ' CE1' ' CG1' ' A' ' 352' ' ' ILE . 9.2 m-85 -55.58 -34.53 64.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 295' ' ' LYS . . . -66.64 -53.07 37.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.058 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.524 HG11 ' HB1' ' A' ' 313' ' ' ALA . 35.9 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.524 ' HB1' HG11 ' A' ' 299' ' ' VAL . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.832 0.348 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.65 -45.77 72.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.7 t30 -67.81 -51.02 53.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.937 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 315' ' ' ASN . 18.4 mmtt -36.61 -59.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 318' ' ' ARG . 92.8 mt -42.17 -54.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.157 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 317' ' ' ILE . 76.4 mtt-85 -38.09 -35.84 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.7 mt -83.87 -43.95 14.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.91 -69.24 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.567 HG22 HG13 ' A' ' 291' ' ' ILE . 68.3 p -49.15 -46.79 45.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.48 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 7.3 tm-20 -46.76 -43.67 18.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -87.59 -10.14 52.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' HIS . . . . . 0.669 ' CD2' HG21 ' A' ' 291' ' ' ILE . 44.8 t60 -89.34 -26.18 21.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.742 HD12 HG23 ' A' ' 337' ' ' ILE . 19.5 mt -93.59 -53.32 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -50.62 -27.93 7.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -84.5 -27.71 27.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.58 ' HD2' ' CE2' ' A' ' 287' ' ' TYR . 42.0 tttp -62.26 -55.19 30.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.848 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.1 OUTLIER -123.31 108.39 31.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.642 0.734 . . . . 0.0 110.86 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 330' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 329' ' ' PHE . 53.9 Cg_endo -69.75 -21.08 34.02 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.691 2.261 . . . . 0.0 112.328 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.43 -35.5 75.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 329' ' ' PHE . 9.9 p -71.7 153.47 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.173 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 333' ' ' ASP . . . . . 0.497 ' O ' HD12 ' A' ' 337' ' ' ILE . 6.3 t0 -93.47 161.42 14.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -61.97 -47.04 86.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' PHE . . . . . 0.597 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.4 t80 -51.41 -16.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.46 ' HB2' HG22 ' A' ' 332' ' ' VAL . 22.2 mm-40 -89.09 -34.54 16.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.915 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.742 HG23 HD12 ' A' ' 325' ' ' LEU . 2.8 mp -73.81 -30.33 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 28.1 mt -77.84 -61.83 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.62 ' O ' HD12 ' A' ' 343' ' ' ILE . 6.9 tp10 -52.67 -35.7 55.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 340' ' ' SER . . . . . 0.407 ' O ' HG23 ' A' ' 344' ' ' VAL . 4.4 p -57.02 -47.79 80.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -56.85 -50.47 72.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -40.42 -51.48 2.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.9 mp -65.1 -38.07 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.169 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.536 HG21 ' CG2' ' A' ' 288' ' ' THR . 77.8 t -60.85 -63.64 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -37.69 -51.99 1.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.079 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -54.84 -42.73 72.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 347' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 344' ' ' VAL . 20.0 tp10 -60.31 -54.74 42.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.947 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.463 HG21 HD12 ' A' ' 296' ' ' LEU . 49.2 t -57.56 -69.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.116 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.461 ' O ' ' N ' ' A' ' 352' ' ' ILE . 13.0 m-85 -35.32 -55.6 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 350' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 349' ' ' PHE . 15.4 tpt180 -36.85 -57.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 47.3 t -65.31 -31.25 72.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' ILE . . . . . 0.505 ' CG1' ' CE1' ' A' ' 297' ' ' TYR . 51.0 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.113 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.151 0 CA-C-O 120.822 0.259 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.57 121.28 26.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 283' ' ' GLU . . . -53.24 -57.46 10.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.066 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 282' ' ' ALA . 4.5 pt-20 -38.1 -44.46 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' ILE . . . . . 0.744 HD11 HG21 ' A' ' 332' ' ' VAL . 74.6 mt -69.82 -55.98 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 88.0 t -37.81 -46.1 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.162 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -58.1 -55.94 28.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' TYR . . . . . 0.449 ' HA ' HD13 ' A' ' 290' ' ' ILE . 40.9 t80 -60.23 -26.72 66.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 16.9 m -69.31 -20.17 63.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 293' ' ' MET . 25.6 mttt -80.69 -38.26 29.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 287' ' ' TYR . 3.1 mp -60.23 -32.31 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ILE . . . . . 0.7 ' CD1' HG22 ' A' ' 321' ' ' THR . 16.9 pt -95.37 -46.84 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.126 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ALA . . . . . 0.481 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -62.79 -47.68 82.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 293' ' ' MET . . . . . 0.446 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 10.5 ttm -57.04 -60.97 2.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -48.77 -60.89 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 298' ' ' ALA . 27.0 mtmt -55.41 -62.94 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 67.0 mt -41.71 -49.05 4.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -67.59 -28.78 68.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -70.59 -40.4 73.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.078 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' VAL . . . . . 0.566 ' CG1' ' HB1' ' A' ' 313' ' ' ALA . 30.6 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' ALA . . . . . 0.566 ' HB1' ' CG1' ' A' ' 299' ' ' VAL . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.849 0.356 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.4 t -77.44 -54.8 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.141 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.7 OUTLIER -51.54 -53.04 42.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 316' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 315' ' ' ASN . 15.9 mmmt -34.58 -51.66 0.48 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.507 HG22 ' CE1' ' A' ' 341' ' ' PHE . 82.5 mt -41.69 -58.85 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 317' ' ' ILE . 25.5 mtp180 -37.11 -43.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.2 mt -80.5 -44.26 19.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -56.57 -62.02 2.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.7 HG22 ' CD1' ' A' ' 291' ' ' ILE . 25.3 p -54.51 -57.51 11.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.43 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 17.0 tt0 -40.77 -34.92 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.89 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -87.84 -28.58 21.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 321' ' ' THR . 18.8 t-80 -75.0 -21.26 59.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.832 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.632 HD12 HG23 ' A' ' 337' ' ' ILE . 14.8 mt -93.2 -63.03 1.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 325' ' ' LEU . 8.4 tmtt? -35.98 -52.67 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -53.71 -44.85 70.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.869 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 328' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 325' ' ' LEU . 33.7 tttp -59.53 -44.08 93.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 329' ' ' PHE . . . . . 0.565 ' CE1' HG12 ' A' ' 284' ' ' ILE . 0.3 OUTLIER -115.97 89.19 23.81 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.676 0.751 . . . . 0.0 110.918 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -26.64 27.29 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.696 2.264 . . . . 0.0 112.308 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.89 -29.03 55.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' VAL . . . . . 0.744 HG21 HD11 ' A' ' 284' ' ' ILE . 39.8 t -70.72 153.28 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.15 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 333' ' ' ASP . . . . . 0.41 ' N ' ' CG1' ' A' ' 332' ' ' VAL . 7.9 t0 -88.45 154.25 20.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -57.61 -47.97 80.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.67 -23.83 4.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 336' ' ' GLU . . . . . 0.483 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 7.7 mt-10 -79.83 -29.05 40.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 337' ' ' ILE . . . . . 0.632 HG23 HD12 ' A' ' 325' ' ' LEU . 1.5 mp -89.23 -23.73 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 64.6 mt -74.15 -53.94 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 339' ' ' GLU . . . . . 0.534 ' O ' HD12 ' A' ' 343' ' ' ILE . 19.6 mm-40 -64.06 -45.97 86.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 90.8 p -39.77 -50.73 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 341' ' ' PHE . . . . . 0.507 ' CE1' HG22 ' A' ' 317' ' ' ILE . 51.4 t80 -59.09 -56.56 20.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -38.24 -44.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.2 mp -69.45 -42.4 80.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 344' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 345' ' ' ALA . 53.7 t -58.94 -63.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.113 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 345' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.34 -55.59 0.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -47.92 -53.8 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -48.65 -61.37 2.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 348' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 349' ' ' PHE . 41.1 t -55.46 -62.03 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.201 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 349' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 348' ' ' VAL . 6.6 m-85 -34.68 -63.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -39.29 -62.15 0.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 42.5 t -46.11 -45.26 16.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 77.9 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.933 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.0 m -152.08 161.41 42.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.376 . . . . 0.0 110.871 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 34.2 p -157.73 162.51 38.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 90.24 131.28 4.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.474 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.8 m -91.83 126.92 37.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 0.0 110.877 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 17.9 p -174.99 124.53 0.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.842 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 89.75 -166.8 33.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.468 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 2.83 3.17 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.688 2.259 . . . . 0.0 112.31 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -65.99 116.16 6.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -69.71 168.96 13.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 278' ' ' PHE . 10.8 mt -104.69 158.27 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.503 ' N ' HG22 ' A' ' 277' ' ' ILE . 6.1 m-85 -75.62 148.36 38.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 22.3 p -90.03 154.25 47.3 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.575 0.702 . . . . 0.0 111.168 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -168.95 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.639 2.226 . . . . 0.0 112.366 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.688 ' O ' HG23 ' A' ' 285' ' ' VAL . 50.0 m -76.09 132.47 40.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -73.86 -45.53 50.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.089 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 329' ' ' PHE . 15.6 pt-20 -41.35 -46.29 3.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.538 HD11 HG21 ' A' ' 332' ' ' VAL . 7.0 mt -73.33 -59.8 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 281' ' ' SER . 85.0 t -34.97 -41.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.077 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -63.67 -48.89 75.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 284' ' ' ILE . 54.1 t80 -69.48 -19.25 63.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.933 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.768 ' HB ' HG21 ' A' ' 344' ' ' VAL . 9.5 m -72.89 -23.06 60.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.129 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 23.1 mttt -77.05 -43.35 34.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -55.7 -31.74 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.563 HG21 ' CD2' ' A' ' 324' ' ' HIS . 6.7 pt -98.04 -51.49 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.082 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 288' ' ' THR . . . -59.02 -46.87 87.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.086 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 16.9 ttm -55.05 -69.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 293' ' ' MET . 15.7 mt-10 -37.84 -63.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 298' ' ' ALA . 40.9 mttm -53.98 -65.57 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 45.7 mt -38.04 -42.1 0.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.585 ' CE2' HG13 ' A' ' 348' ' ' VAL . 10.8 m-85 -75.98 -36.03 59.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -69.44 -26.71 64.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.072 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 29.9 m -89.23 -34.63 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.629 ' CD2' HD13 ' A' ' 352' ' ' ILE . 0.4 OUTLIER -67.14 -51.26 56.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 89.5 m -52.05 -35.37 47.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -109.25 -177.31 3.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 68.28 35.39 3.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -79.79 -54.02 6.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.884 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -52.2 -50.52 61.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.486 ' CB ' ' HB2' ' A' ' 309' ' ' SER . 0.9 OUTLIER -84.33 140.5 31.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -90.95 -39.49 12.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 61.3 t -81.55 -37.67 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.486 ' HB2' ' CB ' ' A' ' 306' ' ' ASP . 3.8 t -46.05 -36.63 5.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.495 ' O ' HG23 ' A' ' 314' ' ' VAL . 16.4 ptm180 -84.53 -27.27 27.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -58.37 -43.63 88.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -78.63 -35.17 45.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -58.18 -43.83 87.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 310' ' ' ARG . 59.1 t -69.33 -61.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.3 t30 -51.87 -47.9 64.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 315' ' ' ASN . 12.2 mmtp -35.98 -53.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.872 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 321' ' ' THR . 51.1 mt -46.49 -55.59 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -39.1 -32.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.2 mt -89.85 -36.39 15.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.975 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 317' ' ' ILE . 47.3 t0 -66.86 -63.41 1.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.449 HG23 HG23 ' A' ' 317' ' ' ILE . 24.2 p -48.65 -44.58 37.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.119 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -50.75 -33.08 21.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.27 -16.54 30.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.852 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' HIS . . . . . 0.563 ' CD2' HG21 ' A' ' 291' ' ' ILE . 84.3 t60 -91.85 -22.23 20.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.46 HD11 HG23 ' A' ' 288' ' ' THR . 41.9 mt -94.4 -61.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -45.9 -22.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -79.07 -41.64 28.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -69.02 -33.9 74.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 329' ' ' PHE . 2.0 m-85 -116.56 83.0 13.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.678 0.751 . . . . 0.0 110.874 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -22.75 31.56 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 0.0 112.331 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -84.39 -30.53 25.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.538 HG21 HD11 ' A' ' 284' ' ' ILE . 45.4 t -66.37 157.9 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.164 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ASP . . . . . 0.471 ' N ' ' CG1' ' A' ' 332' ' ' VAL . 6.1 t70 -85.57 149.41 25.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' GLN . . . . . 0.403 ' C ' ' OE1' ' A' ' 334' ' ' GLN . 1.0 OUTLIER -59.08 -32.11 69.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.919 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -68.94 -14.29 62.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.47 ' CA ' ' OE1' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -89.49 -21.56 22.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.413 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.8 mp -85.31 -26.45 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.12 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 339' ' ' GLU . 2.7 mp -88.11 -69.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.101 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.602 ' O ' HD12 ' A' ' 343' ' ' ILE . 4.8 tp10 -42.83 -34.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.572 ' HB2' HG22 ' A' ' 285' ' ' VAL . 18.8 p -62.8 -50.72 69.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 344' ' ' VAL . 50.1 t80 -49.93 -54.38 20.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 341' ' ' PHE . 7.7 m-80 -36.57 -55.71 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.602 HD12 ' O ' ' A' ' 339' ' ' GLU . 5.0 mp -58.45 -38.08 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.14 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.768 HG21 ' HB ' ' A' ' 288' ' ' THR . 52.3 t -65.63 -52.15 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -46.8 -67.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -39.2 6.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -56.83 -49.69 74.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.585 HG13 ' CE2' ' A' ' 297' ' ' TYR . 48.2 t -61.44 -60.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 348' ' ' VAL . 11.4 m-85 -34.42 -59.96 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -44.32 -51.93 8.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.402 ' HA ' HD13 ' A' ' 354' ' ' LEU . 10.4 m -58.89 -33.28 70.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.629 HD13 ' CD2' ' A' ' 300' ' ' PHE . 69.8 mt -73.76 -29.18 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.169 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 353' ' ' ILE . 16.8 mm -70.96 -12.73 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 351' ' ' SER . 7.3 mp -79.15 -11.27 59.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.95 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.19 25.82 8.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' GLU . . . . . 0.582 ' OE2' ' CZ ' ' A' ' 300' ' ' PHE . 23.9 pt-20 -175.14 133.7 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.444 ' CG ' ' O ' ' A' ' 357' ' ' TYR . 16.5 t80 65.2 37.11 6.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -130.54 177.57 7.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -146.99 134.37 20.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 1.9 t 54.0 44.14 29.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -48.39 -49.85 33.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 154.14 90.7 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.519 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -41.19 155.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.771 0.32 . . . . 0.0 110.887 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -131.61 146.37 52.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.846 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 29.3 t -103.38 -38.12 7.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -100.98 -157.74 27.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.486 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 130.7 19.81 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.658 2.239 . . . . 0.0 112.329 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.1 m -84.06 -52.73 6.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.2 t -107.42 95.29 5.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 86.1 p -113.88 42.11 2.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.883 0.373 . . . . 0.0 110.84 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 35.0 m -154.38 176.38 12.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.843 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 169.79 83.99 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.477 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.2 m -68.59 121.02 15.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.839 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 25.1 p -87.21 167.17 14.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.812 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 170.96 -158.12 29.48 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -3.09 11.28 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.711 2.274 . . . . 0.0 112.332 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -71.18 143.85 50.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 147.92 50.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.97 163.05 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.136 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -126.19 141.19 52.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 29.6 p -79.68 153.08 75.67 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.562 0.696 . . . . 0.0 111.192 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 171.24 14.74 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.731 2.287 . . . . 0.0 112.337 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.1 t -68.64 130.7 43.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.94 -36.62 82.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -52.0 -38.43 56.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.711 HD11 HG21 ' A' ' 332' ' ' VAL . 20.0 mt -76.65 -53.97 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.143 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 281' ' ' SER . 82.0 t -39.71 -49.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -55.43 -44.49 76.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -73.51 -26.88 61.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.498 HG23 HD11 ' A' ' 325' ' ' LEU . 41.7 m -68.28 -15.95 63.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.177 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 293' ' ' MET . 18.1 mttm -82.99 -40.17 20.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -59.93 -27.14 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.095 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.679 ' CD1' HG22 ' A' ' 321' ' ' THR . 17.1 pt -98.1 -46.96 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.482 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.14 -48.12 68.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.133 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 19.4 ttm -51.89 -60.32 3.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -45.78 -70.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 298' ' ' ALA . 8.4 mmmm -47.27 -62.01 1.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.419 HD22 ' CZ ' ' A' ' 349' ' ' PHE . 49.8 mt -41.67 -48.36 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.484 ' CE2' HG13 ' A' ' 348' ' ' VAL . 13.5 m-85 -75.22 -21.69 58.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -78.29 -26.76 47.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 28.4 m -90.26 -30.97 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.542 ' CD2' HG21 ' A' ' 352' ' ' ILE . 1.5 t80 -72.15 -44.7 62.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 297' ' ' TYR . 8.0 t -74.96 2.17 11.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.118 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -117.49 -66.63 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.834 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.525 ' CZ ' ' HG2' ' A' ' 310' ' ' ARG . 0.4 OUTLIER -79.61 62.87 4.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -88.8 -64.92 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -55.77 -50.9 69.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -109.26 84.06 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 309' ' ' SER . 3.6 tmtt? -83.48 -66.53 0.88 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 2.1 p -38.98 -25.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 307' ' ' LYS . 36.9 m -71.84 -60.37 2.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.525 ' HG2' ' CZ ' ' A' ' 303' ' ' TYR . 9.7 tpt180 -92.05 37.6 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -68.33 -29.14 67.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 312' ' ' GLU . 2.0 pm0 -54.3 -36.3 63.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -50.91 -53.21 34.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.081 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.442 HG13 ' HZ ' ' A' ' 349' ' ' PHE . 55.7 t -46.83 -29.89 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.147 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -87.31 -41.33 13.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.449 ' N ' ' HD2' ' A' ' 316' ' ' LYS . 3.7 mptt -40.74 -53.87 2.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.418 ' O ' ' C ' ' A' ' 318' ' ' ARG . 52.7 mt -45.41 -57.52 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.123 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 317' ' ' ILE . 16.0 tpp85 -37.22 -44.59 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.8 mt -77.65 -43.75 30.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.76 -69.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.679 HG22 ' CD1' ' A' ' 291' ' ' ILE . 16.5 p -46.27 -51.37 14.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -48.08 -45.19 32.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -80.05 -14.04 58.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' HIS . . . . . 0.504 ' ND1' HG21 ' A' ' 291' ' ' ILE . 40.6 t-80 -91.11 -22.57 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.498 HD11 HG23 ' A' ' 288' ' ' THR . 23.0 mt -94.18 -60.3 1.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 325' ' ' LEU . 1.0 OUTLIER -35.86 -44.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -60.26 -46.35 90.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.454 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 26.8 tptt -60.58 -39.56 88.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.585 ' CE2' HG12 ' A' ' 284' ' ' ILE . 2.8 m-85 -117.43 83.68 17.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.634 0.731 . . . . 0.0 110.851 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 -24.53 29.24 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.24 -30.66 30.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.711 HG21 HD11 ' A' ' 284' ' ' ILE . 85.3 t -70.2 144.12 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.194 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -73.86 150.56 40.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -61.33 -45.56 93.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.1 t80 -51.22 -17.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.891 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.99 -44.13 10.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.6 mp -63.76 -39.99 87.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.96 -58.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.636 ' OE2' HD11 ' A' ' 343' ' ' ILE . 7.5 tm-20 -49.02 -52.21 26.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.406 ' CB ' HG22 ' A' ' 285' ' ' VAL . 1.8 p -43.28 -41.63 4.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 344' ' ' VAL . 73.6 t80 -62.16 -56.45 18.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 341' ' ' PHE . 11.2 m-80 -35.72 -36.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.636 HD11 ' OE2' ' A' ' 339' ' ' GLU . 5.2 mp -79.47 -43.03 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.15 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 341' ' ' PHE . 50.8 t -59.94 -41.62 86.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -54.97 -69.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.074 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -53.03 -33.01 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.8 -31.99 73.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.484 HG13 ' CE2' ' A' ' 297' ' ' TYR . 34.7 t -92.12 -57.36 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.442 ' HZ ' HG13 ' A' ' 314' ' ' VAL . 38.1 m-85 -42.3 -55.84 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -51.19 -43.14 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.479 ' HA ' ' CD2' ' A' ' 354' ' ' LEU . 2.8 t -59.49 -18.93 44.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.816 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.542 HG21 ' CD2' ' A' ' 300' ' ' PHE . 48.2 mt -95.27 -49.77 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.114 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 353' ' ' ILE . 1.7 mp -55.23 -36.89 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.906 HD12 ' N ' ' A' ' 355' ' ' ASN . 1.4 pp -48.32 -24.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ASN . . . . . 0.906 ' N ' HD12 ' A' ' 354' ' ' LEU . 28.6 m-20 -47.54 -39.55 16.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -48.51 -47.78 38.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -104.83 105.56 15.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -112.63 156.56 22.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.14 174.09 14.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 21.4 p -74.01 152.73 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.15 142.91 51.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -80.01 -90.13 0.48 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.462 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 364' ' ' ASP . 41.2 mtp180 -143.2 122.6 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.862 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 363' ' ' ARG . 6.3 t70 -36.91 141.49 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 45.5 t -79.78 -60.6 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.843 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -174.3 171.33 44.46 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 119.72 6.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.248 . . . . 0.0 112.369 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 4.2 t -150.6 156.79 42.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.54 -3.94 56.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.858 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.476 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.6 t -116.9 44.59 2.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 0.0 110.891 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.3 t -82.15 85.69 6.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 154.82 -102.0 0.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.496 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 47.2 m 43.1 51.69 5.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.869 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 14.5 t -82.06 142.91 31.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 170.41 -158.18 29.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.498 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -1.08 7.83 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.741 2.294 . . . . 0.0 112.352 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -71.69 158.81 35.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -73.4 164.23 26.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.532 ' C ' HD12 ' A' ' 277' ' ' ILE . 2.6 pp -97.71 162.14 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.092 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -126.39 139.85 52.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 34.9 p -86.44 153.52 56.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.584 0.707 . . . . 0.0 111.171 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 177.33 5.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.716 2.277 . . . . 0.0 112.323 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 2.1 m -71.52 120.52 17.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 283' ' ' GLU . . . -60.09 -56.72 18.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 282' ' ' ALA . 10.7 pt-20 -34.6 -45.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.646 HD11 HG21 ' A' ' 332' ' ' VAL . 27.3 mt -68.99 -57.73 7.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 87.3 t -38.13 -57.04 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -52.1 -40.84 61.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -73.83 -27.03 60.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.801 ' HB ' HG21 ' A' ' 344' ' ' VAL . 17.5 m -67.6 -19.08 65.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.174 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 293' ' ' MET . 28.4 mttt -79.57 -41.79 26.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -58.47 -29.85 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.627 HG13 HG22 ' A' ' 321' ' ' THR . 7.6 pt -97.53 -49.55 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.452 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -62.06 -48.04 82.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.478 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 11.9 ttm -54.94 -52.27 63.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -51.79 -68.65 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 298' ' ' ALA . 69.8 mttt -50.35 -58.65 5.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.954 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.659 ' HG ' HD13 ' A' ' 317' ' ' ILE . 42.6 mt -42.6 -58.23 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.62 ' O ' HG23 ' A' ' 301' ' ' THR . 11.0 m-85 -61.56 -29.64 70.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.964 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 295' ' ' LYS . . . -67.33 -48.92 66.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 24.0 m -74.8 -26.96 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -79.32 -33.14 43.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 297' ' ' TYR . 27.3 p -76.87 -34.4 57.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -83.02 -46.41 12.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -87.07 75.53 9.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -83.09 -67.88 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -65.62 -48.95 70.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.52 63.43 7.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -76.72 -60.6 2.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 6.2 p -70.0 -16.69 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 2.5 m -82.63 -34.29 27.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.803 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -106.79 30.19 6.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.83 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.38 -27.31 68.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 7.4 pm0 -61.82 -32.73 73.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -64.78 -48.34 74.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.081 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 46.0 t -57.54 -28.37 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 317' ' ' ILE . 7.0 t-20 -80.79 -44.04 19.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.93 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.645 ' HA ' HD12 ' A' ' 319' ' ' LEU . 25.6 mttt -40.52 -24.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.659 HD13 ' HG ' ' A' ' 296' ' ' LEU . 94.8 mt -58.96 -67.16 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.148 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 319' ' ' LEU . 7.3 ptp180 -37.97 -32.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 316' ' ' LYS . 18.8 mt -76.58 -42.69 41.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 317' ' ' ILE . 15.7 t0 -74.41 -62.86 1.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.627 HG22 HG13 ' A' ' 291' ' ' ILE . 7.5 p -42.04 -54.73 3.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -45.02 -49.33 11.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -68.9 -21.34 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' HIS . . . . . 0.532 ' ND1' HG21 ' A' ' 291' ' ' ILE . 25.5 t-80 -86.63 -23.06 25.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.828 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.55 ' HB2' HG23 ' A' ' 337' ' ' ILE . 42.8 mt -88.71 -58.02 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.935 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 325' ' ' LEU . 0.2 OUTLIER -37.14 -48.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -53.27 -54.53 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.453 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 26.2 tptt -53.4 -47.52 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.584 ' CE2' HG12 ' A' ' 284' ' ' ILE . 0.4 OUTLIER -113.05 86.72 9.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.651 0.739 . . . . 0.0 110.886 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -38.63 7.54 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 2.24 . . . . 0.0 112.359 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.78 -26.82 66.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 284' ' ' ILE . 96.0 t -73.06 141.99 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.087 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -79.57 147.49 32.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.851 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -51.41 -49.14 62.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.3 t80 -46.51 -21.28 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.434 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 7.5 mm-40 -88.71 -38.82 14.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.6 mp -70.81 -30.17 40.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 79.7 mt -77.13 -66.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.575 ' OE1' HD11 ' A' ' 343' ' ' ILE . 3.2 tm-20 -43.53 -49.19 7.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 7.4 p -43.16 -47.18 6.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.602 ' CE1' HG22 ' A' ' 317' ' ' ILE . 61.2 t80 -52.32 -56.08 17.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.828 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 341' ' ' PHE . 12.1 m120 -35.07 -57.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.632 ' H ' HD12 ' A' ' 343' ' ' ILE . 5.2 mp -56.24 -51.57 61.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.801 HG21 ' HB ' ' A' ' 288' ' ' THR . 21.6 t -51.0 -66.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -38.92 -58.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -37.72 -52.14 1.25 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -56.87 -65.78 0.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 297' ' ' TYR . 46.9 t -42.66 -42.44 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.087 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' A' ' 350' ' ' ARG . 4.9 m-85 -57.83 -65.01 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 349' ' ' PHE . 13.0 tpp85 -37.39 -65.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 68.5 p -41.23 -59.51 1.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.402 HG12 ' CE1' ' A' ' 297' ' ' TYR . 48.8 mt -55.59 -63.08 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.16 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 30.8 mm -40.91 -47.03 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.136 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.0 -37.14 72.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -61.94 -40.07 94.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -58.52 -55.44 35.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -152.19 116.52 4.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -84.85 144.96 28.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -134.36 156.9 47.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 72.2 m -46.36 100.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.05 150.97 17.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -122.09 141.53 14.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.5 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -129.53 148.63 51.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.811 0.339 . . . . 0.0 110.884 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -123.46 172.96 8.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 7.5 t -57.69 158.28 6.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -119.31 159.88 14.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.479 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 169.08 19.71 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.341 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 74.7 m -118.98 161.06 20.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 29.2 t -47.88 158.48 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.483 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 10.1 t -66.63 166.13 13.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.946 0.403 . . . . 0.0 110.818 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.7 m -107.25 107.91 19.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -83.42 -143.77 5.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.485 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 41.7 t -107.93 -45.03 4.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.886 0.374 . . . . 0.0 110.833 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 4.7 m -92.18 109.41 20.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.857 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -143.64 146.18 16.59 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -14.48 36.12 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.658 2.239 . . . . 0.0 112.353 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -74.84 163.6 27.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.429 ' HG3' ' N ' ' A' ' 277' ' ' ILE . 27.5 tptt -82.98 148.94 27.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 278' ' ' PHE . 51.2 mm -95.66 154.23 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.443 ' N ' HG22 ' A' ' 277' ' ' ILE . 3.1 m-85 -129.93 143.64 50.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 70.4 p -75.93 151.68 84.33 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.574 0.702 . . . . 0.0 111.132 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 166.6 27.0 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.667 2.245 . . . . 0.0 112.35 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.418 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.2 t -68.26 121.37 16.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.844 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.63 82.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.099 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -50.9 -37.83 46.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.91 HD11 HG21 ' A' ' 332' ' ' VAL . 59.2 mt -76.52 -44.04 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 281' ' ' SER . 47.3 t -50.34 -60.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -40.19 -47.01 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -72.23 -39.85 68.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.778 HG23 HD11 ' A' ' 325' ' ' LEU . 4.1 m -54.73 -17.94 4.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.182 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 293' ' ' MET . 42.1 mttt -79.47 -46.43 17.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 290' ' ' ILE . 2.4 mp -58.4 -22.65 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.095 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.516 HD11 ' HA ' ' A' ' 288' ' ' THR . 7.3 pt -98.17 -51.92 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.481 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -66.88 -48.22 69.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 29.8 ttm -49.44 -71.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -41.45 -69.35 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 298' ' ' ALA . 0.0 OUTLIER -42.44 -63.88 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 39.7 mt -43.97 -43.02 6.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.576 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.9 m-85 -70.69 -30.76 67.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -70.2 -65.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 7.0 m -47.54 -27.39 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.121 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.594 ' CD2' HG21 ' A' ' 352' ' ' ILE . 2.7 t80 -76.73 -49.5 15.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 45.1 m -54.17 -35.69 62.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -83.68 -61.98 1.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 303' ' ' TYR . 0.3 OUTLIER -88.26 87.04 7.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -94.19 -50.99 5.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.843 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -78.36 -41.2 34.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.845 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.31 50.44 1.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.847 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -60.4 -58.03 10.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.559 HG23 ' N ' ' A' ' 309' ' ' SER . 30.2 m -71.55 -48.88 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.113 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.559 ' N ' HG23 ' A' ' 308' ' ' VAL . 3.5 m -49.95 -44.12 50.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -108.44 37.01 2.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -70.65 -17.48 62.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -53.68 -24.42 14.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -72.55 -55.17 7.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.421 HG11 ' HZ ' ' A' ' 349' ' ' PHE . 60.2 t -52.47 -44.18 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.9 t30 -70.26 -47.77 59.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 315' ' ' ASN . 10.8 mmtm -35.86 -51.98 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.441 ' O ' ' N ' ' A' ' 320' ' ' ASP . 42.0 mt -45.12 -54.07 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.112 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -39.22 -33.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.55 -34.19 15.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 317' ' ' ILE . 6.5 t0 -67.63 -68.15 0.41 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.51 HG22 HD12 ' A' ' 291' ' ' ILE . 17.1 p -42.91 -44.2 4.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -50.2 -46.57 54.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.13 -17.66 60.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.835 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -87.84 -28.3 21.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.778 HD11 HG23 ' A' ' 288' ' ' THR . 19.0 mt -90.62 -59.07 2.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 325' ' ' LEU . 7.3 tmtt? -38.22 -45.53 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.54 -39.62 94.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.887 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 325' ' ' LEU . 22.1 tptt -65.01 -44.9 87.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.59 ' CE2' HG12 ' A' ' 284' ' ' ILE . 0.5 OUTLIER -113.72 86.17 10.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.638 0.733 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -22.08 32.64 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.73 2.287 . . . . 0.0 112.346 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -84.06 -26.08 29.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.91 HG21 HD11 ' A' ' 284' ' ' ILE . 48.7 t -75.89 138.73 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.124 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -72.08 142.86 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.812 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -51.57 -47.92 63.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.597 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 1.5 t80 -47.45 -20.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.408 ' HB2' HG12 ' A' ' 332' ' ' VAL . 20.8 mt-10 -88.09 -45.57 10.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.4 mp -60.3 -26.21 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.134 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 340' ' ' SER . 76.7 mt -89.34 -64.95 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -41.88 -26.11 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.919 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 338' ' ' ILE . 2.4 p -65.77 -46.57 78.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.44 ' CE2' HG22 ' A' ' 317' ' ' ILE . 23.3 t80 -53.92 -52.74 59.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 341' ' ' PHE . 28.2 m-80 -34.53 -48.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.507 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.7 mp -73.46 -41.75 56.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.15 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.48 HG11 ' HB3' ' A' ' 292' ' ' ALA . 25.2 t -58.25 -59.97 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' ALA . . . . . 0.412 ' HB2' ' CE1' ' A' ' 341' ' ' PHE . . . -38.17 -64.9 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.104 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -46.34 -60.72 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.943 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -39.86 -34.99 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 344' ' ' VAL . 22.0 t -81.21 -53.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.158 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.0 m-85 -52.5 -64.48 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 349' ' ' PHE . 23.9 ptt85 -37.77 -28.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.866 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.716 ' O ' HD22 ' A' ' 354' ' ' LEU . 15.8 t -84.17 -41.74 16.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.594 HG21 ' CD2' ' A' ' 300' ' ' PHE . 83.6 mt -63.68 -17.1 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 18.7 mm -64.93 -22.28 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.176 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.716 HD22 ' O ' ' A' ' 351' ' ' SER . 1.3 pt? -54.58 -24.17 19.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ASN . . . . . 0.55 ' N ' HD23 ' A' ' 354' ' ' LEU . 1.9 t30 -95.63 -13.26 24.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 357' ' ' TYR . 52.4 mm-40 -91.53 87.33 6.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 356' ' ' GLU . 1.1 p90 36.75 53.47 1.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -143.24 128.13 18.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.69 159.73 33.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.89 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 31.8 p -162.13 174.49 12.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.855 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -78.76 99.79 6.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -148.76 127.69 2.59 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.518 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 364' ' ' ASP . 22.8 ptt180 -46.76 -46.47 20.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.801 0.334 . . . . 0.0 110.919 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.416 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 2.8 t70 -112.06 139.78 47.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.809 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 29.8 p -77.62 -53.57 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 170.16 148.19 5.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.496 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 153.36 68.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.611 2.207 . . . . 0.0 112.348 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 11.5 t -98.43 117.31 32.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.7 t -129.68 166.7 19.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.831 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.475 -179.969 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 58.0 m -100.35 -56.13 2.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.891 0.377 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.7 t -77.18 130.52 37.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.791 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -171.69 161.88 34.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.471 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 83.8 p -161.43 135.87 7.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 110.828 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 45.1 t -50.88 -66.26 0.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 104.27 83.83 1.72 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -21.57 33.43 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.733 2.289 . . . . 0.0 112.352 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -68.2 158.44 33.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -73.31 115.53 12.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.856 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.6 HG22 ' N ' ' A' ' 278' ' ' PHE . 14.4 mt -94.18 163.0 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.6 ' N ' HG22 ' A' ' 277' ' ' ILE . 5.7 m-85 -78.82 150.73 32.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 18.3 p -72.61 152.83 91.66 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.615 0.721 . . . . 0.0 111.122 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 173.32 11.14 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 0.0 112.31 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.837 ' O ' HG23 ' A' ' 285' ' ' VAL . 2.1 m -74.58 137.17 42.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.07 -48.44 62.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -42.66 -45.56 4.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.79 HD11 HG21 ' A' ' 332' ' ' VAL . 25.1 mt -74.45 -54.03 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.853 HG22 ' CB ' ' A' ' 340' ' ' SER . 95.4 t -45.16 -43.11 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -61.94 -36.14 80.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -80.3 -30.69 38.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.546 ' HA ' HD11 ' A' ' 291' ' ' ILE . 9.9 m -60.49 -19.92 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.508 ' HG3' HG22 ' A' ' 344' ' ' VAL . 42.0 mttt -80.54 -48.94 12.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.419 ' H ' HD12 ' A' ' 290' ' ' ILE . 3.0 mp -54.78 -22.74 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.546 HD11 ' HA ' ' A' ' 288' ' ' THR . 5.2 pt -98.71 -52.2 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.594 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -68.76 -49.19 60.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.498 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 20.0 ttm -43.1 -65.22 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -46.63 -63.07 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.856 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 298' ' ' ALA . 47.1 mmtt -46.39 -65.46 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.641 ' O ' HG22 ' A' ' 299' ' ' VAL . 31.5 mt -42.85 -53.85 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.813 ' CE2' HG13 ' A' ' 348' ' ' VAL . 11.2 m-85 -64.94 -23.53 67.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.96 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.418 ' O ' HG22 ' A' ' 301' ' ' THR . . . -76.05 -32.98 59.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.126 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 296' ' ' LEU . 28.2 m -82.08 -27.74 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -83.63 -31.88 25.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 298' ' ' ALA . 5.4 t -70.44 -20.23 62.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.28 -58.69 1.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.65 88.3 4.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -94.06 -44.48 8.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.634 ' CD2' ' OD1' ' A' ' 306' ' ' ASP . 44.4 p-80 -89.64 -49.08 6.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.634 ' OD1' ' CD2' ' A' ' 305' ' ' HIS . 5.0 m-20 -84.03 77.55 9.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -80.8 -69.73 0.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 28.9 m -66.1 -34.65 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.138 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.5 m -46.93 -44.98 20.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.878 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -116.26 49.44 1.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.854 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.27 -11.61 33.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -63.1 -34.04 76.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.611 ' HB1' ' CG1' ' A' ' 299' ' ' VAL . . . -57.87 -42.21 84.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.1 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.0 -61.08 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.129 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -50.98 -46.47 61.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -38.9 -58.24 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 320' ' ' ASP . 32.2 mt -41.17 -59.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 317' ' ' ILE . 56.1 ttt180 -34.87 -39.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.6 mt -81.82 -41.15 21.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 317' ' ' ILE . 3.7 t70 -60.14 -69.14 0.23 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.436 HG22 HG13 ' A' ' 291' ' ' ILE . 69.7 p -47.85 -42.21 25.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.5 ' C ' ' CD ' ' A' ' 322' ' ' GLU . 4.2 tm-20 -53.62 -40.66 65.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -87.37 -15.5 37.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -86.49 -27.15 24.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.795 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.531 HD11 HG23 ' A' ' 288' ' ' THR . 35.4 mt -88.21 -58.07 2.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 325' ' ' LEU . 1.4 tmmm? -35.92 -60.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -47.38 -50.24 22.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.471 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 22.3 tttp -55.78 -48.96 74.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.916 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.569 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 4.7 m-85 -110.89 82.42 3.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.64 0.733 . . . . 0.0 110.897 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -31.79 19.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.642 2.228 . . . . 0.0 112.318 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.56 -24.0 53.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.79 HG21 HD11 ' A' ' 284' ' ' ILE . 68.8 t -74.58 146.42 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -67.44 147.13 53.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' GLN . . . . . 0.548 ' O ' HD12 ' A' ' 338' ' ' ILE . 11.2 tt0 -61.88 -33.32 73.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.941 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -68.9 -14.98 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -84.13 -25.22 29.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.446 HG23 HD12 ' A' ' 325' ' ' LEU . 2.2 mp -83.64 -25.02 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 334' ' ' GLN . 2.0 mp -80.93 -49.75 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.165 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 340' ' ' SER . 19.0 mt-10 -57.33 -62.55 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.853 ' CB ' HG22 ' A' ' 285' ' ' VAL . 75.2 p -35.78 -43.99 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.841 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 344' ' ' VAL . 77.6 t80 -63.68 -55.94 19.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 341' ' ' PHE . 8.1 m120 -38.19 -42.0 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.0 mp -67.72 -43.11 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' A' ' 292' ' ' ALA . 70.0 t -58.7 -60.56 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.114 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -41.0 -49.27 3.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -65.75 -34.59 78.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.05 -67.09 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.813 HG13 ' CE2' ' A' ' 297' ' ' TYR . 42.5 t -51.43 -37.25 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.673 ' O ' HD12 ' A' ' 353' ' ' ILE . 3.2 m-30 -60.57 -66.55 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -40.25 -31.04 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.946 ' O ' HD12 ' A' ' 354' ' ' LEU . 4.2 t -68.3 -46.57 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 349' ' ' PHE . 11.3 mt -72.37 -40.85 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.125 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 349' ' ' PHE . 5.3 mp -76.28 -14.65 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.075 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.998 HD13 ' N ' ' A' ' 355' ' ' ASN . 0.0 OUTLIER -42.99 -23.56 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ASN . . . . . 0.998 ' N ' HD13 ' A' ' 354' ' ' LEU . 16.7 m-80 -48.49 -38.65 20.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.833 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -65.67 -69.68 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -61.9 150.54 37.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 358' ' ' LYS . 1.4 mppt? -101.6 89.22 3.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.909 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 -109.39 124.97 51.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 28.3 p -102.1 41.32 1.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -142.98 146.54 34.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 81.11 168.5 40.04 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.488 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -123.68 149.89 44.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.347 . . . . 0.0 110.878 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -132.22 145.22 51.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 21.1 p -148.53 172.49 14.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.821 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -159.58 83.78 0.13 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.523 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 170.34 16.75 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.689 2.259 . . . . 0.0 112.375 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 30.4 m -62.39 156.68 21.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.841 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.6 m -122.9 127.49 49.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 -179.976 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 44.0 p -120.43 175.41 5.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.939 0.399 . . . . 0.0 110.801 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.2 t -96.23 169.74 9.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -92.03 -98.48 1.33 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.501 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 77.3 p -168.61 177.78 5.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.829 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 26.9 t -109.76 171.89 7.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.845 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -84.33 142.5 20.47 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.484 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -174.47 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.686 2.257 . . . . 0.0 112.347 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.477 ' O ' HD12 ' A' ' 277' ' ' ILE . 4.0 tp60 -103.79 150.67 23.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -83.57 113.94 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.948 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.477 HD12 ' O ' ' A' ' 275' ' ' GLN . 4.3 mp -90.71 151.21 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.141 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -124.92 137.59 54.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.4 p -125.93 153.18 73.64 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.538 0.685 . . . . 0.0 111.145 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -170.71 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.628 2.219 . . . . 0.0 112.363 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.583 ' O ' HG23 ' A' ' 285' ' ' VAL . 13.2 m -73.82 122.7 22.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.74 81.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.099 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -41.61 -46.66 3.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.738 HD11 HG21 ' A' ' 332' ' ' VAL . 13.6 mt -72.68 -52.08 24.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.668 HG22 ' HB2' ' A' ' 340' ' ' SER . 89.8 t -46.15 -38.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.093 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -61.83 -47.57 84.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -73.87 -26.55 60.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.967 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 97.5 m -65.38 -17.67 64.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 31.7 mttt -80.17 -44.21 20.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.899 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.71 -24.03 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.131 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.677 HG21 ' CD2' ' A' ' 324' ' ' HIS . 10.7 pt -98.31 -49.81 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.485 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.7 -48.54 66.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.074 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 12.3 ttm -49.42 -61.4 2.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -46.87 -72.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 16.8 mtmm -43.78 -61.86 1.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 56.7 mt -44.09 -46.5 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -69.56 -28.22 65.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.73 -48.3 66.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.515 HG11 ' HB1' ' A' ' 313' ' ' ALA . 33.5 m -73.21 -23.7 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.112 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 300' ' ' PHE . 0.8 OUTLIER -53.95 -64.15 0.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.848 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 24.8 m -47.83 -49.99 27.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.166 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -84.42 179.69 7.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 303' ' ' TYR . 1.6 m-30 55.98 48.6 17.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.954 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -92.13 -56.06 3.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -84.65 -39.19 18.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.807 ' HB3' HG22 ' A' ' 308' ' ' VAL . 81.8 m-20 -38.42 129.85 1.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.96 -33.51 70.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.807 HG22 ' HB3' ' A' ' 306' ' ' ASP . 13.0 m -44.93 -29.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 310' ' ' ARG . 3.4 m 49.73 49.47 20.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.441 ' O ' HG23 ' A' ' 314' ' ' VAL . 28.5 ptt-85 35.82 53.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -89.2 -31.02 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.845 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 313' ' ' ALA . 15.1 pt-20 -94.83 -47.73 6.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.515 ' HB1' HG11 ' A' ' 299' ' ' VAL . . . -49.38 -44.89 45.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.134 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 310' ' ' ARG . 26.2 t -70.38 -64.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.113 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -48.76 -24.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 15.3 mmtp -64.99 -37.64 88.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.11 -55.69 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.413 ' HG2' ' CE2' ' A' ' 341' ' ' PHE . 17.9 mmm-85 -39.36 -30.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.0 mt -90.42 -40.58 11.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.7 -60.87 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.605 HG22 HD12 ' A' ' 291' ' ' ILE . 3.2 p -52.24 -40.47 61.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.472 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 17.7 tt0 -53.41 -41.1 65.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -84.44 -15.26 46.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' HIS . . . . . 0.677 ' CD2' HG21 ' A' ' 291' ' ' ILE . 77.8 t60 -87.27 -22.18 25.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.441 HD12 HG23 ' A' ' 337' ' ' ILE . 32.5 mt -94.15 -59.66 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.463 ' HD3' HD13 ' A' ' 337' ' ' ILE . 1.3 mmmp? -34.12 -53.19 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -48.26 -51.39 25.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -56.7 -40.33 75.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.491 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 6.4 m-85 -118.7 84.27 24.43 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.611 0.719 . . . . 0.0 110.879 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -28.79 25.14 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.72 2.28 . . . . 0.0 112.362 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.24 -25.21 42.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.738 HG21 HD11 ' A' ' 284' ' ' ILE . 41.6 t -71.08 151.37 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -81.86 150.22 27.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' GLN . . . . . 0.477 ' O ' HD12 ' A' ' 338' ' ' ILE . 20.1 tt0 -58.45 -33.88 70.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.588 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.0 t80 -63.76 -17.34 62.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -87.37 -35.25 18.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.472 ' CG2' ' HA ' ' A' ' 322' ' ' GLU . 2.1 mp -71.61 -37.27 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.477 HD12 ' O ' ' A' ' 334' ' ' GLN . 2.8 mp -74.29 -71.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.111 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.621 ' O ' HD12 ' A' ' 343' ' ' ILE . 6.8 tp10 -38.19 -50.49 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.668 ' HB2' HG22 ' A' ' 285' ' ' VAL . 9.5 p -45.17 -43.67 10.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.858 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 344' ' ' VAL . 46.4 t80 -58.94 -55.35 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.903 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 341' ' ' PHE . 11.2 m120 -36.23 -55.23 0.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.702 ' H ' HD12 ' A' ' 343' ' ' ILE . 5.4 mp -56.28 -41.3 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 341' ' ' PHE . 68.0 t -64.35 -59.18 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -40.83 -61.16 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -44.71 -51.5 9.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.949 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.72 -70.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 99.2 t -38.06 -62.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.158 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.592 ' HA ' HD12 ' A' ' 352' ' ' ILE . 10.5 m-85 -44.82 -66.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.852 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 349' ' ' PHE . 12.1 tpt180 -35.58 -56.25 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 1.3 t -49.46 -46.79 48.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 349' ' ' PHE . 64.8 mt -55.26 -60.26 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.163 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.776 ' H ' HD12 ' A' ' 353' ' ' ILE . 4.4 mp -44.33 -49.41 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.109 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 14.3 mt -60.62 -48.59 81.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -43.16 -42.22 4.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -40.52 -43.87 1.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -44.61 152.68 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.946 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -39.61 126.83 1.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -119.12 173.05 7.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.859 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 26.2 p -64.38 118.1 8.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.49 -64.33 0.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 65.55 -114.4 6.63 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -114.1 147.25 39.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 0.0 110.925 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -141.12 116.88 10.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.6 t -94.73 -62.4 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 102.02 146.51 18.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.485 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 176.85 6.19 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.67 2.247 . . . . 0.0 112.374 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 75.7 p -116.04 171.99 7.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.883 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 18.2 m -112.54 146.58 38.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.465 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 68.9 m -131.24 154.15 48.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.899 0.38 . . . . 0.0 110.836 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 2.1 m -106.21 117.8 34.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.854 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 121.78 113.62 2.25 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.5 t -165.78 155.88 12.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.86 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 38.4 t -62.53 121.07 12.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.835 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 164.57 -89.72 0.1 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.478 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -174.01 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.667 2.245 . . . . 0.0 112.332 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -74.93 160.59 30.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -87.42 138.0 31.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.423 ' C ' HD12 ' A' ' 277' ' ' ILE . 2.6 pp -104.74 149.29 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.1 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -95.38 138.93 32.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.883 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 81.2 p -74.52 151.17 87.24 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.555 0.693 . . . . 0.0 111.11 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' PRO . . . . . 0.424 ' HD3' ' CD ' ' A' ' 339' ' ' GLU . 54.0 Cg_endo -69.75 172.25 12.97 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.728 2.285 . . . . 0.0 112.369 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.948 ' O ' HG23 ' A' ' 285' ' ' VAL . 5.1 t -73.3 142.23 47.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -76.09 -40.35 53.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.17 -39.34 63.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.555 HG12 ' CE1' ' A' ' 329' ' ' PHE . 18.3 mt -77.1 -49.35 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.948 HG23 ' O ' ' A' ' 281' ' ' SER . 48.2 t -51.26 -33.93 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.145 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -68.84 -40.64 79.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.414 ' HA ' HD13 ' A' ' 290' ' ' ILE . 54.7 t80 -73.79 -27.83 61.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 42.2 m -63.23 -19.66 64.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.134 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 293' ' ' MET . 2.7 mptm? -75.56 -44.54 42.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.472 ' H ' HD12 ' A' ' 290' ' ' ILE . 3.3 mp -55.74 -27.87 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.521 HG21 ' CD2' ' A' ' 324' ' ' HIS . 6.2 pt -98.25 -51.99 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.132 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.71 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -63.82 -48.45 76.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 25.2 ttm -56.33 -64.2 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -45.55 -56.97 4.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.881 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 298' ' ' ALA . 17.4 mmtp -58.5 -69.32 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.43 ' HB2' HG11 ' A' ' 348' ' ' VAL . 86.5 mt -37.04 -42.54 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.96 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -74.33 -38.71 63.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -59.22 -28.89 67.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.133 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 296' ' ' LEU . 30.9 m -90.73 -36.18 7.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 300' ' ' PHE . 0.2 OUTLIER -38.83 -64.36 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 22.2 m -51.67 -51.97 51.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -47.78 -73.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -88.18 86.83 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.958 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 305' ' ' HIS . 18.1 mt-10 -95.79 -48.87 5.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 304' ' ' GLU . 2.2 t-80 -34.45 -65.97 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -140.94 166.53 24.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -48.9 11.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 18.3 m -49.21 -32.9 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.072 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 1.9 m -50.78 117.07 2.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 51.97 43.24 30.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -47.08 -27.63 1.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -47.23 -28.82 2.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -59.73 -59.23 5.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.101 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.17 -56.46 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -47.47 -39.78 16.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -54.15 -55.29 29.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 320' ' ' ASP . 87.6 mt -42.32 -60.8 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.432 ' HB3' ' NH1' ' A' ' 318' ' ' ARG . 8.8 mtp-105 -36.56 -34.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.826 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 11.6 mt -86.16 -39.5 16.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.4 t70 -63.94 -63.93 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.456 HG22 ' CG1' ' A' ' 291' ' ' ILE . 68.9 p -53.29 -40.85 65.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.444 ' C ' ' OE1' ' A' ' 322' ' ' GLU . 0.0 OUTLIER -54.01 -37.36 63.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -92.59 -13.07 30.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' HIS . . . . . 0.521 ' CD2' HG21 ' A' ' 291' ' ' ILE . 54.3 t60 -86.89 -28.06 23.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.5 HD12 HG23 ' A' ' 337' ' ' ILE . 17.3 mt -89.8 -54.37 4.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.439 ' N ' HG12 ' A' ' 337' ' ' ILE . 25.4 tttm -44.06 -39.97 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.7 -39.76 91.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.495 ' HB3' ' CE1' ' A' ' 329' ' ' PHE . 47.0 tttp -57.16 -42.64 81.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.701 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.2 OUTLIER -129.99 91.91 38.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.607 0.718 . . . . 0.0 110.895 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 329' ' ' PHE . 53.6 Cg_endo -69.77 -20.78 34.34 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.698 2.266 . . . . 0.0 112.358 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -78.69 -33.07 47.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 329' ' ' PHE . 1.5 p -65.79 150.27 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -70.53 156.04 39.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' GLN . . . . . 0.465 ' HG3' ' CD1' ' A' ' 338' ' ' ILE . 2.5 tp-100 -68.08 -41.86 81.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -58.69 -13.94 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -82.63 -31.33 28.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.5 HG23 HD12 ' A' ' 325' ' ' LEU . 1.9 mp -81.16 -28.87 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.465 ' CD1' ' HG3' ' A' ' 334' ' ' GLN . 2.6 mp -77.17 -53.58 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.625 ' O ' HD12 ' A' ' 343' ' ' ILE . 10.0 tt0 -60.95 -44.41 97.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.533 ' HB2' HG22 ' A' ' 285' ' ' VAL . 96.3 p -47.49 -49.44 25.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 344' ' ' VAL . 71.5 t80 -58.35 -56.83 17.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 341' ' ' PHE . 17.9 m-80 -35.09 -43.96 0.22 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.625 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.1 mp -66.96 -46.86 83.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.71 HG11 ' HB3' ' A' ' 292' ' ' ALA . 71.6 t -55.65 -66.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -37.41 -64.3 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -42.99 -43.24 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -67.63 -70.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 296' ' ' LEU . 88.8 t -40.89 -50.64 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.145 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -52.51 -61.34 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 -44.98 -43.33 9.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.427 ' O ' HD11 ' A' ' 354' ' ' LEU . 3.3 t -51.29 -34.78 34.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.449 HG21 ' CD1' ' A' ' 300' ' ' PHE . 14.8 mt -93.73 -32.33 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 355' ' ' ASN . 44.9 mm -58.39 -42.8 85.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.093 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.764 HD12 ' N ' ' A' ' 355' ' ' ASN . 0.9 OUTLIER -43.19 -23.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ASN . . . . . 0.764 ' N ' HD12 ' A' ' 354' ' ' LEU . 11.8 t-20 -61.59 -43.17 99.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -95.66 -52.04 4.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.463 ' CE1' ' HG2' ' A' ' 359' ' ' ARG . 6.8 t80 -90.08 89.11 7.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -118.81 89.04 3.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' ARG . . . . . 0.463 ' HG2' ' CE1' ' A' ' 357' ' ' TYR . 20.7 ptt180 -171.46 115.92 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.832 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 43.0 t -78.95 112.63 16.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -162.4 166.95 24.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 175.05 -52.97 0.13 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.49 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -81.95 159.25 23.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.834 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.2 160.07 39.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 16.8 t -91.55 162.88 14.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -85.58 -156.64 27.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.479 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -36.45 10.73 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.706 2.271 . . . . 0.0 112.326 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 35.9 p -59.15 100.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 92.1 p -166.66 176.94 6.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.503 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.9 m -98.94 174.07 6.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.87 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 45.4 p -163.63 174.32 11.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.874 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -125.05 -135.82 4.44 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 2.1 t -167.32 134.6 2.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.902 0.382 . . . . 0.0 110.803 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 95.4 p -156.52 154.02 29.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.861 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 131.35 160.13 9.75 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -4.91 14.94 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.705 2.27 . . . . 0.0 112.367 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -68.13 143.72 55.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -87.75 115.61 25.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 3.8 mt -113.65 151.48 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.119 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -75.71 147.61 39.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 33.5 p -102.18 153.58 37.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.553 0.692 . . . . 0.0 111.156 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -174.06 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.66 2.24 . . . . 0.0 112.358 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.542 ' HB2' HD12 ' A' ' 284' ' ' ILE . 21.2 m -73.08 119.99 18.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.837 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 284' ' ' ILE . . . -57.17 -55.44 34.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 282' ' ' ALA . 13.7 pt-20 -36.44 -33.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.62 HD11 HG21 ' A' ' 332' ' ' VAL . 47.1 mt -83.46 -54.35 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.672 HG12 ' NZ ' ' A' ' 289' ' ' LYS . 49.6 t -38.83 -53.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -57.1 -55.75 30.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -59.65 -20.9 59.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.483 HG23 HD11 ' A' ' 325' ' ' LEU . 49.2 m -75.15 -25.36 58.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.158 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.672 ' NZ ' HG12 ' A' ' 285' ' ' VAL . 14.4 mttp -77.13 -41.08 43.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.6 mp -56.65 -30.13 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.487 HG13 ' N ' ' A' ' 292' ' ' ALA . 10.4 pt -97.76 -49.81 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.487 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -61.87 -48.02 82.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.473 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 13.9 ttm -51.9 -60.24 3.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -47.82 -53.32 15.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 298' ' ' ALA . 29.1 mtpt -60.42 -67.99 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.462 HD23 ' CD1' ' A' ' 317' ' ' ILE . 90.9 mt -38.6 -38.55 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.475 ' CE1' HG12 ' A' ' 352' ' ' ILE . 8.6 m-85 -77.99 -37.06 48.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -67.23 -34.58 77.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.116 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 29.4 m -87.49 -24.11 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.531 ' CE2' HG23 ' A' ' 352' ' ' ILE . 2.0 t80 -54.53 -54.86 35.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 9.4 t -77.37 -17.89 57.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.146 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -62.99 -71.91 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.43 ' HA ' ' NE2' ' A' ' 305' ' ' HIS . 12.4 p90 -85.61 17.43 3.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.961 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 305' ' ' HIS . 15.5 tm-20 -38.15 -56.53 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 304' ' ' GLU . 8.9 p80 -34.8 -46.06 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -159.56 136.91 9.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -70.29 -62.14 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.858 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 9.6 p -41.01 -30.63 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.168 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 10.5 t -78.79 114.58 17.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 73.59 34.67 0.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -51.14 -25.25 4.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 6.0 pt-20 -55.36 -27.35 46.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -57.62 -50.42 73.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 55.0 t -66.89 -69.38 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.118 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -41.19 -42.92 2.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.494 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 0.9 OUTLIER -40.86 -60.45 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.53 HG22 ' CE2' ' A' ' 341' ' ' PHE . 29.8 mt -41.4 -63.43 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.141 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.444 ' HB2' ' NH1' ' A' ' 318' ' ' ARG . 23.8 ttm105 -36.43 -39.1 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.856 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.2 mt -83.51 -39.63 20.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.95 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.2 t0 -62.51 -63.87 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.453 HG22 HG13 ' A' ' 291' ' ' ILE . 72.9 p -51.84 -52.77 46.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -47.05 -36.6 8.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -85.88 -18.93 31.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -89.43 -19.7 24.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.521 ' HB2' HG23 ' A' ' 337' ' ' ILE . 47.9 mt -93.31 -60.06 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -44.16 -35.3 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.33 -38.36 87.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.43 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 26.2 tptt -72.42 -42.59 64.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.566 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 3.2 m-85 -110.46 85.03 4.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -35.41 12.65 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.335 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.84 -31.53 66.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.62 HG21 HD11 ' A' ' 284' ' ' ILE . 74.9 t -67.94 149.73 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -79.71 144.35 33.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' GLN . . . . . 0.47 ' O ' HD12 ' A' ' 338' ' ' ILE . 25.6 tt0 -53.46 -38.29 63.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.443 ' CD2' ' OE1' ' A' ' 336' ' ' GLU . 7.2 t80 -59.7 -21.16 60.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.443 ' OE1' ' CD2' ' A' ' 335' ' ' PHE . 0.0 OUTLIER -86.92 -18.52 30.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.886 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.4 mp -88.32 -27.41 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 334' ' ' GLN . 3.5 mp -89.75 -51.99 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.56 ' O ' HD12 ' A' ' 343' ' ' ILE . 7.7 tt0 -51.52 -31.47 24.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 2.1 p -66.37 -36.1 82.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.53 ' CE2' HG22 ' A' ' 317' ' ' ILE . 39.1 t80 -68.35 -31.05 70.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.847 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -56.42 -32.01 64.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.56 HD12 ' O ' ' A' ' 339' ' ' GLU . 5.0 mp -88.13 -37.92 11.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 81.0 t -64.23 -51.3 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 345' ' ' ALA . . . . . 0.5 ' HB2' ' CE1' ' A' ' 341' ' ' PHE . . . -51.12 -66.78 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.062 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' LYS . . . . . 0.403 ' C ' ' HD3' ' A' ' 346' ' ' LYS . 0.0 OUTLIER -50.39 -31.29 14.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -67.68 -66.94 0.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 98.2 t -45.71 -44.2 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 352' ' ' ILE . 4.1 m-85 -45.6 -60.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.462 HH21 HG21 ' A' ' 353' ' ' ILE . 3.4 tpm_? -37.3 -62.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.64 ' HA ' HD13 ' A' ' 354' ' ' LEU . 28.1 m -47.55 -33.29 6.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.531 HG23 ' CE2' ' A' ' 300' ' ' PHE . 93.6 mt -79.7 -34.81 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.153 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.462 HG21 HH21 ' A' ' 350' ' ' ARG . 5.0 mm -60.77 -23.06 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.64 HD13 ' HA ' ' A' ' 351' ' ' SER . 10.1 mp -47.61 -20.53 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -117.8 102.72 9.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -61.27 83.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -40.95 109.25 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.953 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 12.9 pttp -166.35 137.18 3.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 70.1 mmt-85 -40.88 133.6 2.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 4.8 p -104.92 -33.04 8.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 40.79 45.76 2.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -166.84 132.78 2.71 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.45 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -114.31 95.76 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 110.847 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 63.97 31.09 13.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 7.5 m -118.02 136.0 53.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 83.53 147.33 7.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.489 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 89.8 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.674 2.25 . . . . 0.0 112.335 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 13.1 t -131.81 98.75 4.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 37.5 m -37.37 -53.09 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.464 -179.976 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 26.1 m -115.46 85.07 2.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.933 0.397 . . . . 0.0 110.856 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 57.4 m -85.56 92.79 8.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.886 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -101.85 -145.15 15.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.469 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 42.5 t -111.06 -43.9 3.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 0.0 110.833 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 32.1 m -62.72 97.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 120.93 178.98 16.07 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.498 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 178.88 4.13 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.677 2.251 . . . . 0.0 112.332 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -100.12 151.32 21.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.73 139.41 41.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.452 ' C ' HD12 ' A' ' 277' ' ' ILE . 2.7 pp -114.54 151.52 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -122.83 133.71 54.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 67.2 p -103.24 152.2 38.63 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.605 0.717 . . . . 0.0 111.125 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -178.59 2.4 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.701 2.268 . . . . 0.0 112.386 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 285' ' ' VAL . 72.7 m -68.56 134.37 49.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.874 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -72.57 -40.74 66.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -55.26 -36.24 65.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.899 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.852 HD11 HG21 ' A' ' 332' ' ' VAL . 22.8 mt -78.33 -41.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 281' ' ' SER . 77.7 t -58.46 -46.42 89.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -60.65 -37.02 80.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -73.78 -34.22 64.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.507 ' CG2' HG21 ' A' ' 344' ' ' VAL . 92.0 m -56.38 -19.29 14.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.162 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.543 ' NZ ' HG22 ' A' ' 344' ' ' VAL . 7.2 mptt -77.13 -49.23 15.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 290' ' ' ILE . 2.9 mp -53.74 -24.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.162 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.491 HG13 ' N ' ' A' ' 292' ' ' ALA . 7.0 pt -98.83 -52.4 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.148 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.491 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.94 -49.29 62.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.061 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.517 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 19.1 ttm -45.42 -62.26 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -52.29 -72.56 0.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 298' ' ' ALA . 35.1 mtmt -42.14 -63.83 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.516 HD23 ' CD1' ' A' ' 317' ' ' ILE . 81.7 mt -42.3 -52.33 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.472 ' CE1' ' CG1' ' A' ' 352' ' ' ILE . 7.7 m-85 -62.2 -26.54 68.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.975 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -72.18 -51.1 22.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.092 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.854 ' HB ' ' HB1' ' A' ' 313' ' ' ALA . 18.8 m -75.02 -24.32 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.108 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.696 ' CE2' HG23 ' A' ' 352' ' ' ILE . 0.2 OUTLIER -40.26 -68.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 301' ' ' THR . 28.1 m -63.61 -9.63 14.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.177 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 304' ' ' GLU . 1.7 t70 -80.25 179.63 7.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.854 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.518 ' CE2' ' O ' ' A' ' 299' ' ' VAL . 46.0 p90 37.56 28.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 302' ' ' ASP . 17.5 tt0 -37.26 -45.59 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.85 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.431 ' C ' ' O ' ' A' ' 304' ' ' GLU . 77.6 t60 -36.15 -60.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -166.71 135.47 2.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 311' ' ' ASP . 12.9 ttmt -57.35 -58.26 9.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 309' ' ' SER . 32.9 m -55.11 -40.82 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.08 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.424 ' N ' HG23 ' A' ' 308' ' ' VAL . 31.4 t -48.42 -54.13 15.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -124.75 42.31 3.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 307' ' ' LYS . 4.0 p30 -49.28 -25.53 2.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -41.39 -32.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.943 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.854 ' HB1' ' HB ' ' A' ' 299' ' ' VAL . . . -56.96 -52.89 63.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.3 t -79.84 -38.58 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.118 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.9 OUTLIER -59.75 -54.23 48.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.931 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 315' ' ' ASN . 22.7 mtmt -35.15 -62.74 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.93 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.516 ' CD1' HD23 ' A' ' 296' ' ' LEU . 31.8 mt -36.63 -58.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 317' ' ' ILE . 0.0 OUTLIER -35.19 -42.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.5 mt -80.68 -39.31 27.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 317' ' ' ILE . 19.8 t0 -60.96 -70.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.457 HG23 HG23 ' A' ' 317' ' ' ILE . 68.1 p -45.77 -45.84 14.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.158 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -51.29 -36.21 41.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.34 -20.99 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -85.6 -18.93 31.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 42.8 mt -93.18 -59.54 2.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -41.47 -36.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.7 -52.58 50.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.476 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 30.4 tttp -54.59 -41.82 70.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.586 ' CE2' HG12 ' A' ' 284' ' ' ILE . 1.3 m-85 -116.12 83.95 13.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.661 0.743 . . . . 0.0 110.823 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -30.24 22.54 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.348 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -77.92 -18.46 56.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.852 HG21 HD11 ' A' ' 284' ' ' ILE . 53.4 t -80.39 152.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -82.9 151.72 25.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -60.55 -41.04 93.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -53.85 -26.27 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.42 -30.45 33.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 337' ' ' ILE . 1.8 mp -84.62 -14.43 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.145 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 36.5 mt -87.33 -52.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' ' 343' ' ' ILE . 4.7 tt0 -59.83 -48.36 81.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.545 ' O ' HG23 ' A' ' 344' ' ' VAL . 40.3 m -39.76 -50.82 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.51 ' CE1' HG22 ' A' ' 317' ' ' ILE . 42.7 t80 -56.03 -57.92 10.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 341' ' ' PHE . 67.4 m-20 -37.47 -46.47 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.52 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.4 mp -68.41 -40.08 81.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 340' ' ' SER . 81.1 t -61.36 -64.18 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.08 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -42.71 -55.96 3.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -48.62 -30.16 5.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -83.73 -64.37 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 56.5 t -43.89 -27.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -74.02 -62.75 1.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.673 ' O ' HD13 ' A' ' 354' ' ' LEU . 21.0 ttm105 -41.5 -44.78 3.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 25.6 p -60.39 -50.83 72.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.696 HG23 ' CE2' ' A' ' 300' ' ' PHE . 50.1 mt -51.14 -52.22 19.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 353' ' ' ILE . 2.5 mp -59.96 -53.04 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.673 HD13 ' O ' ' A' ' 350' ' ' ARG . 7.0 mp -49.43 -49.41 45.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.92 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 354' ' ' LEU . 51.1 t-20 -37.33 -28.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 354' ' ' LEU . 5.2 tp10 -82.17 -67.71 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.859 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.411 ' C ' ' O ' ' A' ' 356' ' ' GLU . 15.4 m-85 -35.7 -53.63 0.71 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.44 89.97 3.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.848 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -60.03 165.05 3.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 31.0 p -145.91 151.91 38.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -86.59 103.88 15.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.847 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 174.22 86.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 17.3 mmm-85 -74.71 160.62 30.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.829 0.347 . . . . 0.0 110.888 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.86 -56.02 2.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 58.2 p 39.1 41.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -137.39 83.66 0.25 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.452 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 151.98 69.27 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.267 . . . . 0.0 112.343 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.6 m -114.46 134.41 55.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.816 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 53.5 p -162.97 163.12 26.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.838 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 -179.97 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.7 m -43.92 136.78 3.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 110.815 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 99.3 p -149.06 145.19 27.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 106.58 62.99 0.6 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 5.3 p -80.13 124.28 28.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 0.0 110.863 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 77.6 p -173.77 132.7 0.44 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -170.73 -175.98 39.74 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.48 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -33.95 15.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -78.56 162.03 26.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -70.09 116.14 10.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 278' ' ' PHE . 45.6 mm -94.5 158.28 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.523 ' N ' HG22 ' A' ' 277' ' ' ILE . 5.8 m-85 -87.57 140.0 29.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 55.0 p -99.28 151.66 37.5 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.599 0.714 . . . . 0.0 111.148 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' PRO . . . . . 0.409 ' HD3' ' CD ' ' A' ' 339' ' ' GLU . 53.9 Cg_endo -69.74 179.62 3.56 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.725 2.283 . . . . 0.0 112.308 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.552 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.8 t -69.78 120.96 16.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.04 96.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -49.77 -41.15 43.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.808 HD11 HG21 ' A' ' 332' ' ' VAL . 22.1 mt -75.95 -42.32 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 281' ' ' SER . 75.3 t -54.5 -42.68 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 286' ' ' LYS . 0.4 OUTLIER -62.53 -36.43 82.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.478 ' CD2' ' HD3' ' A' ' 328' ' ' LYS . 31.5 t80 -76.87 -31.36 56.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.836 ' HB ' HG21 ' A' ' 344' ' ' VAL . 33.2 m -64.01 -23.73 67.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.606 ' HG3' HG13 ' A' ' 344' ' ' VAL . 30.7 mttt -76.19 -39.57 54.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.402 ' CD1' ' O ' ' A' ' 286' ' ' LYS . 2.6 mp -61.7 -28.49 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.838 HG21 ' CD2' ' A' ' 324' ' ' HIS . 23.6 pt -97.77 -43.4 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.122 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.454 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -69.25 -47.8 63.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.485 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 9.5 ttm -52.53 -71.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.889 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 293' ' ' MET . 18.3 mt-10 -36.94 -60.01 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -53.92 -66.21 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.648 ' CD2' HG13 ' A' ' 314' ' ' VAL . 75.8 mt -39.11 -49.79 1.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.671 ' CE2' HG13 ' A' ' 348' ' ' VAL . 11.8 m-85 -65.34 -40.27 93.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.93 -50.43 73.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 296' ' ' LEU . 27.9 m -64.92 -28.8 45.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.499 ' CD2' HG21 ' A' ' 352' ' ' ILE . 4.4 t80 -69.45 -57.02 5.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 297' ' ' TYR . 8.5 t -67.85 -18.53 64.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.148 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -83.4 -63.07 1.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -86.72 95.13 9.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -93.59 -52.7 4.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.922 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -86.34 -71.11 0.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -44.88 103.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -84.31 -36.76 22.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 1.6 p -54.82 -29.54 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.2 m -89.62 -36.66 15.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 24.0 ttp180 -67.67 -17.07 64.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -85.41 -45.4 11.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 15.3 pt-20 -77.7 -17.71 57.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -75.2 -49.4 19.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.055 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.648 HG13 ' CD2' ' A' ' 296' ' ' LEU . 66.1 t -68.76 -36.89 76.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.7 -12.33 60.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.492 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 22.3 mmtt -82.55 -17.58 44.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.553 HD12 ' CD2' ' A' ' 296' ' ' LEU . 72.9 mt -67.55 -56.7 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' A' ' 322' ' ' GLU . 7.3 ptm180 -41.2 -35.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 316' ' ' LYS . 4.8 mt -76.08 -37.78 57.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 27.3 t70 -73.97 -69.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.853 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.715 HG22 HD12 ' A' ' 291' ' ' ILE . 14.5 p -41.3 -47.6 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 318' ' ' ARG . 33.0 mt-10 -45.73 -49.99 14.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.85 -18.47 60.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' HIS . . . . . 0.838 ' CD2' HG21 ' A' ' 291' ' ' ILE . 79.3 t60 -84.88 -23.96 28.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.467 ' HB2' HG23 ' A' ' 337' ' ' ILE . 19.3 mt -93.77 -54.49 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.928 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.34 -26.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.95 -35.62 37.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.478 ' HD3' ' CD2' ' A' ' 287' ' ' TYR . 37.6 tttp -69.84 -39.34 76.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.587 ' CE1' HG23 ' A' ' 284' ' ' ILE . 2.8 m-85 -117.06 87.44 22.91 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.678 0.751 . . . . 0.0 110.875 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -40.71 5.01 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.685 2.257 . . . . 0.0 112.316 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.53 -24.46 65.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.808 HG21 HD11 ' A' ' 284' ' ' ILE . 41.5 t -73.47 154.14 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ASP . . . . . 0.413 ' N ' ' CG1' ' A' ' 332' ' ' VAL . 5.7 t70 -83.35 147.28 28.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.38 -37.08 74.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.495 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 7.3 t80 -61.98 -13.32 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -90.61 -26.66 19.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.467 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.9 mp -82.54 -24.55 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.428 ' O ' ' ND2' ' A' ' 342' ' ' ASN . 3.2 mp -89.77 -35.5 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.409 ' CD ' ' HD3' ' A' ' 280' ' ' PRO . 11.5 tt0 -72.67 -22.51 60.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 341' ' ' PHE . 10.9 m -74.55 -65.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.484 ' CE1' HG22 ' A' ' 317' ' ' ILE . 73.8 t80 -36.6 -41.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 338' ' ' ILE . 4.0 m-80 -49.1 -51.95 28.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.497 ' H ' HD12 ' A' ' 343' ' ' ILE . 3.9 mp -68.84 -33.58 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.153 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.836 HG21 ' HB ' ' A' ' 288' ' ' THR . 32.8 t -62.57 -63.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -35.72 -66.67 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.123 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -40.66 -53.55 2.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -44.38 -39.25 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.671 HG13 ' CE2' ' A' ' 297' ' ' TYR . 39.9 t -76.49 -43.49 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.412 ' C ' ' N ' ' A' ' 351' ' ' SER . 3.3 m-85 -49.56 -70.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 31.1 ptt85 -43.09 -23.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.851 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 349' ' ' PHE . 3.2 t -78.89 -52.29 8.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.812 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.499 HG21 ' CD2' ' A' ' 300' ' ' PHE . 44.8 mt -70.64 -57.42 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.136 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 1.7 mt -43.63 -39.95 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -75.6 -58.77 3.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -37.55 -39.03 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -86.68 -59.87 2.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -115.56 89.05 3.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -50.14 151.36 2.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -159.23 147.09 17.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 31.5 p -130.92 120.91 24.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -134.69 173.82 11.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -97.86 -123.43 4.7 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.527 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 27.8 mmt-85 -125.64 55.23 1.44 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.896 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 364' ' ' ASP . 4.2 p-10 -93.69 49.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 8.2 t -153.15 -179.93 8.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -122.66 83.42 0.36 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 164.66 33.76 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.688 2.259 . . . . 0.0 112.33 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 33.4 t -89.93 -54.23 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 30.7 t -63.29 -47.6 81.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.984 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 60.2 p -166.77 148.91 6.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.914 0.388 . . . . 0.0 110.85 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.4 t -75.77 -62.32 1.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.844 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -65.79 -151.39 0.12 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.474 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 59.6 p -40.13 100.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 110.825 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.2 t -52.18 -53.51 42.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -158.1 85.21 0.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.53 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -35.41 12.69 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.708 2.272 . . . . 0.0 112.314 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -81.55 162.96 22.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.923 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -87.93 127.72 35.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.479 ' C ' HD12 ' A' ' 277' ' ' ILE . 2.7 pp -104.93 162.95 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.08 150.63 23.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.8 p -74.0 154.92 88.73 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.613 0.721 . . . . 0.0 111.134 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -170.29 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.743 2.295 . . . . 0.0 112.349 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.87 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.0 OUTLIER -75.84 133.04 40.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.869 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -77.98 -42.23 33.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.136 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -51.49 -39.04 56.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.562 HG12 ' CZ ' ' A' ' 329' ' ' PHE . 12.1 mt -79.11 -44.09 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.119 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.891 HG22 ' HB2' ' A' ' 340' ' ' SER . 74.7 t -54.61 -37.69 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.085 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -64.24 -35.74 81.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -79.87 -24.46 41.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.486 ' HB ' HG21 ' A' ' 344' ' ' VAL . 8.9 m -66.49 -18.22 65.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.123 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 293' ' ' MET . 1.0 OUTLIER -77.27 -44.91 28.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.02 -29.18 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.156 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.583 HD12 HG22 ' A' ' 321' ' ' THR . 8.7 pt -98.31 -50.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.541 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -63.93 -48.28 77.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.493 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 10.6 ttm -58.88 -67.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -43.31 -58.8 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -55.3 -65.78 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.476 ' O ' HG22 ' A' ' 299' ' ' VAL . 49.4 mt -40.61 -58.49 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -54.98 -38.56 67.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.03 -49.49 72.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.147 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 296' ' ' LEU . 16.7 m -66.46 -35.21 74.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.573 ' CD2' HD13 ' A' ' 352' ' ' ILE . 10.2 m-85 -71.79 -38.1 70.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 59.4 m -68.41 -40.71 81.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.181 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.62 -56.88 4.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -79.9 71.22 6.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 305' ' ' HIS . 13.7 pt-20 -89.96 -37.66 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.909 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 304' ' ' GLU . 14.2 m80 -35.98 -42.79 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.856 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -173.5 154.97 2.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -50.27 30.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.5 -31.26 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.144 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 310' ' ' ARG . 26.4 t -59.29 135.77 57.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' A' ' 309' ' ' SER . 5.5 mpt_? 37.08 48.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -62.65 -30.42 71.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -45.49 -22.51 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -68.82 -47.18 66.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 74.8 t -58.95 -34.96 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' ASN . . . . . 0.413 ' O ' HD22 ' A' ' 319' ' ' LEU . 10.7 t30 -83.14 -41.35 18.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.451 ' HA ' HD23 ' A' ' 319' ' ' LEU . 13.5 mmtp -43.03 -30.24 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 318' ' ' ARG . 49.2 mt -61.75 -60.21 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.486 ' HD2' HD13 ' A' ' 319' ' ' LEU . 3.3 tmt_? -34.28 -70.91 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.709 ' N ' HD13 ' A' ' 319' ' ' LEU . 0.0 OUTLIER -44.58 -43.13 7.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -66.02 -70.48 0.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.583 HG22 HD12 ' A' ' 291' ' ' ILE . 37.5 p -44.83 -55.49 5.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.153 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -45.6 -49.47 14.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -77.65 -12.41 59.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -90.74 -25.54 19.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.609 HD12 HG23 ' A' ' 337' ' ' ILE . 23.3 mt -94.37 -56.73 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -45.91 -24.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -81.82 -32.77 31.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 325' ' ' LEU . 26.5 tttp -69.23 -36.72 77.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.562 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 0.5 OUTLIER -122.38 90.94 49.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.688 0.756 . . . . 0.0 110.892 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -20.45 34.75 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.715 2.277 . . . . 0.0 112.337 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.31 -40.78 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.657 ' CG1' HD11 ' A' ' 337' ' ' ILE . 0.8 OUTLIER -62.98 161.57 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.114 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -93.39 160.06 14.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -67.07 -38.42 85.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -57.36 -15.42 6.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -90.51 -26.07 19.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.657 HD11 ' CG1' ' A' ' 332' ' ' VAL . 3.0 mp -86.69 -45.25 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.31 -52.15 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -62.3 -55.23 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.891 ' HB2' HG22 ' A' ' 285' ' ' VAL . 16.1 p -38.8 -39.27 0.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 344' ' ' VAL . 35.3 t80 -64.15 -53.39 50.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 341' ' ' PHE . 5.4 m120 -36.5 -37.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 343' ' ' ILE . 5.3 mp -78.55 -41.22 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.541 HG11 ' HB3' ' A' ' 292' ' ' ALA . 50.4 t -57.72 -47.84 84.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -54.74 -63.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -54.2 -23.37 14.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -78.16 -31.24 49.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 344' ' ' VAL . 89.7 t -86.04 -32.72 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.085 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 351' ' ' SER . 5.5 m-85 -59.9 -67.04 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.497 ' O ' ' CD1' ' A' ' 354' ' ' LEU . 30.8 ptt180 -37.73 -28.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 349' ' ' PHE . 8.0 t -78.86 -45.19 21.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 300' ' ' PHE . 65.2 mt -70.42 -21.76 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 31.2 mm -70.18 -27.17 31.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 350' ' ' ARG . 5.6 mp -83.39 -51.48 7.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 354' ' ' LEU . 28.8 m-20 -35.57 -49.97 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -54.37 -54.47 40.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.911 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.505 ' CG ' ' O ' ' A' ' 357' ' ' TYR . 8.6 p90 -143.36 114.31 7.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.917 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -92.37 140.34 29.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.88 -31.75 6.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.823 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 2.1 t -99.71 83.97 2.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -56.21 136.06 53.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 174.63 -139.68 4.99 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.456 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -106.12 175.38 5.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.853 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -104.19 115.01 29.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 49.6 m -93.31 113.92 26.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -148.23 141.97 9.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.5 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 368' ' ' SER . 54.2 Cg_endo -69.73 -6.52 18.78 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.68 2.253 . . . . 0.0 112.361 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 368' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 367' ' ' PRO . 77.9 p -37.04 104.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 51.3 m -89.7 149.02 22.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.489 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 7.8 t -172.55 147.34 1.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.942 0.401 . . . . 0.0 110.833 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 53.3 p -83.87 81.45 8.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.822 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -161.75 -104.49 0.19 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 93.4 p -99.27 132.99 44.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.841 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 29.2 t -88.3 -51.05 5.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -136.74 -157.46 7.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.497 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 93.79 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.712 2.274 . . . . 0.0 112.337 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -117.77 146.06 44.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -86.81 148.91 25.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.903 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.804 HD13 ' H ' ' A' ' 277' ' ' ILE . 0.2 OUTLIER -113.54 161.55 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -128.51 146.99 50.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 74.7 p -72.02 151.21 92.74 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.592 0.711 . . . . 0.0 111.143 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 175.87 7.5 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.674 2.249 . . . . 0.0 112.323 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.2 t -72.96 120.53 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.72 -49.4 70.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.117 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -43.04 -43.05 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.535 HG12 ' CE1' ' A' ' 329' ' ' PHE . 30.4 mt -73.52 -48.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.146 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.49 HG22 ' HB2' ' A' ' 340' ' ' SER . 98.1 t -47.19 -36.11 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -68.5 -57.26 6.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.43 ' HA ' HD13 ' A' ' 290' ' ' ILE . 43.0 t80 -55.75 -24.83 37.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.486 ' CG2' HG21 ' A' ' 344' ' ' VAL . 32.1 m -68.97 -26.24 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.092 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -75.13 -43.59 51.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 287' ' ' TYR . 3.1 mp -54.75 -29.62 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.114 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.521 HG13 HG22 ' A' ' 321' ' ' THR . 8.5 pt -98.12 -51.22 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.607 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -58.4 -48.15 81.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 19.7 ttm -53.88 -60.18 3.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -45.4 -60.2 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 298' ' ' ALA . 29.4 mtpt -58.04 -67.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.832 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.612 HD12 HG21 ' A' ' 348' ' ' VAL . 86.2 mt -37.93 -33.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.445 ' O ' HG23 ' A' ' 301' ' ' THR . 7.7 m-85 -84.63 -37.48 21.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -64.76 -31.95 73.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.053 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 35.1 m -85.27 -23.56 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.557 ' CZ ' ' OE1' ' A' ' 304' ' ' GLU . 5.3 t80 -75.2 -47.26 29.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 297' ' ' TYR . 79.4 p -53.07 -40.87 64.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.102 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.71 -60.89 2.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.816 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -82.86 44.14 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.557 ' OE1' ' CZ ' ' A' ' 300' ' ' PHE . 14.9 tp10 -64.33 -42.69 96.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 304' ' ' GLU . 7.4 m170 -34.45 -50.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -166.1 174.22 9.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -80.7 -50.54 9.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.835 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.453 HG23 ' N ' ' A' ' 309' ' ' SER . 28.4 m -45.68 -42.28 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.141 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.453 ' N ' HG23 ' A' ' 308' ' ' VAL . 10.0 t -48.12 104.14 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.42 37.83 22.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.849 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -40.27 -40.0 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -39.77 -42.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -47.07 -45.96 22.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.068 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.2 -68.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' A' ' 316' ' ' LYS . 3.8 t30 -43.17 -50.34 6.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 315' ' ' ASN . 11.3 mmmt -34.64 -58.3 0.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 318' ' ' ARG . 63.9 mt -38.22 -61.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 317' ' ' ILE . 3.6 tmt_? -35.19 -49.72 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 6.8 mt -69.92 -44.21 70.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -61.67 -68.86 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.888 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.521 HG22 HG13 ' A' ' 291' ' ' ILE . 14.2 p -45.5 -47.25 14.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -49.24 -50.59 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -71.18 -16.07 62.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -90.15 -21.92 21.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.463 HD11 HG23 ' A' ' 288' ' ' THR . 45.0 mt -93.45 -54.9 3.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 25.7 tttm -49.61 -26.71 3.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 328' ' ' LYS . 10.8 pt-20 -78.01 -39.27 42.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.492 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 27.4 tptt -59.58 -48.62 80.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.616 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.2 OUTLIER -114.86 89.97 21.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -18.65 37.32 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.71 2.273 . . . . 0.0 112.399 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.91 -24.31 30.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 329' ' ' PHE . 0.8 OUTLIER -77.05 154.93 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -82.83 155.0 24.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' GLN . . . . . 0.472 ' HG2' ' CD1' ' A' ' 338' ' ' ILE . 35.7 tt0 -63.93 -49.58 72.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -47.41 -19.85 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -81.65 -39.32 24.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.572 HD11 ' CG1' ' A' ' 332' ' ' VAL . 1.8 mp -71.24 -22.24 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.472 ' CD1' ' HG2' ' A' ' 334' ' ' GLN . 2.5 mp -81.81 -55.25 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.158 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.624 ' O ' HD12 ' A' ' 343' ' ' ILE . 0.6 OUTLIER -60.38 -37.22 80.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.49 ' HB2' HG22 ' A' ' 285' ' ' VAL . 96.5 p -55.73 -54.89 38.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 342' ' ' ASN . 48.6 t80 -53.35 -52.45 59.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 341' ' ' PHE . 5.6 m-80 -36.01 -47.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.624 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.0 mp -64.2 -47.74 88.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.607 HG11 ' HB3' ' A' ' 292' ' ' ALA . 90.0 t -47.81 -56.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -44.5 -53.89 6.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.049 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -51.82 -38.52 56.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.69 -66.21 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.612 HG21 HD12 ' A' ' 296' ' ' LEU . 14.9 t -47.6 -55.89 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.105 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.449 ' O ' ' C ' ' A' ' 350' ' ' ARG . 6.1 m-85 -46.88 -60.31 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.554 ' O ' HD23 ' A' ' 354' ' ' LEU . 17.7 tpp85 -34.53 -52.86 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 70.9 m -61.32 -57.51 12.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 89.1 mt -47.41 -40.57 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 6.4 mm -62.45 -41.88 93.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.117 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 350' ' ' ARG . 3.8 mm? -63.53 -44.85 93.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -39.26 -39.8 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -88.51 -53.14 4.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -53.45 137.23 36.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -94.74 117.53 30.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.909 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -136.69 127.07 26.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 6.8 t -78.88 128.68 33.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.62 121.24 44.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -156.51 -122.35 0.74 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.48 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 13.7 ptt85 -50.1 -44.01 51.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.799 0.333 . . . . 0.0 110.908 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 364' ' ' ASP . 19.6 p-10 -53.64 97.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.1 t 73.05 41.18 0.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.818 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -92.72 -81.61 1.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.537 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 -6.86 19.64 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.698 2.265 . . . . 0.0 112.325 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 73.1 p -69.87 122.34 19.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.815 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 19.5 p -108.48 43.17 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.467 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.1 t -142.7 149.5 38.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.839 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.8 t -85.88 131.56 34.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 150.97 -171.02 30.72 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 17.1 m -95.09 90.89 6.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.858 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 86.6 p -168.57 136.37 2.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 81.03 163.18 29.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 98.97 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.648 2.232 . . . . 0.0 112.36 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -108.8 164.66 12.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.403 ' HG3' ' N ' ' A' ' 277' ' ' ILE . 0.2 OUTLIER -86.55 156.51 20.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 277' ' ' ILE . 0.2 OUTLIER -114.62 145.88 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.115 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -109.58 143.09 39.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.0 p -118.78 154.96 53.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.59 0.709 . . . . 0.0 111.137 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -166.73 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.672 2.248 . . . . 0.0 112.377 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.843 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.9 t -78.1 120.86 23.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.82 -48.01 83.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.099 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -45.95 -41.34 11.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.754 HD11 HG21 ' A' ' 332' ' ' VAL . 24.5 mt -77.08 -43.95 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 281' ' ' SER . 43.5 t -53.9 -40.48 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -63.82 -42.81 97.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -72.66 -32.85 66.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.616 HG23 HD11 ' A' ' 325' ' ' LEU . 28.2 m -59.48 -22.54 61.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 293' ' ' MET . 51.2 mttt -76.31 -46.55 27.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -54.8 -27.55 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 292' ' ' ALA . 7.0 pt -98.48 -52.19 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.488 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -63.83 -48.78 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.089 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.498 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 30.9 ttm -51.97 -64.78 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -40.18 -56.38 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 298' ' ' ALA . 16.6 mmmt -59.15 -66.09 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.768 HD12 HG21 ' A' ' 348' ' ' VAL . 91.6 mt -38.68 -42.09 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.572 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.9 m-85 -73.54 -35.65 65.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -68.98 -54.02 17.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.13 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 300' ' ' PHE . 34.3 m -56.53 -40.4 68.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.415 ' N ' HG23 ' A' ' 299' ' ' VAL . 5.7 t80 -55.04 -57.46 11.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 26.1 m -46.99 -40.16 13.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.89 -175.76 3.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.628 ' CE2' ' HB1' ' A' ' 313' ' ' ALA . 2.1 m-85 60.24 44.34 12.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -89.38 -53.88 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -69.05 -43.16 75.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -43.2 153.22 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 309' ' ' SER . 4.1 ttpm? -77.41 -41.42 40.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 307' ' ' LYS . 10.9 m -36.86 -30.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 307' ' ' LYS . 18.2 m 54.96 47.02 23.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.401 ' O ' HG23 ' A' ' 314' ' ' VAL . 2.6 mpp_? 60.34 40.5 17.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' ' 311' ' ' ASP . 9.9 t0 -86.93 -62.93 1.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 313' ' ' ALA . 12.5 pt-20 -75.43 -37.31 60.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.628 ' HB1' ' CE2' ' A' ' 303' ' ' TYR . . . -55.11 -36.45 65.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.093 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 310' ' ' ARG . 60.1 t -82.54 -54.98 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.6 OUTLIER -48.87 -48.98 41.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 317' ' ' ILE . 16.9 mtmm -38.2 -58.1 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 320' ' ' ASP . 68.3 mt -33.95 -57.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.089 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 317' ' ' ILE . 50.8 ttt180 -34.53 -59.07 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.6 mt -58.9 -39.57 81.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.5 t70 -66.05 -69.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.468 HG22 HG13 ' A' ' 291' ' ' ILE . 27.1 p -47.12 -47.3 23.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.181 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.36 -39.11 60.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -84.61 -12.93 53.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' HIS . . . . . 0.421 ' CD2' HG21 ' A' ' 291' ' ' ILE . 70.4 t60 -92.97 -26.3 17.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.616 HD11 HG23 ' A' ' 288' ' ' THR . 18.8 mt -92.63 -59.37 2.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -39.57 -34.15 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.26 -39.1 55.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.541 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 32.5 tptt -54.18 -49.94 68.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.643 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.1 OUTLIER -117.14 91.14 35.73 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 110.901 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.66 -18.62 37.35 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.706 2.271 . . . . 0.0 112.34 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.3 -0.16 57.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.754 HG21 HD11 ' A' ' 284' ' ' ILE . 0.8 OUTLIER -98.02 148.96 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -72.53 154.47 40.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -67.19 -45.43 76.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -54.19 -15.31 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -81.85 -31.62 31.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.58 HD11 HG11 ' A' ' 332' ' ' VAL . 1.7 mp -85.54 -32.33 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.143 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 46.5 mt -69.75 -41.06 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.449 ' O ' HD12 ' A' ' 343' ' ' ILE . 6.0 tt0 -74.52 -56.56 4.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 344' ' ' VAL . 57.2 p -34.71 -45.48 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 344' ' ' VAL . 56.9 t80 -59.9 -60.39 3.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 341' ' ' PHE . 14.5 m-80 -37.03 -47.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.591 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.8 mp -66.5 -41.86 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 340' ' ' SER . 61.5 t -60.79 -50.86 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -44.16 -67.32 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' LYS . . . . . 0.529 ' HE2' HG23 ' A' ' 343' ' ' ILE . 32.9 pttt -48.53 -44.77 36.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 347' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 346' ' ' LYS . 16.1 mt-10 -55.61 -50.42 70.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.768 HG21 HD12 ' A' ' 296' ' ' LEU . 57.7 t -59.93 -48.06 89.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.126 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.5 m-85 -54.93 -55.11 34.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -44.49 -33.47 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.666 ' O ' HD22 ' A' ' 354' ' ' LEU . 6.3 m -82.87 -30.63 28.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.841 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.572 HG12 ' CE1' ' A' ' 297' ' ' TYR . 86.0 mt -79.82 -17.19 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.131 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.46 HD13 ' HA ' ' A' ' 353' ' ' ILE . 9.5 mm -60.52 -18.99 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.11 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 351' ' ' SER . 1.3 pt? -57.07 -23.88 49.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' ASN . . . . . 0.428 ' C ' ' CD ' ' A' ' 356' ' ' GLU . 8.9 t30 -89.42 22.13 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' GLU . . . . . 0.428 ' CD ' ' C ' ' A' ' 355' ' ' ASN . 39.5 mp0 -144.5 116.58 8.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 72.64 45.28 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -41.68 113.07 0.38 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.92 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -128.58 179.79 5.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 75.6 m -70.18 102.59 2.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -136.85 167.77 20.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -91.66 -124.02 3.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -107.4 140.75 39.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 110.89 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -141.25 158.77 43.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 5.8 t -43.26 131.03 4.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.831 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 66.35 82.05 0.13 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.485 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 95.63 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.742 2.294 . . . . 0.0 112.35 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 369' ' ' SER . 13.2 t -76.67 -48.84 17.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.836 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 368' ' ' SER . 87.9 p 36.19 41.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.485 -179.959 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.0 m 38.7 48.51 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.392 . . . . 0.0 110.874 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 80.2 p -118.42 -32.92 4.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.865 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 52.56 -124.62 26.88 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.497 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -43.0 156.04 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.884 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 98.3 p -149.03 145.6 27.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.871 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -101.28 -83.26 1.72 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.455 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 142.9 49.34 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.686 2.258 . . . . 0.0 112.317 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -67.39 121.4 15.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -104.59 141.73 35.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.684 HD13 ' H ' ' A' ' 277' ' ' ILE . 0.2 OUTLIER -92.99 159.06 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -130.28 139.82 50.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 41.2 p -106.0 151.77 40.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.583 0.706 . . . . 0.0 111.137 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -174.06 0.83 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.702 2.268 . . . . 0.0 112.366 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.69 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.3 t -69.98 121.92 18.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.829 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.93 -48.12 77.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -46.08 -42.19 13.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.715 HD11 HG21 ' A' ' 332' ' ' VAL . 22.7 mt -73.77 -40.18 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 281' ' ' SER . 90.7 t -57.12 -46.36 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.409 ' O ' HD12 ' A' ' 290' ' ' ILE . 35.0 mttm -60.87 -40.89 94.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.418 ' HA ' HD13 ' A' ' 290' ' ' ILE . 49.5 t80 -74.89 -30.86 61.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.406 HG23 HD11 ' A' ' 325' ' ' LEU . 42.9 m -62.91 -22.34 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 293' ' ' MET . 30.3 mttt -77.76 -43.57 30.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 287' ' ' TYR . 3.0 mp -55.72 -28.56 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.591 HG13 HG22 ' A' ' 321' ' ' THR . 5.8 pt -98.13 -51.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.455 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -62.76 -48.21 80.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.493 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 32.4 ttm -55.51 -70.25 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -40.27 -54.61 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.495 ' HB3' HD11 ' A' ' 317' ' ' ILE . 26.8 mttp -58.75 -69.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.427 HD12 HG21 ' A' ' 348' ' ' VAL . 86.4 mt -37.92 -43.39 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.584 ' CE1' HG12 ' A' ' 352' ' ' ILE . 10.4 m-85 -71.61 -38.95 70.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -62.12 -46.68 87.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.101 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 26.4 m -70.74 -27.02 29.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.499 ' CD2' HG21 ' A' ' 352' ' ' ILE . 3.2 t80 -76.39 -48.1 20.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 3.5 m -56.53 -20.51 20.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.091 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.535 ' OD2' ' CE1' ' A' ' 303' ' ' TYR . 17.9 t0 -99.29 -64.3 1.05 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.871 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.535 ' CE1' ' OD2' ' A' ' 302' ' ' ASP . 5.0 m-85 -77.51 66.01 3.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 305' ' ' HIS . 34.4 mt-10 -88.7 -50.61 6.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.433 ' O ' ' CG ' ' A' ' 306' ' ' ASP . 34.6 p-80 -35.76 -36.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.834 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 305' ' ' HIS . 15.8 m-20 -162.29 150.25 14.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.41 -26.11 20.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.954 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 310' ' ' ARG . 2.8 m -76.83 -34.41 22.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.3 m -52.03 86.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 308' ' ' VAL . 14.9 ttp180 73.84 48.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -56.63 -25.73 54.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -39.29 -34.1 0.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -55.17 -60.29 3.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.45 -53.96 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -53.22 -36.83 61.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.453 ' HA ' HD12 ' A' ' 319' ' ' LEU . 13.3 mmtp -57.2 -32.08 66.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.552 HG22 ' CE1' ' A' ' 341' ' ' PHE . 8.7 mm -48.12 -71.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 317' ' ' ILE . 31.2 ttt180 -33.95 -45.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 316' ' ' LYS . 13.6 mt -69.56 -44.3 71.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 317' ' ' ILE . 32.1 t0 -67.06 -66.19 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.591 HG22 HG13 ' A' ' 291' ' ' ILE . 16.9 p -47.21 -51.74 17.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -49.4 -43.92 44.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -82.31 -11.99 58.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -89.39 -27.9 20.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.568 ' HB2' HG23 ' A' ' 337' ' ' ILE . 20.0 mt -90.19 -52.62 4.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 325' ' ' LEU . 0.4 OUTLIER -36.81 -44.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -64.44 -46.65 82.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 21.1 tptt -55.33 -42.49 73.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.577 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 0.2 OUTLIER -120.62 89.87 45.24 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.686 0.755 . . . . 0.0 110.873 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.94 2.4 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.242 . . . . 0.0 112.362 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -61.98 -25.65 67.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.715 HG21 HD11 ' A' ' 284' ' ' ILE . 97.2 t -73.75 148.81 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -84.65 147.84 26.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -53.57 -45.14 69.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.6 t80 -51.98 -18.79 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.401 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 47.5 mt-10 -88.92 -41.15 12.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.568 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.5 mp -69.31 -31.72 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.183 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 39.6 mt -76.22 -66.64 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.118 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.619 ' O ' HD12 ' A' ' 343' ' ' ILE . 8.5 tp10 -42.1 -53.86 3.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.54 ' CB ' HG22 ' A' ' 285' ' ' VAL . 2.2 p -40.5 -41.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.837 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 317' ' ' ILE . 75.7 t80 -62.43 -53.03 60.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.851 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -42.53 -43.33 3.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.642 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.7 mp -65.94 -34.14 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 341' ' ' PHE . 73.9 t -70.66 -58.74 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.129 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -37.18 -61.74 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.074 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -45.5 -51.25 11.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -55.81 -59.67 4.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 352' ' ' ILE . 88.5 t -48.98 -62.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.114 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.1 m-85 -44.5 -69.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 349' ' ' PHE . 20.9 ttp180 -34.3 -54.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 41.9 m -56.5 -42.67 78.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.584 HG12 ' CE1' ' A' ' 297' ' ' TYR . 61.8 mt -68.31 -21.76 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 353' ' ' ILE . 10.8 mm -70.08 -11.99 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.172 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 354' ' ' LEU . 2.4 mm? -83.66 -1.59 54.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 355' ' ' ASN . 2.9 p-10 -52.84 85.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 354' ' ' LEU . 6.1 mm-40 64.0 40.52 7.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -122.03 120.8 35.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -100.81 131.47 46.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.891 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -129.36 153.28 48.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.873 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 361' ' ' ASP . 13.0 t -99.12 -43.31 6.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.929 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 361' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 360' ' ' CYS . 68.7 m-20 -37.14 140.11 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -147.13 -91.89 0.11 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.491 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -73.94 108.75 6.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -49.51 171.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.3 t -69.41 -57.58 5.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -158.76 146.81 13.68 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.474 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 87.07 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.699 2.266 . . . . 0.0 112.342 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 88.5 p -66.08 143.1 57.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.855 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 20.1 m -113.51 -54.69 2.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.846 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 -179.966 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.2 t 49.68 41.64 22.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.915 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.3 t -100.37 121.51 41.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 124.04 128.07 3.27 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.453 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 17.3 m -124.82 103.1 7.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.391 . . . . 0.0 110.875 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 64.4 p -106.66 129.72 54.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.884 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 73.19 -176.74 43.81 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 95.36 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.696 2.264 . . . . 0.0 112.321 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -119.99 127.45 52.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.56 119.91 13.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.907 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 7.5 mm -96.93 146.6 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.155 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -124.66 142.95 51.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 43.6 p -74.73 151.63 86.9 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.583 0.706 . . . . 0.0 111.15 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.99 6.04 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.664 2.243 . . . . 0.0 112.339 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.635 ' HB2' HD12 ' A' ' 284' ' ' ILE . 66.5 m -68.91 127.5 33.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.85 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 284' ' ' ILE . . . -70.98 -52.18 21.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -39.86 -27.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.881 HG23 ' CE1' ' A' ' 329' ' ' PHE . 22.0 mt -92.27 -43.25 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 281' ' ' SER . 77.6 t -53.65 -35.93 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -66.01 -34.69 78.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.906 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.407 ' HA ' HD13 ' A' ' 290' ' ' ILE . 50.3 t80 -76.95 -27.21 54.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.654 HG23 HD11 ' A' ' 325' ' ' LEU . 2.7 m -65.64 -20.68 66.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 293' ' ' MET . 0.7 OUTLIER -76.5 -45.71 29.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.451 ' H ' HD12 ' A' ' 290' ' ' ILE . 3.2 mp -52.58 -32.1 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.501 ' CD1' HG22 ' A' ' 321' ' ' THR . 6.9 pt -98.49 -52.08 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.68 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -60.78 -48.56 81.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.07 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 33.8 ttm -55.36 -69.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 293' ' ' MET . 16.2 mt-10 -37.91 -67.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.867 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 298' ' ' ALA . 45.5 mmtt -50.37 -63.44 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 72.6 mt -42.96 -30.38 0.41 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.589 ' CE2' HG13 ' A' ' 348' ' ' VAL . 10.1 m-85 -88.84 -31.25 18.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -69.79 -48.99 57.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.076 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 19.5 m -64.55 -34.64 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.165 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.731 ' CE2' HG21 ' A' ' 352' ' ' ILE . 3.6 t80 -57.05 -59.88 4.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.6 m -67.5 -37.0 82.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -64.86 -69.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -85.77 82.53 8.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 305' ' ' HIS . 14.4 pt-20 -86.67 -49.11 7.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.414 ' N ' ' HG3' ' A' ' 304' ' ' GLU . 50.5 p-80 -91.85 -50.39 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.86 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -44.01 121.37 2.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.845 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -90.82 -67.73 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.563 HG13 ' N ' ' A' ' 309' ' ' SER . 8.0 p -44.82 -49.87 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.563 ' N ' HG13 ' A' ' 308' ' ' VAL . 14.6 m -56.56 -41.91 77.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.453 ' NH2' ' CD2' ' A' ' 300' ' ' PHE . 7.3 tpt85 -59.01 -52.48 65.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -49.5 -64.19 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.816 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.1 -31.27 65.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -64.48 -65.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 23.8 t -54.98 -41.9 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.6 -44.67 85.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -44.24 -57.09 3.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.643 HG22 ' CE1' ' A' ' 341' ' ' PHE . 58.8 mt -41.49 -55.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -39.75 -35.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.0 mt -88.62 -32.29 18.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 24.8 t70 -67.48 -65.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.501 HG22 ' CD1' ' A' ' 291' ' ' ILE . 71.8 p -51.77 -44.46 63.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -44.69 -54.4 6.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -76.81 -13.1 60.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.836 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -85.96 -26.19 25.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.654 HD11 HG23 ' A' ' 288' ' ' THR . 26.6 mt -91.62 -62.22 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -39.83 -43.78 1.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -62.86 -38.15 89.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 325' ' ' LEU . 44.2 tttp -60.33 -45.74 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.881 ' CE1' HG23 ' A' ' 284' ' ' ILE . 0.9 OUTLIER -117.97 94.71 46.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.688 0.756 . . . . 0.0 110.863 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -20.63 34.47 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.652 2.235 . . . . 0.0 112.327 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.02 -40.22 28.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.597 HG11 HD11 ' A' ' 337' ' ' ILE . 0.9 OUTLIER -63.93 156.16 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -90.98 156.49 17.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -62.94 -42.9 99.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.6 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 4.3 t80 -54.03 -15.96 1.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -88.18 -27.58 21.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.641 HG23 HD12 ' A' ' 325' ' ' LEU . 2.6 mp -85.67 -56.83 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 338' ' ' ILE . . . . . 0.41 ' O ' ' ND2' ' A' ' 342' ' ' ASN . 72.8 mt -48.56 -33.12 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.123 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.421 ' O ' HD12 ' A' ' 343' ' ' ILE . 17.0 tt0 -79.22 -42.4 26.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.407 ' HB3' HG22 ' A' ' 285' ' ' VAL . 73.8 m -52.23 -53.07 48.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.643 ' CE1' HG22 ' A' ' 317' ' ' ILE . 56.0 t80 -46.61 -53.03 12.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 338' ' ' ILE . 37.6 m-80 -42.55 -52.49 4.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 343' ' ' ILE . 3.7 mp -56.3 -40.04 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.161 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.68 HG11 ' HB3' ' A' ' 292' ' ' ALA . 91.3 t -63.89 -62.11 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.131 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.1 -66.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -46.44 -58.13 4.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -42.69 -62.34 1.02 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.589 HG13 ' CE2' ' A' ' 297' ' ' TYR . 37.0 t -50.33 -66.13 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.144 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 351' ' ' SER . 8.0 m-85 -39.01 -69.49 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 349' ' ' PHE . 35.8 ttm180 -36.33 -32.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 355' ' ' ASN . 1.6 t -76.89 -56.37 4.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.731 HG21 ' CE2' ' A' ' 300' ' ' PHE . 80.2 mt -47.51 -51.37 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.102 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.407 ' H ' HD12 ' A' ' 353' ' ' ILE . 2.7 mp -55.95 -32.22 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 77.5 mt -100.83 -0.49 36.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 351' ' ' SER . 41.6 t30 -102.06 96.86 7.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.851 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' GLU . . . . . 0.44 ' HG2' ' C ' ' A' ' 355' ' ' ASN . 7.8 pt-20 43.62 42.02 3.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.445 ' C ' ' CD1' ' A' ' 357' ' ' TYR . 5.5 t80 -127.08 -56.72 1.34 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.973 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -136.6 139.97 42.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 7.0 mtm-85 -87.11 94.1 9.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 30.1 t -74.74 135.18 41.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -75.89 102.51 5.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 155.12 108.15 0.29 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.446 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -82.67 44.57 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.808 0.337 . . . . 0.0 110.858 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -117.21 -57.79 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 61.5 m -74.49 114.61 13.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -117.16 -157.84 10.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.472 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -25.25 29.14 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.744 2.296 . . . . 0.0 112.343 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 32.2 m -40.8 117.62 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 370' ' ' GLY . 69.6 m -150.83 158.87 44.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.834 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 369' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.541 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.6 t -171.5 121.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 0.0 110.911 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 25.9 p -173.28 166.49 4.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -167.77 141.82 7.09 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.461 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -167.43 160.18 13.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 110.877 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.4 m -171.09 148.71 2.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.879 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 127.33 -93.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.477 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 1.22 4.61 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.677 2.251 . . . . 0.0 112.356 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -66.06 163.78 16.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -93.12 137.83 32.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 3.1 mm -108.81 110.49 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.148 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -108.74 147.47 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 72.6 p -75.68 151.18 84.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.562 0.696 . . . . 0.0 111.142 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -176.02 1.35 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.641 2.228 . . . . 0.0 112.339 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.685 ' O ' HG23 ' A' ' 285' ' ' VAL . 14.1 m -77.6 124.67 28.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.5 76.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.12 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -46.78 -29.67 2.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.756 ' CD1' HG21 ' A' ' 332' ' ' VAL . 17.4 mt -89.18 -52.4 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.112 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 281' ' ' SER . 40.2 t -44.22 -35.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -66.0 -35.56 80.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.461 ' CD2' ' HD3' ' A' ' 328' ' ' LYS . 28.4 t80 -81.5 -18.77 43.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.412 HG23 HD11 ' A' ' 325' ' ' LEU . 28.3 m -70.38 -26.09 63.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.563 ' HD2' HG22 ' A' ' 344' ' ' VAL . 0.0 OUTLIER -75.79 -43.35 46.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.889 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.6 mp -54.58 -31.25 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.767 HG21 ' CD2' ' A' ' 324' ' ' HIS . 6.3 pt -98.09 -51.83 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.466 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -60.45 -48.1 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.1 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 11.9 ttm -55.9 -62.26 1.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -39.75 -72.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 298' ' ' ALA . 13.7 mptt -50.23 -63.61 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.456 ' CD2' HG13 ' A' ' 314' ' ' VAL . 45.1 mt -37.66 -43.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -78.67 -33.36 47.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -65.67 -36.56 84.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.095 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 24.0 m -80.8 -27.09 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.511 ' CZ ' HG23 ' A' ' 352' ' ' ILE . 3.6 t80 -69.0 -50.81 45.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 33.3 p -53.36 -53.66 47.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.153 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -58.74 -74.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -76.56 54.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 305' ' ' HIS . 10.2 tm-20 -66.77 -58.35 5.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.447 ' C ' ' O ' ' A' ' 304' ' ' GLU . 6.3 t-80 -34.82 -58.12 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -139.59 128.0 22.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' LYS . . . . . 0.549 ' HE3' HG21 ' A' ' 314' ' ' VAL . 0.4 OUTLIER -89.96 -52.65 4.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 13.8 m -54.65 -22.05 8.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.138 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 51.9 p -60.97 -27.52 68.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.791 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -133.55 49.71 2.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.33 -30.07 17.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 9.6 pt-20 -51.4 -25.45 6.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -75.11 -68.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.07 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.549 HG21 ' HE3' ' A' ' 307' ' ' LYS . 58.4 t -55.61 -42.29 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.5 OUTLIER -59.95 -55.54 32.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 9.6 mmmt -35.53 -43.71 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.44 HD12 HD23 ' A' ' 296' ' ' LEU . 50.5 mt -47.49 -52.43 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.436 ' HG2' ' CE2' ' A' ' 341' ' ' PHE . 14.6 mmm-85 -40.01 -39.22 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.0 mt -82.98 -44.83 14.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.73 -69.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.85 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.527 HG22 HG13 ' A' ' 291' ' ' ILE . 37.6 p -46.04 -47.95 16.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.482 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 60.5 tt0 -45.22 -52.3 9.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.92 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -78.66 -14.54 59.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' HIS . . . . . 0.767 ' CD2' HG21 ' A' ' 291' ' ' ILE . 44.5 t60 -82.1 -29.71 31.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.867 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.607 HD12 HG23 ' A' ' 337' ' ' ILE . 15.9 mt -92.39 -59.78 2.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.4 ' NZ ' ' HB2' ' A' ' 334' ' ' GLN . 39.8 tttp -43.14 -29.67 0.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.88 -35.36 50.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.504 ' HE3' ' CZ ' ' A' ' 329' ' ' PHE . 37.9 tttp -58.51 -55.66 32.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.982 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.1 OUTLIER -117.89 107.64 43.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.663 0.744 . . . . 0.0 110.866 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 329' ' ' PHE . 53.6 Cg_endo -69.77 -21.9 32.77 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.679 2.253 . . . . 0.0 112.344 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.57 -35.72 70.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.982 HG12 ' O ' ' A' ' 329' ' ' PHE . 7.1 p -63.8 146.0 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' ASP . . . . . 0.627 ' O ' HD12 ' A' ' 337' ' ' ILE . 1.4 t70 -87.17 157.9 19.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' GLN . . . . . 0.4 ' HB2' ' NZ ' ' A' ' 326' ' ' LYS . 9.7 tt0 -65.16 -35.92 82.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.465 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 9.5 t80 -63.55 -9.77 14.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -93.38 -41.35 9.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 333' ' ' ASP . 4.9 mp -69.64 -45.57 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.11 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.81 -41.05 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.662 ' O ' HD12 ' A' ' 343' ' ' ILE . 16.6 tt0 -73.61 -42.77 61.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 341' ' ' PHE . 37.1 m -51.11 -62.35 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 344' ' ' VAL . 68.6 t80 -37.78 -59.39 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 341' ' ' PHE . 2.4 m-80 -36.63 -54.56 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.7 mp -57.75 -36.6 55.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.563 HG22 ' HD2' ' A' ' 289' ' ' LYS . 97.1 t -72.14 -59.12 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -36.26 -66.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -49.62 -36.51 24.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 344' ' ' VAL . 1.5 tp10 -57.33 -40.09 77.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.09 -40.09 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.145 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 350' ' ' ARG . 6.1 m-85 -51.94 -70.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 349' ' ' PHE . 10.1 ptt85 -35.33 -42.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 23.4 m -64.11 -49.0 73.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.511 HG23 ' CZ ' ' A' ' 300' ' ' PHE . 97.3 mt -63.91 -43.57 97.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.111 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 4.4 mm -49.27 -38.32 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.162 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 3.5 mp -90.32 -12.74 36.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.78 -7.87 54.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' GLU . . . . . 0.504 ' O ' ' CD2' ' A' ' 357' ' ' TYR . 8.2 pt-20 -114.83 56.61 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 356' ' ' GLU . 43.3 m-85 -165.52 124.46 1.68 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -63.7 93.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -141.57 122.12 14.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 57.3 m -93.34 129.68 39.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -92.92 -50.04 5.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 159.17 -107.87 0.34 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.477 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -80.26 88.41 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -87.76 158.15 18.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 46.1 t -130.08 106.48 8.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.852 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -108.78 -82.99 1.46 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.508 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 112.2 3.01 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.71 2.273 . . . . 0.0 112.331 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 24.8 p -90.89 41.19 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.856 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 74.4 m 62.87 41.97 8.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.488 -179.992 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.481 -0.247 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 19.6 t -118.21 -55.84 2.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.887 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 27.6 p 46.78 42.17 11.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.868 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -132.26 106.96 0.68 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.502 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.0 m -115.77 174.03 6.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.353 . . . . 0.0 110.868 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 16.5 m -152.46 151.12 30.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -134.96 169.22 23.36 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.435 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 102.13 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.656 2.237 . . . . 0.0 112.325 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 276' ' ' LYS . 3.7 tp-100 -113.69 152.03 31.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' LYS . . . . . 0.408 ' N ' ' HG3' ' A' ' 275' ' ' GLN . 21.4 mttp -83.45 109.36 17.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.512 HD13 ' H ' ' A' ' 277' ' ' ILE . 0.1 OUTLIER -107.69 158.56 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.179 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 278' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' A' ' 278' ' ' PHE . 0.1 OUTLIER -74.86 147.3 41.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 68.3 p -74.18 152.21 88.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.556 0.693 . . . . 0.0 111.201 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -176.57 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.673 2.249 . . . . 0.0 112.341 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 285' ' ' VAL . 2.3 t -69.99 125.71 27.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.38 -30.92 70.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.66 -40.08 74.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.682 HD11 HG21 ' A' ' 332' ' ' VAL . 17.4 mt -76.79 -45.85 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 281' ' ' SER . 91.5 t -48.94 -39.19 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -65.06 -44.29 89.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.495 ' CE1' ' NZ ' ' A' ' 328' ' ' LYS . 49.4 t80 -72.17 -26.36 62.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 110.978 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 49.4 m -69.37 -20.94 63.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.163 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 27.9 mttt -78.84 -43.55 24.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.25 -31.09 31.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.65 HG13 HG22 ' A' ' 321' ' ' THR . 6.1 pt -97.77 -51.33 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.538 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -59.82 -46.96 87.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.111 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 33.3 ttm -55.93 -68.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.865 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 293' ' ' MET . 49.2 mt-10 -35.92 -59.91 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 298' ' ' ALA . 31.3 mmtt -60.06 -64.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.474 HD13 ' HB ' ' A' ' 348' ' ' VAL . 48.4 mt -36.03 -37.88 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.894 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.503 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.8 m-85 -78.48 -44.25 24.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -59.36 -40.16 85.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.063 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.442 ' HB ' ' HB1' ' A' ' 313' ' ' ALA . 28.1 m -77.64 -38.21 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.686 ' CD1' HG21 ' A' ' 352' ' ' ILE . 15.8 t80 -42.37 -46.37 4.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 11.1 m -77.28 -23.6 51.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.149 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 299' ' ' VAL . 26.1 t0 -64.08 -60.68 2.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.547 ' OH ' HG22 ' A' ' 314' ' ' VAL . 37.9 p90 -100.53 20.38 15.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.89 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.423 ' OE2' ' CG ' ' A' ' 305' ' ' HIS . 2.1 pp20? -44.72 -42.42 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.423 ' CG ' ' OE2' ' A' ' 304' ' ' GLU . 8.6 m-70 -50.26 -71.81 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -124.8 154.01 41.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -67.57 -51.7 47.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' VAL . . . . . 0.577 HG23 ' N ' ' A' ' 309' ' ' SER . 19.3 m -55.36 -52.78 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.153 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.577 ' N ' HG23 ' A' ' 308' ' ' VAL . 93.1 p -45.62 114.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? 61.7 35.62 16.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.912 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -53.42 -28.69 31.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 21.6 pm0 -56.16 -27.77 55.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.442 ' HB1' ' HB ' ' A' ' 299' ' ' VAL . . . -56.95 -42.95 81.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' VAL . . . . . 0.547 HG22 ' OH ' ' A' ' 303' ' ' TYR . 54.5 t -72.56 -62.87 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -50.47 -41.67 53.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 8.4 mmtp -41.61 -64.77 0.52 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.567 HG22 ' CE2' ' A' ' 341' ' ' PHE . 41.5 mt -42.29 -61.88 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.123 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.464 ' HD2' ' CD1' ' A' ' 341' ' ' PHE . 15.8 mmm180 -36.82 -33.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 317' ' ' ILE . 10.0 mt -88.11 -41.49 13.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 317' ' ' ILE . 41.2 m-20 -61.28 -61.8 2.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.65 HG22 HG13 ' A' ' 291' ' ' ILE . 36.2 p -54.16 -46.47 72.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -49.33 -40.13 34.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -85.46 -19.75 30.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' HIS . . . . . 0.544 ' CD2' HG21 ' A' ' 291' ' ' ILE . 74.7 t60 -82.46 -25.79 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.674 ' HB2' HG23 ' A' ' 337' ' ' ILE . 32.5 mt -89.76 -56.47 3.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.93 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.416 ' N ' HG12 ' A' ' 337' ' ' ILE . 2.2 tmmm? -38.2 -45.74 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.63 -37.8 85.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.608 ' HG2' ' CE2' ' A' ' 329' ' ' PHE . 9.9 tptm -57.95 -49.2 77.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.608 ' CE2' ' HG2' ' A' ' 328' ' ' LYS . 9.5 m-85 -124.26 94.66 44.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.629 0.728 . . . . 0.0 110.848 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 329' ' ' PHE . 53.7 Cg_endo -69.75 -41.99 3.8 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.668 2.245 . . . . 0.0 112.341 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -63.71 -25.71 68.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.682 HG21 HD11 ' A' ' 284' ' ' ILE . 53.0 t -69.17 148.77 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -72.53 150.51 43.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -62.48 -40.05 95.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.93 -11.09 16.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.409 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 6.6 mm-40 -87.26 -34.26 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.674 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.5 mp -75.04 -35.63 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.88 -64.62 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.458 ' O ' HD12 ' A' ' 343' ' ' ILE . 1.8 tp10 -44.9 -53.9 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 46.9 m -41.03 -34.96 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.567 ' CE2' HG22 ' A' ' 317' ' ' ILE . 48.0 t80 -70.01 -53.05 19.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -40.77 -40.19 1.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.458 HD12 ' O ' ' A' ' 339' ' ' GLU . 5.1 mp -73.67 -42.87 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.538 HG11 ' HB3' ' A' ' 292' ' ' ALA . 20.1 t -60.91 -62.64 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.116 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -40.28 -67.03 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -39.22 -51.74 1.96 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -56.08 -68.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 296' ' ' LEU . 38.3 t -44.44 -30.95 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.566 ' O ' HD12 ' A' ' 353' ' ' ILE . 13.7 m-85 -73.98 -64.38 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.02 -19.53 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 6.3 p -87.07 -32.02 20.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.686 HG21 ' CD1' ' A' ' 300' ' ' PHE . 54.3 mt -70.97 -54.52 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.146 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.646 ' H ' HD12 ' A' ' 353' ' ' ILE . 5.0 mp -50.95 -29.28 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.151 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 55.7 mt -94.67 -27.8 15.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -46.3 -43.19 15.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -45.57 -43.49 12.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -99.55 102.91 14.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 358' ' ' LYS . 0.1 OUTLIER -74.05 107.87 6.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.909 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -112.49 36.79 3.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 57.2 m -145.61 155.52 43.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -56.97 -59.21 5.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 363' ' ' ARG . . . 156.44 45.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 362' ' ' GLY . 11.3 ttp85 -35.54 101.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 110.856 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -95.15 -57.34 2.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.4 t 57.92 34.66 24.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -137.93 85.96 0.23 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.521 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 368' ' ' SER . 53.9 Cg_endo -69.73 -42.5 3.37 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.67 2.247 . . . . 0.0 112.372 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 368' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 367' ' ' PRO . 49.1 m -35.55 122.71 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 15.1 p -65.13 -9.57 23.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.89 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.515 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.6 t -173.13 149.47 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 110.861 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 12.4 p -98.31 23.24 8.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 61.55 174.33 1.55 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 82.9 p -157.87 169.02 25.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.375 . . . . 0.0 110.842 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 57.7 p -125.44 137.26 53.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.864 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 170.94 -160.31 32.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.526 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 2.16 3.77 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.658 2.239 . . . . 0.0 112.319 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -65.99 133.8 51.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -66.04 168.91 7.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.446 ' C ' HD12 ' A' ' 277' ' ' ILE . 2.5 pp -105.16 160.69 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.149 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -122.29 148.09 45.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 53.0 p -73.07 151.58 90.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.543 0.687 . . . . 0.0 111.128 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 170.28 16.91 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.663 2.242 . . . . 0.0 112.35 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 9.9 m -68.61 125.89 27.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.77 87.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -38.78 -35.29 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.755 ' CD1' HG21 ' A' ' 332' ' ' VAL . 22.0 mt -86.72 -56.99 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.113 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 91.9 t -40.84 -36.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -64.65 -41.98 95.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 284' ' ' ILE . 55.1 t80 -74.26 -31.44 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.62 HG23 HD11 ' A' ' 325' ' ' LEU . 22.8 m -60.34 -20.98 61.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 293' ' ' MET . 21.4 mttt -77.98 -43.79 28.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.4 mp -58.88 -27.2 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.484 HG13 HG22 ' A' ' 321' ' ' THR . 5.5 pt -98.1 -51.13 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.476 ' N ' ' CG1' ' A' ' 291' ' ' ILE . . . -61.92 -46.28 90.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.094 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.519 ' HE2' ' HB2' ' A' ' 293' ' ' MET . 8.0 ttm -52.19 -63.46 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 293' ' ' MET . 14.9 mt-10 -37.53 -73.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 296' ' ' LEU . 1.1 mptm? -46.59 -64.14 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.606 HD12 HG21 ' A' ' 348' ' ' VAL . 51.1 mt -36.04 -55.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.587 ' CE1' HG12 ' A' ' 352' ' ' ILE . 11.5 m-85 -60.82 -41.95 96.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.935 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -58.83 -52.75 64.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.083 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 296' ' ' LEU . 27.7 m -65.44 -25.31 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.652 ' CD2' HG21 ' A' ' 352' ' ' ILE . 16.0 t80 -69.64 -62.37 1.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 14.6 t -58.09 -18.15 22.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.133 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -86.06 -65.09 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -89.39 48.6 1.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 305' ' ' HIS . 10.0 tp10 -64.67 -48.74 73.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.894 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 304' ' ' GLU . 34.9 t60 -35.9 -45.25 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.851 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -167.43 130.64 1.73 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -59.78 -53.35 58.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 2.7 m -41.41 -33.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 7.5 t -53.22 111.57 0.71 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 46.96 42.0 11.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 313' ' ' ALA . 1.0 OUTLIER -43.15 -25.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.834 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.469 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 7.8 pt-20 -39.29 -29.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 311' ' ' ASP . . . -62.0 -53.71 51.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 96.0 t -61.15 -66.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.9 t30 -43.25 -49.65 6.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.919 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.469 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 20.5 mmtt -37.8 -55.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 320' ' ' ASP . 54.2 mt -43.08 -62.81 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 317' ' ' ILE . 4.4 tmt_? -34.41 -38.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 8.4 mt -79.82 -43.09 23.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 317' ' ' ILE . 1.5 t70 -61.32 -65.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.484 HG22 HG13 ' A' ' 291' ' ' ILE . 71.7 p -50.79 -46.46 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.424 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 0.3 OUTLIER -48.08 -35.64 11.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -93.18 -20.22 20.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -81.29 -21.6 39.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.62 HD11 HG23 ' A' ' 288' ' ' THR . 22.8 mt -94.22 -65.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -39.93 -29.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 328' ' ' LYS . 4.9 pt-20 -75.08 -43.01 55.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.538 ' HE3' ' CZ ' ' A' ' 329' ' ' PHE . 45.3 tttp -53.54 -45.52 69.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.986 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.1 OUTLIER -123.1 107.94 32.59 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.642 0.734 . . . . 0.0 110.926 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -22.5 32.13 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.657 2.238 . . . . 0.0 112.352 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -72.3 -39.45 68.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.986 HG12 ' O ' ' A' ' 329' ' ' PHE . 7.3 p -57.03 147.98 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' ASP . . . . . 0.688 ' O ' HD12 ' A' ' 337' ' ' ILE . 1.5 t70 -96.56 154.33 17.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -61.81 -21.67 64.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.593 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.5 t80 -76.44 -9.67 58.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -96.31 -46.87 6.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 333' ' ' ASP . 5.4 mp -62.15 -37.69 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 48.4 mt -71.18 -59.35 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -62.32 -12.29 20.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 341' ' ' PHE . 3.5 m -80.19 -68.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.821 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 340' ' ' SER . 40.0 t80 -34.82 -44.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -42.61 -49.99 5.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.1 mp -63.42 -47.51 91.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.131 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 345' ' ' ALA . 53.9 t -48.89 -67.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.18 -66.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.133 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -38.45 -44.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 348' ' ' VAL . 15.6 tt0 -62.37 -68.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.606 HG21 HD12 ' A' ' 296' ' ' LEU . 96.1 t -35.18 -68.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 352' ' ' ILE . 9.5 m-85 -34.72 -68.86 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 349' ' ' PHE . 17.2 ttt180 -34.24 -50.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 3.5 m -67.07 -40.38 87.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.875 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.652 HG21 ' CD2' ' A' ' 300' ' ' PHE . 70.7 mt -59.71 -21.42 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.165 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.621 HG23 ' HB2' ' A' ' 357' ' ' TYR . 23.5 mm -68.82 -24.78 29.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.149 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -57.31 -16.9 9.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.947 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -84.77 58.17 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 357' ' ' TYR . 23.5 mt-10 41.38 51.17 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.621 ' HB2' HG23 ' A' ' 353' ' ' ILE . 32.9 t80 -37.17 142.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 357' ' ' TYR . 1.1 pptp? -38.17 149.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.914 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 67.68 46.17 1.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 8.2 t -108.73 166.08 11.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -138.99 171.44 14.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 105.57 69.49 0.75 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.515 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -84.92 41.71 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.806 0.336 . . . . 0.0 110.878 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -131.82 113.98 14.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 17.0 m -132.25 123.17 26.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 88.43 146.6 12.55 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 368' ' ' SER . 54.0 Cg_endo -69.74 2.73 3.26 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.698 2.266 . . . . 0.0 112.35 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 368' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 367' ' ' PRO . 22.9 t -34.63 124.86 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 368' ' ' SER . 75.4 m -37.63 144.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.848 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.455 179.979 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.0 m 50.06 42.43 24.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 110.897 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 39.7 m -59.47 120.13 8.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.852 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 129.98 78.29 0.19 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.495 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 3.3 m -68.78 124.74 24.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 0.0 110.825 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 56.2 p -73.99 -41.16 62.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.84 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -127.77 -174.03 13.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.486 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 106.91 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.736 2.291 . . . . 0.0 112.361 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -67.34 157.27 34.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.41 155.19 36.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ILE . . . . . 0.417 ' C ' HD12 ' A' ' 277' ' ' ILE . 2.7 pp -96.01 148.33 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -132.15 137.74 47.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 17.0 p -95.79 153.59 39.29 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.591 0.71 . . . . 0.0 111.104 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' PRO . . . . . 0.425 ' HA ' ' OE1' ' A' ' 336' ' ' GLU . 53.9 Cg_endo -69.81 167.14 25.36 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.705 2.27 . . . . 0.0 112.322 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.4 p -72.95 122.88 22.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.537 ' HB1' ' HE2' ' A' ' 286' ' ' LYS . . . -62.04 -49.14 77.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.077 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -44.53 -42.79 7.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.737 HD12 HG21 ' A' ' 332' ' ' VAL . 8.8 mt -77.16 -44.21 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 281' ' ' SER . 40.5 t -52.13 -43.75 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' LYS . . . . . 0.537 ' HE2' ' HB1' ' A' ' 282' ' ' ALA . 0.0 OUTLIER -61.25 -30.52 70.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.58 ' CE2' ' HD2' ' A' ' 328' ' ' LYS . 47.6 t80 -84.47 -22.94 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.933 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.536 ' CG2' HG21 ' A' ' 344' ' ' VAL . 30.0 m -66.31 -22.96 66.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 2.1 mptm? -75.75 -44.1 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 287' ' ' TYR . 2.9 mp -53.64 -30.87 19.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.108 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.669 HG21 ' CD2' ' A' ' 324' ' ' HIS . 5.4 pt -98.37 -51.99 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.455 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -61.49 -48.61 80.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.096 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 15.4 ttm -55.11 -62.28 1.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -47.72 -64.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 298' ' ' ALA . 85.0 mttt -51.34 -63.7 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.463 HD12 HG21 ' A' ' 348' ' ' VAL . 51.3 mt -40.59 -57.43 1.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' TYR . . . . . 0.505 ' CE1' ' CG1' ' A' ' 352' ' ' ILE . 9.2 m-85 -55.58 -34.53 64.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 295' ' ' LYS . . . -66.64 -53.07 37.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.058 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.524 HG11 ' HB1' ' A' ' 313' ' ' ALA . 35.9 m -68.42 -25.82 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -50.57 -56.46 11.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 69.0 p -73.13 -11.53 60.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.14 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -77.46 -55.68 5.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -100.25 13.18 35.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -37.36 -34.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -41.77 -55.76 2.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -163.09 171.26 16.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.2 -62.25 1.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 38.4 t -48.25 -35.32 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 10.3 m -55.22 120.97 7.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 42.93 35.95 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -50.83 -20.76 1.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.843 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 6.7 pt-20 -57.56 -19.9 28.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.524 ' HB1' HG11 ' A' ' 299' ' ' VAL . . . -67.91 -58.9 3.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.125 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.65 -45.77 72.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.7 t30 -67.81 -51.02 53.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.937 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.472 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 18.4 mmtt -36.61 -59.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 318' ' ' ARG . 92.8 mt -42.17 -54.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.157 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 317' ' ' ILE . 76.4 mtt-85 -38.09 -35.84 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.7 mt -83.87 -43.95 14.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.91 -69.24 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.567 HG22 HG13 ' A' ' 291' ' ' ILE . 68.3 p -49.15 -46.79 45.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.48 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 7.3 tm-20 -46.76 -43.67 18.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -87.59 -10.14 52.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' HIS . . . . . 0.669 ' CD2' HG21 ' A' ' 291' ' ' ILE . 44.8 t60 -89.34 -26.18 21.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.742 HD12 HG23 ' A' ' 337' ' ' ILE . 19.5 mt -93.59 -53.32 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -50.62 -27.93 7.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -84.5 -27.71 27.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.58 ' HD2' ' CE2' ' A' ' 287' ' ' TYR . 42.0 tttp -62.26 -55.19 30.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.848 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.1 OUTLIER -123.31 108.39 31.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.642 0.734 . . . . 0.0 110.86 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 330' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 329' ' ' PHE . 53.9 Cg_endo -69.75 -21.08 34.02 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.691 2.261 . . . . 0.0 112.328 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.43 -35.5 75.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 329' ' ' PHE . 9.9 p -71.7 153.47 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.173 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' ASP . . . . . 0.497 ' O ' HD12 ' A' ' 337' ' ' ILE . 6.3 t0 -93.47 161.42 14.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -61.97 -47.04 86.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' PHE . . . . . 0.597 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.4 t80 -51.41 -16.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.46 ' HB2' HG22 ' A' ' 332' ' ' VAL . 22.2 mm-40 -89.09 -34.54 16.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.915 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.742 HG23 HD12 ' A' ' 325' ' ' LEU . 2.8 mp -73.81 -30.33 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 28.1 mt -77.84 -61.83 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.62 ' O ' HD12 ' A' ' 343' ' ' ILE . 6.9 tp10 -52.67 -35.7 55.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' SER . . . . . 0.407 ' O ' HG23 ' A' ' 344' ' ' VAL . 4.4 p -57.02 -47.79 80.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -56.85 -50.47 72.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -40.42 -51.48 2.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.9 mp -65.1 -38.07 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.169 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.536 HG21 ' CG2' ' A' ' 288' ' ' THR . 77.8 t -60.85 -63.64 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -37.69 -51.99 1.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.079 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -54.84 -42.73 72.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 344' ' ' VAL . 20.0 tp10 -60.31 -54.74 42.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.947 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.463 HG21 HD12 ' A' ' 296' ' ' LEU . 49.2 t -57.56 -69.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.116 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.461 ' O ' ' N ' ' A' ' 352' ' ' ILE . 13.0 m-85 -35.32 -55.6 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 350' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 349' ' ' PHE . 15.4 tpt180 -36.85 -57.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' SER . . . . . 0.625 ' O ' HD22 ' A' ' 354' ' ' LEU . 47.3 t -65.31 -31.25 72.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 352' ' ' ILE . . . . . 0.505 ' CG1' ' CE1' ' A' ' 297' ' ' TYR . 51.0 mt -76.39 -11.2 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.113 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 353' ' ' ILE . 12.0 mm -69.87 -15.88 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 354' ' ' LEU . . . . . 0.625 HD22 ' O ' ' A' ' 351' ' ' SER . 1.6 pt? -53.44 -27.39 24.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -95.3 -63.5 1.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -63.77 80.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -97.17 56.77 1.4 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp 50.89 45.0 28.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -106.0 36.45 2.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 31.4 p -39.63 154.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -86.23 -47.56 9.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 100.99 -125.37 8.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.48 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -105.1 153.5 21.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 110.87 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -154.61 173.15 16.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.828 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 29.8 t -75.95 158.91 31.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 139.1 146.4 4.93 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -24.82 29.22 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.649 2.232 . . . . 0.0 112.368 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 4.1 t -54.34 127.75 28.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.6 t -163.78 159.75 21.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.866 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.5 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 31.4 t -96.93 87.58 4.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 0.0 110.873 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.0 m 51.53 42.13 29.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -96.05 174.2 31.15 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 10.0 t -93.35 155.21 17.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.83 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 60.5 p -87.26 145.62 26.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.817 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 126.5 -72.78 0.45 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 156.97 61.94 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.704 2.269 . . . . 0.0 112.326 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -98.61 131.58 44.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.56 120.29 36.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 24.5 mm -94.37 142.36 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.108 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -108.4 143.04 37.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.1 p -82.61 152.49 66.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.567 0.699 . . . . 0.0 111.11 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 178.85 4.18 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.678 2.252 . . . . 0.0 112.308 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.57 121.28 26.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 283' ' ' GLU . . . -53.24 -57.46 10.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.066 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 282' ' ' ALA . 4.5 pt-20 -38.1 -44.46 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' ILE . . . . . 0.744 HD11 HG21 ' A' ' 332' ' ' VAL . 74.6 mt -69.82 -55.98 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 88.0 t -37.81 -46.1 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.162 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -58.1 -55.94 28.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' TYR . . . . . 0.449 ' HA ' HD13 ' A' ' 290' ' ' ILE . 40.9 t80 -60.23 -26.72 66.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 16.9 m -69.31 -20.17 63.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 293' ' ' MET . 25.6 mttt -80.69 -38.26 29.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 287' ' ' TYR . 3.1 mp -60.23 -32.31 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ILE . . . . . 0.7 ' CD1' HG22 ' A' ' 321' ' ' THR . 16.9 pt -95.37 -46.84 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.126 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ALA . . . . . 0.481 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -62.79 -47.68 82.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' MET . . . . . 0.446 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 10.5 ttm -57.04 -60.97 2.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -48.77 -60.89 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 298' ' ' ALA . 27.0 mtmt -55.41 -62.94 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 67.0 mt -41.71 -49.05 4.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -67.59 -28.78 68.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -70.59 -40.4 73.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.078 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' VAL . . . . . 0.566 ' CG1' ' HB1' ' A' ' 313' ' ' ALA . 30.6 m -78.79 -46.64 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' PHE . . . . . 0.515 ' N ' HG23 ' A' ' 299' ' ' VAL . 12.1 m-85 -63.54 -56.69 13.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 89.7 m -48.17 -48.48 34.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.15 -45.27 70.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 299' ' ' VAL . 15.9 m-85 -97.82 76.62 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 305' ' ' HIS . 11.6 pt-20 -95.05 -41.35 9.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 304' ' ' GLU . 52.3 m80 -34.96 -58.15 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -152.45 154.78 36.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -69.93 -48.07 59.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.931 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.3 m -52.24 -22.52 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.5 t -69.22 103.67 2.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.815 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 62.49 37.66 13.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -50.02 -42.44 49.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -45.09 -36.54 3.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' ALA . . . . . 0.566 ' HB1' ' CG1' ' A' ' 299' ' ' VAL . . . -51.28 -37.89 49.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.047 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.4 t -77.44 -54.8 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.141 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.7 OUTLIER -51.54 -53.04 42.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 316' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 315' ' ' ASN . 15.9 mmmt -34.58 -51.66 0.48 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.507 HG22 ' CE1' ' A' ' 341' ' ' PHE . 82.5 mt -41.69 -58.85 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 317' ' ' ILE . 25.5 mtp180 -37.11 -43.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.2 mt -80.5 -44.26 19.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -56.57 -62.02 2.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.7 HG22 ' CD1' ' A' ' 291' ' ' ILE . 25.3 p -54.51 -57.51 11.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.43 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 17.0 tt0 -40.77 -34.92 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.89 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -87.84 -28.58 21.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' HIS . . . . . 0.481 ' N ' ' O ' ' A' ' 321' ' ' THR . 18.8 t-80 -75.0 -21.26 59.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.832 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.632 HD12 HG23 ' A' ' 337' ' ' ILE . 14.8 mt -93.2 -63.03 1.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 325' ' ' LEU . 8.4 tmtt? -35.98 -52.67 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -53.71 -44.85 70.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.869 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 325' ' ' LEU . 33.7 tttp -59.53 -44.08 93.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' PHE . . . . . 0.565 ' CE1' HG12 ' A' ' 284' ' ' ILE . 0.3 OUTLIER -115.97 89.19 23.81 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.676 0.751 . . . . 0.0 110.918 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -26.64 27.29 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.696 2.264 . . . . 0.0 112.308 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.89 -29.03 55.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' VAL . . . . . 0.744 HG21 HD11 ' A' ' 284' ' ' ILE . 39.8 t -70.72 153.28 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.15 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' ASP . . . . . 0.41 ' N ' ' CG1' ' A' ' 332' ' ' VAL . 7.9 t0 -88.45 154.25 20.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -57.61 -47.97 80.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.67 -23.83 4.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' GLU . . . . . 0.483 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 7.7 mt-10 -79.83 -29.05 40.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 337' ' ' ILE . . . . . 0.632 HG23 HD12 ' A' ' 325' ' ' LEU . 1.5 mp -89.23 -23.73 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 64.6 mt -74.15 -53.94 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.534 ' O ' HD12 ' A' ' 343' ' ' ILE . 19.6 mm-40 -64.06 -45.97 86.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 90.8 p -39.77 -50.73 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' PHE . . . . . 0.507 ' CE1' HG22 ' A' ' 317' ' ' ILE . 51.4 t80 -59.09 -56.56 20.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -38.24 -44.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.2 mp -69.45 -42.4 80.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 345' ' ' ALA . 53.7 t -58.94 -63.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.113 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.34 -55.59 0.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -47.92 -53.8 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -48.65 -61.37 2.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 348' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 349' ' ' PHE . 41.1 t -55.46 -62.03 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.201 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' PHE . . . . . 0.485 ' O ' HD12 ' A' ' 353' ' ' ILE . 6.6 m-85 -34.68 -63.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -39.29 -62.15 0.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 42.5 t -46.11 -45.26 16.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 77.9 mt -56.79 -47.75 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 349' ' ' PHE . 3.2 mp -61.95 -36.42 73.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.107 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.69 -31.49 71.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 357' ' ' TYR . 35.1 m-20 -70.37 85.23 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 356' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 355' ' ' ASN . 58.3 mt-10 -32.58 92.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' A' ' 355' ' ' ASN . 73.7 m-85 -38.22 151.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 357' ' ' TYR . 0.6 OUTLIER -34.97 -64.33 0.27 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -91.71 98.92 11.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 4.1 t -87.14 168.89 12.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -133.63 42.47 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 140.15 104.16 0.57 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.497 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -88.82 175.64 7.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.896 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -146.31 118.22 8.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 83.7 p 42.28 44.27 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 58.64 -156.82 21.83 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.482 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 145.28 56.35 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 2.24 . . . . 0.0 112.343 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.4 t -173.53 156.03 2.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 31.4 t -131.34 140.02 49.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.908 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.483 -179.979 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.466 -0.132 0 CA-C-O 120.776 0.24 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.688 ' O ' HG23 ' A' ' 285' ' ' VAL . 50.0 m -76.09 132.47 40.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -73.86 -45.53 50.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.089 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 329' ' ' PHE . 15.6 pt-20 -41.35 -46.29 3.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.538 HD11 HG21 ' A' ' 332' ' ' VAL . 7.0 mt -73.33 -59.8 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 281' ' ' SER . 85.0 t -34.97 -41.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.077 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -63.67 -48.89 75.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 284' ' ' ILE . 54.1 t80 -69.48 -19.25 63.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.933 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.768 ' HB ' HG21 ' A' ' 344' ' ' VAL . 9.5 m -72.89 -23.06 60.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.129 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 23.1 mttt -77.05 -43.35 34.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -55.7 -31.74 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.563 HG21 ' CD2' ' A' ' 324' ' ' HIS . 6.7 pt -98.04 -51.49 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.082 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 288' ' ' THR . . . -59.02 -46.87 87.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.086 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 16.9 ttm -55.05 -69.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 293' ' ' MET . 15.7 mt-10 -37.84 -63.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 298' ' ' ALA . 40.9 mttm -53.98 -65.57 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 45.7 mt -38.04 -42.1 0.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.585 ' CE2' HG13 ' A' ' 348' ' ' VAL . 10.8 m-85 -75.98 -36.03 59.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -69.44 -26.71 64.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.072 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 29.9 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.801 0.334 . . . . 0.0 111.118 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 59.1 t -69.33 -61.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.3 t30 -51.87 -47.9 64.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 315' ' ' ASN . 12.2 mmtp -35.98 -53.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.872 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 321' ' ' THR . 51.1 mt -46.49 -55.59 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -39.1 -32.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.2 mt -89.85 -36.39 15.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.975 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 317' ' ' ILE . 47.3 t0 -66.86 -63.41 1.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.449 HG23 HG23 ' A' ' 317' ' ' ILE . 24.2 p -48.65 -44.58 37.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.119 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -50.75 -33.08 21.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.27 -16.54 30.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.852 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . 0.563 ' CD2' HG21 ' A' ' 291' ' ' ILE . 84.3 t60 -91.85 -22.23 20.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.46 HD11 HG23 ' A' ' 288' ' ' THR . 41.9 mt -94.4 -61.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -45.9 -22.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -79.07 -41.64 28.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -69.02 -33.9 74.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 329' ' ' PHE . 2.0 m-85 -116.56 83.0 13.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.678 0.751 . . . . 0.0 110.874 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -22.75 31.56 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 0.0 112.331 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -84.39 -30.53 25.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.538 HG21 HD11 ' A' ' 284' ' ' ILE . 45.4 t -66.37 157.9 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.164 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . 0.471 ' N ' ' CG1' ' A' ' 332' ' ' VAL . 6.1 t70 -85.57 149.41 25.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . 0.403 ' C ' ' OE1' ' A' ' 334' ' ' GLN . 1.0 OUTLIER -59.08 -32.11 69.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.919 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -68.94 -14.29 62.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.47 ' CA ' ' OE1' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -89.49 -21.56 22.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.413 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.8 mp -85.31 -26.45 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.12 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 339' ' ' GLU . 2.7 mp -88.11 -69.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.101 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.602 ' O ' HD12 ' A' ' 343' ' ' ILE . 4.8 tp10 -42.83 -34.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.572 ' HB2' HG22 ' A' ' 285' ' ' VAL . 18.8 p -62.8 -50.72 69.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 344' ' ' VAL . 50.1 t80 -49.93 -54.38 20.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 341' ' ' PHE . 7.7 m-80 -36.57 -55.71 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.602 HD12 ' O ' ' A' ' 339' ' ' GLU . 5.0 mp -58.45 -38.08 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.14 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.768 HG21 ' HB ' ' A' ' 288' ' ' THR . 52.3 t -65.63 -52.15 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -46.8 -67.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -39.2 6.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -56.83 -49.69 74.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.585 HG13 ' CE2' ' A' ' 297' ' ' TYR . 48.2 t -61.44 -60.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 348' ' ' VAL . 11.4 m-85 -34.42 -59.96 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -44.32 -51.93 8.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 10.4 m -58.89 -33.28 70.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.58 HG12 ' CE1' ' A' ' 297' ' ' TYR . 69.8 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.169 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.804 0.252 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.1 t -68.64 130.7 43.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.94 -36.62 82.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -52.0 -38.43 56.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.711 HD11 HG21 ' A' ' 332' ' ' VAL . 20.0 mt -76.65 -53.97 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.143 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 281' ' ' SER . 82.0 t -39.71 -49.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -55.43 -44.49 76.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -73.51 -26.88 61.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.498 HG23 HD11 ' A' ' 325' ' ' LEU . 41.7 m -68.28 -15.95 63.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.177 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 293' ' ' MET . 18.1 mttm -82.99 -40.17 20.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -59.93 -27.14 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.095 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.693 HG21 ' CD2' ' A' ' 324' ' ' HIS . 17.1 pt -98.1 -46.96 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.482 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.14 -48.12 68.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.133 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 19.4 ttm -51.89 -60.32 3.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -45.78 -70.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 298' ' ' ALA . 8.4 mmmm -47.27 -62.01 1.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.419 HD22 ' CZ ' ' A' ' 349' ' ' PHE . 49.8 mt -41.67 -48.36 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.484 ' CE2' HG13 ' A' ' 348' ' ' VAL . 13.5 m-85 -75.22 -21.69 58.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -78.29 -26.76 47.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 28.4 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.946 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.849 0.356 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . 0.442 HG13 ' HZ ' ' A' ' 349' ' ' PHE . 55.7 t -46.83 -29.89 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.147 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -87.31 -41.33 13.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.449 ' N ' ' HD2' ' A' ' 316' ' ' LYS . 3.7 mptt -40.74 -53.87 2.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.418 ' O ' ' C ' ' A' ' 318' ' ' ARG . 52.7 mt -45.41 -57.52 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.123 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 317' ' ' ILE . 16.0 tpp85 -37.22 -44.59 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.8 mt -77.65 -43.75 30.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.76 -69.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.679 HG22 ' CD1' ' A' ' 291' ' ' ILE . 16.5 p -46.27 -51.37 14.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -48.08 -45.19 32.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -80.05 -14.04 58.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . 0.693 ' CD2' HG21 ' A' ' 291' ' ' ILE . 80.9 t60 -91.11 -22.57 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.498 HD11 HG23 ' A' ' 288' ' ' THR . 23.0 mt -94.18 -60.3 1.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 325' ' ' LEU . 1.0 OUTLIER -35.86 -44.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -60.26 -46.35 90.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.454 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 26.8 tptt -60.58 -39.56 88.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.585 ' CE2' HG12 ' A' ' 284' ' ' ILE . 2.8 m-85 -117.43 83.68 17.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.634 0.731 . . . . 0.0 110.851 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 -24.53 29.24 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.24 -30.66 30.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.711 HG21 HD11 ' A' ' 284' ' ' ILE . 85.3 t -70.2 144.12 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.194 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -73.86 150.56 40.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -61.33 -45.56 93.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.1 t80 -51.22 -17.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.891 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.99 -44.13 10.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.6 mp -63.76 -39.99 87.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.96 -58.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.636 ' OE2' HD11 ' A' ' 343' ' ' ILE . 7.5 tm-20 -49.02 -52.21 26.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.406 ' CB ' HG22 ' A' ' 285' ' ' VAL . 1.8 p -43.28 -41.63 4.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 344' ' ' VAL . 73.6 t80 -62.16 -56.45 18.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 341' ' ' PHE . 11.2 m-80 -35.72 -36.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.636 HD11 ' OE2' ' A' ' 339' ' ' GLU . 5.2 mp -79.47 -43.03 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.15 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 341' ' ' PHE . 50.8 t -59.94 -41.62 86.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -54.97 -69.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.074 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -53.03 -33.01 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.8 -31.99 73.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.484 HG13 ' CE2' ' A' ' 297' ' ' TYR . 34.7 t -92.12 -57.36 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.442 ' HZ ' HG13 ' A' ' 314' ' ' VAL . 38.1 m-85 -42.3 -55.84 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -51.19 -43.14 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 2.8 t -59.49 -18.93 44.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.816 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 48.2 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.114 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 N--CA 1.466 -0.147 0 CA-C-O 120.818 0.258 . . . . 0.0 112.323 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 2.1 m -71.52 120.52 17.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 283' ' ' GLU . . . -60.09 -56.72 18.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 282' ' ' ALA . 10.7 pt-20 -34.6 -45.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.646 HD11 HG21 ' A' ' 332' ' ' VAL . 27.3 mt -68.99 -57.73 7.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 87.3 t -38.13 -57.04 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -52.1 -40.84 61.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -73.83 -27.03 60.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.801 ' HB ' HG21 ' A' ' 344' ' ' VAL . 17.5 m -67.6 -19.08 65.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.174 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 293' ' ' MET . 28.4 mttt -79.57 -41.79 26.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -58.47 -29.85 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.773 HG21 ' HD2' ' A' ' 324' ' ' HIS . 7.6 pt -97.53 -49.55 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.452 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -62.06 -48.04 82.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.478 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 11.9 ttm -54.94 -52.27 63.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -51.79 -68.65 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 298' ' ' ALA . 69.8 mttt -50.35 -58.65 5.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.954 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.659 ' HG ' HD13 ' A' ' 317' ' ' ILE . 42.6 mt -42.6 -58.23 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.419 ' CE2' HG13 ' A' ' 348' ' ' VAL . 11.0 m-85 -61.56 -29.64 70.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.964 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 295' ' ' LYS . . . -67.33 -48.92 66.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.986 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.786 0.327 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 46.0 t -57.54 -28.37 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 317' ' ' ILE . 0.5 OUTLIER -80.79 -44.04 19.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.93 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.645 ' HA ' HD12 ' A' ' 319' ' ' LEU . 25.6 mttt -40.52 -24.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.659 HD13 ' HG ' ' A' ' 296' ' ' LEU . 94.8 mt -58.96 -67.16 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.148 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 319' ' ' LEU . 7.3 ptp180 -37.97 -32.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 316' ' ' LYS . 18.8 mt -76.58 -42.69 41.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 317' ' ' ILE . 15.7 t0 -74.41 -62.86 1.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.627 HG22 HG13 ' A' ' 291' ' ' ILE . 7.5 p -42.04 -54.73 3.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -45.02 -49.33 11.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -68.9 -21.34 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . 0.773 ' HD2' HG21 ' A' ' 291' ' ' ILE . 78.7 t60 -86.63 -23.06 25.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.828 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.55 ' HB2' HG23 ' A' ' 337' ' ' ILE . 42.8 mt -88.71 -58.02 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.935 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 325' ' ' LEU . 0.2 OUTLIER -37.14 -48.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -53.27 -54.53 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.453 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 26.2 tptt -53.4 -47.52 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.584 ' CE2' HG12 ' A' ' 284' ' ' ILE . 0.4 OUTLIER -113.05 86.72 9.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.651 0.739 . . . . 0.0 110.886 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -38.63 7.54 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 2.24 . . . . 0.0 112.359 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.78 -26.82 66.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 284' ' ' ILE . 96.0 t -73.06 141.99 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.087 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -79.57 147.49 32.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.851 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -51.41 -49.14 62.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.3 t80 -46.51 -21.28 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.434 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 7.5 mm-40 -88.71 -38.82 14.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.6 mp -70.81 -30.17 40.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 79.7 mt -77.13 -66.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.575 ' OE1' HD11 ' A' ' 343' ' ' ILE . 3.2 tm-20 -43.53 -49.19 7.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 7.4 p -43.16 -47.18 6.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.602 ' CE1' HG22 ' A' ' 317' ' ' ILE . 61.2 t80 -52.32 -56.08 17.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.828 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 341' ' ' PHE . 21.1 m-80 -35.07 -57.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.632 ' H ' HD12 ' A' ' 343' ' ' ILE . 5.2 mp -56.24 -51.57 61.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.801 HG21 ' HB ' ' A' ' 288' ' ' THR . 21.6 t -51.0 -66.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -38.92 -58.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -37.72 -52.14 1.25 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -56.87 -65.78 0.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 297' ' ' TYR . 46.9 t -42.66 -42.44 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.087 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' A' ' 350' ' ' ARG . 4.9 m-85 -57.83 -65.01 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 349' ' ' PHE . 13.0 tpp85 -37.39 -65.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 68.5 p -41.23 -59.51 1.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.402 HG12 ' CE1' ' A' ' 297' ' ' TYR . 48.8 mt . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.16 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.16 0 CA-C-O 120.786 0.244 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.418 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.2 t -68.26 121.37 16.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.844 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.63 82.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.099 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -50.9 -37.83 46.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.91 HD11 HG21 ' A' ' 332' ' ' VAL . 59.2 mt -76.52 -44.04 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 281' ' ' SER . 47.3 t -50.34 -60.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -40.19 -47.01 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -72.23 -39.85 68.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.778 HG23 HD11 ' A' ' 325' ' ' LEU . 4.1 m -54.73 -17.94 4.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.182 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 293' ' ' MET . 42.1 mttt -79.47 -46.43 17.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 290' ' ' ILE . 2.4 mp -58.4 -22.65 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.095 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.516 HD11 ' HA ' ' A' ' 288' ' ' THR . 7.3 pt -98.17 -51.92 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.481 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -66.88 -48.22 69.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 29.8 ttm -49.44 -71.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -41.45 -69.35 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 298' ' ' ALA . 0.0 OUTLIER -42.44 -63.88 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 39.7 mt -43.97 -43.02 6.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.576 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.9 m-85 -70.69 -30.76 67.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -70.2 -65.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 7.0 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.121 179.991 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.849 0.357 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . 0.421 HG11 ' HZ ' ' A' ' 349' ' ' PHE . 60.2 t -52.47 -44.18 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.9 t30 -70.26 -47.77 59.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 315' ' ' ASN . 10.8 mmtm -35.86 -51.98 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.441 ' O ' ' N ' ' A' ' 320' ' ' ASP . 42.0 mt -45.12 -54.07 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.112 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -39.22 -33.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.55 -34.19 15.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 317' ' ' ILE . 6.5 t0 -67.63 -68.15 0.41 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.51 HG22 HD12 ' A' ' 291' ' ' ILE . 17.1 p -42.91 -44.2 4.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -50.2 -46.57 54.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.13 -17.66 60.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.835 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -87.84 -28.3 21.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.778 HD11 HG23 ' A' ' 288' ' ' THR . 19.0 mt -90.62 -59.07 2.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 325' ' ' LEU . 7.3 tmtt? -38.22 -45.53 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.54 -39.62 94.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.887 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 325' ' ' LEU . 22.1 tptt -65.01 -44.9 87.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.59 ' CE2' HG12 ' A' ' 284' ' ' ILE . 0.5 OUTLIER -113.72 86.17 10.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.638 0.733 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -22.08 32.64 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.73 2.287 . . . . 0.0 112.346 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -84.06 -26.08 29.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.91 HG21 HD11 ' A' ' 284' ' ' ILE . 48.7 t -75.89 138.73 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.124 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -72.08 142.86 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.812 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -51.57 -47.92 63.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.597 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 1.5 t80 -47.45 -20.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.408 ' HB2' HG12 ' A' ' 332' ' ' VAL . 20.8 mt-10 -88.09 -45.57 10.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.4 mp -60.3 -26.21 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.134 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 340' ' ' SER . 76.7 mt -89.34 -64.95 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -41.88 -26.11 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.919 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 338' ' ' ILE . 2.4 p -65.77 -46.57 78.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.44 ' CE2' HG22 ' A' ' 317' ' ' ILE . 23.3 t80 -53.92 -52.74 59.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 341' ' ' PHE . 28.2 m-80 -34.53 -48.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.507 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.7 mp -73.46 -41.75 56.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.15 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.48 HG11 ' HB3' ' A' ' 292' ' ' ALA . 25.2 t -58.25 -59.97 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . 0.412 ' HB2' ' CE1' ' A' ' 341' ' ' PHE . . . -38.17 -64.9 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.104 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -46.34 -60.72 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.943 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -39.86 -34.99 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 344' ' ' VAL . 22.0 t -81.21 -53.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.158 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.0 m-85 -52.5 -64.48 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 349' ' ' PHE . 23.9 ptt85 -37.77 -28.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.866 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 349' ' ' PHE . 15.8 t -84.17 -41.74 16.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.576 HG12 ' CE1' ' A' ' 297' ' ' TYR . 83.6 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo . . . . . 0 C--O 1.231 0.146 0 CA-C-O 120.867 0.278 . . . . 0.0 112.31 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.837 ' O ' HG23 ' A' ' 285' ' ' VAL . 2.1 m -74.58 137.17 42.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.07 -48.44 62.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -42.66 -45.56 4.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.79 HD11 HG21 ' A' ' 332' ' ' VAL . 25.1 mt -74.45 -54.03 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.853 HG22 ' CB ' ' A' ' 340' ' ' SER . 95.4 t -45.16 -43.11 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -61.94 -36.14 80.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -80.3 -30.69 38.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.546 ' HA ' HD11 ' A' ' 291' ' ' ILE . 9.9 m -60.49 -19.92 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.508 ' HG3' HG22 ' A' ' 344' ' ' VAL . 42.0 mttt -80.54 -48.94 12.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.419 ' H ' HD12 ' A' ' 290' ' ' ILE . 3.0 mp -54.78 -22.74 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.546 HD11 ' HA ' ' A' ' 288' ' ' THR . 5.2 pt -98.71 -52.2 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.594 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -68.76 -49.19 60.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.498 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 20.0 ttm -43.1 -65.22 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -46.63 -63.07 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.856 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 298' ' ' ALA . 47.1 mmtt -46.39 -65.46 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.641 ' O ' HG22 ' A' ' 299' ' ' VAL . 31.5 mt -42.85 -53.85 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.813 ' CE2' HG13 ' A' ' 348' ' ' VAL . 11.2 m-85 -64.94 -23.53 67.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.96 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -76.05 -32.98 59.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.126 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 296' ' ' LEU . 28.2 m . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.611 ' HB1' ' CG1' ' A' ' 299' ' ' VAL . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.822 0.344 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.0 -61.08 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.129 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.98 -46.47 61.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -38.9 -58.24 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 320' ' ' ASP . 32.2 mt -41.17 -59.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 317' ' ' ILE . 56.1 ttt180 -34.87 -39.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.6 mt -81.82 -41.15 21.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 317' ' ' ILE . 3.7 t70 -60.14 -69.14 0.23 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.436 HG22 HG13 ' A' ' 291' ' ' ILE . 69.7 p -47.85 -42.21 25.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.5 ' C ' ' CD ' ' A' ' 322' ' ' GLU . 4.2 tm-20 -53.62 -40.66 65.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -87.37 -15.5 37.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -86.49 -27.15 24.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.795 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.531 HD11 HG23 ' A' ' 288' ' ' THR . 35.4 mt -88.21 -58.07 2.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 325' ' ' LEU . 1.4 tmmm? -35.92 -60.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -47.38 -50.24 22.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.471 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 22.3 tttp -55.78 -48.96 74.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.916 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.569 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 4.7 m-85 -110.89 82.42 3.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.64 0.733 . . . . 0.0 110.897 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -31.79 19.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.642 2.228 . . . . 0.0 112.318 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.56 -24.0 53.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.79 HG21 HD11 ' A' ' 284' ' ' ILE . 68.8 t -74.58 146.42 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -67.44 147.13 53.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . 0.548 ' O ' HD12 ' A' ' 338' ' ' ILE . 11.2 tt0 -61.88 -33.32 73.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.941 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -68.9 -14.98 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -84.13 -25.22 29.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.446 HG23 HD12 ' A' ' 325' ' ' LEU . 2.2 mp -83.64 -25.02 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 334' ' ' GLN . 2.0 mp -80.93 -49.75 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.165 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 340' ' ' SER . 19.0 mt-10 -57.33 -62.55 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.853 ' CB ' HG22 ' A' ' 285' ' ' VAL . 75.2 p -35.78 -43.99 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.841 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 344' ' ' VAL . 77.6 t80 -63.68 -55.94 19.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 341' ' ' PHE . 26.7 m-80 -38.19 -42.0 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.0 mp -67.72 -43.11 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' A' ' 292' ' ' ALA . 70.0 t -58.7 -60.56 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.114 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -41.0 -49.27 3.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -65.75 -34.59 78.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.05 -67.09 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.813 HG13 ' CE2' ' A' ' 297' ' ' TYR . 42.5 t -51.43 -37.25 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.439 ' HE1' HD22 ' A' ' 296' ' ' LEU . 3.2 m-30 -60.57 -66.55 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -40.25 -31.04 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 4.2 t -68.3 -46.57 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 349' ' ' PHE . 11.3 mt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.125 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo . . . . . 0 N--CA 1.466 -0.138 0 CA-C-O 120.798 0.249 . . . . 0.0 112.363 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.583 ' O ' HG23 ' A' ' 285' ' ' VAL . 13.2 m -73.82 122.7 22.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.74 81.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.099 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -41.61 -46.66 3.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.738 HD11 HG21 ' A' ' 332' ' ' VAL . 13.6 mt -72.68 -52.08 24.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.668 HG22 ' HB2' ' A' ' 340' ' ' SER . 89.8 t -46.15 -38.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.093 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -61.83 -47.57 84.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -73.87 -26.55 60.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.967 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 97.5 m -65.38 -17.67 64.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 31.7 mttt -80.17 -44.21 20.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.899 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.71 -24.03 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.131 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.677 HG21 ' CD2' ' A' ' 324' ' ' HIS . 10.7 pt -98.31 -49.81 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.485 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.7 -48.54 66.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.074 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 12.3 ttm -49.42 -61.4 2.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -46.87 -72.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 16.8 mtmm -43.78 -61.86 1.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 56.7 mt -44.09 -46.5 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -69.56 -28.22 65.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.73 -48.3 66.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.515 HG11 ' HB1' ' A' ' 313' ' ' ALA . 33.5 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.112 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.515 ' HB1' HG11 ' A' ' 299' ' ' VAL . . . . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.823 0.344 . . . . 0.0 111.134 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 26.2 t -70.38 -64.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.113 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -48.76 -24.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 15.3 mmtp -64.99 -37.64 88.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.11 -55.69 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.413 ' HG2' ' CE2' ' A' ' 341' ' ' PHE . 17.9 mmm-85 -39.36 -30.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.0 mt -90.42 -40.58 11.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.7 -60.87 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.605 HG22 HD12 ' A' ' 291' ' ' ILE . 3.2 p -52.24 -40.47 61.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.472 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 17.7 tt0 -53.41 -41.1 65.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -84.44 -15.26 46.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . 0.677 ' CD2' HG21 ' A' ' 291' ' ' ILE . 77.8 t60 -87.27 -22.18 25.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.441 HD12 HG23 ' A' ' 337' ' ' ILE . 32.5 mt -94.15 -59.66 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.463 ' HD3' HD13 ' A' ' 337' ' ' ILE . 1.3 mmmp? -34.12 -53.19 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -48.26 -51.39 25.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -56.7 -40.33 75.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.491 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 6.4 m-85 -118.7 84.27 24.43 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.611 0.719 . . . . 0.0 110.879 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -28.79 25.14 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.72 2.28 . . . . 0.0 112.362 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.24 -25.21 42.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.738 HG21 HD11 ' A' ' 284' ' ' ILE . 41.6 t -71.08 151.37 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -81.86 150.22 27.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . 0.477 ' O ' HD12 ' A' ' 338' ' ' ILE . 20.1 tt0 -58.45 -33.88 70.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.588 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.0 t80 -63.76 -17.34 62.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -87.37 -35.25 18.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.472 ' CG2' ' HA ' ' A' ' 322' ' ' GLU . 2.1 mp -71.61 -37.27 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.477 HD12 ' O ' ' A' ' 334' ' ' GLN . 2.8 mp -74.29 -71.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.111 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.621 ' O ' HD12 ' A' ' 343' ' ' ILE . 6.8 tp10 -38.19 -50.49 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.668 ' HB2' HG22 ' A' ' 285' ' ' VAL . 9.5 p -45.17 -43.67 10.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.858 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 344' ' ' VAL . 46.4 t80 -58.94 -55.35 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.903 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 341' ' ' PHE . 33.5 m-80 -36.23 -55.23 0.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.702 ' H ' HD12 ' A' ' 343' ' ' ILE . 5.4 mp -56.28 -41.3 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 341' ' ' PHE . 68.0 t -64.35 -59.18 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -40.83 -61.16 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -44.71 -51.5 9.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.949 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.72 -70.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 99.2 t -38.06 -62.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.158 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.592 ' HA ' HD12 ' A' ' 352' ' ' ILE . 10.5 m-85 -44.82 -66.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.852 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 349' ' ' PHE . 12.1 tpt180 -35.58 -56.25 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 1.3 t -49.46 -46.79 48.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 349' ' ' PHE . 64.8 mt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.163 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . 0.424 ' HD3' ' CD ' ' A' ' 339' ' ' GLU . 54.0 Cg_endo . . . . . 0 N--CA 1.465 -0.179 0 CA-C-O 120.757 0.232 . . . . 0.0 112.369 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.948 ' O ' HG23 ' A' ' 285' ' ' VAL . 5.1 t -73.3 142.23 47.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -76.09 -40.35 53.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.17 -39.34 63.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.555 HG12 ' CE1' ' A' ' 329' ' ' PHE . 18.3 mt -77.1 -49.35 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.948 HG23 ' O ' ' A' ' 281' ' ' SER . 48.2 t -51.26 -33.93 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.145 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -68.84 -40.64 79.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.414 ' HA ' HD13 ' A' ' 290' ' ' ILE . 54.7 t80 -73.79 -27.83 61.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 42.2 m -63.23 -19.66 64.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.134 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 293' ' ' MET . 2.7 mptm? -75.56 -44.54 42.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.472 ' H ' HD12 ' A' ' 290' ' ' ILE . 3.3 mp -55.74 -27.87 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.521 HG21 ' CD2' ' A' ' 324' ' ' HIS . 6.2 pt -98.25 -51.99 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.132 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.71 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -63.82 -48.45 76.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 25.2 ttm -56.33 -64.2 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -45.55 -56.97 4.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.881 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 298' ' ' ALA . 17.4 mmtp -58.5 -69.32 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.43 ' HB2' HG11 ' A' ' 348' ' ' VAL . 86.5 mt -37.04 -42.54 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.96 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -74.33 -38.71 63.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -59.22 -28.89 67.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.133 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 296' ' ' LEU . 30.9 m . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.816 0.341 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.17 -56.46 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -47.47 -39.78 16.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -54.15 -55.29 29.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 320' ' ' ASP . 87.6 mt -42.32 -60.8 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.432 ' HB3' ' NH1' ' A' ' 318' ' ' ARG . 8.8 mtp-105 -36.56 -34.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.826 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 11.6 mt -86.16 -39.5 16.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.4 t70 -63.94 -63.93 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.456 HG22 ' CG1' ' A' ' 291' ' ' ILE . 68.9 p -53.29 -40.85 65.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.444 ' C ' ' OE1' ' A' ' 322' ' ' GLU . 0.0 OUTLIER -54.01 -37.36 63.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -92.59 -13.07 30.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . 0.521 ' CD2' HG21 ' A' ' 291' ' ' ILE . 54.3 t60 -86.89 -28.06 23.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.5 HD12 HG23 ' A' ' 337' ' ' ILE . 17.3 mt -89.8 -54.37 4.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.439 ' N ' HG12 ' A' ' 337' ' ' ILE . 25.4 tttm -44.06 -39.97 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.7 -39.76 91.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.495 ' HB3' ' CE1' ' A' ' 329' ' ' PHE . 47.0 tttp -57.16 -42.64 81.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.701 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.2 OUTLIER -129.99 91.91 38.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.607 0.718 . . . . 0.0 110.895 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 329' ' ' PHE . 53.6 Cg_endo -69.77 -20.78 34.34 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.698 2.266 . . . . 0.0 112.358 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -78.69 -33.07 47.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 329' ' ' PHE . 1.5 p -65.79 150.27 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -70.53 156.04 39.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . 0.465 ' HG3' ' CD1' ' A' ' 338' ' ' ILE . 2.5 tp-100 -68.08 -41.86 81.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -58.69 -13.94 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -82.63 -31.33 28.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.5 HG23 HD12 ' A' ' 325' ' ' LEU . 1.9 mp -81.16 -28.87 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.465 ' CD1' ' HG3' ' A' ' 334' ' ' GLN . 2.6 mp -77.17 -53.58 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.625 ' O ' HD12 ' A' ' 343' ' ' ILE . 10.0 tt0 -60.95 -44.41 97.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.533 ' HB2' HG22 ' A' ' 285' ' ' VAL . 96.3 p -47.49 -49.44 25.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 344' ' ' VAL . 71.5 t80 -58.35 -56.83 17.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 341' ' ' PHE . 17.9 m-80 -35.09 -43.96 0.22 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.625 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.1 mp -66.96 -46.86 83.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.71 HG11 ' HB3' ' A' ' 292' ' ' ALA . 71.6 t -55.65 -66.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -37.41 -64.3 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -42.99 -43.24 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -67.63 -70.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 296' ' ' LEU . 88.8 t -40.89 -50.64 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.145 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -52.51 -61.34 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 -44.98 -43.33 9.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 3.3 t -51.29 -34.78 34.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 14.8 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.932 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.163 0 CA-C-O 120.813 0.255 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.542 ' HB2' HD12 ' A' ' 284' ' ' ILE . 21.2 m -73.08 119.99 18.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.837 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 284' ' ' ILE . . . -57.17 -55.44 34.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 282' ' ' ALA . 13.7 pt-20 -36.44 -33.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.62 HD11 HG21 ' A' ' 332' ' ' VAL . 47.1 mt -83.46 -54.35 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.672 HG12 ' NZ ' ' A' ' 289' ' ' LYS . 49.6 t -38.83 -53.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -57.1 -55.75 30.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -59.65 -20.9 59.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.483 HG23 HD11 ' A' ' 325' ' ' LEU . 49.2 m -75.15 -25.36 58.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.158 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.672 ' NZ ' HG12 ' A' ' 285' ' ' VAL . 14.4 mttp -77.13 -41.08 43.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.6 mp -56.65 -30.13 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.537 HG21 ' CD2' ' A' ' 324' ' ' HIS . 10.4 pt -97.76 -49.81 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.487 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -61.87 -48.02 82.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.473 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 13.9 ttm -51.9 -60.24 3.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -47.82 -53.32 15.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 298' ' ' ALA . 29.1 mtpt -60.42 -67.99 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.462 HD23 ' CD1' ' A' ' 317' ' ' ILE . 90.9 mt -38.6 -38.55 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.475 ' CE1' HG12 ' A' ' 352' ' ' ILE . 8.6 m-85 -77.99 -37.06 48.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -67.23 -34.58 77.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.116 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 29.4 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.829 0.347 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 55.0 t -66.89 -69.38 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.118 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . 0.417 ' ND2' HD11 ' A' ' 319' ' ' LEU . 0.5 OUTLIER -41.19 -42.92 2.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -40.86 -60.45 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.53 HG22 ' CE2' ' A' ' 341' ' ' PHE . 29.8 mt -41.4 -63.43 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.141 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.444 ' HB2' ' NH1' ' A' ' 318' ' ' ARG . 23.8 ttm105 -36.43 -39.1 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.856 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.417 HD11 ' ND2' ' A' ' 315' ' ' ASN . 5.2 mt -83.51 -39.63 20.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.95 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.2 t0 -62.51 -63.87 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.453 HG22 HG13 ' A' ' 291' ' ' ILE . 72.9 p -51.84 -52.77 46.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -47.05 -36.6 8.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -85.88 -18.93 31.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . 0.537 ' CD2' HG21 ' A' ' 291' ' ' ILE . 80.1 t60 -89.43 -19.7 24.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.521 ' HB2' HG23 ' A' ' 337' ' ' ILE . 47.9 mt -93.31 -60.06 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -44.16 -35.3 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.33 -38.36 87.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.43 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 26.2 tptt -72.42 -42.59 64.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.566 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 3.2 m-85 -110.46 85.03 4.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -35.41 12.65 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.335 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.84 -31.53 66.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.62 HG21 HD11 ' A' ' 284' ' ' ILE . 74.9 t -67.94 149.73 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -79.71 144.35 33.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . 0.47 ' O ' HD12 ' A' ' 338' ' ' ILE . 25.6 tt0 -53.46 -38.29 63.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.443 ' CD2' ' OE1' ' A' ' 336' ' ' GLU . 7.2 t80 -59.7 -21.16 60.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.443 ' OE1' ' CD2' ' A' ' 335' ' ' PHE . 0.0 OUTLIER -86.92 -18.52 30.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.886 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.4 mp -88.32 -27.41 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 334' ' ' GLN . 3.5 mp -89.75 -51.99 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.56 ' O ' HD12 ' A' ' 343' ' ' ILE . 7.7 tt0 -51.52 -31.47 24.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 2.1 p -66.37 -36.1 82.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.53 ' CE2' HG22 ' A' ' 317' ' ' ILE . 39.1 t80 -68.35 -31.05 70.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.847 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -56.42 -32.01 64.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.56 HD12 ' O ' ' A' ' 339' ' ' GLU . 5.0 mp -88.13 -37.92 11.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 81.0 t -64.23 -51.3 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . 0.5 ' HB2' ' CE1' ' A' ' 341' ' ' PHE . . . -51.12 -66.78 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.062 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . 0.403 ' C ' ' HD3' ' A' ' 346' ' ' LYS . 0.0 OUTLIER -50.39 -31.29 14.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -67.68 -66.94 0.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 98.2 t -45.71 -44.2 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 352' ' ' ILE . 4.1 m-85 -45.6 -60.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.414 ' C ' ' O ' ' A' ' 349' ' ' PHE . 3.4 tpm_? -37.3 -62.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 28.1 m -47.55 -33.29 6.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.475 HG12 ' CE1' ' A' ' 297' ' ' TYR . 93.6 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.153 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.232 0.203 0 CA-C-O 120.769 0.237 . . . . 0.0 112.386 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 285' ' ' VAL . 72.7 m -68.56 134.37 49.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.874 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -72.57 -40.74 66.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -55.26 -36.24 65.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.899 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.852 HD11 HG21 ' A' ' 332' ' ' VAL . 22.8 mt -78.33 -41.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 281' ' ' SER . 77.7 t -58.46 -46.42 89.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -60.65 -37.02 80.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -73.78 -34.22 64.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.507 ' CG2' HG21 ' A' ' 344' ' ' VAL . 92.0 m -56.38 -19.29 14.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.162 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.543 ' NZ ' HG22 ' A' ' 344' ' ' VAL . 7.2 mptt -77.13 -49.23 15.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 290' ' ' ILE . 2.9 mp -53.74 -24.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.162 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.491 HG13 ' N ' ' A' ' 292' ' ' ALA . 7.0 pt -98.83 -52.4 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.148 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.491 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.94 -49.29 62.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.061 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.517 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 19.1 ttm -45.42 -62.26 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -52.29 -72.56 0.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 298' ' ' ALA . 35.1 mtmt -42.14 -63.83 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.516 HD23 ' CD1' ' A' ' 317' ' ' ILE . 81.7 mt -42.3 -52.33 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.472 ' CE1' ' CG1' ' A' ' 352' ' ' ILE . 7.7 m-85 -62.2 -26.54 68.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.975 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -72.18 -51.1 22.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.092 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.854 ' HB ' ' HB1' ' A' ' 313' ' ' ALA . 18.8 m . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.854 ' HB1' ' HB ' ' A' ' 299' ' ' VAL . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.806 0.336 . . . . 0.0 111.114 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.3 t -79.84 -38.58 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.118 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.9 OUTLIER -59.75 -54.23 48.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.931 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 315' ' ' ASN . 22.7 mtmt -35.15 -62.74 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.93 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.516 ' CD1' HD23 ' A' ' 296' ' ' LEU . 31.8 mt -36.63 -58.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 317' ' ' ILE . 0.0 OUTLIER -35.19 -42.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.5 mt -80.68 -39.31 27.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 317' ' ' ILE . 19.8 t0 -60.96 -70.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.457 HG23 HG23 ' A' ' 317' ' ' ILE . 68.1 p -45.77 -45.84 14.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.158 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -51.29 -36.21 41.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.34 -20.99 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -85.6 -18.93 31.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 42.8 mt -93.18 -59.54 2.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -41.47 -36.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.7 -52.58 50.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.476 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 30.4 tttp -54.59 -41.82 70.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.586 ' CE2' HG12 ' A' ' 284' ' ' ILE . 1.3 m-85 -116.12 83.95 13.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.661 0.743 . . . . 0.0 110.823 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -30.24 22.54 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.348 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -77.92 -18.46 56.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.852 HG21 HD11 ' A' ' 284' ' ' ILE . 53.4 t -80.39 152.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -82.9 151.72 25.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -60.55 -41.04 93.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -53.85 -26.27 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.42 -30.45 33.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 337' ' ' ILE . 1.8 mp -84.62 -14.43 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.145 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 36.5 mt -87.33 -52.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' ' 343' ' ' ILE . 4.7 tt0 -59.83 -48.36 81.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.545 ' O ' HG23 ' A' ' 344' ' ' VAL . 40.3 m -39.76 -50.82 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.51 ' CE1' HG22 ' A' ' 317' ' ' ILE . 42.7 t80 -56.03 -57.92 10.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 341' ' ' PHE . 67.4 m-20 -37.47 -46.47 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.52 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.4 mp -68.41 -40.08 81.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 340' ' ' SER . 81.1 t -61.36 -64.18 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.08 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -42.71 -55.96 3.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -48.62 -30.16 5.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -83.73 -64.37 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 56.5 t -43.89 -27.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -74.02 -62.75 1.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 350' ' ' ARG . 21.0 ttm105 -41.5 -44.78 3.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 25.6 p -60.39 -50.83 72.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.472 ' CG1' ' CE1' ' A' ' 297' ' ' TYR . 50.1 mt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . 0.409 ' HD3' ' CD ' ' A' ' 339' ' ' GLU . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.838 0.266 . . . . 0.0 112.308 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.552 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.8 t -69.78 120.96 16.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.04 96.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -49.77 -41.15 43.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.808 HD11 HG21 ' A' ' 332' ' ' VAL . 22.1 mt -75.95 -42.32 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 281' ' ' SER . 75.3 t -54.5 -42.68 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 286' ' ' LYS . 0.4 OUTLIER -62.53 -36.43 82.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.478 ' CD2' ' HD3' ' A' ' 328' ' ' LYS . 31.5 t80 -76.87 -31.36 56.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.836 ' HB ' HG21 ' A' ' 344' ' ' VAL . 33.2 m -64.01 -23.73 67.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.606 ' HG3' HG13 ' A' ' 344' ' ' VAL . 30.7 mttt -76.19 -39.57 54.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.402 ' CD1' ' O ' ' A' ' 286' ' ' LYS . 2.6 mp -61.7 -28.49 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.838 HG21 ' CD2' ' A' ' 324' ' ' HIS . 23.6 pt -97.77 -43.4 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.122 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.454 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -69.25 -47.8 63.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.485 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 9.5 ttm -52.53 -71.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.889 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 293' ' ' MET . 18.3 mt-10 -36.94 -60.01 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -53.92 -66.21 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.648 ' CD2' HG13 ' A' ' 314' ' ' VAL . 75.8 mt -39.11 -49.79 1.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.671 ' CE2' HG13 ' A' ' 348' ' ' VAL . 11.8 m-85 -65.34 -40.27 93.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.93 -50.43 73.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 296' ' ' LEU . 27.9 m . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.803 0.335 . . . . 0.0 111.055 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . 0.648 HG13 ' CD2' ' A' ' 296' ' ' LEU . 66.1 t -68.76 -36.89 76.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.7 -12.33 60.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.472 ' HA ' HD12 ' A' ' 319' ' ' LEU . 22.3 mmtt -82.55 -17.58 44.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.553 HD12 ' CD2' ' A' ' 296' ' ' LEU . 72.9 mt -67.55 -56.7 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' A' ' 322' ' ' GLU . 7.3 ptm180 -41.2 -35.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 316' ' ' LYS . 4.8 mt -76.08 -37.78 57.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 27.3 t70 -73.97 -69.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.853 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.715 HG22 HD12 ' A' ' 291' ' ' ILE . 14.5 p -41.3 -47.6 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 318' ' ' ARG . 33.0 mt-10 -45.73 -49.99 14.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.85 -18.47 60.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . 0.838 ' CD2' HG21 ' A' ' 291' ' ' ILE . 79.3 t60 -84.88 -23.96 28.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.467 ' HB2' HG23 ' A' ' 337' ' ' ILE . 19.3 mt -93.77 -54.49 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.928 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.34 -26.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.95 -35.62 37.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.478 ' HD3' ' CD2' ' A' ' 287' ' ' TYR . 37.6 tttp -69.84 -39.34 76.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.587 ' CE1' HG23 ' A' ' 284' ' ' ILE . 2.8 m-85 -117.06 87.44 22.91 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.678 0.751 . . . . 0.0 110.875 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -40.71 5.01 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.685 2.257 . . . . 0.0 112.316 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.53 -24.46 65.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.808 HG21 HD11 ' A' ' 284' ' ' ILE . 41.5 t -73.47 154.14 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . 0.413 ' N ' ' CG1' ' A' ' 332' ' ' VAL . 5.7 t70 -83.35 147.28 28.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.38 -37.08 74.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.495 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 7.3 t80 -61.98 -13.32 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -90.61 -26.66 19.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.467 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.9 mp -82.54 -24.55 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.428 ' O ' ' ND2' ' A' ' 342' ' ' ASN . 3.2 mp -89.77 -35.5 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.409 ' CD ' ' HD3' ' A' ' 280' ' ' PRO . 11.5 tt0 -72.67 -22.51 60.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 341' ' ' PHE . 10.9 m -74.55 -65.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.484 ' CE1' HG22 ' A' ' 317' ' ' ILE . 73.8 t80 -36.6 -41.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 338' ' ' ILE . 4.0 m-80 -49.1 -51.95 28.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.497 ' H ' HD12 ' A' ' 343' ' ' ILE . 3.9 mp -68.84 -33.58 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.153 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.836 HG21 ' HB ' ' A' ' 288' ' ' THR . 32.8 t -62.57 -63.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -35.72 -66.67 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.123 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -40.66 -53.55 2.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -44.38 -39.25 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.671 HG13 ' CE2' ' A' ' 297' ' ' TYR . 39.9 t -76.49 -43.49 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.412 ' C ' ' N ' ' A' ' 351' ' ' SER . 3.3 m-85 -49.56 -70.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 31.1 ptt85 -43.09 -23.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.851 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 349' ' ' PHE . 3.2 t -78.89 -52.29 8.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.812 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 44.8 mt . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.136 179.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.142 0 CA-C-O 120.79 0.246 . . . . 0.0 112.349 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.87 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.0 OUTLIER -75.84 133.04 40.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.869 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -77.98 -42.23 33.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.136 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -51.49 -39.04 56.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.562 HG12 ' CZ ' ' A' ' 329' ' ' PHE . 12.1 mt -79.11 -44.09 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.119 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.891 HG22 ' HB2' ' A' ' 340' ' ' SER . 74.7 t -54.61 -37.69 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.085 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -64.24 -35.74 81.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -79.87 -24.46 41.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.486 ' HB ' HG21 ' A' ' 344' ' ' VAL . 8.9 m -66.49 -18.22 65.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.123 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 293' ' ' MET . 1.0 OUTLIER -77.27 -44.91 28.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.02 -29.18 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.156 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.583 HD12 HG22 ' A' ' 321' ' ' THR . 8.7 pt -98.31 -50.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.541 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -63.93 -48.28 77.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.493 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 10.6 ttm -58.88 -67.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -43.31 -58.8 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -55.3 -65.78 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.476 ' O ' HG22 ' A' ' 299' ' ' VAL . 49.4 mt -40.61 -58.49 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -54.98 -38.56 67.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.03 -49.49 72.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.147 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 296' ' ' LEU . 16.7 m . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.875 0.369 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 74.8 t -58.95 -34.96 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . 0.413 ' O ' HD22 ' A' ' 319' ' ' LEU . 10.7 t30 -83.14 -41.35 18.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.451 ' HA ' HD23 ' A' ' 319' ' ' LEU . 13.5 mmtp -43.03 -30.24 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 318' ' ' ARG . 49.2 mt -61.75 -60.21 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.486 ' HD2' HD13 ' A' ' 319' ' ' LEU . 3.3 tmt_? -34.28 -70.91 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.709 ' N ' HD13 ' A' ' 319' ' ' LEU . 0.0 OUTLIER -44.58 -43.13 7.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -66.02 -70.48 0.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.583 HG22 HD12 ' A' ' 291' ' ' ILE . 37.5 p -44.83 -55.49 5.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.153 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -45.6 -49.47 14.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -77.65 -12.41 59.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -90.74 -25.54 19.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.609 HD12 HG23 ' A' ' 337' ' ' ILE . 23.3 mt -94.37 -56.73 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -45.91 -24.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -81.82 -32.77 31.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 325' ' ' LEU . 26.5 tttp -69.23 -36.72 77.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.562 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 0.5 OUTLIER -122.38 90.94 49.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.688 0.756 . . . . 0.0 110.892 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -20.45 34.75 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.715 2.277 . . . . 0.0 112.337 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.31 -40.78 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.657 ' CG1' HD11 ' A' ' 337' ' ' ILE . 0.8 OUTLIER -62.98 161.57 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.114 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -93.39 160.06 14.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -67.07 -38.42 85.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -57.36 -15.42 6.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -90.51 -26.07 19.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.657 HD11 ' CG1' ' A' ' 332' ' ' VAL . 3.0 mp -86.69 -45.25 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.31 -52.15 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -62.3 -55.23 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.891 ' HB2' HG22 ' A' ' 285' ' ' VAL . 16.1 p -38.8 -39.27 0.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 344' ' ' VAL . 35.3 t80 -64.15 -53.39 50.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 341' ' ' PHE . 17.5 m-80 -36.5 -37.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 343' ' ' ILE . 5.3 mp -78.55 -41.22 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.541 HG11 ' HB3' ' A' ' 292' ' ' ALA . 50.4 t -57.72 -47.84 84.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -54.74 -63.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -54.2 -23.37 14.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -78.16 -31.24 49.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 344' ' ' VAL . 89.7 t -86.04 -32.72 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.085 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 351' ' ' SER . 5.5 m-85 -59.9 -67.04 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 349' ' ' PHE . 30.8 ptt180 -37.73 -28.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 349' ' ' PHE . 8.0 t -78.86 -45.19 21.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 349' ' ' PHE . 65.2 mt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.797 0.249 . . . . 0.0 112.323 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.2 t -72.96 120.53 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.72 -49.4 70.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.117 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -43.04 -43.05 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.535 HG12 ' CE1' ' A' ' 329' ' ' PHE . 30.4 mt -73.52 -48.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.146 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.49 HG22 ' HB2' ' A' ' 340' ' ' SER . 98.1 t -47.19 -36.11 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -68.5 -57.26 6.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.43 ' HA ' HD13 ' A' ' 290' ' ' ILE . 43.0 t80 -55.75 -24.83 37.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.486 ' CG2' HG21 ' A' ' 344' ' ' VAL . 32.1 m -68.97 -26.24 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.092 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -75.13 -43.59 51.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 287' ' ' TYR . 3.1 mp -54.75 -29.62 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.114 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.521 HG13 HG22 ' A' ' 321' ' ' THR . 8.5 pt -98.12 -51.22 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.607 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -58.4 -48.15 81.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 19.7 ttm -53.88 -60.18 3.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -45.4 -60.2 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 298' ' ' ALA . 29.4 mtpt -58.04 -67.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.832 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.612 HD12 HG21 ' A' ' 348' ' ' VAL . 86.2 mt -37.93 -33.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -84.63 -37.48 21.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -64.76 -31.95 73.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.053 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.144 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.826 0.345 . . . . 0.0 111.068 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.2 -68.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' A' ' 316' ' ' LYS . 3.8 t30 -43.17 -50.34 6.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 315' ' ' ASN . 11.3 mmmt -34.64 -58.3 0.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 318' ' ' ARG . 63.9 mt -38.22 -61.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 317' ' ' ILE . 3.6 tmt_? -35.19 -49.72 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 6.8 mt -69.92 -44.21 70.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -61.67 -68.86 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.888 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.521 HG22 HG13 ' A' ' 291' ' ' ILE . 14.2 p -45.5 -47.25 14.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -49.24 -50.59 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -71.18 -16.07 62.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . 0.472 ' CD2' HG21 ' A' ' 291' ' ' ILE . 82.0 t60 -90.15 -21.92 21.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.463 HD11 HG23 ' A' ' 288' ' ' THR . 45.0 mt -93.45 -54.9 3.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 25.7 tttm -49.61 -26.71 3.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 328' ' ' LYS . 10.8 pt-20 -78.01 -39.27 42.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.492 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 27.4 tptt -59.58 -48.62 80.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.616 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.2 OUTLIER -114.86 89.97 21.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -18.65 37.32 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.71 2.273 . . . . 0.0 112.399 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.91 -24.31 30.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 329' ' ' PHE . 0.8 OUTLIER -77.05 154.93 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -82.83 155.0 24.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . 0.472 ' HG2' ' CD1' ' A' ' 338' ' ' ILE . 35.7 tt0 -63.93 -49.58 72.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -47.41 -19.85 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -81.65 -39.32 24.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.572 HD11 ' CG1' ' A' ' 332' ' ' VAL . 1.8 mp -71.24 -22.24 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.472 ' CD1' ' HG2' ' A' ' 334' ' ' GLN . 2.5 mp -81.81 -55.25 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.158 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.624 ' O ' HD12 ' A' ' 343' ' ' ILE . 0.6 OUTLIER -60.38 -37.22 80.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.49 ' HB2' HG22 ' A' ' 285' ' ' VAL . 96.5 p -55.73 -54.89 38.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 342' ' ' ASN . 48.6 t80 -53.35 -52.45 59.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 341' ' ' PHE . 5.6 m-80 -36.01 -47.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.624 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.0 mp -64.2 -47.74 88.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.607 HG11 ' HB3' ' A' ' 292' ' ' ALA . 90.0 t -47.81 -56.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -44.5 -53.89 6.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.049 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -51.82 -38.52 56.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.69 -66.21 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.612 HG21 HD12 ' A' ' 296' ' ' LEU . 14.9 t -47.6 -55.89 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.105 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.449 ' O ' ' C ' ' A' ' 350' ' ' ARG . 6.1 m-85 -46.88 -60.31 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.449 ' C ' ' O ' ' A' ' 349' ' ' PHE . 17.7 tpp85 -34.53 -52.86 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 70.9 m -61.32 -57.51 12.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 89.1 mt . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.148 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.755 0.231 . . . . 0.0 112.377 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.843 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.9 t -78.1 120.86 23.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.82 -48.01 83.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.099 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -45.95 -41.34 11.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.754 HD11 HG21 ' A' ' 332' ' ' VAL . 24.5 mt -77.08 -43.95 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 281' ' ' SER . 43.5 t -53.9 -40.48 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -63.82 -42.81 97.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -72.66 -32.85 66.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.616 HG23 HD11 ' A' ' 325' ' ' LEU . 28.2 m -59.48 -22.54 61.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 293' ' ' MET . 51.2 mttt -76.31 -46.55 27.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -54.8 -27.55 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 292' ' ' ALA . 7.0 pt -98.48 -52.19 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.488 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -63.83 -48.78 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.089 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.498 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 30.9 ttm -51.97 -64.78 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -40.18 -56.38 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 298' ' ' ALA . 16.6 mmmt -59.15 -66.09 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.768 HD12 HG21 ' A' ' 348' ' ' VAL . 91.6 mt -38.68 -42.09 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.572 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.9 m-85 -73.54 -35.65 65.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -68.98 -54.02 17.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.13 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.966 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.821 0.343 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 60.1 t -82.54 -54.98 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.6 OUTLIER -48.87 -48.98 41.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 317' ' ' ILE . 16.9 mtmm -38.2 -58.1 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 320' ' ' ASP . 68.3 mt -33.95 -57.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.089 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 317' ' ' ILE . 50.8 ttt180 -34.53 -59.07 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.6 mt -58.9 -39.57 81.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.5 t70 -66.05 -69.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.468 HG22 HG13 ' A' ' 291' ' ' ILE . 27.1 p -47.12 -47.3 23.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.181 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.36 -39.11 60.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -84.61 -12.93 53.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . 0.421 ' CD2' HG21 ' A' ' 291' ' ' ILE . 70.4 t60 -92.97 -26.3 17.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.616 HD11 HG23 ' A' ' 288' ' ' THR . 18.8 mt -92.63 -59.37 2.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -39.57 -34.15 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.26 -39.1 55.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.541 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 32.5 tptt -54.18 -49.94 68.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.643 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.1 OUTLIER -117.14 91.14 35.73 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 110.901 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.66 -18.62 37.35 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.706 2.271 . . . . 0.0 112.34 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.3 -0.16 57.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.754 HG21 HD11 ' A' ' 284' ' ' ILE . 0.8 OUTLIER -98.02 148.96 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -72.53 154.47 40.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -67.19 -45.43 76.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -54.19 -15.31 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -81.85 -31.62 31.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.58 HD11 HG11 ' A' ' 332' ' ' VAL . 1.7 mp -85.54 -32.33 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.143 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 46.5 mt -69.75 -41.06 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.449 ' O ' HD12 ' A' ' 343' ' ' ILE . 6.0 tt0 -74.52 -56.56 4.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 344' ' ' VAL . 57.2 p -34.71 -45.48 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 344' ' ' VAL . 56.9 t80 -59.9 -60.39 3.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 341' ' ' PHE . 14.5 m-80 -37.03 -47.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.591 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.8 mp -66.5 -41.86 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 340' ' ' SER . 61.5 t -60.79 -50.86 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -44.16 -67.32 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . 0.529 ' HE2' HG23 ' A' ' 343' ' ' ILE . 32.9 pttt -48.53 -44.77 36.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 346' ' ' LYS . 16.1 mt-10 -55.61 -50.42 70.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.768 HG21 HD12 ' A' ' 296' ' ' LEU . 57.7 t -59.93 -48.06 89.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.126 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.5 m-85 -54.93 -55.11 34.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -44.49 -33.47 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 6.3 m -82.87 -30.63 28.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.841 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.572 HG12 ' CE1' ' A' ' 297' ' ' TYR . 86.0 mt . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.131 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.781 0.242 . . . . 0.0 112.366 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.69 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.3 t -69.98 121.92 18.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.829 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.93 -48.12 77.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -46.08 -42.19 13.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.715 HD11 HG21 ' A' ' 332' ' ' VAL . 22.7 mt -73.77 -40.18 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 281' ' ' SER . 90.7 t -57.12 -46.36 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.409 ' O ' HD12 ' A' ' 290' ' ' ILE . 35.0 mttm -60.87 -40.89 94.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.418 ' HA ' HD13 ' A' ' 290' ' ' ILE . 49.5 t80 -74.89 -30.86 61.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.406 HG23 HD11 ' A' ' 325' ' ' LEU . 42.9 m -62.91 -22.34 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 293' ' ' MET . 30.3 mttt -77.76 -43.57 30.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 287' ' ' TYR . 3.0 mp -55.72 -28.56 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.591 HG13 HG22 ' A' ' 321' ' ' THR . 5.8 pt -98.13 -51.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.455 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -62.76 -48.21 80.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.493 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 32.4 ttm -55.51 -70.25 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -40.27 -54.61 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.495 ' HB3' HD11 ' A' ' 317' ' ' ILE . 26.8 mttp -58.75 -69.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.427 HD12 HG21 ' A' ' 348' ' ' VAL . 86.4 mt -37.92 -43.39 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.584 ' CE1' HG12 ' A' ' 352' ' ' ILE . 10.4 m-85 -71.61 -38.95 70.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -62.12 -46.68 87.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.101 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 26.4 m . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.126 179.996 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.799 0.333 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.45 -53.96 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.22 -36.83 61.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.453 ' HA ' HD12 ' A' ' 319' ' ' LEU . 13.3 mmtp -57.2 -32.08 66.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.552 HG22 ' CE1' ' A' ' 341' ' ' PHE . 8.7 mm -48.12 -71.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 317' ' ' ILE . 31.2 ttt180 -33.95 -45.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 316' ' ' LYS . 13.6 mt -69.56 -44.3 71.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 317' ' ' ILE . 32.1 t0 -67.06 -66.19 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.591 HG22 HG13 ' A' ' 291' ' ' ILE . 16.9 p -47.21 -51.74 17.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -49.4 -43.92 44.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -82.31 -11.99 58.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -89.39 -27.9 20.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.568 ' HB2' HG23 ' A' ' 337' ' ' ILE . 20.0 mt -90.19 -52.62 4.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 325' ' ' LEU . 0.4 OUTLIER -36.81 -44.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -64.44 -46.65 82.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 21.1 tptt -55.33 -42.49 73.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.577 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 0.2 OUTLIER -120.62 89.87 45.24 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.686 0.755 . . . . 0.0 110.873 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.94 2.4 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.242 . . . . 0.0 112.362 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -61.98 -25.65 67.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.715 HG21 HD11 ' A' ' 284' ' ' ILE . 97.2 t -73.75 148.81 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -84.65 147.84 26.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -53.57 -45.14 69.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.6 t80 -51.98 -18.79 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.401 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 47.5 mt-10 -88.92 -41.15 12.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.568 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.5 mp -69.31 -31.72 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.183 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 39.6 mt -76.22 -66.64 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.118 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.619 ' O ' HD12 ' A' ' 343' ' ' ILE . 8.5 tp10 -42.1 -53.86 3.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.54 ' CB ' HG22 ' A' ' 285' ' ' VAL . 2.2 p -40.5 -41.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.837 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 317' ' ' ILE . 75.7 t80 -62.43 -53.03 60.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.851 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -42.53 -43.33 3.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.642 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.7 mp -65.94 -34.14 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 341' ' ' PHE . 73.9 t -70.66 -58.74 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.129 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -37.18 -61.74 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.074 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -45.5 -51.25 11.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -55.81 -59.67 4.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 352' ' ' ILE . 88.5 t -48.98 -62.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.114 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.1 m-85 -44.5 -69.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 349' ' ' PHE . 20.9 ttp180 -34.3 -54.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 41.9 m -56.5 -42.67 78.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.584 HG12 ' CE1' ' A' ' 297' ' ' TYR . 61.8 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 120.827 0.261 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.635 ' HB2' HD12 ' A' ' 284' ' ' ILE . 66.5 m -68.91 127.5 33.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.85 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 284' ' ' ILE . . . -70.98 -52.18 21.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -39.86 -27.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.881 HG23 ' CE1' ' A' ' 329' ' ' PHE . 22.0 mt -92.27 -43.25 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 281' ' ' SER . 77.6 t -53.65 -35.93 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -66.01 -34.69 78.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.906 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.407 ' HA ' HD13 ' A' ' 290' ' ' ILE . 50.3 t80 -76.95 -27.21 54.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.654 HG23 HD11 ' A' ' 325' ' ' LEU . 2.7 m -65.64 -20.68 66.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 293' ' ' MET . 0.7 OUTLIER -76.5 -45.71 29.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.451 ' H ' HD12 ' A' ' 290' ' ' ILE . 3.2 mp -52.58 -32.1 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.504 HG21 ' CD2' ' A' ' 324' ' ' HIS . 6.9 pt -98.49 -52.08 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.68 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -60.78 -48.56 81.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.07 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 33.8 ttm -55.36 -69.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 293' ' ' MET . 16.2 mt-10 -37.91 -67.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.867 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 298' ' ' ALA . 45.5 mmtt -50.37 -63.44 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 72.6 mt -42.96 -30.38 0.41 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.589 ' CE2' HG13 ' A' ' 348' ' ' VAL . 10.1 m-85 -88.84 -31.25 18.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -69.79 -48.99 57.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.076 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 19.5 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.165 179.944 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.825 0.345 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 23.8 t -54.98 -41.9 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.6 -44.67 85.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -44.24 -57.09 3.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.643 HG22 ' CE1' ' A' ' 341' ' ' PHE . 58.8 mt -41.49 -55.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -39.75 -35.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.0 mt -88.62 -32.29 18.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 24.8 t70 -67.48 -65.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.501 HG22 ' CD1' ' A' ' 291' ' ' ILE . 71.8 p -51.77 -44.46 63.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -44.69 -54.4 6.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -76.81 -13.1 60.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.836 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . 0.504 ' CD2' HG21 ' A' ' 291' ' ' ILE . 47.8 t60 -85.96 -26.19 25.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.654 HD11 HG23 ' A' ' 288' ' ' THR . 26.6 mt -91.62 -62.22 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -39.83 -43.78 1.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -62.86 -38.15 89.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 325' ' ' LEU . 44.2 tttp -60.33 -45.74 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.881 ' CE1' HG23 ' A' ' 284' ' ' ILE . 0.9 OUTLIER -117.97 94.71 46.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.688 0.756 . . . . 0.0 110.863 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -20.63 34.47 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.652 2.235 . . . . 0.0 112.327 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.02 -40.22 28.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.597 HG11 HD11 ' A' ' 337' ' ' ILE . 0.9 OUTLIER -63.93 156.16 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -90.98 156.49 17.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -62.94 -42.9 99.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.6 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 4.3 t80 -54.03 -15.96 1.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -88.18 -27.58 21.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.641 HG23 HD12 ' A' ' 325' ' ' LEU . 2.6 mp -85.67 -56.83 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . 0.41 ' O ' ' ND2' ' A' ' 342' ' ' ASN . 72.8 mt -48.56 -33.12 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.123 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.421 ' O ' HD12 ' A' ' 343' ' ' ILE . 17.0 tt0 -79.22 -42.4 26.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.407 ' HB3' HG22 ' A' ' 285' ' ' VAL . 73.8 m -52.23 -53.07 48.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.643 ' CE1' HG22 ' A' ' 317' ' ' ILE . 56.0 t80 -46.61 -53.03 12.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 338' ' ' ILE . 37.6 m-80 -42.55 -52.49 4.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 343' ' ' ILE . 3.7 mp -56.3 -40.04 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.161 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.68 HG11 ' HB3' ' A' ' 292' ' ' ALA . 91.3 t -63.89 -62.11 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.131 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.1 -66.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -46.44 -58.13 4.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -42.69 -62.34 1.02 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.589 HG13 ' CE2' ' A' ' 297' ' ' TYR . 37.0 t -50.33 -66.13 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.144 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 351' ' ' SER . 8.0 m-85 -39.01 -69.49 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 349' ' ' PHE . 35.8 ttm180 -36.33 -32.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 349' ' ' PHE . 1.6 t -76.89 -56.37 4.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.575 HG12 ' CE1' ' A' ' 297' ' ' TYR . 80.2 mt . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.102 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 N--CA 1.466 -0.125 0 CA-C-O 120.815 0.256 . . . . 0.0 112.339 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.685 ' O ' HG23 ' A' ' 285' ' ' VAL . 14.1 m -77.6 124.67 28.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.5 76.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.12 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -46.78 -29.67 2.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.756 ' CD1' HG21 ' A' ' 332' ' ' VAL . 17.4 mt -89.18 -52.4 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.112 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 281' ' ' SER . 40.2 t -44.22 -35.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -66.0 -35.56 80.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.461 ' CD2' ' HD3' ' A' ' 328' ' ' LYS . 28.4 t80 -81.5 -18.77 43.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.412 HG23 HD11 ' A' ' 325' ' ' LEU . 28.3 m -70.38 -26.09 63.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.563 ' HD2' HG22 ' A' ' 344' ' ' VAL . 0.0 OUTLIER -75.79 -43.35 46.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.889 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.6 mp -54.58 -31.25 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.767 HG21 ' CD2' ' A' ' 324' ' ' HIS . 6.3 pt -98.09 -51.83 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.466 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -60.45 -48.1 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.1 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 11.9 ttm -55.9 -62.26 1.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -39.75 -72.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 298' ' ' ALA . 13.7 mptt -50.23 -63.61 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.456 ' CD2' HG13 ' A' ' 314' ' ' VAL . 45.1 mt -37.66 -43.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -78.67 -33.36 47.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -65.67 -36.56 84.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.095 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 -179.955 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.809 0.338 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . 0.456 HG13 ' CD2' ' A' ' 296' ' ' LEU . 58.4 t -55.61 -42.29 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.5 OUTLIER -59.95 -55.54 32.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 315' ' ' ASN . 9.6 mmmt -35.53 -43.71 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.44 HD12 HD23 ' A' ' 296' ' ' LEU . 50.5 mt -47.49 -52.43 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.436 ' HG2' ' CE2' ' A' ' 341' ' ' PHE . 14.6 mmm-85 -40.01 -39.22 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.0 mt -82.98 -44.83 14.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.73 -69.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.85 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.527 HG22 HG13 ' A' ' 291' ' ' ILE . 37.6 p -46.04 -47.95 16.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.482 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 60.5 tt0 -45.22 -52.3 9.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.92 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -78.66 -14.54 59.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . 0.767 ' CD2' HG21 ' A' ' 291' ' ' ILE . 44.5 t60 -82.1 -29.71 31.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.867 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.607 HD12 HG23 ' A' ' 337' ' ' ILE . 15.9 mt -92.39 -59.78 2.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.4 ' NZ ' ' HB2' ' A' ' 334' ' ' GLN . 39.8 tttp -43.14 -29.67 0.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.88 -35.36 50.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.504 ' HE3' ' CZ ' ' A' ' 329' ' ' PHE . 37.9 tttp -58.51 -55.66 32.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.982 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.1 OUTLIER -117.89 107.64 43.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.663 0.744 . . . . 0.0 110.866 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 329' ' ' PHE . 53.6 Cg_endo -69.77 -21.9 32.77 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.679 2.253 . . . . 0.0 112.344 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.57 -35.72 70.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.982 HG12 ' O ' ' A' ' 329' ' ' PHE . 7.1 p -63.8 146.0 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . 0.627 ' O ' HD12 ' A' ' 337' ' ' ILE . 1.4 t70 -87.17 157.9 19.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . 0.4 ' HB2' ' NZ ' ' A' ' 326' ' ' LYS . 9.7 tt0 -65.16 -35.92 82.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.465 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 9.5 t80 -63.55 -9.77 14.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -93.38 -41.35 9.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 333' ' ' ASP . 4.9 mp -69.64 -45.57 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.11 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.81 -41.05 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.662 ' O ' HD12 ' A' ' 343' ' ' ILE . 16.6 tt0 -73.61 -42.77 61.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 341' ' ' PHE . 37.1 m -51.11 -62.35 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 344' ' ' VAL . 68.6 t80 -37.78 -59.39 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 341' ' ' PHE . 2.4 m-80 -36.63 -54.56 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.7 mp -57.75 -36.6 55.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.563 HG22 ' HD2' ' A' ' 289' ' ' LYS . 97.1 t -72.14 -59.12 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -36.26 -66.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -49.62 -36.51 24.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 344' ' ' VAL . 1.5 tp10 -57.33 -40.09 77.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.09 -40.09 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.145 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 350' ' ' ARG . 6.1 m-85 -51.94 -70.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 349' ' ' PHE . 10.1 ptt85 -35.33 -42.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 23.4 m -64.11 -49.0 73.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.428 ' N ' ' O ' ' A' ' 349' ' ' PHE . 97.3 mt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.111 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.817 0.257 . . . . 0.0 112.341 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 285' ' ' VAL . 2.3 t -69.99 125.71 27.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.38 -30.92 70.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.66 -40.08 74.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.682 HD11 HG21 ' A' ' 332' ' ' VAL . 17.4 mt -76.79 -45.85 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 281' ' ' SER . 91.5 t -48.94 -39.19 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -65.06 -44.29 89.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.495 ' CE1' ' NZ ' ' A' ' 328' ' ' LYS . 49.4 t80 -72.17 -26.36 62.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 110.978 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 49.4 m -69.37 -20.94 63.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.163 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 27.9 mttt -78.84 -43.55 24.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.25 -31.09 31.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.65 HG13 HG22 ' A' ' 321' ' ' THR . 6.1 pt -97.77 -51.33 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.538 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -59.82 -46.96 87.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.111 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 33.3 ttm -55.93 -68.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.865 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 293' ' ' MET . 49.2 mt-10 -35.92 -59.91 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 298' ' ' ALA . 31.3 mmtt -60.06 -64.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.474 HD13 ' HB ' ' A' ' 348' ' ' VAL . 48.4 mt -36.03 -37.88 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.894 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.503 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.8 m-85 -78.48 -44.25 24.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -59.36 -40.16 85.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.063 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.442 ' HB ' ' HB1' ' A' ' 313' ' ' ALA . 28.1 m . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.442 ' HB1' ' HB ' ' A' ' 299' ' ' VAL . . . . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.806 0.336 . . . . 0.0 111.135 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 54.5 t -72.56 -62.87 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . 0.502 ' ND2' HD11 ' A' ' 319' ' ' LEU . 4.1 t30 -50.47 -41.67 53.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -41.61 -64.77 0.52 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.567 HG22 ' CE2' ' A' ' 341' ' ' PHE . 41.5 mt -42.29 -61.88 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.123 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.464 ' HD2' ' CD1' ' A' ' 341' ' ' PHE . 15.8 mmm180 -36.82 -33.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . 0.502 HD11 ' ND2' ' A' ' 315' ' ' ASN . 10.0 mt -88.11 -41.49 13.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 317' ' ' ILE . 41.2 m-20 -61.28 -61.8 2.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.65 HG22 HG13 ' A' ' 291' ' ' ILE . 36.2 p -54.16 -46.47 72.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -49.33 -40.13 34.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -85.46 -19.75 30.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . 0.544 ' CD2' HG21 ' A' ' 291' ' ' ILE . 74.7 t60 -82.46 -25.79 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.674 ' HB2' HG23 ' A' ' 337' ' ' ILE . 32.5 mt -89.76 -56.47 3.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.93 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.416 ' N ' HG12 ' A' ' 337' ' ' ILE . 2.2 tmmm? -38.2 -45.74 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.63 -37.8 85.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.608 ' HG2' ' CE2' ' A' ' 329' ' ' PHE . 9.9 tptm -57.95 -49.2 77.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.608 ' CE2' ' HG2' ' A' ' 328' ' ' LYS . 9.5 m-85 -124.26 94.66 44.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.629 0.728 . . . . 0.0 110.848 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 329' ' ' PHE . 53.7 Cg_endo -69.75 -41.99 3.8 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.668 2.245 . . . . 0.0 112.341 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -63.71 -25.71 68.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.682 HG21 HD11 ' A' ' 284' ' ' ILE . 53.0 t -69.17 148.77 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -72.53 150.51 43.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -62.48 -40.05 95.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.93 -11.09 16.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.409 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 6.6 mm-40 -87.26 -34.26 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.674 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.5 mp -75.04 -35.63 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.88 -64.62 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.458 ' O ' HD12 ' A' ' 343' ' ' ILE . 1.8 tp10 -44.9 -53.9 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 46.9 m -41.03 -34.96 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.567 ' CE2' HG22 ' A' ' 317' ' ' ILE . 48.0 t80 -70.01 -53.05 19.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -40.77 -40.19 1.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.458 HD12 ' O ' ' A' ' 339' ' ' GLU . 5.1 mp -73.67 -42.87 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.538 HG11 ' HB3' ' A' ' 292' ' ' ALA . 20.1 t -60.91 -62.64 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.116 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -40.28 -67.03 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -39.22 -51.74 1.96 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -56.08 -68.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 296' ' ' LEU . 38.3 t -44.44 -30.95 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -73.98 -64.38 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.02 -19.53 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 6.3 p -87.07 -32.02 20.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.503 HG12 ' CE1' ' A' ' 297' ' ' TYR . 54.3 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.146 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.806 0.252 . . . . 0.0 112.35 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 9.9 m -68.61 125.89 27.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.77 87.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -38.78 -35.29 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.755 ' CD1' HG21 ' A' ' 332' ' ' VAL . 22.0 mt -86.72 -56.99 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.113 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 91.9 t -40.84 -36.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -64.65 -41.98 95.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 284' ' ' ILE . 55.1 t80 -74.26 -31.44 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.62 HG23 HD11 ' A' ' 325' ' ' LEU . 22.8 m -60.34 -20.98 61.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 293' ' ' MET . 21.4 mttt -77.98 -43.79 28.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.4 mp -58.88 -27.2 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.484 HG13 HG22 ' A' ' 321' ' ' THR . 5.5 pt -98.1 -51.13 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.476 ' N ' ' CG1' ' A' ' 291' ' ' ILE . . . -61.92 -46.28 90.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.094 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.519 ' HE2' ' HB2' ' A' ' 293' ' ' MET . 8.0 ttm -52.19 -63.46 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 293' ' ' MET . 14.9 mt-10 -37.53 -73.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 296' ' ' LEU . 1.1 mptm? -46.59 -64.14 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.606 HD12 HG21 ' A' ' 348' ' ' VAL . 51.1 mt -36.04 -55.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.587 ' CE1' HG12 ' A' ' 352' ' ' ILE . 11.5 m-85 -60.82 -41.95 96.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.935 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -58.83 -52.75 64.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.083 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 296' ' ' LEU . 27.7 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.821 0.343 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 96.0 t -61.15 -66.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.9 t30 -43.25 -49.65 6.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.919 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 315' ' ' ASN . 20.5 mmtt -37.8 -55.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 320' ' ' ASP . 54.2 mt -43.08 -62.81 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 317' ' ' ILE . 4.4 tmt_? -34.41 -38.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 8.4 mt -79.82 -43.09 23.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 317' ' ' ILE . 1.5 t70 -61.32 -65.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.484 HG22 HG13 ' A' ' 291' ' ' ILE . 71.7 p -50.79 -46.46 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.424 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 0.3 OUTLIER -48.08 -35.64 11.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -93.18 -20.22 20.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -81.29 -21.6 39.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.62 HD11 HG23 ' A' ' 288' ' ' THR . 22.8 mt -94.22 -65.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -39.93 -29.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 328' ' ' LYS . 4.9 pt-20 -75.08 -43.01 55.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.538 ' HE3' ' CZ ' ' A' ' 329' ' ' PHE . 45.3 tttp -53.54 -45.52 69.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.986 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.1 OUTLIER -123.1 107.94 32.59 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.642 0.734 . . . . 0.0 110.926 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -22.5 32.13 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.657 2.238 . . . . 0.0 112.352 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -72.3 -39.45 68.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.986 HG12 ' O ' ' A' ' 329' ' ' PHE . 7.3 p -57.03 147.98 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . 0.688 ' O ' HD12 ' A' ' 337' ' ' ILE . 1.5 t70 -96.56 154.33 17.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -61.81 -21.67 64.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.593 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.5 t80 -76.44 -9.67 58.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -96.31 -46.87 6.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 333' ' ' ASP . 5.4 mp -62.15 -37.69 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 48.4 mt -71.18 -59.35 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -62.32 -12.29 20.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 341' ' ' PHE . 3.5 m -80.19 -68.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.821 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 340' ' ' SER . 40.0 t80 -34.82 -44.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -42.61 -49.99 5.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.1 mp -63.42 -47.51 91.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.131 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 345' ' ' ALA . 53.9 t -48.89 -67.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.18 -66.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.133 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -38.45 -44.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 348' ' ' VAL . 15.6 tt0 -62.37 -68.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.606 HG21 HD12 ' A' ' 296' ' ' LEU . 96.1 t -35.18 -68.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 352' ' ' ILE . 9.5 m-85 -34.72 -68.86 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 349' ' ' PHE . 17.2 ttt180 -34.24 -50.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 3.5 m -67.07 -40.38 87.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.875 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.587 HG12 ' CE1' ' A' ' 297' ' ' TYR . 70.7 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.165 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . 0.425 ' HA ' ' OE1' ' A' ' 336' ' ' GLU . 53.9 Cg_endo . . . . . 0 C--O 1.231 0.165 0 CA-C-O 120.807 0.253 . . . . 0.0 112.322 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.4 p -72.95 122.88 22.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.537 ' HB1' ' HE2' ' A' ' 286' ' ' LYS . . . -62.04 -49.14 77.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.077 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -44.53 -42.79 7.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.737 HD12 HG21 ' A' ' 332' ' ' VAL . 8.8 mt -77.16 -44.21 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 281' ' ' SER . 40.5 t -52.13 -43.75 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . 0.537 ' HE2' ' HB1' ' A' ' 282' ' ' ALA . 0.0 OUTLIER -61.25 -30.52 70.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.58 ' CE2' ' HD2' ' A' ' 328' ' ' LYS . 47.6 t80 -84.47 -22.94 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.933 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.536 ' CG2' HG21 ' A' ' 344' ' ' VAL . 30.0 m -66.31 -22.96 66.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 2.1 mptm? -75.75 -44.1 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 287' ' ' TYR . 2.9 mp -53.64 -30.87 19.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.108 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.669 HG21 ' CD2' ' A' ' 324' ' ' HIS . 5.4 pt -98.37 -51.99 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.455 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -61.49 -48.61 80.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.096 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 15.4 ttm -55.11 -62.28 1.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -47.72 -64.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 298' ' ' ALA . 85.0 mttt -51.34 -63.7 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.463 HD12 HG21 ' A' ' 348' ' ' VAL . 51.3 mt -40.59 -57.43 1.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . 0.505 ' CE1' ' CG1' ' A' ' 352' ' ' ILE . 9.2 m-85 -55.58 -34.53 64.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 295' ' ' LYS . . . -66.64 -53.07 37.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.058 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.524 HG11 ' HB1' ' A' ' 313' ' ' ALA . 35.9 m . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.524 ' HB1' HG11 ' A' ' 299' ' ' VAL . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.832 0.348 . . . . 0.0 111.125 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.65 -45.77 72.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.7 t30 -67.81 -51.02 53.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.937 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.416 ' C ' ' O ' ' A' ' 315' ' ' ASN . 18.4 mmtt -36.61 -59.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 318' ' ' ARG . 92.8 mt -42.17 -54.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.157 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 317' ' ' ILE . 76.4 mtt-85 -38.09 -35.84 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.7 mt -83.87 -43.95 14.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.91 -69.24 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.567 HG22 HG13 ' A' ' 291' ' ' ILE . 68.3 p -49.15 -46.79 45.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.48 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 7.3 tm-20 -46.76 -43.67 18.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -87.59 -10.14 52.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . 0.669 ' CD2' HG21 ' A' ' 291' ' ' ILE . 44.8 t60 -89.34 -26.18 21.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.742 HD12 HG23 ' A' ' 337' ' ' ILE . 19.5 mt -93.59 -53.32 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -50.62 -27.93 7.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -84.5 -27.71 27.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.58 ' HD2' ' CE2' ' A' ' 287' ' ' TYR . 42.0 tttp -62.26 -55.19 30.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.848 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.1 OUTLIER -123.31 108.39 31.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.642 0.734 . . . . 0.0 110.86 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 329' ' ' PHE . 53.9 Cg_endo -69.75 -21.08 34.02 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.691 2.261 . . . . 0.0 112.328 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.43 -35.5 75.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 329' ' ' PHE . 9.9 p -71.7 153.47 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.173 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . 0.497 ' O ' HD12 ' A' ' 337' ' ' ILE . 6.3 t0 -93.47 161.42 14.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -61.97 -47.04 86.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . 0.597 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.4 t80 -51.41 -16.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.46 ' HB2' HG22 ' A' ' 332' ' ' VAL . 22.2 mm-40 -89.09 -34.54 16.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.915 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.742 HG23 HD12 ' A' ' 325' ' ' LEU . 2.8 mp -73.81 -30.33 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 28.1 mt -77.84 -61.83 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.62 ' O ' HD12 ' A' ' 343' ' ' ILE . 6.9 tp10 -52.67 -35.7 55.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . 0.407 ' O ' HG23 ' A' ' 344' ' ' VAL . 4.4 p -57.02 -47.79 80.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -56.85 -50.47 72.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -40.42 -51.48 2.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.9 mp -65.1 -38.07 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.169 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.536 HG21 ' CG2' ' A' ' 288' ' ' THR . 77.8 t -60.85 -63.64 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -37.69 -51.99 1.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.079 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -54.84 -42.73 72.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 344' ' ' VAL . 20.0 tp10 -60.31 -54.74 42.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.947 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.463 HG21 HD12 ' A' ' 296' ' ' LEU . 49.2 t -57.56 -69.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.116 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.461 ' O ' ' N ' ' A' ' 352' ' ' ILE . 13.0 m-85 -35.32 -55.6 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 349' ' ' PHE . 15.4 tpt180 -36.85 -57.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 47.3 t -65.31 -31.25 72.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . 0.505 ' CG1' ' CE1' ' A' ' 297' ' ' TYR . 51.0 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.113 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.151 0 CA-C-O 120.822 0.259 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.57 121.28 26.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 283' ' ' GLU . . . -53.24 -57.46 10.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.066 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 282' ' ' ALA . 4.5 pt-20 -38.1 -44.46 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' ILE . . . . . 0.744 HD11 HG21 ' A' ' 332' ' ' VAL . 74.6 mt -69.82 -55.98 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 88.0 t -37.81 -46.1 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.162 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -58.1 -55.94 28.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' TYR . . . . . 0.449 ' HA ' HD13 ' A' ' 290' ' ' ILE . 40.9 t80 -60.23 -26.72 66.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 16.9 m -69.31 -20.17 63.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 293' ' ' MET . 25.6 mttt -80.69 -38.26 29.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 287' ' ' TYR . 3.1 mp -60.23 -32.31 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ILE . . . . . 0.7 ' CD1' HG22 ' A' ' 321' ' ' THR . 16.9 pt -95.37 -46.84 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.126 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . 0.481 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -62.79 -47.68 82.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' MET . . . . . 0.446 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 10.5 ttm -57.04 -60.97 2.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -48.77 -60.89 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 298' ' ' ALA . 27.0 mtmt -55.41 -62.94 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 67.0 mt -41.71 -49.05 4.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -67.59 -28.78 68.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -70.59 -40.4 73.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.078 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' VAL . . . . . 0.566 ' CG1' ' HB1' ' A' ' 313' ' ' ALA . 30.6 m . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' ALA . . . . . 0.566 ' HB1' ' CG1' ' A' ' 299' ' ' VAL . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.849 0.356 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.4 t -77.44 -54.8 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.141 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.7 OUTLIER -51.54 -53.04 42.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 315' ' ' ASN . 15.9 mmmt -34.58 -51.66 0.48 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.507 HG22 ' CE1' ' A' ' 341' ' ' PHE . 82.5 mt -41.69 -58.85 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 317' ' ' ILE . 25.5 mtp180 -37.11 -43.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.2 mt -80.5 -44.26 19.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -56.57 -62.02 2.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.7 HG22 ' CD1' ' A' ' 291' ' ' ILE . 25.3 p -54.51 -57.51 11.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.43 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 17.0 tt0 -40.77 -34.92 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.89 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -87.84 -28.58 21.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' HIS . . . . . 0.676 ' CD2' HG21 ' A' ' 291' ' ' ILE . 71.4 t60 -75.0 -21.26 59.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.832 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.632 HD12 HG23 ' A' ' 337' ' ' ILE . 14.8 mt -93.2 -63.03 1.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 325' ' ' LEU . 8.4 tmtt? -35.98 -52.67 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -53.71 -44.85 70.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.869 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 325' ' ' LEU . 33.7 tttp -59.53 -44.08 93.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' PHE . . . . . 0.565 ' CE1' HG12 ' A' ' 284' ' ' ILE . 0.3 OUTLIER -115.97 89.19 23.81 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.676 0.751 . . . . 0.0 110.918 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -26.64 27.29 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.696 2.264 . . . . 0.0 112.308 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.89 -29.03 55.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' VAL . . . . . 0.744 HG21 HD11 ' A' ' 284' ' ' ILE . 39.8 t -70.72 153.28 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.15 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' ASP . . . . . 0.41 ' N ' ' CG1' ' A' ' 332' ' ' VAL . 7.9 t0 -88.45 154.25 20.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -57.61 -47.97 80.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.67 -23.83 4.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' GLU . . . . . 0.483 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 7.7 mt-10 -79.83 -29.05 40.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' ILE . . . . . 0.632 HG23 HD12 ' A' ' 325' ' ' LEU . 1.5 mp -89.23 -23.73 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 64.6 mt -74.15 -53.94 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' GLU . . . . . 0.534 ' O ' HD12 ' A' ' 343' ' ' ILE . 19.6 mm-40 -64.06 -45.97 86.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 90.8 p -39.77 -50.73 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' PHE . . . . . 0.507 ' CE1' HG22 ' A' ' 317' ' ' ILE . 51.4 t80 -59.09 -56.56 20.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -38.24 -44.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.2 mp -69.45 -42.4 80.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 345' ' ' ALA . 53.7 t -58.94 -63.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.113 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.34 -55.59 0.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -47.92 -53.8 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -48.65 -61.37 2.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 349' ' ' PHE . 41.1 t -55.46 -62.03 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.201 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 348' ' ' VAL . 6.6 m-85 -34.68 -63.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -39.29 -62.15 0.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 42.5 t -46.11 -45.26 16.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 77.9 mt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.933 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.0 m -152.08 161.41 42.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.891 0.376 . . . . 0.0 110.871 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 34.2 p -157.73 162.51 38.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 90.24 131.28 4.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.474 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.8 m -91.83 126.92 37.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.9 0.381 . . . . 0.0 110.877 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 17.9 p -174.99 124.53 0.25 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.842 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 89.75 -166.8 33.01 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.468 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 2.83 3.17 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.688 2.259 . . . . 0.0 112.31 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -65.99 116.16 6.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -69.71 168.96 13.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.503 HG22 ' N ' ' A' ' 278' ' ' PHE . 10.8 mt -104.69 158.27 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.119 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.503 ' N ' HG22 ' A' ' 277' ' ' ILE . 6.1 m-85 -75.62 148.36 38.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.93 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 22.3 p -90.03 154.25 47.3 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.575 0.702 . . . . 0.0 111.168 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -168.95 0.3 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.639 2.226 . . . . 0.0 112.366 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.688 ' O ' HG23 ' A' ' 285' ' ' VAL . 50.0 m -76.09 132.47 40.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -73.86 -45.53 50.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.089 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.408 ' HG3' ' CE2' ' A' ' 329' ' ' PHE . 15.6 pt-20 -41.35 -46.29 3.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.538 HD11 HG21 ' A' ' 332' ' ' VAL . 7.0 mt -73.33 -59.8 3.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 281' ' ' SER . 85.0 t -34.97 -41.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.077 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -63.67 -48.89 75.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.451 ' N ' ' O ' ' A' ' 284' ' ' ILE . 54.1 t80 -69.48 -19.25 63.75 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.933 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.768 ' HB ' HG21 ' A' ' 344' ' ' VAL . 9.5 m -72.89 -23.06 60.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.129 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 23.1 mttt -77.05 -43.35 34.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -55.7 -31.74 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.135 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.563 HG21 ' CD2' ' A' ' 324' ' ' HIS . 6.7 pt -98.04 -51.49 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.082 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 288' ' ' THR . . . -59.02 -46.87 87.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.086 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 16.9 ttm -55.05 -69.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 293' ' ' MET . 15.7 mt-10 -37.84 -63.52 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 298' ' ' ALA . 40.9 mttm -53.98 -65.57 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 45.7 mt -38.04 -42.1 0.62 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.91 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.585 ' CE2' HG13 ' A' ' 348' ' ' VAL . 10.8 m-85 -75.98 -36.03 59.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.934 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.479 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -69.44 -26.71 64.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.072 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 29.9 m -89.23 -34.63 6.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.629 ' CD2' HD13 ' A' ' 352' ' ' ILE . 0.4 OUTLIER -67.14 -51.26 56.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 89.5 m -52.05 -35.37 47.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -109.25 -177.31 3.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.872 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 68.28 35.39 3.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -79.79 -54.02 6.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.884 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -52.2 -50.52 61.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.904 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.486 ' CB ' ' HB2' ' A' ' 309' ' ' SER . 0.9 OUTLIER -84.33 140.5 31.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.896 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 19.3 mtmm -90.95 -39.49 12.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.878 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 61.3 t -81.55 -37.67 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.137 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.486 ' HB2' ' CB ' ' A' ' 306' ' ' ASP . 3.8 t -46.05 -36.63 5.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.495 ' O ' HG23 ' A' ' 314' ' ' VAL . 16.4 ptm180 -84.53 -27.27 27.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.914 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -58.37 -43.63 88.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -78.63 -35.17 45.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -58.18 -43.83 87.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.118 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 310' ' ' ARG . 59.1 t -69.33 -61.78 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.14 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.3 t30 -51.87 -47.9 64.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 315' ' ' ASN . 12.2 mmtp -35.98 -53.06 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.872 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.449 HG23 HG23 ' A' ' 321' ' ' THR . 51.1 mt -46.49 -55.59 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.123 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -39.1 -32.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.866 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.2 mt -89.85 -36.39 15.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.975 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 317' ' ' ILE . 47.3 t0 -66.86 -63.41 1.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.903 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.449 HG23 HG23 ' A' ' 317' ' ' ILE . 24.2 p -48.65 -44.58 37.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.119 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -50.75 -33.08 21.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.27 -16.54 30.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.852 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . 0.563 ' CD2' HG21 ' A' ' 291' ' ' ILE . 84.3 t60 -91.85 -22.23 20.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.46 HD11 HG23 ' A' ' 288' ' ' THR . 41.9 mt -94.4 -61.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -45.9 -22.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.898 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -79.07 -41.64 28.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 54.4 tttp -69.02 -33.9 74.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.494 ' CD1' ' N ' ' A' ' 329' ' ' PHE . 2.0 m-85 -116.56 83.0 13.04 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.678 0.751 . . . . 0.0 110.874 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -22.75 31.56 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 0.0 112.331 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -84.39 -30.53 25.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.872 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.538 HG21 HD11 ' A' ' 284' ' ' ILE . 45.4 t -66.37 157.9 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.164 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . 0.471 ' N ' ' CG1' ' A' ' 332' ' ' VAL . 6.1 t70 -85.57 149.41 25.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . 0.403 ' C ' ' OE1' ' A' ' 334' ' ' GLN . 1.0 OUTLIER -59.08 -32.11 69.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.919 -179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -68.94 -14.29 62.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.87 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.47 ' CA ' ' OE1' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -89.49 -21.56 22.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.413 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.8 mp -85.31 -26.45 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.12 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 339' ' ' GLU . 2.7 mp -88.11 -69.89 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.101 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.602 ' O ' HD12 ' A' ' 343' ' ' ILE . 4.8 tp10 -42.83 -34.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.572 ' HB2' HG22 ' A' ' 285' ' ' VAL . 18.8 p -62.8 -50.72 69.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.845 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 344' ' ' VAL . 50.1 t80 -49.93 -54.38 20.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.856 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 341' ' ' PHE . 7.7 m-80 -36.57 -55.71 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.602 HD12 ' O ' ' A' ' 339' ' ' GLU . 5.0 mp -58.45 -38.08 67.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.14 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.768 HG21 ' HB ' ' A' ' 288' ' ' THR . 52.3 t -65.63 -52.15 54.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -46.8 -67.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -39.2 6.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -56.83 -49.69 74.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.898 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.585 HG13 ' CE2' ' A' ' 297' ' ' TYR . 48.2 t -61.44 -60.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.137 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 348' ' ' VAL . 11.4 m-85 -34.42 -59.96 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 30.5 ttm180 -44.32 -51.93 8.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.402 ' HA ' HD13 ' A' ' 354' ' ' LEU . 10.4 m -58.89 -33.28 70.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.816 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.629 HD13 ' CD2' ' A' ' 300' ' ' PHE . 69.8 mt -73.76 -29.18 25.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.169 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 353' ' ' ILE . 16.8 mm -70.96 -12.73 16.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.117 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.402 HD13 ' HA ' ' A' ' 351' ' ' SER . 7.3 mp -79.15 -11.27 59.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.95 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -123.19 25.82 8.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . 0.582 ' OE2' ' CZ ' ' A' ' 300' ' ' PHE . 23.9 pt-20 -175.14 133.7 0.32 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.901 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.444 ' CG ' ' O ' ' A' ' 357' ' ' TYR . 16.5 t80 65.2 37.11 6.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 1.7 mmmm -130.54 177.57 7.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -146.99 134.37 20.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.879 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 1.9 t 54.0 44.14 29.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 53.5 m-20 -48.39 -49.85 33.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 154.14 90.7 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.519 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -41.19 155.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.771 0.32 . . . . 0.0 110.887 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -131.61 146.37 52.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.846 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 29.3 t -103.38 -38.12 7.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.866 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -100.98 -157.74 27.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.486 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 130.7 19.81 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.658 2.239 . . . . 0.0 112.329 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.1 m -84.06 -52.73 6.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.861 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 1.2 t -107.42 95.29 5.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.504 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 86.1 p -113.88 42.11 2.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.883 0.373 . . . . 0.0 110.84 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 35.0 m -154.38 176.38 12.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.843 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 169.79 83.99 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.477 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 16.2 m -68.59 121.02 15.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.894 0.378 . . . . 0.0 110.839 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 25.1 p -87.21 167.17 14.36 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.812 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 170.96 -158.12 29.48 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.509 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.71 -3.09 11.28 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.711 2.274 . . . . 0.0 112.332 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -71.18 143.85 50.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.64 147.92 50.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.875 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.97 163.05 2.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.136 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -126.19 141.19 52.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 29.6 p -79.68 153.08 75.67 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.562 0.696 . . . . 0.0 111.192 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 171.24 14.74 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.731 2.287 . . . . 0.0 112.337 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.452 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.1 t -68.64 130.7 43.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.94 -36.62 82.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -52.0 -38.43 56.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.711 HD11 HG21 ' A' ' 332' ' ' VAL . 20.0 mt -76.65 -53.97 14.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.143 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 281' ' ' SER . 82.0 t -39.71 -49.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.149 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -55.43 -44.49 76.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -73.51 -26.88 61.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.898 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.498 HG23 HD11 ' A' ' 325' ' ' LEU . 41.7 m -68.28 -15.95 63.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.177 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 293' ' ' MET . 18.1 mttm -82.99 -40.17 20.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -59.93 -27.14 37.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.095 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.693 HG21 ' CD2' ' A' ' 324' ' ' HIS . 17.1 pt -98.1 -46.96 12.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.139 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.482 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.14 -48.12 68.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.133 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.499 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 19.4 ttm -51.89 -60.32 3.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -45.78 -70.37 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.91 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.473 ' O ' ' N ' ' A' ' 298' ' ' ALA . 8.4 mmmm -47.27 -62.01 1.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.932 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.419 HD22 ' CZ ' ' A' ' 349' ' ' PHE . 49.8 mt -41.67 -48.36 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.484 ' CE2' HG13 ' A' ' 348' ' ' VAL . 13.5 m-85 -75.22 -21.69 58.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.92 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -78.29 -26.76 47.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 28.4 m -90.26 -30.97 5.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.124 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.542 ' CD2' HG21 ' A' ' 352' ' ' ILE . 1.5 t80 -72.15 -44.7 62.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 297' ' ' TYR . 8.0 t -74.96 2.17 11.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.118 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -117.49 -66.63 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.834 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.525 ' CZ ' ' HG2' ' A' ' 310' ' ' ARG . 0.4 OUTLIER -79.61 62.87 4.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.879 -179.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -88.8 -64.92 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -55.77 -50.9 69.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -109.26 84.06 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 309' ' ' SER . 3.6 tmtt? -83.48 -66.53 0.88 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 2.1 p -38.98 -25.94 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.142 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 307' ' ' LYS . 36.9 m -71.84 -60.37 2.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.525 ' HG2' ' CZ ' ' A' ' 303' ' ' TYR . 9.7 tpt180 -92.05 37.6 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.853 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 15.4 t0 -68.33 -29.14 67.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.424 ' CD ' ' H ' ' A' ' 312' ' ' GLU . 2.0 pm0 -54.3 -36.3 63.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -50.91 -53.21 34.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.081 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.442 HG13 ' HZ ' ' A' ' 349' ' ' PHE . 55.7 t -46.83 -29.89 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.147 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -87.31 -41.33 13.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.449 ' N ' ' HD2' ' A' ' 316' ' ' LYS . 3.7 mptt -40.74 -53.87 2.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.418 ' O ' ' C ' ' A' ' 318' ' ' ARG . 52.7 mt -45.41 -57.52 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.123 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 317' ' ' ILE . 16.0 tpp85 -37.22 -44.59 0.59 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.829 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.8 mt -77.65 -43.75 30.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.76 -69.26 0.2 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.679 HG22 ' CD1' ' A' ' 291' ' ' ILE . 16.5 p -46.27 -51.37 14.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.136 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -48.08 -45.19 32.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.914 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -80.05 -14.04 58.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.913 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . 0.693 ' CD2' HG21 ' A' ' 291' ' ' ILE . 80.9 t60 -91.11 -22.57 20.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.855 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.498 HD11 HG23 ' A' ' 288' ' ' THR . 23.0 mt -94.18 -60.3 1.77 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 325' ' ' LEU . 1.0 OUTLIER -35.86 -44.54 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.923 179.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -60.26 -46.35 90.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.896 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.454 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 26.8 tptt -60.58 -39.56 88.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.899 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.585 ' CE2' HG12 ' A' ' 284' ' ' ILE . 2.8 m-85 -117.43 83.68 17.07 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.634 0.731 . . . . 0.0 110.851 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.83 -24.53 29.24 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.694 2.262 . . . . 0.0 112.323 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -82.24 -30.66 30.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.894 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.711 HG21 HD11 ' A' ' 284' ' ' ILE . 85.3 t -70.2 144.12 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.194 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -73.86 150.56 40.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.856 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -61.33 -45.56 93.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.1 t80 -51.22 -17.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.891 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.99 -44.13 10.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . . . . . . . . . 2.6 mp -63.76 -39.99 87.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.115 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.96 -58.6 5.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.636 ' OE2' HD11 ' A' ' 343' ' ' ILE . 7.5 tm-20 -49.02 -52.21 26.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.922 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.406 ' CB ' HG22 ' A' ' 285' ' ' VAL . 1.8 p -43.28 -41.63 4.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.482 ' O ' ' N ' ' A' ' 344' ' ' VAL . 73.6 t80 -62.16 -56.45 18.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.917 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 341' ' ' PHE . 11.2 m-80 -35.72 -36.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.942 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.636 HD11 ' OE2' ' A' ' 339' ' ' GLU . 5.2 mp -79.47 -43.03 23.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.15 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.482 ' N ' ' O ' ' A' ' 341' ' ' PHE . 50.8 t -59.94 -41.62 86.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.157 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -54.97 -69.67 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.074 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 31.4 pttt -53.03 -33.01 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -62.8 -31.99 73.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.484 HG13 ' CE2' ' A' ' 297' ' ' TYR . 34.7 t -92.12 -57.36 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.134 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.442 ' HZ ' HG13 ' A' ' 314' ' ' VAL . 38.1 m-85 -42.3 -55.84 3.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -51.19 -43.14 61.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.873 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.479 ' HA ' ' CD2' ' A' ' 354' ' ' LEU . 2.8 t -59.49 -18.93 44.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.816 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.542 HG21 ' CD2' ' A' ' 300' ' ' PHE . 48.2 mt -95.27 -49.77 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.114 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.438 ' N ' HD12 ' A' ' 353' ' ' ILE . 1.7 mp -55.23 -36.89 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.906 HD12 ' N ' ' A' ' 355' ' ' ASN . 1.4 pp -48.32 -24.16 1.13 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.925 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.906 ' N ' HD12 ' A' ' 354' ' ' LEU . 28.6 m-20 -47.54 -39.55 16.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -48.51 -47.78 38.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -104.83 105.56 15.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.903 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -112.63 156.56 22.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.14 174.09 14.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 21.4 p -74.01 152.73 39.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.905 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.15 142.91 51.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -80.01 -90.13 0.48 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.462 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.415 ' O ' ' C ' ' A' ' 364' ' ' ASP . 41.2 mtp180 -143.2 122.6 13.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.828 0.347 . . . . 0.0 110.862 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 363' ' ' ARG . 6.3 t70 -36.91 141.49 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 45.5 t -79.78 -60.6 2.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.843 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -174.3 171.33 44.46 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.488 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 119.72 6.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.673 2.248 . . . . 0.0 112.369 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 4.2 t -150.6 156.79 42.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -82.54 -3.94 56.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.858 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.476 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 8.6 t -116.9 44.59 2.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.886 0.374 . . . . 0.0 110.891 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.3 t -82.15 85.69 6.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 154.82 -102.0 0.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.496 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 47.2 m 43.1 51.69 5.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.886 0.374 . . . . 0.0 110.869 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 14.5 t -82.06 142.91 31.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 170.41 -158.18 29.86 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.498 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 -1.08 7.83 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.741 2.294 . . . . 0.0 112.352 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -71.69 158.81 35.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -73.4 164.23 26.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.908 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.532 ' C ' HD12 ' A' ' 277' ' ' ILE . 2.6 pp -97.71 162.14 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.092 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -126.39 139.85 52.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 34.9 p -86.44 153.52 56.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.584 0.707 . . . . 0.0 111.171 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 177.33 5.67 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.716 2.277 . . . . 0.0 112.323 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 2.1 m -71.52 120.52 17.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.838 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 283' ' ' GLU . . . -60.09 -56.72 18.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.067 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 282' ' ' ALA . 10.7 pt-20 -34.6 -45.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.646 HD11 HG21 ' A' ' 332' ' ' VAL . 27.3 mt -68.99 -57.73 7.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.159 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 87.3 t -38.13 -57.04 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.153 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 4.1 mmmm -52.1 -40.84 61.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -73.83 -27.03 60.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.801 ' HB ' HG21 ' A' ' 344' ' ' VAL . 17.5 m -67.6 -19.08 65.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.174 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 293' ' ' MET . 28.4 mttt -79.57 -41.79 26.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -58.47 -29.85 39.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.124 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.773 HG21 ' HD2' ' A' ' 324' ' ' HIS . 7.6 pt -97.53 -49.55 11.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.452 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -62.06 -48.04 82.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.478 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 11.9 ttm -54.94 -52.27 63.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -51.79 -68.65 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 298' ' ' ALA . 69.8 mttt -50.35 -58.65 5.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.954 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.659 ' HG ' HD13 ' A' ' 317' ' ' ILE . 42.6 mt -42.6 -58.23 2.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.62 ' O ' HG23 ' A' ' 301' ' ' THR . 11.0 m-85 -61.56 -29.64 70.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.964 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 295' ' ' LYS . . . -67.33 -48.92 66.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.079 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 24.0 m -74.8 -26.96 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.102 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -79.32 -33.14 43.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.62 HG23 ' O ' ' A' ' 297' ' ' TYR . 27.3 p -76.87 -34.4 57.8 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -83.02 -46.41 12.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -87.07 75.53 9.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -83.09 -67.88 0.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.891 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -65.62 -48.95 70.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.52 63.43 7.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.905 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -76.72 -60.6 2.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.855 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 6.2 p -70.0 -16.69 20.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 2.5 m -82.63 -34.29 27.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.803 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -106.79 30.19 6.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.83 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.38 -27.31 68.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 7.4 pm0 -61.82 -32.73 73.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -64.78 -48.34 74.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.081 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 46.0 t -57.54 -28.37 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.14 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.468 ' O ' ' N ' ' A' ' 317' ' ' ILE . 0.5 OUTLIER -80.79 -44.04 19.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.93 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.645 ' HA ' HD12 ' A' ' 319' ' ' LEU . 25.6 mttt -40.52 -24.73 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.659 HD13 ' HG ' ' A' ' 296' ' ' LEU . 94.8 mt -58.96 -67.16 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.148 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 319' ' ' LEU . 7.3 ptp180 -37.97 -32.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.84 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.645 HD12 ' HA ' ' A' ' 316' ' ' LYS . 18.8 mt -76.58 -42.69 41.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.921 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 317' ' ' ILE . 15.7 t0 -74.41 -62.86 1.38 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.83 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.627 HG22 HG13 ' A' ' 291' ' ' ILE . 7.5 p -42.04 -54.73 3.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.144 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -45.02 -49.33 11.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -68.9 -21.34 64.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . 0.773 ' HD2' HG21 ' A' ' 291' ' ' ILE . 78.7 t60 -86.63 -23.06 25.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.828 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.55 ' HB2' HG23 ' A' ' 337' ' ' ILE . 42.8 mt -88.71 -58.02 2.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.935 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 325' ' ' LEU . 0.2 OUTLIER -37.14 -48.81 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -53.27 -54.53 34.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.453 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 26.2 tptt -53.4 -47.52 69.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.892 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.584 ' CE2' HG12 ' A' ' 284' ' ' ILE . 0.4 OUTLIER -113.05 86.72 9.55 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.651 0.739 . . . . 0.0 110.886 179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -38.63 7.54 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 2.24 . . . . 0.0 112.359 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -67.78 -26.82 66.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.646 HG21 HD11 ' A' ' 284' ' ' ILE . 96.0 t -73.06 141.99 15.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.087 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -79.57 147.49 32.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.851 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -51.41 -49.14 62.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.3 t80 -46.51 -21.28 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.434 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 7.5 mm-40 -88.71 -38.82 14.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.897 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.6 mp -70.81 -30.17 40.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 79.7 mt -77.13 -66.46 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.119 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.575 ' OE1' HD11 ' A' ' 343' ' ' ILE . 3.2 tm-20 -43.53 -49.19 7.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 7.4 p -43.16 -47.18 6.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.84 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.602 ' CE1' HG22 ' A' ' 317' ' ' ILE . 61.2 t80 -52.32 -56.08 17.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.828 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 341' ' ' PHE . 21.1 m-80 -35.07 -57.57 0.56 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.859 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.632 ' H ' HD12 ' A' ' 343' ' ' ILE . 5.2 mp -56.24 -51.57 61.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.141 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.801 HG21 ' HB ' ' A' ' 288' ' ' THR . 21.6 t -51.0 -66.29 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.123 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -38.92 -58.52 1.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 18.6 mmtp -37.72 -52.14 1.25 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.915 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -56.87 -65.78 0.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 297' ' ' TYR . 46.9 t -42.66 -42.44 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.087 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' A' ' 350' ' ' ARG . 4.9 m-85 -57.83 -65.01 0.71 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.406 ' C ' ' O ' ' A' ' 349' ' ' PHE . 13.0 tpp85 -37.39 -65.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 68.5 p -41.23 -59.51 1.5 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.402 HG12 ' CE1' ' A' ' 297' ' ' TYR . 48.8 mt -55.59 -63.08 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.16 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 30.8 mm -40.91 -47.03 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.136 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -71.0 -37.14 72.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.876 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -61.94 -40.07 94.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.896 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 74.9 mt-10 -58.52 -55.44 35.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -152.19 116.52 4.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 10.9 ttpt -84.85 144.96 28.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.899 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 21.9 ttt180 -134.36 156.9 47.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 72.2 m -46.36 100.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -161.05 150.97 17.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -122.09 141.53 14.37 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.5 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -129.53 148.63 51.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.811 0.339 . . . . 0.0 110.884 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -123.46 172.96 8.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.868 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 7.5 t -57.69 158.28 6.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -119.31 159.88 14.48 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.479 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 169.08 19.71 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.66 2.24 . . . . 0.0 112.341 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 74.7 m -118.98 161.06 20.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.882 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 29.2 t -47.88 158.48 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.829 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.483 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.458 -0.257 . . . . 0.0 112.458 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 10.1 t -66.63 166.13 13.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.946 0.403 . . . . 0.0 110.818 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 14.7 m -107.25 107.91 19.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.861 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -83.42 -143.77 5.43 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.485 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 41.7 t -107.93 -45.03 4.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.886 0.374 . . . . 0.0 110.833 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 4.7 m -92.18 109.41 20.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.857 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -143.64 146.18 16.59 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.5 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -14.48 36.12 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.658 2.239 . . . . 0.0 112.353 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 19.1 tt0 -74.84 163.6 27.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.429 ' HG3' ' N ' ' A' ' 277' ' ' ILE . 27.5 tptt -82.98 148.94 27.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.443 HG22 ' N ' ' A' ' 278' ' ' PHE . 51.2 mm -95.66 154.23 3.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.112 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.443 ' N ' HG22 ' A' ' 277' ' ' ILE . 3.1 m-85 -129.93 143.64 50.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 70.4 p -75.93 151.68 84.33 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.574 0.702 . . . . 0.0 111.132 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.73 166.6 27.0 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.667 2.245 . . . . 0.0 112.35 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.418 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.2 t -68.26 121.37 16.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.844 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.32 -40.63 82.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.099 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -50.9 -37.83 46.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.91 HD11 HG21 ' A' ' 332' ' ' VAL . 59.2 mt -76.52 -44.04 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.112 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 281' ' ' SER . 47.3 t -50.34 -60.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 16.6 mtpp -40.19 -47.01 2.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -72.23 -39.85 68.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.912 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.778 HG23 HD11 ' A' ' 325' ' ' LEU . 4.1 m -54.73 -17.94 4.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.182 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.484 ' O ' ' CB ' ' A' ' 293' ' ' MET . 42.1 mttt -79.47 -46.43 17.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.533 ' N ' HD12 ' A' ' 290' ' ' ILE . 2.4 mp -58.4 -22.65 20.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.095 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.516 HD11 ' HA ' ' A' ' 288' ' ' THR . 7.3 pt -98.17 -51.92 9.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.481 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -66.88 -48.22 69.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 29.8 ttm -49.44 -71.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -41.45 -69.35 0.14 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.907 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 298' ' ' ALA . 0.0 OUTLIER -42.44 -63.88 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 39.7 mt -43.97 -43.02 6.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.576 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.9 m-85 -70.69 -30.76 67.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.41 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -70.2 -65.57 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.087 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 7.0 m -47.54 -27.39 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.121 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.594 ' CD2' HG21 ' A' ' 352' ' ' ILE . 2.7 t80 -76.73 -49.5 15.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 45.1 m -54.17 -35.69 62.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.108 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -83.68 -61.98 1.69 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' A' ' 303' ' ' TYR . 0.3 OUTLIER -88.26 87.04 7.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.941 -179.857 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 54.7 tt0 -94.19 -50.99 5.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.843 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 8.4 t-80 -78.36 -41.2 34.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.845 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.31 50.44 1.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.847 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 7.8 tmtm? -60.4 -58.03 10.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.919 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.559 HG23 ' N ' ' A' ' 309' ' ' SER . 30.2 m -71.55 -48.88 50.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.113 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.559 ' N ' HG23 ' A' ' 308' ' ' VAL . 3.5 m -49.95 -44.12 50.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -108.44 37.01 2.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.885 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -70.65 -17.48 62.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -53.68 -24.42 14.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.902 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -72.55 -55.17 7.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.421 HG11 ' HZ ' ' A' ' 349' ' ' PHE . 60.2 t -52.47 -44.18 43.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.134 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.9 t30 -70.26 -47.77 59.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.898 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 315' ' ' ASN . 10.8 mmtm -35.86 -51.98 0.71 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.441 ' O ' ' N ' ' A' ' 320' ' ' ASP . 42.0 mt -45.12 -54.07 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.112 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 20.5 ttm180 -39.22 -33.67 0.15 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.3 mt -90.55 -34.19 15.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 317' ' ' ILE . 6.5 t0 -67.63 -68.15 0.41 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.51 HG22 HD12 ' A' ' 291' ' ' ILE . 17.1 p -42.91 -44.2 4.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -50.2 -46.57 54.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -74.13 -17.66 60.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.835 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -87.84 -28.3 21.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.871 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.778 HD11 HG23 ' A' ' 288' ' ' THR . 19.0 mt -90.62 -59.07 2.28 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 325' ' ' LEU . 7.3 tmtt? -38.22 -45.53 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -62.54 -39.62 94.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.887 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 325' ' ' LEU . 22.1 tptt -65.01 -44.9 87.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.59 ' CE2' HG12 ' A' ' 284' ' ' ILE . 0.5 OUTLIER -113.72 86.17 10.36 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.638 0.733 . . . . 0.0 110.882 179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -22.08 32.64 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.73 2.287 . . . . 0.0 112.346 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -84.06 -26.08 29.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.926 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.91 HG21 HD11 ' A' ' 284' ' ' ILE . 48.7 t -75.89 138.73 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.124 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -72.08 142.86 49.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.812 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -51.57 -47.92 63.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.895 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.597 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 1.5 t80 -47.45 -20.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.408 ' HB2' HG12 ' A' ' 332' ' ' VAL . 20.8 mt-10 -88.09 -45.57 10.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.841 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.4 mp -60.3 -26.21 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.134 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.407 ' O ' ' N ' ' A' ' 340' ' ' SER . 76.7 mt -89.34 -64.95 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.142 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -41.88 -26.11 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.919 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.407 ' N ' ' O ' ' A' ' 338' ' ' ILE . 2.4 p -65.77 -46.57 78.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.84 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.44 ' CE2' HG22 ' A' ' 317' ' ' ILE . 23.3 t80 -53.92 -52.74 59.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.887 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.44 ' C ' ' O ' ' A' ' 341' ' ' PHE . 28.2 m-80 -34.53 -48.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.507 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.7 mp -73.46 -41.75 56.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.15 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.48 HG11 ' HB3' ' A' ' 292' ' ' ALA . 25.2 t -58.25 -59.97 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . 0.412 ' HB2' ' CE1' ' A' ' 341' ' ' PHE . . . -38.17 -64.9 0.38 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.104 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -46.34 -60.72 2.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.943 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -39.86 -34.99 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 344' ' ' VAL . 22.0 t -81.21 -53.15 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.158 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.502 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.0 m-85 -52.5 -64.48 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.404 ' C ' ' O ' ' A' ' 349' ' ' PHE . 23.9 ptt85 -37.77 -28.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.866 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.716 ' O ' HD22 ' A' ' 354' ' ' LEU . 15.8 t -84.17 -41.74 16.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.857 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.594 HG21 ' CD2' ' A' ' 300' ' ' PHE . 83.6 mt -63.68 -17.1 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.117 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 18.7 mm -64.93 -22.28 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.176 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.716 HD22 ' O ' ' A' ' 351' ' ' SER . 1.3 pt? -54.58 -24.17 19.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.873 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.55 ' N ' HD23 ' A' ' 354' ' ' LEU . 1.9 t30 -95.63 -13.26 24.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 357' ' ' TYR . 52.4 mm-40 -91.53 87.33 6.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.914 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.413 ' C ' ' O ' ' A' ' 356' ' ' GLU . 1.1 p90 36.75 53.47 1.08 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.925 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 20.3 tttp -143.24 128.13 18.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.69 159.73 33.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.89 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 31.8 p -162.13 174.49 12.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.855 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -78.76 99.79 6.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.842 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -148.76 127.69 2.59 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.518 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.416 ' HG3' ' N ' ' A' ' 364' ' ' ASP . 22.8 ptt180 -46.76 -46.47 20.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.801 0.334 . . . . 0.0 110.919 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.416 ' N ' ' HG3' ' A' ' 363' ' ' ARG . 2.8 t70 -112.06 139.78 47.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.809 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 29.8 p -77.62 -53.57 7.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.882 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 170.16 148.19 5.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.496 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.84 153.36 68.66 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.611 2.207 . . . . 0.0 112.348 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 11.5 t -98.43 117.31 32.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 5.7 t -129.68 166.7 19.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.831 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.475 -179.969 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 58.0 m -100.35 -56.13 2.43 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.891 0.377 . . . . 0.0 110.848 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.7 t -77.18 130.52 37.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.791 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -171.69 161.88 34.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.471 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 83.8 p -161.43 135.87 7.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.923 0.392 . . . . 0.0 110.828 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 45.1 t -50.88 -66.26 0.42 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.877 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 104.27 83.83 1.72 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.492 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -21.57 33.43 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.733 2.289 . . . . 0.0 112.352 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -68.2 158.44 33.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -73.31 115.53 12.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.856 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.6 HG22 ' N ' ' A' ' 278' ' ' PHE . 14.4 mt -94.18 163.0 2.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.138 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.6 ' N ' HG22 ' A' ' 277' ' ' ILE . 5.7 m-85 -78.82 150.73 32.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 18.3 p -72.61 152.83 91.66 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.615 0.721 . . . . 0.0 111.122 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 173.32 11.14 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.703 2.269 . . . . 0.0 112.31 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.837 ' O ' HG23 ' A' ' 285' ' ' VAL . 2.1 m -74.58 137.17 42.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.07 -48.44 62.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.101 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -42.66 -45.56 4.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.79 HD11 HG21 ' A' ' 332' ' ' VAL . 25.1 mt -74.45 -54.03 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.853 HG22 ' CB ' ' A' ' 340' ' ' SER . 95.4 t -45.16 -43.11 2.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.115 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 29.7 mttm -61.94 -36.14 80.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.927 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -80.3 -30.69 38.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.546 ' HA ' HD11 ' A' ' 291' ' ' ILE . 9.9 m -60.49 -19.92 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.171 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.508 ' HG3' HG22 ' A' ' 344' ' ' VAL . 42.0 mttt -80.54 -48.94 12.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.419 ' H ' HD12 ' A' ' 290' ' ' ILE . 3.0 mp -54.78 -22.74 10.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.147 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.546 HD11 ' HA ' ' A' ' 288' ' ' THR . 5.2 pt -98.71 -52.2 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.145 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.594 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -68.76 -49.19 60.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.116 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.498 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 20.0 ttm -43.1 -65.22 0.51 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -46.63 -63.07 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.856 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.412 ' O ' ' N ' ' A' ' 298' ' ' ALA . 47.1 mmtt -46.39 -65.46 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.921 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.641 ' O ' HG22 ' A' ' 299' ' ' VAL . 31.5 mt -42.85 -53.85 4.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.813 ' CE2' HG13 ' A' ' 348' ' ' VAL . 11.2 m-85 -64.94 -23.53 67.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.96 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.418 ' O ' HG22 ' A' ' 301' ' ' THR . . . -76.05 -32.98 59.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.126 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.641 HG22 ' O ' ' A' ' 296' ' ' LEU . 28.2 m -82.08 -27.74 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.117 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -83.63 -31.88 25.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 298' ' ' ALA . 5.4 t -70.44 -20.23 62.92 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.118 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.28 -58.69 1.86 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -78.65 88.3 4.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.91 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -94.06 -44.48 8.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.884 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.556 ' CE1' ' OD1' ' A' ' 306' ' ' ASP . 9.3 p80 -89.64 -49.08 6.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.556 ' OD1' ' CE1' ' A' ' 305' ' ' HIS . 5.0 m-20 -84.03 77.55 9.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -80.8 -69.73 0.58 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.928 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 28.9 m -66.1 -34.65 71.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.138 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.5 m -46.93 -44.98 20.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.878 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 57.9 mtt-85 -116.26 49.44 1.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.854 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -64.27 -11.61 33.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -63.1 -34.04 76.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.611 ' HB1' ' CG1' ' A' ' 299' ' ' VAL . . . -57.87 -42.21 84.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.1 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.0 -61.08 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.129 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -50.98 -46.47 61.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -38.9 -58.24 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.883 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.471 ' O ' ' N ' ' A' ' 320' ' ' ASP . 32.2 mt -41.17 -59.14 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.176 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.445 ' C ' ' O ' ' A' ' 317' ' ' ILE . 56.1 ttt180 -34.87 -39.66 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.894 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.6 mt -81.82 -41.15 21.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.471 ' N ' ' O ' ' A' ' 317' ' ' ILE . 3.7 t70 -60.14 -69.14 0.23 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.436 HG22 HG13 ' A' ' 291' ' ' ILE . 69.7 p -47.85 -42.21 25.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.5 ' C ' ' CD ' ' A' ' 322' ' ' GLU . 4.2 tm-20 -53.62 -40.66 65.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.903 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -87.37 -15.5 37.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.841 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -86.49 -27.15 24.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.795 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.531 HD11 HG23 ' A' ' 288' ' ' THR . 35.4 mt -88.21 -58.07 2.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 325' ' ' LEU . 1.4 tmmm? -35.92 -60.59 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -47.38 -50.24 22.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.471 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 22.3 tttp -55.78 -48.96 74.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.916 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.569 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 4.7 m-85 -110.89 82.42 3.05 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.64 0.733 . . . . 0.0 110.897 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 -31.79 19.5 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.642 2.228 . . . . 0.0 112.318 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.56 -24.0 53.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.851 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.79 HG21 HD11 ' A' ' 284' ' ' ILE . 68.8 t -74.58 146.42 9.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -67.44 147.13 53.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.89 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . 0.548 ' O ' HD12 ' A' ' 338' ' ' ILE . 11.2 tt0 -61.88 -33.32 73.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.941 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -68.9 -14.98 63.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -84.13 -25.22 29.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.446 HG23 HD12 ' A' ' 325' ' ' LEU . 2.2 mp -83.64 -25.02 7.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 334' ' ' GLN . 2.0 mp -80.93 -49.75 17.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.165 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 340' ' ' SER . 19.0 mt-10 -57.33 -62.55 1.69 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.899 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.853 ' CB ' HG22 ' A' ' 285' ' ' VAL . 75.2 p -35.78 -43.99 0.32 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.841 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.427 ' O ' ' N ' ' A' ' 344' ' ' VAL . 77.6 t80 -63.68 -55.94 19.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.884 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.404 ' C ' ' O ' ' A' ' 341' ' ' PHE . 26.7 m-80 -38.19 -42.0 0.64 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.913 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.409 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.0 mp -67.72 -43.11 86.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.594 HG11 ' HB3' ' A' ' 292' ' ' ALA . 70.0 t -58.7 -60.56 2.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.114 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -41.0 -49.27 3.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 36.2 mmtt -65.75 -34.59 78.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -65.05 -67.09 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.813 HG13 ' CE2' ' A' ' 297' ' ' TYR . 42.5 t -51.43 -37.25 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.105 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.673 ' O ' HD12 ' A' ' 353' ' ' ILE . 3.2 m-30 -60.57 -66.55 0.51 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.922 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 43.2 ttp180 -40.25 -31.04 0.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.827 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.946 ' O ' HD12 ' A' ' 354' ' ' LEU . 4.2 t -68.3 -46.57 69.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.403 ' N ' ' O ' ' A' ' 349' ' ' PHE . 11.3 mt -72.37 -40.85 64.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.125 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 349' ' ' PHE . 5.3 mp -76.28 -14.65 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.075 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.998 HD13 ' N ' ' A' ' 355' ' ' ASN . 0.0 OUTLIER -42.99 -23.56 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.901 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.998 ' N ' HD13 ' A' ' 354' ' ' LEU . 16.7 m-80 -48.49 -38.65 20.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.833 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -65.67 -69.68 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.873 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -61.9 150.54 37.26 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' A' ' 358' ' ' LYS . 1.4 mppt? -101.6 89.22 3.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.909 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 -109.39 124.97 51.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.877 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 28.3 p -102.1 41.32 1.23 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -142.98 146.54 34.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 81.11 168.5 40.04 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.488 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -123.68 149.89 44.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.83 0.347 . . . . 0.0 110.878 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -132.22 145.22 51.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.876 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 21.1 p -148.53 172.49 14.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.821 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -159.58 83.78 0.13 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.523 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 170.34 16.75 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.689 2.259 . . . . 0.0 112.375 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 30.4 m -62.39 156.68 21.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.841 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.6 m -122.9 127.49 49.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.839 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.503 -179.976 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 44.0 p -120.43 175.41 5.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.939 0.399 . . . . 0.0 110.801 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.2 t -96.23 169.74 9.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.851 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -92.03 -98.48 1.33 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.501 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 77.3 p -168.61 177.78 5.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.881 0.372 . . . . 0.0 110.829 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 26.9 t -109.76 171.89 7.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.845 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -84.33 142.5 20.47 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.484 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -174.47 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.686 2.257 . . . . 0.0 112.347 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.477 ' O ' HD12 ' A' ' 277' ' ' ILE . 4.0 tp60 -103.79 150.67 23.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -83.57 113.94 21.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.948 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.477 HD12 ' O ' ' A' ' 275' ' ' GLN . 4.3 mp -90.71 151.21 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.141 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -124.92 137.59 54.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.919 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.4 p -125.93 153.18 73.64 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.538 0.685 . . . . 0.0 111.145 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 -170.71 0.41 Allowed 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.628 2.219 . . . . 0.0 112.363 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.583 ' O ' HG23 ' A' ' 285' ' ' VAL . 13.2 m -73.82 122.7 22.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.74 81.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.099 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -41.61 -46.66 3.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.738 HD11 HG21 ' A' ' 332' ' ' VAL . 13.6 mt -72.68 -52.08 24.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.103 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.668 HG22 ' HB2' ' A' ' 340' ' ' SER . 89.8 t -46.15 -38.74 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.093 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -61.83 -47.57 84.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -73.87 -26.55 60.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.967 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 97.5 m -65.38 -17.67 64.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.149 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 31.7 mttt -80.17 -44.21 20.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.899 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.71 -24.03 24.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.131 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.677 HG21 ' CD2' ' A' ' 324' ' ' HIS . 10.7 pt -98.31 -49.81 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.137 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.485 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.7 -48.54 66.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.074 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 12.3 ttm -49.42 -61.4 2.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.934 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -46.87 -72.17 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 16.8 mtmm -43.78 -61.86 1.29 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.912 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 56.7 mt -44.09 -46.5 8.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.94 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -69.56 -28.22 65.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.923 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -67.73 -48.3 66.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.059 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.515 HG11 ' HB1' ' A' ' 313' ' ' ALA . 33.5 m -73.21 -23.7 20.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.112 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.421 ' CD1' ' C ' ' A' ' 300' ' ' PHE . 0.8 OUTLIER -53.95 -64.15 0.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.848 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 24.8 m -47.83 -49.99 27.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.166 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -84.42 179.69 7.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 303' ' ' TYR . 1.6 m-30 55.98 48.6 17.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.954 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -92.13 -56.06 3.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 59.5 m80 -84.65 -39.19 18.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.855 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.807 ' HB3' HG22 ' A' ' 308' ' ' VAL . 81.8 m-20 -38.42 129.85 1.35 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.87 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.96 -33.51 70.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.918 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.807 HG22 ' HB3' ' A' ' 306' ' ' ASP . 13.0 m -44.93 -29.1 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.126 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 310' ' ' ARG . 3.4 m 49.73 49.47 20.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.441 ' O ' HG23 ' A' ' 314' ' ' VAL . 28.5 ptt-85 35.82 53.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.855 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -89.2 -31.02 18.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.845 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.463 ' HG3' ' N ' ' A' ' 313' ' ' ALA . 15.1 pt-20 -94.83 -47.73 6.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 -179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.515 ' HB1' HG11 ' A' ' 299' ' ' VAL . . . -49.38 -44.89 45.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.134 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 310' ' ' ARG . 26.2 t -70.38 -64.02 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.113 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -48.76 -24.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 15.3 mmtp -64.99 -37.64 88.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.11 -55.69 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.117 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.413 ' HG2' ' CE2' ' A' ' 341' ' ' PHE . 17.9 mmm-85 -39.36 -30.87 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.0 mt -90.42 -40.58 11.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -65.7 -60.87 2.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.605 HG22 HD12 ' A' ' 291' ' ' ILE . 3.2 p -52.24 -40.47 61.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.162 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.472 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 17.7 tt0 -53.41 -41.1 65.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -84.44 -15.26 46.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.85 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . 0.677 ' CD2' HG21 ' A' ' 291' ' ' ILE . 77.8 t60 -87.27 -22.18 25.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.853 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.441 HD12 HG23 ' A' ' 337' ' ' ILE . 32.5 mt -94.15 -59.66 1.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.463 ' HD3' HD13 ' A' ' 337' ' ' ILE . 1.3 mmmp? -34.12 -53.19 0.48 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -48.26 -51.39 25.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 37.4 tttm -56.7 -40.33 75.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.895 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.491 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 6.4 m-85 -118.7 84.27 24.43 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.611 0.719 . . . . 0.0 110.879 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 -28.79 25.14 Favored 'Trans proline' 0 N--CA 1.466 -0.136 0 C-N-CA 122.72 2.28 . . . . 0.0 112.362 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -79.24 -25.21 42.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.872 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.738 HG21 HD11 ' A' ' 284' ' ' ILE . 41.6 t -71.08 151.37 9.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.151 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -81.86 150.22 27.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.837 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . 0.477 ' O ' HD12 ' A' ' 338' ' ' ILE . 20.1 tt0 -58.45 -33.88 70.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.588 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.0 t80 -63.76 -17.34 62.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.868 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 336' ' ' GLU . 0.0 OUTLIER -87.37 -35.25 18.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.891 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.472 ' CG2' ' HA ' ' A' ' 322' ' ' GLU . 2.1 mp -71.61 -37.27 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.477 HD12 ' O ' ' A' ' 334' ' ' GLN . 2.8 mp -74.29 -71.4 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.111 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.621 ' O ' HD12 ' A' ' 343' ' ' ILE . 6.8 tp10 -38.19 -50.49 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.668 ' HB2' HG22 ' A' ' 285' ' ' VAL . 9.5 p -45.17 -43.67 10.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.858 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.443 ' O ' ' N ' ' A' ' 344' ' ' VAL . 46.4 t80 -58.94 -55.35 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.903 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 341' ' ' PHE . 33.5 m-80 -36.23 -55.23 0.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.855 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.702 ' H ' HD12 ' A' ' 343' ' ' ILE . 5.4 mp -56.28 -41.3 70.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.167 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.443 ' N ' ' O ' ' A' ' 341' ' ' PHE . 68.0 t -64.35 -59.18 4.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.119 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -40.83 -61.16 1.01 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.097 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -44.71 -51.5 9.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.949 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -54.72 -70.57 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 99.2 t -38.06 -62.98 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.158 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.592 ' HA ' HD12 ' A' ' 352' ' ' ILE . 10.5 m-85 -44.82 -66.02 0.45 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.852 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 349' ' ' PHE . 12.1 tpt180 -35.58 -56.25 0.67 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.856 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 1.3 t -49.46 -46.79 48.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 349' ' ' PHE . 64.8 mt -55.26 -60.26 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.163 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.776 ' H ' HD12 ' A' ' 353' ' ' ILE . 4.4 mp -44.33 -49.41 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.109 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 14.3 mt -60.62 -48.59 81.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -43.16 -42.22 4.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.842 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -40.52 -43.87 1.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.931 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -44.61 152.68 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.946 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 34.4 tttm -39.61 126.83 1.92 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 6.2 ptt180 -119.12 173.05 7.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.859 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 26.2 p -64.38 118.1 8.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.49 -64.33 0.84 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.873 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 65.55 -114.4 6.63 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.467 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 31.9 ttt180 -114.1 147.25 39.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 0.0 110.925 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -141.12 116.88 10.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.857 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.6 t -94.73 -62.4 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.865 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 102.02 146.51 18.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.485 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 176.85 6.19 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.67 2.247 . . . . 0.0 112.374 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 75.7 p -116.04 171.99 7.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.883 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 18.2 m -112.54 146.58 38.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.883 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.465 -179.975 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 68.9 m -131.24 154.15 48.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.899 0.38 . . . . 0.0 110.836 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 2.1 m -106.21 117.8 34.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.854 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 121.78 113.62 2.25 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.5 t -165.78 155.88 12.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.841 0.353 . . . . 0.0 110.86 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 38.4 t -62.53 121.07 12.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.835 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 164.57 -89.72 0.1 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.478 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -174.01 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.145 0 C-N-CA 122.667 2.245 . . . . 0.0 112.332 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 26.5 mm100 -74.93 160.59 30.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.926 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 36.7 mtpt -87.42 138.0 31.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.423 ' C ' HD12 ' A' ' 277' ' ' ILE . 2.6 pp -104.74 149.29 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.1 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -95.38 138.93 32.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.883 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 81.2 p -74.52 151.17 87.24 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.555 0.693 . . . . 0.0 111.11 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . 0.424 ' HD3' ' CD ' ' A' ' 339' ' ' GLU . 54.0 Cg_endo -69.75 172.25 12.97 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.728 2.285 . . . . 0.0 112.369 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.948 ' O ' HG23 ' A' ' 285' ' ' VAL . 5.1 t -73.3 142.23 47.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.868 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -76.09 -40.35 53.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -53.17 -39.34 63.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.555 HG12 ' CE1' ' A' ' 329' ' ' PHE . 18.3 mt -77.1 -49.35 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.15 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.948 HG23 ' O ' ' A' ' 281' ' ' SER . 48.2 t -51.26 -33.93 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.145 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -68.84 -40.64 79.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.414 ' HA ' HD13 ' A' ' 290' ' ' ILE . 54.7 t80 -73.79 -27.83 61.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.912 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . . . . . . . . . 42.2 m -63.23 -19.66 64.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.134 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 293' ' ' MET . 2.7 mptm? -75.56 -44.54 42.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.881 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.472 ' H ' HD12 ' A' ' 290' ' ' ILE . 3.3 mp -55.74 -27.87 22.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.521 HG21 ' CD2' ' A' ' 324' ' ' HIS . 6.2 pt -98.25 -51.99 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.132 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.71 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -63.82 -48.45 76.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.096 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 25.2 ttm -56.33 -64.2 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 25.7 mm-40 -45.55 -56.97 4.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.881 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 298' ' ' ALA . 17.4 mmtp -58.5 -69.32 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.865 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.43 ' HB2' HG11 ' A' ' 348' ' ' VAL . 86.5 mt -37.04 -42.54 0.42 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.96 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -74.33 -38.71 63.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.906 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -59.22 -28.89 67.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.133 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 296' ' ' LEU . 30.9 m -90.73 -36.18 7.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.523 ' CD1' ' C ' ' A' ' 300' ' ' PHE . 0.2 OUTLIER -38.83 -64.36 0.45 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.863 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 22.2 m -51.67 -51.97 51.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -47.78 -73.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.914 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -88.18 86.83 7.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.958 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 305' ' ' HIS . 18.1 mt-10 -95.79 -48.87 5.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.91 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.451 ' CD2' ' OD1' ' A' ' 306' ' ' ASP . 13.6 t60 -34.45 -65.97 0.19 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.451 ' OD1' ' CD2' ' A' ' 305' ' ' HIS . 3.8 m-20 -140.94 166.53 24.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.62 -48.9 11.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.92 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 18.3 m -49.21 -32.9 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.072 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 1.9 m -50.78 117.07 2.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? 51.97 43.24 30.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -47.08 -27.63 1.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.824 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -47.23 -28.82 2.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.874 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -59.73 -59.23 5.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.101 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.17 -56.46 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.113 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -47.47 -39.78 16.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.868 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -54.15 -55.29 29.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.468 ' O ' ' N ' ' A' ' 320' ' ' ASP . 87.6 mt -42.32 -60.8 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.107 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.432 ' HB3' ' NH1' ' A' ' 318' ' ' ARG . 8.8 mtp-105 -36.56 -34.37 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.826 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 11.6 mt -86.16 -39.5 16.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.4 t70 -63.94 -63.93 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.882 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.456 HG22 ' CG1' ' A' ' 291' ' ' ILE . 68.9 p -53.29 -40.85 65.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.444 ' C ' ' OE1' ' A' ' 322' ' ' GLU . 0.0 OUTLIER -54.01 -37.36 63.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.896 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -92.59 -13.07 30.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.884 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . 0.521 ' CD2' HG21 ' A' ' 291' ' ' ILE . 54.3 t60 -86.89 -28.06 23.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.826 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.5 HD12 HG23 ' A' ' 337' ' ' ILE . 17.3 mt -89.8 -54.37 4.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.88 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.439 ' N ' HG12 ' A' ' 337' ' ' ILE . 25.4 tttm -44.06 -39.97 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.909 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -65.7 -39.76 91.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.495 ' HB3' ' CE1' ' A' ' 329' ' ' PHE . 47.0 tttp -57.16 -42.64 81.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.867 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.701 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.2 OUTLIER -129.99 91.91 38.19 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.607 0.718 . . . . 0.0 110.895 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 329' ' ' PHE . 53.6 Cg_endo -69.77 -20.78 34.34 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.698 2.266 . . . . 0.0 112.358 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -78.69 -33.07 47.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.87 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.701 HG12 ' O ' ' A' ' 329' ' ' PHE . 1.5 p -65.79 150.27 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.155 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -70.53 156.04 39.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.857 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . 0.465 ' HG3' ' CD1' ' A' ' 338' ' ' ILE . 2.5 tp-100 -68.08 -41.86 81.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -58.69 -13.94 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -82.63 -31.33 28.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.5 HG23 HD12 ' A' ' 325' ' ' LEU . 1.9 mp -81.16 -28.87 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.148 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.465 ' CD1' ' HG3' ' A' ' 334' ' ' GLN . 2.6 mp -77.17 -53.58 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.125 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.625 ' O ' HD12 ' A' ' 343' ' ' ILE . 10.0 tt0 -60.95 -44.41 97.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.533 ' HB2' HG22 ' A' ' 285' ' ' VAL . 96.3 p -47.49 -49.44 25.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 344' ' ' VAL . 71.5 t80 -58.35 -56.83 17.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.835 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 341' ' ' PHE . 17.9 m-80 -35.09 -43.96 0.22 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.867 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.625 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.1 mp -66.96 -46.86 83.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.71 HG11 ' HB3' ' A' ' 292' ' ' ALA . 71.6 t -55.65 -66.33 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.101 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -37.41 -64.3 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.09 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.9 mtpp -42.99 -43.24 4.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.932 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -67.63 -70.41 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.858 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 296' ' ' LEU . 88.8 t -40.89 -50.64 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.145 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 13.0 m-85 -52.51 -61.34 2.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.872 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 -44.98 -43.33 9.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.427 ' O ' HD11 ' A' ' 354' ' ' LEU . 3.3 t -51.29 -34.78 34.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.841 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.449 HG21 ' CD1' ' A' ' 300' ' ' PHE . 14.8 mt -93.73 -32.33 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.135 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' A' ' 355' ' ' ASN . 44.9 mm -58.39 -42.8 85.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.093 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.764 HD12 ' N ' ' A' ' 355' ' ' ASN . 0.9 OUTLIER -43.19 -23.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.953 179.916 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.764 ' N ' HD12 ' A' ' 354' ' ' LEU . 11.8 t-20 -61.59 -43.17 99.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.871 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -95.66 -52.04 4.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.899 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.463 ' CE1' ' HG2' ' A' ' 359' ' ' ARG . 6.8 t80 -90.08 89.11 7.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -118.81 89.04 3.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . 0.463 ' HG2' ' CE1' ' A' ' 357' ' ' TYR . 20.7 ptt180 -171.46 115.92 0.4 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.832 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 43.0 t -78.95 112.63 16.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.854 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -162.4 166.95 24.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 175.05 -52.97 0.13 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.49 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -81.95 159.25 23.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.877 0.37 . . . . 0.0 110.834 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -156.2 160.07 39.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 16.8 t -91.55 162.88 14.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.837 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -85.58 -156.64 27.28 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.479 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -36.45 10.73 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.706 2.271 . . . . 0.0 112.326 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 35.9 p -59.15 100.21 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 92.1 p -166.66 176.94 6.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.503 179.985 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 16.9 m -98.94 174.07 6.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 0.0 110.87 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 45.4 p -163.63 174.32 11.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.874 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -125.05 -135.82 4.44 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.461 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 2.1 t -167.32 134.6 2.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.902 0.382 . . . . 0.0 110.803 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 95.4 p -156.52 154.02 29.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.861 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 131.35 160.13 9.75 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 -4.91 14.94 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.705 2.27 . . . . 0.0 112.367 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -68.13 143.72 55.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -87.75 115.61 25.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.91 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 3.8 mt -113.65 151.48 15.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.119 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -75.71 147.61 39.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.862 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 33.5 p -102.18 153.58 37.96 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.553 0.692 . . . . 0.0 111.156 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -174.06 0.83 Allowed 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.66 2.24 . . . . 0.0 112.358 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.542 ' HB2' HD12 ' A' ' 284' ' ' ILE . 21.2 m -73.08 119.99 18.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.837 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 284' ' ' ILE . . . -57.17 -55.44 34.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.092 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 282' ' ' ALA . 13.7 pt-20 -36.44 -33.26 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.849 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.62 HD11 HG21 ' A' ' 332' ' ' VAL . 47.1 mt -83.46 -54.35 9.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.672 HG12 ' NZ ' ' A' ' 289' ' ' LYS . 49.6 t -38.83 -53.12 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.115 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -57.1 -55.75 30.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.942 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -59.65 -20.9 59.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.946 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.483 HG23 HD11 ' A' ' 325' ' ' LEU . 49.2 m -75.15 -25.36 58.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.158 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.672 ' NZ ' HG12 ' A' ' 285' ' ' VAL . 14.4 mttp -77.13 -41.08 43.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.6 mp -56.65 -30.13 31.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.537 HG21 ' CD2' ' A' ' 324' ' ' HIS . 10.4 pt -97.76 -49.81 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.133 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.487 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -61.87 -48.02 82.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.062 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.473 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 13.9 ttm -51.9 -60.24 3.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.907 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -47.82 -53.32 15.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 298' ' ' ALA . 29.1 mtpt -60.42 -67.99 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.897 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.462 HD23 ' CD1' ' A' ' 317' ' ' ILE . 90.9 mt -38.6 -38.55 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.475 ' CE1' HG12 ' A' ' 352' ' ' ILE . 8.6 m-85 -77.99 -37.06 48.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -67.23 -34.58 77.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.116 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 29.4 m -87.49 -24.11 6.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.144 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.531 ' CE2' HG23 ' A' ' 352' ' ' ILE . 2.0 t80 -54.53 -54.86 35.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 9.4 t -77.37 -17.89 57.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.146 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -62.99 -71.91 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.43 ' HA ' ' NE2' ' A' ' 305' ' ' HIS . 12.4 p90 -85.61 17.43 3.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.961 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 305' ' ' HIS . 15.5 tm-20 -38.15 -56.53 1.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.438 ' C ' ' O ' ' A' ' 304' ' ' GLU . 8.9 p80 -34.8 -46.06 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -159.56 136.91 9.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 4.3 mtpm? -70.29 -62.14 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.858 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 9.6 p -41.01 -30.63 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.168 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 10.5 t -78.79 114.58 17.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.852 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 73.59 34.67 0.93 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.852 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -51.14 -25.25 4.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.886 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 6.0 pt-20 -55.36 -27.35 46.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -57.62 -50.42 73.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 55.0 t -66.89 -69.38 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.118 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.417 ' ND2' HD11 ' A' ' 319' ' ' LEU . 0.5 OUTLIER -41.19 -42.92 2.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.494 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 0.9 OUTLIER -40.86 -60.45 1.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.53 HG22 ' CE2' ' A' ' 341' ' ' PHE . 29.8 mt -41.4 -63.43 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.141 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.444 ' HB2' ' NH1' ' A' ' 318' ' ' ARG . 23.8 ttm105 -36.43 -39.1 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.856 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.417 HD11 ' ND2' ' A' ' 315' ' ' ASN . 5.2 mt -83.51 -39.63 20.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.95 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.443 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.2 t0 -62.51 -63.87 1.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.453 HG22 HG13 ' A' ' 291' ' ' ILE . 72.9 p -51.84 -52.77 46.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.154 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -47.05 -36.6 8.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -85.88 -18.93 31.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . 0.537 ' CD2' HG21 ' A' ' 291' ' ' ILE . 80.1 t60 -89.43 -19.7 24.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.886 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.521 ' HB2' HG23 ' A' ' 337' ' ' ILE . 47.9 mt -93.31 -60.06 1.88 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.931 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 38.1 tttm -44.16 -35.3 2.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -66.33 -38.36 87.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.43 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 26.2 tptt -72.42 -42.59 64.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.566 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 3.2 m-85 -110.46 85.03 4.3 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 0.0 110.872 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -35.41 12.65 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.66 2.24 . . . . 0.0 112.335 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -71.84 -31.53 66.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.842 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.62 HG21 HD11 ' A' ' 284' ' ' ILE . 74.9 t -67.94 149.73 11.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -79.71 144.35 33.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . 0.47 ' O ' HD12 ' A' ' 338' ' ' ILE . 25.6 tt0 -53.46 -38.29 63.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.443 ' CD2' ' OE1' ' A' ' 336' ' ' GLU . 7.2 t80 -59.7 -21.16 60.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.443 ' OE1' ' CD2' ' A' ' 335' ' ' PHE . 0.0 OUTLIER -86.92 -18.52 30.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.886 -179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.521 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.4 mp -88.32 -27.41 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.132 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.47 HD12 ' O ' ' A' ' 334' ' ' GLN . 3.5 mp -89.75 -51.99 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.146 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.56 ' O ' HD12 ' A' ' 343' ' ' ILE . 7.7 tt0 -51.52 -31.47 24.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.891 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 2.1 p -66.37 -36.1 82.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.53 ' CE2' HG22 ' A' ' 317' ' ' ILE . 39.1 t80 -68.35 -31.05 70.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.847 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -56.42 -32.01 64.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.56 HD12 ' O ' ' A' ' 339' ' ' GLU . 5.0 mp -88.13 -37.92 11.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.153 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 81.0 t -64.23 -51.3 70.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . 0.5 ' HB2' ' CE1' ' A' ' 341' ' ' PHE . . . -51.12 -66.78 0.33 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.062 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . 0.403 ' C ' ' HD3' ' A' ' 346' ' ' LYS . 0.0 OUTLIER -50.39 -31.29 14.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.893 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -67.68 -66.94 0.5 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 98.2 t -45.71 -44.2 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.092 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 352' ' ' ILE . 4.1 m-85 -45.6 -60.99 1.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.918 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.462 HH21 HG21 ' A' ' 353' ' ' ILE . 3.4 tpm_? -37.3 -62.98 0.47 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.64 ' HA ' HD13 ' A' ' 354' ' ' LEU . 28.1 m -47.55 -33.29 6.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.531 HG23 ' CE2' ' A' ' 300' ' ' PHE . 93.6 mt -79.7 -34.81 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.153 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.462 HG21 HH21 ' A' ' 350' ' ' ARG . 5.0 mm -60.77 -23.06 27.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.102 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.64 HD13 ' HA ' ' A' ' 351' ' ' SER . 10.1 mp -47.61 -20.53 0.27 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 12.9 t-20 -117.8 102.72 9.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.919 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -61.27 83.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 35.3 p90 -40.95 109.25 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.953 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 12.9 pttp -166.35 137.18 3.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.922 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 70.1 mmt-85 -40.88 133.6 2.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 4.8 p -104.92 -33.04 8.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 40.79 45.76 2.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -166.84 132.78 2.71 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.45 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 21.1 ttt180 -114.31 95.76 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.811 0.339 . . . . 0.0 110.847 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 63.97 31.09 13.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 7.5 m -118.02 136.0 53.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 83.53 147.33 7.48 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.489 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 89.8 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.674 2.25 . . . . 0.0 112.335 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 13.1 t -131.81 98.75 4.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 37.5 m -37.37 -53.09 1.12 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.878 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.464 -179.976 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 26.1 m -115.46 85.07 2.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.933 0.397 . . . . 0.0 110.856 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 57.4 m -85.56 92.79 8.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.886 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -101.85 -145.15 15.86 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.469 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 42.5 t -111.06 -43.9 3.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.835 0.35 . . . . 0.0 110.833 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 32.1 m -62.72 97.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 120.93 178.98 16.07 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.498 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 178.88 4.13 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.677 2.251 . . . . 0.0 112.332 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -100.12 151.32 21.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.941 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.73 139.41 41.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.452 ' C ' HD12 ' A' ' 277' ' ' ILE . 2.7 pp -114.54 151.52 16.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.157 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -122.83 133.71 54.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 67.2 p -103.24 152.2 38.63 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.605 0.717 . . . . 0.0 111.125 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 -178.59 2.4 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.701 2.268 . . . . 0.0 112.386 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.684 ' O ' HG23 ' A' ' 285' ' ' VAL . 72.7 m -68.56 134.37 49.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.874 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -72.57 -40.74 66.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.122 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -55.26 -36.24 65.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.899 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.852 HD11 HG21 ' A' ' 332' ' ' VAL . 22.8 mt -78.33 -41.74 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.101 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.684 HG23 ' O ' ' A' ' 281' ' ' SER . 77.7 t -58.46 -46.42 89.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.141 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -60.65 -37.02 80.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.89 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -73.78 -34.22 64.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.883 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.507 ' CG2' HG21 ' A' ' 344' ' ' VAL . 92.0 m -56.38 -19.29 14.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.162 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.543 ' NZ ' HG22 ' A' ' 344' ' ' VAL . 7.2 mptt -77.13 -49.23 15.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.845 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.417 ' H ' HD12 ' A' ' 290' ' ' ILE . 2.9 mp -53.74 -24.4 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.162 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.491 HG13 ' N ' ' A' ' 292' ' ' ALA . 7.0 pt -98.83 -52.4 9.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.148 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.491 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -67.94 -49.29 62.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.061 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.517 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 19.1 ttm -45.42 -62.26 1.34 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.894 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -52.29 -72.56 0.05 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' A' ' 298' ' ' ALA . 35.1 mtmt -42.14 -63.83 0.68 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.897 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.516 HD23 ' CD1' ' A' ' 317' ' ' ILE . 81.7 mt -42.3 -52.33 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.472 ' CE1' ' CG1' ' A' ' 352' ' ' ILE . 7.7 m-85 -62.2 -26.54 68.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.975 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.454 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -72.18 -51.1 22.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.092 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.854 ' HB ' ' HB1' ' A' ' 313' ' ' ALA . 18.8 m -75.02 -24.32 17.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.108 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.696 ' CE2' HG23 ' A' ' 352' ' ' ILE . 0.2 OUTLIER -40.26 -68.66 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 301' ' ' THR . 28.1 m -63.61 -9.63 14.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.177 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 304' ' ' GLU . 1.7 t70 -80.25 179.63 7.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.854 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.518 ' CE2' ' O ' ' A' ' 299' ' ' VAL . 46.0 p90 37.56 28.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 302' ' ' ASP . 17.5 tt0 -37.26 -45.59 0.67 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.85 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.431 ' C ' ' O ' ' A' ' 304' ' ' GLU . 77.6 t60 -36.15 -60.98 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -166.71 135.47 2.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 311' ' ' ASP . 12.9 ttmt -57.35 -58.26 9.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 309' ' ' SER . 32.9 m -55.11 -40.82 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.08 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.424 ' N ' HG23 ' A' ' 308' ' ' VAL . 31.4 t -48.42 -54.13 15.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.873 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -124.75 42.31 3.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 307' ' ' LYS . 4.0 p30 -49.28 -25.53 2.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.867 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -41.39 -32.94 0.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.943 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.854 ' HB1' ' HB ' ' A' ' 299' ' ' VAL . . . -56.96 -52.89 63.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.3 t -79.84 -38.58 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.118 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.9 OUTLIER -59.75 -54.23 48.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.931 179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 315' ' ' ASN . 22.7 mtmt -35.15 -62.74 0.37 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.93 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.516 ' CD1' HD23 ' A' ' 296' ' ' LEU . 31.8 mt -36.63 -58.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.441 ' C ' ' O ' ' A' ' 317' ' ' ILE . 0.0 OUTLIER -35.19 -42.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.892 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.5 mt -80.68 -39.31 27.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.88 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 317' ' ' ILE . 19.8 t0 -60.96 -70.51 0.18 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.873 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.457 HG23 HG23 ' A' ' 317' ' ' ILE . 68.1 p -45.77 -45.84 14.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.158 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -51.29 -36.21 41.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.95 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -89.34 -20.99 23.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 55.6 t60 -85.6 -18.93 31.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 42.8 mt -93.18 -59.54 2.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.897 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 17.1 ttmt -41.47 -36.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -65.7 -52.58 50.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.476 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 30.4 tttp -54.59 -41.82 70.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.586 ' CE2' HG12 ' A' ' 284' ' ' ILE . 1.3 m-85 -116.12 83.95 13.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.661 0.743 . . . . 0.0 110.823 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -30.24 22.54 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.348 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -77.92 -18.46 56.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.852 HG21 HD11 ' A' ' 284' ' ' ILE . 53.4 t -80.39 152.52 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -82.9 151.72 25.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.844 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -60.55 -41.04 93.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -53.85 -26.27 23.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -81.42 -30.45 33.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.915 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 337' ' ' ILE . 1.8 mp -84.62 -14.43 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.145 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 36.5 mt -87.33 -52.54 11.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.139 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' ' 343' ' ' ILE . 4.7 tt0 -59.83 -48.36 81.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.908 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.545 ' O ' HG23 ' A' ' 344' ' ' VAL . 40.3 m -39.76 -50.82 2.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.51 ' CE1' HG22 ' A' ' 317' ' ' ILE . 42.7 t80 -56.03 -57.92 10.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 341' ' ' PHE . 67.4 m-20 -37.47 -46.47 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.52 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.4 mp -68.41 -40.08 81.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 340' ' ' SER . 81.1 t -61.36 -64.18 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.08 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -42.71 -55.96 3.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.086 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 20.5 mmtp -48.62 -30.16 5.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -83.73 -64.37 1.18 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.9 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 56.5 t -43.89 -27.06 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -74.02 -62.75 1.4 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.907 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.673 ' O ' HD13 ' A' ' 354' ' ' LEU . 21.0 ttm105 -41.5 -44.78 3.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.836 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 25.6 p -60.39 -50.83 72.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.839 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.696 HG23 ' CE2' ' A' ' 300' ' ' PHE . 50.1 mt -51.14 -52.22 19.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.093 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 353' ' ' ILE . 2.5 mp -59.96 -53.04 54.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.673 HD13 ' O ' ' A' ' 350' ' ' ARG . 7.0 mp -49.43 -49.41 45.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.92 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.405 ' C ' ' O ' ' A' ' 354' ' ' LEU . 51.1 t-20 -37.33 -28.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.902 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 354' ' ' LEU . 5.2 tp10 -82.17 -67.71 0.76 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.859 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.411 ' C ' ' O ' ' A' ' 356' ' ' GLU . 15.4 m-85 -35.7 -53.63 0.71 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.44 89.97 3.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.848 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -60.03 165.05 3.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.866 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 31.0 p -145.91 151.91 38.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.853 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -86.59 103.88 15.51 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.847 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 174.22 86.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 17.3 mmm-85 -74.71 160.62 30.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.829 0.347 . . . . 0.0 110.888 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.86 -56.02 2.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 58.2 p 39.1 41.76 0.63 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.884 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -137.39 83.66 0.25 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.452 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 151.98 69.27 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.701 2.267 . . . . 0.0 112.343 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 3.6 m -114.46 134.41 55.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.816 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 53.5 p -162.97 163.12 26.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.838 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.468 -179.97 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.7 m -43.92 136.78 3.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.892 0.377 . . . . 0.0 110.815 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 99.3 p -149.06 145.19 27.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.855 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 106.58 62.99 0.6 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.499 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 5.3 p -80.13 124.28 28.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.36 . . . . 0.0 110.863 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 77.6 p -173.77 132.7 0.44 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -170.73 -175.98 39.74 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.48 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -33.95 15.66 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.703 2.269 . . . . 0.0 112.329 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 51.3 mm-40 -78.56 162.03 26.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 9.9 ttmm -70.09 116.14 10.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 278' ' ' PHE . 45.6 mm -94.5 158.28 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.11 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.523 ' N ' HG22 ' A' ' 277' ' ' ILE . 5.8 m-85 -87.57 140.0 29.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 55.0 p -99.28 151.66 37.5 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.599 0.714 . . . . 0.0 111.148 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . 0.409 ' HD3' ' CD ' ' A' ' 339' ' ' GLU . 53.9 Cg_endo -69.74 179.62 3.56 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.725 2.283 . . . . 0.0 112.308 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.552 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.8 t -69.78 120.96 16.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.868 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.24 -44.04 96.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -49.77 -41.15 43.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.808 HD11 HG21 ' A' ' 332' ' ' VAL . 22.1 mt -75.95 -42.32 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.108 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 281' ' ' SER . 75.3 t -54.5 -42.68 60.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.115 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.411 ' HD2' ' N ' ' A' ' 286' ' ' LYS . 0.4 OUTLIER -62.53 -36.43 82.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.852 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.478 ' CD2' ' HD3' ' A' ' 328' ' ' LYS . 31.5 t80 -76.87 -31.36 56.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.928 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.836 ' HB ' HG21 ' A' ' 344' ' ' VAL . 33.2 m -64.01 -23.73 67.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.142 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.606 ' HG3' HG13 ' A' ' 344' ' ' VAL . 30.7 mttt -76.19 -39.57 54.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.882 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.402 ' CD1' ' O ' ' A' ' 286' ' ' LYS . 2.6 mp -61.7 -28.49 44.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.099 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.838 HG21 ' CD2' ' A' ' 324' ' ' HIS . 23.6 pt -97.77 -43.4 12.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.122 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.454 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -69.25 -47.8 63.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.121 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.485 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 9.5 ttm -52.53 -71.94 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.889 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 293' ' ' MET . 18.3 mt-10 -36.94 -60.01 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.893 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 24.9 mmtt -53.92 -66.21 0.43 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.866 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.648 ' CD2' HG13 ' A' ' 314' ' ' VAL . 75.8 mt -39.11 -49.79 1.82 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.919 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.671 ' CE2' HG13 ' A' ' 348' ' ' VAL . 11.8 m-85 -65.34 -40.27 93.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.933 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -59.93 -50.43 73.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 296' ' ' LEU . 27.9 m -64.92 -28.8 45.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.106 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.499 ' CD2' HG21 ' A' ' 352' ' ' ILE . 4.4 t80 -69.45 -57.02 5.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 297' ' ' TYR . 8.5 t -67.85 -18.53 64.84 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.148 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -83.4 -63.07 1.43 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -86.72 95.13 9.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -93.59 -52.7 4.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.922 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -86.34 -71.11 0.56 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.886 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -44.88 103.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -84.31 -36.76 22.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 1.6 p -54.82 -29.54 21.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.115 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 15.2 m -89.62 -36.66 15.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.862 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 24.0 ttp180 -67.67 -17.07 64.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -85.41 -45.4 11.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.874 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 15.3 pt-20 -77.7 -17.71 57.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -75.2 -49.4 19.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.055 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.648 HG13 ' CD2' ' A' ' 296' ' ' LEU . 66.1 t -68.76 -36.89 76.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.136 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -75.7 -12.33 60.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.896 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.492 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 22.3 mmtt -82.55 -17.58 44.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.553 HD12 ' CD2' ' A' ' 296' ' ' LEU . 72.9 mt -67.55 -56.7 12.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.105 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.425 ' O ' ' CG ' ' A' ' 322' ' ' GLU . 7.3 ptm180 -41.2 -35.74 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.846 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 316' ' ' LYS . 4.8 mt -76.08 -37.78 57.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 27.3 t70 -73.97 -69.02 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.853 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.715 HG22 HD12 ' A' ' 291' ' ' ILE . 14.5 p -41.3 -47.6 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.118 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.425 ' CG ' ' O ' ' A' ' 318' ' ' ARG . 33.0 mt-10 -45.73 -49.99 14.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.85 -18.47 60.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . 0.838 ' CD2' HG21 ' A' ' 291' ' ' ILE . 79.3 t60 -84.88 -23.96 28.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.467 ' HB2' HG23 ' A' ' 337' ' ' ILE . 19.3 mt -93.77 -54.49 3.6 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.928 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.34 -26.07 0.75 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.876 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -79.95 -35.62 37.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.478 ' HD3' ' CD2' ' A' ' 287' ' ' TYR . 37.6 tttp -69.84 -39.34 76.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.587 ' CE1' HG23 ' A' ' 284' ' ' ILE . 2.8 m-85 -117.06 87.44 22.91 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.678 0.751 . . . . 0.0 110.875 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -40.71 5.01 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.685 2.257 . . . . 0.0 112.316 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -67.53 -24.46 65.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.881 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.808 HG21 HD11 ' A' ' 284' ' ' ILE . 41.5 t -73.47 154.14 7.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.125 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . 0.413 ' N ' ' CG1' ' A' ' 332' ' ' VAL . 5.7 t70 -83.35 147.28 28.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.916 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -58.38 -37.08 74.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.918 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.495 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 7.3 t80 -61.98 -13.32 24.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -90.61 -26.66 19.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.889 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.467 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.9 mp -82.54 -24.55 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.11 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.428 ' O ' ' ND2' ' A' ' 342' ' ' ASN . 3.2 mp -89.77 -35.5 7.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.123 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.409 ' CD ' ' HD3' ' A' ' 280' ' ' PRO . 11.5 tt0 -72.67 -22.51 60.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.926 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 341' ' ' PHE . 10.9 m -74.55 -65.47 0.86 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.484 ' CE1' HG22 ' A' ' 317' ' ' ILE . 73.8 t80 -36.6 -41.0 0.28 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.906 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 338' ' ' ILE . 4.0 m-80 -49.1 -51.95 28.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.868 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.497 ' H ' HD12 ' A' ' 343' ' ' ILE . 3.9 mp -68.84 -33.58 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.153 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.836 HG21 ' HB ' ' A' ' 288' ' ' THR . 32.8 t -62.57 -63.54 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.101 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -35.72 -66.67 0.19 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.123 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 24.4 mtpp -40.66 -53.55 2.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -44.38 -39.25 4.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.671 HG13 ' CE2' ' A' ' 297' ' ' TYR . 39.9 t -76.49 -43.49 35.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.119 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.412 ' C ' ' N ' ' A' ' 351' ' ' SER . 3.3 m-85 -49.56 -70.85 0.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 31.1 ptt85 -43.09 -23.49 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.851 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.412 ' N ' ' C ' ' A' ' 349' ' ' PHE . 3.2 t -78.89 -52.29 8.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.812 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.499 HG21 ' CD2' ' A' ' 300' ' ' PHE . 44.8 mt -70.64 -57.42 7.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.136 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 1.7 mt -43.63 -39.95 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.102 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -75.6 -58.77 3.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.936 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -37.55 -39.03 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -86.68 -59.87 2.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.89 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -115.56 89.05 3.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 5.8 pttp -50.14 151.36 2.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.9 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -159.23 147.09 17.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 31.5 p -130.92 120.91 24.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -134.69 173.82 11.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -97.86 -123.43 4.7 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.527 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 27.8 mmt-85 -125.64 55.23 1.44 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.896 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 364' ' ' ASP . 4.2 p-10 -93.69 49.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 8.2 t -153.15 -179.93 8.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.817 -179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -122.66 83.42 0.36 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.478 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.8 164.66 33.76 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.688 2.259 . . . . 0.0 112.33 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 33.4 t -89.93 -54.23 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 30.7 t -63.29 -47.6 81.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.475 179.984 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 60.2 p -166.77 148.91 6.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.914 0.388 . . . . 0.0 110.85 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.4 t -75.77 -62.32 1.63 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.844 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -65.79 -151.39 0.12 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.474 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 59.6 p -40.13 100.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.869 0.366 . . . . 0.0 110.825 -179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.2 t -52.18 -53.51 42.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -158.1 85.21 0.13 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.53 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 -35.41 12.69 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.708 2.272 . . . . 0.0 112.314 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -81.55 162.96 22.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.923 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -87.93 127.72 35.37 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.479 ' C ' HD12 ' A' ' 277' ' ' ILE . 2.7 pp -104.93 162.95 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -88.08 150.63 23.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.905 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 9.8 p -74.0 154.92 88.73 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.613 0.721 . . . . 0.0 111.134 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -170.29 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.743 2.295 . . . . 0.0 112.349 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.87 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.0 OUTLIER -75.84 133.04 40.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.869 -179.856 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -77.98 -42.23 33.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.136 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -51.49 -39.04 56.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.928 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.562 HG12 ' CZ ' ' A' ' 329' ' ' PHE . 12.1 mt -79.11 -44.09 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.119 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.891 HG22 ' HB2' ' A' ' 340' ' ' SER . 74.7 t -54.61 -37.69 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.085 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -64.24 -35.74 81.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -79.87 -24.46 41.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.931 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.486 ' HB ' HG21 ' A' ' 344' ' ' VAL . 8.9 m -66.49 -18.22 65.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.123 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 293' ' ' MET . 1.0 OUTLIER -77.27 -44.91 28.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.896 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 3.0 mp -56.02 -29.18 26.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.156 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.583 HD12 HG22 ' A' ' 321' ' ' THR . 8.7 pt -98.31 -50.93 10.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.116 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.541 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -63.93 -48.28 77.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.095 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.493 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 10.6 ttm -58.88 -67.34 0.38 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.879 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -43.31 -58.8 2.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 20.5 mmmt -55.3 -65.78 0.53 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.476 ' O ' HG22 ' A' ' 299' ' ' VAL . 49.4 mt -40.61 -58.49 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -54.98 -38.56 67.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.94 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . . . . . . . . . . . -64.03 -49.49 72.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.147 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 296' ' ' LEU . 16.7 m -66.46 -35.21 74.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.122 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.573 ' CD2' HD13 ' A' ' 352' ' ' ILE . 10.2 m-85 -71.79 -38.1 70.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 59.4 m -68.41 -40.71 81.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.181 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -75.62 -56.88 4.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.884 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -79.9 71.22 6.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.938 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 305' ' ' HIS . 13.7 pt-20 -89.96 -37.66 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.909 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.42 ' C ' ' O ' ' A' ' 304' ' ' GLU . 14.2 m80 -35.98 -42.79 0.29 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.856 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -173.5 154.97 2.68 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.869 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -50.27 30.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.875 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 12.7 p -54.5 -31.26 22.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.144 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.407 ' O ' ' C ' ' A' ' 310' ' ' ARG . 26.4 t -59.29 135.77 57.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.832 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.407 ' C ' ' O ' ' A' ' 309' ' ' SER . 5.5 mpt_? 37.08 48.62 0.75 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.873 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -62.65 -30.42 71.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.866 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -45.49 -22.51 0.15 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -68.82 -47.18 66.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.09 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 74.8 t -58.95 -34.96 54.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.413 ' O ' HD22 ' A' ' 319' ' ' LEU . 10.7 t30 -83.14 -41.35 18.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.867 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.451 ' HA ' HD23 ' A' ' 319' ' ' LEU . 13.5 mmtp -43.03 -30.24 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.435 ' O ' ' C ' ' A' ' 318' ' ' ARG . 49.2 mt -61.75 -60.21 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.486 ' HD2' HD13 ' A' ' 319' ' ' LEU . 3.3 tmt_? -34.28 -70.91 0.07 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.709 ' N ' HD13 ' A' ' 319' ' ' LEU . 0.0 OUTLIER -44.58 -43.13 7.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -66.02 -70.48 0.24 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.871 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.583 HG22 HD12 ' A' ' 291' ' ' ILE . 37.5 p -44.83 -55.49 5.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.153 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -45.6 -49.47 14.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.907 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -77.65 -12.41 59.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -90.74 -25.54 19.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.609 HD12 HG23 ' A' ' 337' ' ' ILE . 23.3 mt -94.37 -56.73 2.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.868 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -45.91 -24.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -81.82 -32.77 31.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 325' ' ' LEU . 26.5 tttp -69.23 -36.72 77.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.908 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.562 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 0.5 OUTLIER -122.38 90.94 49.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.688 0.756 . . . . 0.0 110.892 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -20.45 34.75 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.715 2.277 . . . . 0.0 112.337 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -81.31 -40.78 23.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.885 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.657 ' CG1' HD11 ' A' ' 337' ' ' ILE . 0.8 OUTLIER -62.98 161.57 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.114 -179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -93.39 160.06 14.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -67.07 -38.42 85.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.921 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -57.36 -15.42 6.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.898 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -90.51 -26.07 19.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.923 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.657 HD11 ' CG1' ' A' ' 332' ' ' VAL . 3.0 mp -86.69 -45.25 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.136 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.31 -52.15 62.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.124 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 6.6 tm-20 -62.3 -55.23 30.2 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.891 ' HB2' HG22 ' A' ' 285' ' ' VAL . 16.1 p -38.8 -39.27 0.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 344' ' ' VAL . 35.3 t80 -64.15 -53.39 50.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.425 ' C ' ' O ' ' A' ' 341' ' ' PHE . 17.5 m-80 -36.5 -37.67 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.912 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.45 ' H ' HD12 ' A' ' 343' ' ' ILE . 5.3 mp -78.55 -41.22 25.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.12 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.541 HG11 ' HB3' ' A' ' 292' ' ' ALA . 50.4 t -57.72 -47.84 84.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.118 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -54.74 -63.6 1.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.148 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 2.4 ptpp? -54.2 -23.37 14.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.899 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -78.16 -31.24 49.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 344' ' ' VAL . 89.7 t -86.04 -32.72 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.085 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 351' ' ' SER . 5.5 m-85 -59.9 -67.04 0.42 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.497 ' O ' ' CD1' ' A' ' 354' ' ' LEU . 30.8 ptt180 -37.73 -28.86 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 349' ' ' PHE . 8.0 t -78.86 -45.19 21.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 300' ' ' PHE . 65.2 mt -70.42 -21.76 23.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.139 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 31.2 mm -70.18 -27.17 31.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' A' ' 350' ' ' ARG . 5.6 mp -83.39 -51.48 7.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 354' ' ' LEU . 28.8 m-20 -35.57 -49.97 0.58 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -54.37 -54.47 40.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.911 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.505 ' CG ' ' O ' ' A' ' 357' ' ' TYR . 8.6 p90 -143.36 114.31 7.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.917 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 25.3 mttm -92.37 140.34 29.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.872 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.88 -31.75 6.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.823 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 2.1 t -99.71 83.97 2.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -56.21 136.06 53.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 174.63 -139.68 4.99 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.456 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 67.2 mtm180 -106.12 175.38 5.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.816 0.341 . . . . 0.0 110.853 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -104.19 115.01 29.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 49.6 m -93.31 113.92 26.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.85 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -148.23 141.97 9.61 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.5 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 368' ' ' SER . 54.2 Cg_endo -69.73 -6.52 18.78 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.68 2.253 . . . . 0.0 112.361 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 367' ' ' PRO . 77.9 p -37.04 104.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.857 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 51.3 m -89.7 149.02 22.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.489 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 7.8 t -172.55 147.34 1.84 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.942 0.401 . . . . 0.0 110.833 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 53.3 p -83.87 81.45 8.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.822 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -161.75 -104.49 0.19 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 93.4 p -99.27 132.99 44.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.875 0.369 . . . . 0.0 110.841 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 29.2 t -88.3 -51.05 5.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.862 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -136.74 -157.46 7.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.497 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 93.79 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.712 2.274 . . . . 0.0 112.337 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -117.77 146.06 44.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -86.81 148.91 25.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.903 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.804 HD13 ' H ' ' A' ' 277' ' ' ILE . 0.2 OUTLIER -113.54 161.55 12.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.109 179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -128.51 146.99 50.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.9 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 74.7 p -72.02 151.21 92.74 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.592 0.711 . . . . 0.0 111.143 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 175.87 7.5 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.674 2.249 . . . . 0.0 112.323 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.2 t -72.96 120.53 18.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.871 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -54.72 -49.4 70.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.117 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -43.04 -43.05 4.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.898 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.535 HG12 ' CE1' ' A' ' 329' ' ' PHE . 30.4 mt -73.52 -48.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.146 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.49 HG22 ' HB2' ' A' ' 340' ' ' SER . 98.1 t -47.19 -36.11 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -68.5 -57.26 6.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.847 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.43 ' HA ' HD13 ' A' ' 290' ' ' ILE . 43.0 t80 -55.75 -24.83 37.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.931 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.486 ' CG2' HG21 ' A' ' 344' ' ' VAL . 32.1 m -68.97 -26.24 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.092 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -75.13 -43.59 51.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.898 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.43 HD13 ' HA ' ' A' ' 287' ' ' TYR . 3.1 mp -54.75 -29.62 21.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.114 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.521 HG13 HG22 ' A' ' 321' ' ' THR . 8.5 pt -98.12 -51.22 10.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.607 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -58.4 -48.15 81.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.105 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . . . . . . . . . 19.7 ttm -53.88 -60.18 3.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.856 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -45.4 -60.2 2.28 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.493 ' O ' ' N ' ' A' ' 298' ' ' ALA . 29.4 mtpt -58.04 -67.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.832 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.612 HD12 HG21 ' A' ' 348' ' ' VAL . 86.2 mt -37.93 -33.86 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.934 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.445 ' O ' HG23 ' A' ' 301' ' ' THR . 7.7 m-85 -84.63 -37.48 21.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -64.76 -31.95 73.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.053 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 35.1 m -85.27 -23.56 7.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.144 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.557 ' CZ ' ' OE1' ' A' ' 304' ' ' GLU . 5.3 t80 -75.2 -47.26 29.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 297' ' ' TYR . 79.4 p -53.07 -40.87 64.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.102 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -77.71 -60.89 2.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.816 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -82.86 44.14 0.9 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.557 ' OE1' ' CZ ' ' A' ' 300' ' ' PHE . 14.9 tp10 -64.33 -42.69 96.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.444 ' C ' ' O ' ' A' ' 304' ' ' GLU . 7.4 m170 -34.45 -50.26 0.42 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -166.1 174.22 9.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -80.7 -50.54 9.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.835 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.453 HG23 ' N ' ' A' ' 309' ' ' SER . 28.4 m -45.68 -42.28 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.141 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.453 ' N ' HG23 ' A' ' 308' ' ' VAL . 10.0 t -48.12 104.14 0.05 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.42 37.83 22.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.849 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -40.27 -40.0 1.06 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.877 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -39.77 -42.93 1.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -47.07 -45.96 22.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.068 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 78.5 t -64.2 -68.4 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.448 ' O ' ' C ' ' A' ' 316' ' ' LYS . 3.8 t30 -43.17 -50.34 6.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 315' ' ' ASN . 11.3 mmmt -34.64 -58.3 0.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.434 ' O ' ' C ' ' A' ' 318' ' ' ARG . 63.9 mt -38.22 -61.22 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.144 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 317' ' ' ILE . 3.6 tmt_? -35.19 -49.72 0.5 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 6.8 mt -69.92 -44.21 70.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.883 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -61.67 -68.86 0.28 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.888 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.521 HG22 HG13 ' A' ' 291' ' ' ILE . 14.2 p -45.5 -47.25 14.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.155 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 13.9 tm-20 -49.24 -50.59 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.922 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -71.18 -16.07 62.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.871 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . 0.472 ' CD2' HG21 ' A' ' 291' ' ' ILE . 82.0 t60 -90.15 -21.92 21.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.865 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.463 HD11 HG23 ' A' ' 288' ' ' THR . 45.0 mt -93.45 -54.9 3.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.89 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 25.7 tttm -49.61 -26.71 3.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . 0.427 ' HG3' ' N ' ' A' ' 328' ' ' LYS . 10.8 pt-20 -78.01 -39.27 42.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.865 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.492 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 27.4 tptt -59.58 -48.62 80.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.616 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.2 OUTLIER -114.86 89.97 21.04 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.635 0.731 . . . . 0.0 110.867 179.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.67 -18.65 37.32 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.71 2.273 . . . . 0.0 112.399 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -83.91 -24.31 30.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 329' ' ' PHE . 0.8 OUTLIER -77.05 154.93 5.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.161 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -82.83 155.0 24.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.848 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . 0.472 ' HG2' ' CD1' ' A' ' 338' ' ' ILE . 35.7 tt0 -63.93 -49.58 72.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -47.41 -19.85 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -81.65 -39.32 24.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.899 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.572 HD11 ' CG1' ' A' ' 332' ' ' VAL . 1.8 mp -71.24 -22.24 22.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.105 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.472 ' CD1' ' HG2' ' A' ' 334' ' ' GLN . 2.5 mp -81.81 -55.25 8.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.158 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.624 ' O ' HD12 ' A' ' 343' ' ' ILE . 0.6 OUTLIER -60.38 -37.22 80.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.49 ' HB2' HG22 ' A' ' 285' ' ' VAL . 96.5 p -55.73 -54.89 38.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 342' ' ' ASN . 48.6 t80 -53.35 -52.45 59.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 341' ' ' PHE . 5.6 m-80 -36.01 -47.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.891 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.624 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.0 mp -64.2 -47.74 88.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.124 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.607 HG11 ' HB3' ' A' ' 292' ' ' ALA . 90.0 t -47.81 -56.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.151 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -44.5 -53.89 6.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.049 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -51.82 -38.52 56.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.878 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -67.69 -66.21 0.59 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.854 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.612 HG21 HD12 ' A' ' 296' ' ' LEU . 14.9 t -47.6 -55.89 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.105 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.449 ' O ' ' C ' ' A' ' 350' ' ' ARG . 6.1 m-85 -46.88 -60.31 2.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.926 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.554 ' O ' HD23 ' A' ' 354' ' ' LEU . 17.7 tpp85 -34.53 -52.86 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 70.9 m -61.32 -57.51 12.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 89.1 mt -47.41 -40.57 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.148 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 6.4 mm -62.45 -41.88 93.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.117 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.554 HD23 ' O ' ' A' ' 350' ' ' ARG . 3.8 mm? -63.53 -44.85 93.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -39.26 -39.8 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -88.51 -53.14 4.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -53.45 137.23 36.43 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.922 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 36.5 mttp -94.74 117.53 30.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.909 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -136.69 127.07 26.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 6.8 t -78.88 128.68 33.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.837 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -109.62 121.24 44.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -156.51 -122.35 0.74 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.48 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 13.7 ptt85 -50.1 -44.01 51.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.799 0.333 . . . . 0.0 110.908 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . 0.417 ' CG ' ' O ' ' A' ' 364' ' ' ASP . 19.6 p-10 -53.64 97.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.1 t 73.05 41.18 0.51 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.818 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -92.72 -81.61 1.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.537 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.83 -6.86 19.64 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.698 2.265 . . . . 0.0 112.325 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 73.1 p -69.87 122.34 19.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.815 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 19.5 p -108.48 43.17 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.467 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 22.1 t -142.7 149.5 38.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.886 0.374 . . . . 0.0 110.839 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.8 t -85.88 131.56 34.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.874 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 150.97 -171.02 30.72 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 17.1 m -95.09 90.89 6.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 0.0 110.858 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 86.6 p -168.57 136.37 2.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.846 -179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 81.03 163.18 29.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 98.97 0.71 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.648 2.232 . . . . 0.0 112.36 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -108.8 164.66 12.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.87 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.403 ' HG3' ' N ' ' A' ' 277' ' ' ILE . 0.2 OUTLIER -86.55 156.51 20.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.888 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.708 HD13 ' H ' ' A' ' 277' ' ' ILE . 0.2 OUTLIER -114.62 145.88 19.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.115 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 11.7 m-85 -109.58 143.09 39.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.892 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 10.0 p -118.78 154.96 53.0 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.59 0.709 . . . . 0.0 111.137 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 -166.73 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.672 2.248 . . . . 0.0 112.377 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.843 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.9 t -78.1 120.86 23.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.834 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.82 -48.01 83.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.099 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -45.95 -41.34 11.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.856 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.754 HD11 HG21 ' A' ' 332' ' ' VAL . 24.5 mt -77.08 -43.95 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.136 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 281' ' ' SER . 43.5 t -53.9 -40.48 44.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.149 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -63.82 -42.81 97.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.862 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -72.66 -32.85 66.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.956 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.616 HG23 HD11 ' A' ' 325' ' ' LEU . 28.2 m -59.48 -22.54 61.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.157 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 293' ' ' MET . 51.2 mttt -76.31 -46.55 27.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.912 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -54.8 -27.55 18.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.488 HG13 ' N ' ' A' ' 292' ' ' ALA . 7.0 pt -98.48 -52.19 9.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.13 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.488 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -63.83 -48.78 75.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.089 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.498 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 30.9 ttm -51.97 -64.78 0.7 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.93 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -40.18 -56.38 1.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.901 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.492 ' O ' ' N ' ' A' ' 298' ' ' ALA . 16.6 mmmt -59.15 -66.09 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.768 HD12 HG21 ' A' ' 348' ' ' VAL . 91.6 mt -38.68 -42.09 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.572 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.9 m-85 -73.54 -35.65 65.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.919 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -68.98 -54.02 17.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.13 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.415 HG23 ' N ' ' A' ' 300' ' ' PHE . 34.3 m -56.53 -40.4 68.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.12 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.415 ' N ' HG23 ' A' ' 299' ' ' VAL . 5.7 t80 -55.04 -57.46 11.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 26.1 m -46.99 -40.16 13.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.121 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.89 -175.76 3.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.628 ' CE2' ' HB1' ' A' ' 313' ' ' ALA . 2.1 m-85 60.24 44.34 12.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -89.38 -53.88 4.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -69.05 -43.16 75.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.884 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -43.2 153.22 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 309' ' ' SER . 4.1 ttpm? -77.41 -41.42 40.06 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.41 ' C ' ' O ' ' A' ' 307' ' ' LYS . 10.9 m -36.86 -30.85 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.15 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 307' ' ' LYS . 18.2 m 54.96 47.02 23.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.401 ' O ' HG23 ' A' ' 314' ' ' VAL . 2.6 mpp_? 60.34 40.5 17.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.84 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' ' 311' ' ' ASP . 9.9 t0 -86.93 -62.93 1.39 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.436 ' HG3' ' N ' ' A' ' 313' ' ' ALA . 12.5 pt-20 -75.43 -37.31 60.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.888 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.628 ' HB1' ' CE2' ' A' ' 303' ' ' TYR . . . -55.11 -36.45 65.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.093 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 310' ' ' ARG . 60.1 t -82.54 -54.98 8.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.107 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.6 OUTLIER -48.87 -48.98 41.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 317' ' ' ILE . 16.9 mtmm -38.2 -58.1 1.02 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' A' ' 320' ' ' ASP . 68.3 mt -33.95 -57.53 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.089 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.439 ' C ' ' O ' ' A' ' 317' ' ' ILE . 50.8 ttt180 -34.53 -59.07 0.47 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.6 mt -58.9 -39.57 81.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.938 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 317' ' ' ILE . 4.5 t70 -66.05 -69.24 0.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.468 HG22 HG13 ' A' ' 291' ' ' ILE . 27.1 p -47.12 -47.3 23.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.181 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.36 -39.11 60.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -84.61 -12.93 53.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . 0.421 ' CD2' HG21 ' A' ' 291' ' ' ILE . 70.4 t60 -92.97 -26.3 17.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.616 HD11 HG23 ' A' ' 288' ' ' THR . 18.8 mt -92.63 -59.37 2.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 9.0 tmtm? -39.57 -34.15 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -76.26 -39.1 55.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.541 ' HG2' ' CE1' ' A' ' 329' ' ' PHE . 32.5 tptt -54.18 -49.94 68.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.903 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.643 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.1 OUTLIER -117.14 91.14 35.73 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.639 0.733 . . . . 0.0 110.901 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.66 -18.62 37.35 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.706 2.271 . . . . 0.0 112.34 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -90.3 -0.16 57.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.754 HG21 HD11 ' A' ' 284' ' ' ILE . 0.8 OUTLIER -98.02 148.96 5.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.119 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -72.53 154.47 40.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.919 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -67.19 -45.43 76.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -54.19 -15.31 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -81.85 -31.62 31.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.844 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.58 HD11 HG11 ' A' ' 332' ' ' VAL . 1.7 mp -85.54 -32.33 7.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.143 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 46.5 mt -69.75 -41.06 79.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.13 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.449 ' O ' HD12 ' A' ' 343' ' ' ILE . 6.0 tt0 -74.52 -56.56 4.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 344' ' ' VAL . 57.2 p -34.71 -45.48 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 344' ' ' VAL . 56.9 t80 -59.9 -60.39 3.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.919 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 341' ' ' PHE . 14.5 m-80 -37.03 -47.69 0.74 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.912 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.591 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.8 mp -66.5 -41.86 89.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.176 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 340' ' ' SER . 61.5 t -60.79 -50.86 78.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.136 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -44.16 -67.32 0.29 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . 0.529 ' HE2' HG23 ' A' ' 343' ' ' ILE . 32.9 pttt -48.53 -44.77 36.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.879 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 346' ' ' LYS . 16.1 mt-10 -55.61 -50.42 70.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.914 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.768 HG21 HD12 ' A' ' 296' ' ' LEU . 57.7 t -59.93 -48.06 89.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.126 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.5 m-85 -54.93 -55.11 34.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -44.49 -33.47 1.73 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.666 ' O ' HD22 ' A' ' 354' ' ' LEU . 6.3 m -82.87 -30.63 28.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.841 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.572 HG12 ' CE1' ' A' ' 297' ' ' TYR . 86.0 mt -79.82 -17.19 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.131 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.46 HD13 ' HA ' ' A' ' 353' ' ' ILE . 9.5 mm -60.52 -18.99 17.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.11 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 351' ' ' SER . 1.3 pt? -57.07 -23.88 49.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.906 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.428 ' C ' ' CD ' ' A' ' 356' ' ' GLU . 8.9 t30 -89.42 22.13 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.86 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . 0.428 ' CD ' ' C ' ' A' ' 355' ' ' ASN . 39.5 mp0 -144.5 116.58 8.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.9 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 72.64 45.28 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.95 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -41.68 113.07 0.38 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.92 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -128.58 179.79 5.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.909 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 75.6 m -70.18 102.59 2.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -136.85 167.77 20.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -91.66 -124.02 3.13 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.488 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 90.5 mtt180 -107.4 140.75 39.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 110.89 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -141.25 158.77 43.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 5.8 t -43.26 131.03 4.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.831 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 66.35 82.05 0.13 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.485 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 95.63 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.742 2.294 . . . . 0.0 112.35 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 369' ' ' SER . 13.2 t -76.67 -48.84 17.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.836 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 368' ' ' SER . 87.9 p 36.19 41.74 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.869 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.485 -179.959 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 2.0 m 38.7 48.51 1.32 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.924 0.392 . . . . 0.0 110.874 -179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 80.2 p -118.42 -32.92 4.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.865 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 52.56 -124.62 26.88 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.497 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -43.0 156.04 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.881 0.372 . . . . 0.0 110.884 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 98.3 p -149.03 145.6 27.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.871 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -101.28 -83.26 1.72 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.455 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 142.9 49.34 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.686 2.258 . . . . 0.0 112.317 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -67.39 121.4 15.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.969 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 8.1 tptp -104.59 141.73 35.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.885 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.684 HD13 ' H ' ' A' ' 277' ' ' ILE . 0.2 OUTLIER -92.99 159.06 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -130.28 139.82 50.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.874 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 41.2 p -106.0 151.77 40.14 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.583 0.706 . . . . 0.0 111.137 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -174.06 0.83 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.702 2.268 . . . . 0.0 112.366 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.69 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.3 t -69.98 121.92 18.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.829 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -63.93 -48.12 77.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.142 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -46.08 -42.19 13.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.715 HD11 HG21 ' A' ' 332' ' ' VAL . 22.7 mt -73.77 -40.18 53.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.15 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 281' ' ' SER . 90.7 t -57.12 -46.36 84.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.112 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.409 ' O ' HD12 ' A' ' 290' ' ' ILE . 35.0 mttm -60.87 -40.89 94.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.418 ' HA ' HD13 ' A' ' 290' ' ' ILE . 49.5 t80 -74.89 -30.86 61.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.925 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.406 HG23 HD11 ' A' ' 325' ' ' LEU . 42.9 m -62.91 -22.34 66.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.161 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.493 ' O ' ' CB ' ' A' ' 293' ' ' MET . 30.3 mttt -77.76 -43.57 30.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 287' ' ' TYR . 3.0 mp -55.72 -28.56 23.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.119 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.591 HG13 HG22 ' A' ' 321' ' ' THR . 5.8 pt -98.13 -51.94 9.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.167 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.455 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -62.76 -48.21 80.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.145 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.493 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 32.4 ttm -55.51 -70.25 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 82.2 mt-10 -40.27 -54.61 2.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.495 ' HB3' HD11 ' A' ' 317' ' ' ILE . 26.8 mttp -58.75 -69.98 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.912 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.427 HD12 HG21 ' A' ' 348' ' ' VAL . 86.4 mt -37.92 -43.39 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.584 ' CE1' HG12 ' A' ' 352' ' ' ILE . 10.4 m-85 -71.61 -38.95 70.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -62.12 -46.68 87.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.101 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 26.4 m -70.74 -27.02 29.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.126 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.499 ' CD2' HG21 ' A' ' 352' ' ' ILE . 3.2 t80 -76.39 -48.1 20.99 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 3.5 m -56.53 -20.51 20.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.091 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.535 ' OD2' ' CE1' ' A' ' 303' ' ' TYR . 17.9 t0 -99.29 -64.3 1.05 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.871 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.535 ' CE1' ' OD2' ' A' ' 302' ' ' ASP . 5.0 m-85 -77.51 66.01 3.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 305' ' ' HIS . 34.4 mt-10 -88.7 -50.61 6.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.433 ' O ' ' CG ' ' A' ' 306' ' ' ASP . 34.6 p-80 -35.76 -36.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.834 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 305' ' ' HIS . 15.8 m-20 -162.29 150.25 14.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.859 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.41 -26.11 20.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.954 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 310' ' ' ARG . 2.8 m -76.83 -34.41 22.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.145 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.3 m -52.03 86.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 308' ' ' VAL . 14.9 ttp180 73.84 48.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -56.63 -25.73 54.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -39.29 -34.1 0.18 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.843 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -55.17 -60.29 3.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 88.6 t -63.45 -53.96 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -53.22 -36.83 61.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.453 ' HA ' HD12 ' A' ' 319' ' ' LEU . 13.3 mmtp -57.2 -32.08 66.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.552 HG22 ' CE1' ' A' ' 341' ' ' PHE . 8.7 mm -48.12 -71.36 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.151 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 317' ' ' ILE . 31.2 ttt180 -33.95 -45.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.865 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 316' ' ' LYS . 13.6 mt -69.56 -44.3 71.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.93 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.495 ' N ' ' O ' ' A' ' 317' ' ' ILE . 32.1 t0 -67.06 -66.19 0.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.836 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.591 HG22 HG13 ' A' ' 291' ' ' ILE . 16.9 p -47.21 -51.74 17.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -49.4 -43.92 44.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -82.31 -11.99 58.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -89.39 -27.9 20.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.836 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.568 ' HB2' HG23 ' A' ' 337' ' ' ILE . 20.0 mt -90.19 -52.62 4.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.931 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 325' ' ' LEU . 0.4 OUTLIER -36.81 -44.11 0.47 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -64.44 -46.65 82.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.472 ' HG2' ' CZ ' ' A' ' 329' ' ' PHE . 21.1 tptt -55.33 -42.49 73.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.577 ' CZ ' HG12 ' A' ' 284' ' ' ILE . 0.2 OUTLIER -120.62 89.87 45.24 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.686 0.755 . . . . 0.0 110.873 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.72 -43.94 2.4 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.242 . . . . 0.0 112.362 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -61.98 -25.65 67.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.913 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.715 HG21 HD11 ' A' ' 284' ' ' ILE . 97.2 t -73.75 148.81 8.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.129 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -84.65 147.84 26.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.865 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -53.57 -45.14 69.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.935 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.6 t80 -51.98 -18.79 1.51 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.401 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 47.5 mt-10 -88.92 -41.15 12.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.894 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.568 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.5 mp -69.31 -31.72 50.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.183 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 39.6 mt -76.22 -66.64 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.118 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.619 ' O ' HD12 ' A' ' 343' ' ' ILE . 8.5 tp10 -42.1 -53.86 3.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.54 ' CB ' HG22 ' A' ' 285' ' ' VAL . 2.2 p -40.5 -41.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.837 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 317' ' ' ILE . 75.7 t80 -62.43 -53.03 60.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.851 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -42.53 -43.33 3.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.901 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.642 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.7 mp -65.94 -34.14 68.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.42 ' N ' ' O ' ' A' ' 341' ' ' PHE . 73.9 t -70.66 -58.74 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.129 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -37.18 -61.74 0.55 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.074 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -45.5 -51.25 11.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -55.81 -59.67 4.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.899 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 352' ' ' ILE . 88.5 t -48.98 -62.57 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.114 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.48 ' O ' ' N ' ' A' ' 352' ' ' ILE . 12.1 m-85 -44.5 -69.65 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.884 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.454 ' C ' ' O ' ' A' ' 349' ' ' PHE . 20.9 ttp180 -34.3 -54.52 0.51 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 41.9 m -56.5 -42.67 78.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.836 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.584 HG12 ' CE1' ' A' ' 297' ' ' TYR . 61.8 mt -68.31 -21.76 26.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.118 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.468 HG22 ' O ' ' A' ' 353' ' ' ILE . 10.8 mm -70.08 -11.99 15.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.172 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 354' ' ' LEU . 2.4 mm? -83.66 -1.59 54.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.498 ' N ' ' OD1' ' A' ' 355' ' ' ASN . 2.9 p-10 -52.84 85.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.901 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . 0.497 ' N ' ' O ' ' A' ' 354' ' ' LEU . 6.1 mm-40 64.0 40.52 7.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -122.03 120.8 35.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -100.81 131.47 46.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.891 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -129.36 153.28 48.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.873 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 361' ' ' ASP . 13.0 t -99.12 -43.31 6.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.929 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 360' ' ' CYS . 68.7 m-20 -37.14 140.11 0.19 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.86 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . -147.13 -91.89 0.11 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.491 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 5.3 tpm_? -73.94 108.75 6.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -49.51 171.68 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 3.3 t -69.41 -57.58 5.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -158.76 146.81 13.68 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.474 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 87.07 0.56 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.699 2.266 . . . . 0.0 112.342 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 88.5 p -66.08 143.1 57.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.855 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 20.1 m -113.51 -54.69 2.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.846 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.49 -179.966 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 5.2 t 49.68 41.64 22.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 110.915 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 1.3 t -100.37 121.51 41.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.86 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 124.04 128.07 3.27 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.453 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 17.3 m -124.82 103.1 7.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.922 0.391 . . . . 0.0 110.875 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 64.4 p -106.66 129.72 54.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.884 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 73.19 -176.74 43.81 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.471 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 95.36 0.55 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.696 2.264 . . . . 0.0 112.321 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -119.99 127.45 52.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.56 119.91 13.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.907 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 7.5 mm -96.93 146.6 7.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.155 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -124.66 142.95 51.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 43.6 p -74.73 151.63 86.9 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.583 0.706 . . . . 0.0 111.15 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 176.99 6.04 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.664 2.243 . . . . 0.0 112.339 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.635 ' HB2' HD12 ' A' ' 284' ' ' ILE . 66.5 m -68.91 127.5 33.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.85 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 284' ' ' ILE . . . -70.98 -52.18 21.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.098 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -39.86 -27.0 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.869 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.881 HG23 ' CE1' ' A' ' 329' ' ' PHE . 22.0 mt -92.27 -43.25 13.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.132 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.606 HG23 ' O ' ' A' ' 281' ' ' SER . 77.6 t -53.65 -35.93 27.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.101 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -66.01 -34.69 78.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.906 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.407 ' HA ' HD13 ' A' ' 290' ' ' ILE . 50.3 t80 -76.95 -27.21 54.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.654 HG23 HD11 ' A' ' 325' ' ' LEU . 2.7 m -65.64 -20.68 66.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 293' ' ' MET . 0.7 OUTLIER -76.5 -45.71 29.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.873 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.451 ' H ' HD12 ' A' ' 290' ' ' ILE . 3.2 mp -52.58 -32.1 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.156 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.504 HG21 ' CD2' ' A' ' 324' ' ' HIS . 6.9 pt -98.49 -52.08 9.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.143 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.68 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -60.78 -48.56 81.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.07 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.496 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 33.8 ttm -55.36 -69.83 0.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.852 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 293' ' ' MET . 16.2 mt-10 -37.91 -67.36 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.867 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 298' ' ' ALA . 45.5 mmtt -50.37 -63.44 1.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.904 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 72.6 mt -42.96 -30.38 0.41 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.589 ' CE2' HG13 ' A' ' 348' ' ' VAL . 10.1 m-85 -88.84 -31.25 18.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -69.79 -48.99 57.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.076 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 19.5 m -64.55 -34.64 70.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.165 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.731 ' CE2' HG21 ' A' ' 352' ' ' ILE . 3.6 t80 -57.05 -59.88 4.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 29.6 m -67.5 -37.0 82.18 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -64.86 -69.36 0.29 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -85.77 82.53 8.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.917 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 305' ' ' HIS . 14.4 pt-20 -86.67 -49.11 7.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.91 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.414 ' N ' ' HG3' ' A' ' 304' ' ' GLU . 50.5 p-80 -91.85 -50.39 5.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.86 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -44.01 121.37 2.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.845 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -90.82 -67.73 0.83 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.904 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.563 HG13 ' N ' ' A' ' 309' ' ' SER . 8.0 p -44.82 -49.87 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.138 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.563 ' N ' HG13 ' A' ' 308' ' ' VAL . 14.6 m -56.56 -41.91 77.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.453 ' NH2' ' CD2' ' A' ' 300' ' ' PHE . 7.3 tpt85 -59.01 -52.48 65.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -49.5 -64.19 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.816 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -57.1 -31.27 65.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.851 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -64.48 -65.33 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 23.8 t -54.98 -41.9 61.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -65.6 -44.67 85.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.911 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -44.24 -57.09 3.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.643 HG22 ' CE1' ' A' ' 341' ' ' PHE . 58.8 mt -41.49 -55.56 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . . . . . . . . . 11.0 tpt180 -39.75 -35.7 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 5.0 mt -88.62 -32.29 18.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.948 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 24.8 t70 -67.48 -65.44 0.69 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.501 HG22 ' CD1' ' A' ' 291' ' ' ILE . 71.8 p -51.77 -44.46 63.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.136 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -44.69 -54.4 6.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -76.81 -13.1 60.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.836 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . 0.504 ' CD2' HG21 ' A' ' 291' ' ' ILE . 47.8 t60 -85.96 -26.19 25.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.874 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.654 HD11 HG23 ' A' ' 288' ' ' THR . 26.6 mt -91.62 -62.22 1.48 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -39.83 -43.78 1.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -62.86 -38.15 89.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.858 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 325' ' ' LEU . 44.2 tttp -60.33 -45.74 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.881 ' CE1' HG23 ' A' ' 284' ' ' ILE . 0.9 OUTLIER -117.97 94.71 46.92 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.688 0.756 . . . . 0.0 110.863 -179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 -20.63 34.47 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.652 2.235 . . . . 0.0 112.327 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -80.02 -40.22 28.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.894 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.597 HG11 HD11 ' A' ' 337' ' ' ILE . 0.9 OUTLIER -63.93 156.16 5.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.138 179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -90.98 156.49 17.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -62.94 -42.9 99.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.93 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.6 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 4.3 t80 -54.03 -15.96 1.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.853 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -88.18 -27.58 21.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.886 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.641 HG23 HD12 ' A' ' 325' ' ' LEU . 2.6 mp -85.67 -56.83 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . 0.41 ' O ' ' ND2' ' A' ' 342' ' ' ASN . 72.8 mt -48.56 -33.12 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.123 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.421 ' O ' HD12 ' A' ' 343' ' ' ILE . 17.0 tt0 -79.22 -42.4 26.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.869 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.407 ' HB3' HG22 ' A' ' 285' ' ' VAL . 73.8 m -52.23 -53.07 48.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.643 ' CE1' HG22 ' A' ' 317' ' ' ILE . 56.0 t80 -46.61 -53.03 12.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 338' ' ' ILE . 37.6 m-80 -42.55 -52.49 4.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.567 ' H ' HD12 ' A' ' 343' ' ' ILE . 3.7 mp -56.3 -40.04 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.161 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.68 HG11 ' HB3' ' A' ' 292' ' ' ALA . 91.3 t -63.89 -62.11 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.131 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.1 -66.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.131 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 45.9 mttt -46.44 -58.13 4.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.875 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -42.69 -62.34 1.02 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.589 HG13 ' CE2' ' A' ' 297' ' ' TYR . 37.0 t -50.33 -66.13 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.144 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.454 ' O ' ' N ' ' A' ' 351' ' ' SER . 8.0 m-85 -39.01 -69.49 0.12 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.915 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 349' ' ' PHE . 35.8 ttm180 -36.33 -32.28 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.872 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.487 ' O ' ' N ' ' A' ' 355' ' ' ASN . 1.6 t -76.89 -56.37 4.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.894 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.731 HG21 ' CE2' ' A' ' 300' ' ' PHE . 80.2 mt -47.51 -51.37 7.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.102 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.407 ' H ' HD12 ' A' ' 353' ' ' ILE . 2.7 mp -55.95 -32.22 32.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 77.5 mt -100.83 -0.49 36.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 351' ' ' SER . 41.6 t30 -102.06 96.86 7.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.851 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . 0.44 ' HG2' ' C ' ' A' ' 355' ' ' ASN . 7.8 pt-20 43.62 42.02 3.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.888 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.445 ' C ' ' CD1' ' A' ' 357' ' ' TYR . 5.5 t80 -127.08 -56.72 1.34 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.973 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 15.7 mmtt -136.6 139.97 42.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.912 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 7.0 mtm-85 -87.11 94.1 9.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.871 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 30.1 t -74.74 135.18 41.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -75.89 102.51 5.57 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.865 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 155.12 108.15 0.29 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.446 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -82.67 44.57 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.808 0.337 . . . . 0.0 110.858 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -117.21 -57.79 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.888 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 61.5 m -74.49 114.61 13.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -117.16 -157.84 10.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.472 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.68 -25.25 29.14 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.744 2.296 . . . . 0.0 112.343 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 32.2 m -40.8 117.62 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.865 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 370' ' ' GLY . 69.6 m -150.83 158.87 44.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.834 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 369' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.541 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 41.6 t -171.5 121.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.859 0.362 . . . . 0.0 110.911 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 25.9 p -173.28 166.49 4.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.891 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -167.77 141.82 7.09 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.461 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 8.3 t -167.43 160.18 13.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 0.0 110.877 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 3.4 m -171.09 148.71 2.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.879 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 127.33 -93.81 0.39 Allowed Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.477 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 1.22 4.61 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.677 2.251 . . . . 0.0 112.356 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -66.06 163.78 16.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.873 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 5.7 pttt -93.12 137.83 32.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 3.1 mm -108.81 110.49 32.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.148 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -108.74 147.47 31.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 72.6 p -75.68 151.18 84.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.562 0.696 . . . . 0.0 111.142 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -176.02 1.35 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.641 2.228 . . . . 0.0 112.339 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.685 ' O ' HG23 ' A' ' 285' ' ' VAL . 14.1 m -77.6 124.67 28.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.5 76.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.12 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -46.78 -29.67 2.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.889 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.756 ' CD1' HG21 ' A' ' 332' ' ' VAL . 17.4 mt -89.18 -52.4 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.112 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.685 HG23 ' O ' ' A' ' 281' ' ' SER . 40.2 t -44.22 -35.38 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.12 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 8.5 mmmm -66.0 -35.56 80.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.461 ' CD2' ' HD3' ' A' ' 328' ' ' LYS . 28.4 t80 -81.5 -18.77 43.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.412 HG23 HD11 ' A' ' 325' ' ' LEU . 28.3 m -70.38 -26.09 63.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.136 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.563 ' HD2' HG22 ' A' ' 344' ' ' VAL . 0.0 OUTLIER -75.79 -43.35 46.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.889 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.6 mp -54.58 -31.25 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.1 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.767 HG21 ' CD2' ' A' ' 324' ' ' HIS . 6.3 pt -98.09 -51.83 9.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.466 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -60.45 -48.1 83.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.1 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.484 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 11.9 ttm -55.9 -62.26 1.82 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.844 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -39.75 -72.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.914 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.494 ' O ' ' N ' ' A' ' 298' ' ' ALA . 13.7 mptt -50.23 -63.61 1.06 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.902 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.456 ' CD2' HG13 ' A' ' 314' ' ' VAL . 45.1 mt -37.66 -43.23 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -78.67 -33.36 47.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -65.67 -36.56 84.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.095 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 24.0 m -80.8 -27.09 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.09 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.511 ' CZ ' HG23 ' A' ' 352' ' ' ILE . 3.6 t80 -69.0 -50.81 45.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 33.3 p -53.36 -53.66 47.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.153 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -58.74 -74.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -76.56 54.19 0.93 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.447 ' O ' ' C ' ' A' ' 305' ' ' HIS . 10.2 tm-20 -66.77 -58.35 5.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.447 ' C ' ' O ' ' A' ' 304' ' ' GLU . 6.3 t-80 -34.82 -58.12 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -139.59 128.0 22.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . 0.549 ' HE3' HG21 ' A' ' 314' ' ' VAL . 0.4 OUTLIER -89.96 -52.65 4.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 13.8 m -54.65 -22.05 8.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.138 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 51.9 p -60.97 -27.52 68.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.791 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 9.0 ttm180 -133.55 49.71 2.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.859 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.33 -30.07 17.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.859 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 9.6 pt-20 -51.4 -25.45 6.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.865 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -75.11 -68.75 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.07 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.549 HG21 ' HE3' ' A' ' 307' ' ' LYS . 58.4 t -55.61 -42.29 68.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.124 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.426 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.5 OUTLIER -59.95 -55.54 32.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.887 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 9.6 mmmt -35.53 -43.71 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.44 HD12 HD23 ' A' ' 296' ' ' LEU . 50.5 mt -47.49 -52.43 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.124 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.436 ' HG2' ' CE2' ' A' ' 341' ' ' PHE . 14.6 mmm-85 -40.01 -39.22 0.83 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.861 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 3.0 mt -82.98 -44.83 14.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.925 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.73 -69.93 0.14 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.85 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.527 HG22 HG13 ' A' ' 291' ' ' ILE . 37.6 p -46.04 -47.95 16.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.13 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.482 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 60.5 tt0 -45.22 -52.3 9.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.92 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -78.66 -14.54 59.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.918 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . 0.767 ' CD2' HG21 ' A' ' 291' ' ' ILE . 44.5 t60 -82.1 -29.71 31.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.867 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.607 HD12 HG23 ' A' ' 337' ' ' ILE . 15.9 mt -92.39 -59.78 2.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.891 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.4 ' NZ ' ' HB2' ' A' ' 334' ' ' GLN . 39.8 tttp -43.14 -29.67 0.39 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -77.88 -35.36 50.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.504 ' HE3' ' CZ ' ' A' ' 329' ' ' PHE . 37.9 tttp -58.51 -55.66 32.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.982 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.1 OUTLIER -117.89 107.64 43.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.663 0.744 . . . . 0.0 110.866 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 329' ' ' PHE . 53.6 Cg_endo -69.77 -21.9 32.77 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.679 2.253 . . . . 0.0 112.344 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -71.57 -35.72 70.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.982 HG12 ' O ' ' A' ' 329' ' ' PHE . 7.1 p -63.8 146.0 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.146 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . 0.627 ' O ' HD12 ' A' ' 337' ' ' ILE . 1.4 t70 -87.17 157.9 19.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.833 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . 0.4 ' HB2' ' NZ ' ' A' ' 326' ' ' LYS . 9.7 tt0 -65.16 -35.92 82.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.928 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.465 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 9.5 t80 -63.55 -9.77 14.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.862 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -93.38 -41.35 9.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.899 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 333' ' ' ASP . 4.9 mp -69.64 -45.57 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.11 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 97.2 mt -63.81 -41.05 91.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.169 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.662 ' O ' HD12 ' A' ' 343' ' ' ILE . 16.6 tt0 -73.61 -42.77 61.05 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.876 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 341' ' ' PHE . 37.1 m -51.11 -62.35 1.67 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.843 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' A' ' 344' ' ' VAL . 68.6 t80 -37.78 -59.39 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 341' ' ' PHE . 2.4 m-80 -36.63 -54.56 0.88 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.7 mp -57.75 -36.6 55.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.563 HG22 ' HD2' ' A' ' 289' ' ' LYS . 97.1 t -72.14 -59.12 3.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . 0.403 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -36.26 -66.9 0.19 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.071 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -49.62 -36.51 24.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.874 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 344' ' ' VAL . 1.5 tp10 -57.33 -40.09 77.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . . . . . . . . . 46.3 t -82.09 -40.09 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.145 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 350' ' ' ARG . 6.1 m-85 -51.94 -70.89 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.861 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 349' ' ' PHE . 10.1 ptt85 -35.33 -42.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.859 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 23.4 m -64.11 -49.0 73.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.511 HG23 ' CZ ' ' A' ' 300' ' ' PHE . 97.3 mt -63.91 -43.57 97.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.111 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 4.4 mm -49.27 -38.32 11.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.162 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 3.5 mp -90.32 -12.74 36.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.914 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.78 -7.87 54.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.889 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . 0.504 ' O ' ' CD2' ' A' ' 357' ' ' TYR . 8.2 pt-20 -114.83 56.61 0.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.868 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.504 ' CD2' ' O ' ' A' ' 356' ' ' GLU . 43.3 m-85 -165.52 124.46 1.68 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -63.7 93.49 0.08 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.901 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 1.7 mmp_? -141.57 122.12 14.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.866 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 57.3 m -93.34 129.68 39.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.85 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -92.92 -50.04 5.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 159.17 -107.87 0.34 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.477 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -80.26 88.41 5.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.85 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -87.76 158.15 18.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.903 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 46.1 t -130.08 106.48 8.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.852 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -108.78 -82.99 1.46 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.508 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 112.2 3.01 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.71 2.273 . . . . 0.0 112.331 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 24.8 p -90.89 41.19 1.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.856 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 74.4 m 62.87 41.97 8.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.329 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.488 -179.992 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 N-CA-C 112.481 -0.247 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 19.6 t -118.21 -55.84 2.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.896 0.379 . . . . 0.0 110.887 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 27.6 p 46.78 42.17 11.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.868 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -132.26 106.96 0.68 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.502 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 20.0 m -115.77 174.03 6.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.84 0.353 . . . . 0.0 110.868 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 16.5 m -152.46 151.12 30.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -134.96 169.22 23.36 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.435 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 102.13 1.0 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.656 2.237 . . . . 0.0 112.325 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 276' ' ' LYS . 3.7 tp-100 -113.69 152.03 31.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.902 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . 0.408 ' N ' ' HG3' ' A' ' 275' ' ' GLN . 21.4 mttp -83.45 109.36 17.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.512 HD13 ' H ' ' A' ' 277' ' ' ILE . 0.1 OUTLIER -107.69 158.56 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.179 179.845 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' A' ' 278' ' ' PHE . 0.1 OUTLIER -74.86 147.3 41.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.881 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 68.3 p -74.18 152.21 88.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.556 0.693 . . . . 0.0 111.201 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.72 -176.57 1.52 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.673 2.249 . . . . 0.0 112.341 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 285' ' ' VAL . 2.3 t -69.99 125.71 27.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.861 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.38 -30.92 70.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -56.66 -40.08 74.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.821 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.682 HD11 HG21 ' A' ' 332' ' ' VAL . 17.4 mt -76.79 -45.85 31.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.147 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 281' ' ' SER . 91.5 t -48.94 -39.19 11.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.141 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -65.06 -44.29 89.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.495 ' CE1' ' NZ ' ' A' ' 328' ' ' LYS . 49.4 t80 -72.17 -26.36 62.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.013 0.435 . . . . 0.0 110.978 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.496 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 49.4 m -69.37 -20.94 63.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.163 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 27.9 mttt -78.84 -43.55 24.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.8 mp -56.25 -31.09 31.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.65 HG13 HG22 ' A' ' 321' ' ' THR . 6.1 pt -97.77 -51.33 10.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.093 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.538 ' HB3' HG11 ' A' ' 344' ' ' VAL . . . -59.82 -46.96 87.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.111 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 33.3 ttm -55.93 -68.1 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.865 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 293' ' ' MET . 49.2 mt-10 -35.92 -59.91 0.57 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 298' ' ' ALA . 31.3 mmtt -60.06 -64.81 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.897 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.474 HD13 ' HB ' ' A' ' 348' ' ' VAL . 48.4 mt -36.03 -37.88 0.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.894 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.503 ' CE1' HG12 ' A' ' 352' ' ' ILE . 9.8 m-85 -78.48 -44.25 24.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -59.36 -40.16 85.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.063 179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.442 ' HB ' ' HB1' ' A' ' 313' ' ' ALA . 28.1 m -77.64 -38.21 25.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.686 ' CD1' HG21 ' A' ' 352' ' ' ILE . 15.8 t80 -42.37 -46.37 4.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 11.1 m -77.28 -23.6 51.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.149 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 299' ' ' VAL . 26.1 t0 -64.08 -60.68 2.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.89 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.547 ' OH ' HG22 ' A' ' 314' ' ' VAL . 37.9 p90 -100.53 20.38 15.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.89 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.423 ' OE2' ' CG ' ' A' ' 305' ' ' HIS . 2.1 pp20? -44.72 -42.42 7.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.423 ' CG ' ' OE2' ' A' ' 304' ' ' GLU . 8.6 m-70 -50.26 -71.81 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.851 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -124.8 154.01 41.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.828 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 7.7 pttm -67.57 -51.7 47.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . 0.577 HG23 ' N ' ' A' ' 309' ' ' SER . 19.3 m -55.36 -52.78 42.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.153 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.577 ' N ' HG23 ' A' ' 308' ' ' VAL . 93.1 p -45.62 114.65 0.79 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? 61.7 35.62 16.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.912 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -53.42 -28.69 31.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.429 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 21.6 pm0 -56.16 -27.77 55.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.878 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.442 ' HB1' ' HB ' ' A' ' 299' ' ' VAL . . . -56.95 -42.95 81.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.135 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . 0.547 HG22 ' OH ' ' A' ' 303' ' ' TYR . 54.5 t -72.56 -62.87 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.502 ' ND2' HD11 ' A' ' 319' ' ' LEU . 4.1 t30 -50.47 -41.67 53.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.906 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 8.4 mmtp -41.61 -64.77 0.52 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.567 HG22 ' CE2' ' A' ' 341' ' ' PHE . 41.5 mt -42.29 -61.88 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.123 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.464 ' HD2' ' CD1' ' A' ' 341' ' ' PHE . 15.8 mmm180 -36.82 -33.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.839 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . 0.502 HD11 ' ND2' ' A' ' 315' ' ' ASN . 10.0 mt -88.11 -41.49 13.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.951 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' A' ' 317' ' ' ILE . 41.2 m-20 -61.28 -61.8 2.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.882 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.65 HG22 HG13 ' A' ' 291' ' ' ILE . 36.2 p -54.16 -46.47 72.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -49.33 -40.13 34.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -85.46 -19.75 30.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.873 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . 0.544 ' CD2' HG21 ' A' ' 291' ' ' ILE . 74.7 t60 -82.46 -25.79 33.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.846 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.674 ' HB2' HG23 ' A' ' 337' ' ' ILE . 32.5 mt -89.76 -56.47 3.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.93 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.416 ' N ' HG12 ' A' ' 337' ' ' ILE . 2.2 tmmm? -38.2 -45.74 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.923 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -66.63 -37.8 85.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.868 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.608 ' HG2' ' CE2' ' A' ' 329' ' ' PHE . 9.9 tptm -57.95 -49.2 77.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.608 ' CE2' ' HG2' ' A' ' 328' ' ' LYS . 9.5 m-85 -124.26 94.66 44.82 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.629 0.728 . . . . 0.0 110.848 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 329' ' ' PHE . 53.7 Cg_endo -69.75 -41.99 3.8 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.668 2.245 . . . . 0.0 112.341 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -63.71 -25.71 68.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.682 HG21 HD11 ' A' ' 284' ' ' ILE . 53.0 t -69.17 148.77 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.142 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -72.53 150.51 43.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -62.48 -40.05 95.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -62.93 -11.09 16.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.409 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 6.6 mm-40 -87.26 -34.26 19.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.901 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.674 HG23 ' HB2' ' A' ' 325' ' ' LEU . 2.5 mp -75.04 -35.63 35.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.13 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 2.9 mp -74.88 -64.62 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.119 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.458 ' O ' HD12 ' A' ' 343' ' ' ILE . 1.8 tp10 -44.9 -53.9 7.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 46.9 m -41.03 -34.96 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.903 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.567 ' CE2' HG22 ' A' ' 317' ' ' ILE . 48.0 t80 -70.01 -53.05 19.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -40.77 -40.19 1.27 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.91 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.458 HD12 ' O ' ' A' ' 339' ' ' GLU . 5.1 mp -73.67 -42.87 54.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.538 HG11 ' HB3' ' A' ' 292' ' ' ALA . 20.1 t -60.91 -62.64 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.116 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -40.28 -67.03 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 37.8 mmtt -39.22 -51.74 1.96 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -56.08 -68.04 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.9 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 296' ' ' LEU . 38.3 t -44.44 -30.95 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.139 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.566 ' O ' HD12 ' A' ' 353' ' ' ILE . 13.7 m-85 -73.98 -64.38 1.02 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -49.02 -19.53 0.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.911 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 6.3 p -87.07 -32.02 20.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.893 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.686 HG21 ' CD1' ' A' ' 300' ' ' PHE . 54.3 mt -70.97 -54.52 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.146 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.646 ' H ' HD12 ' A' ' 353' ' ' ILE . 5.0 mp -50.95 -29.28 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.151 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 55.7 mt -94.67 -27.8 15.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.935 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -46.3 -43.19 15.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.879 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -45.57 -43.49 12.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.899 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -99.55 102.91 14.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 358' ' ' LYS . 0.1 OUTLIER -74.05 107.87 6.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.909 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 10.7 mmt85 -112.49 36.79 3.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.881 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 57.2 m -145.61 155.52 43.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -56.97 -59.21 5.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.841 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 363' ' ' ARG . . . 156.44 45.9 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.471 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . 0.428 ' C ' ' O ' ' A' ' 362' ' ' GLY . 11.3 ttp85 -35.54 101.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.342 . . . . 0.0 110.856 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -95.15 -57.34 2.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 1.4 t 57.92 34.66 24.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . -137.93 85.96 0.23 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.521 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . 0.431 ' O ' ' C ' ' A' ' 368' ' ' SER . 53.9 Cg_endo -69.73 -42.5 3.37 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.67 2.247 . . . . 0.0 112.372 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . 0.431 ' C ' ' O ' ' A' ' 367' ' ' PRO . 49.1 m -35.55 122.71 0.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.889 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 15.1 p -65.13 -9.57 23.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.89 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.515 -179.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 9.6 t -173.13 149.47 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.89 0.376 . . . . 0.0 110.861 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 12.4 p -98.31 23.24 8.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 61.55 174.33 1.55 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.485 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 82.9 p -157.87 169.02 25.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.375 . . . . 0.0 110.842 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 57.7 p -125.44 137.26 53.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.864 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 170.94 -160.31 32.73 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.526 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 2.16 3.77 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.658 2.239 . . . . 0.0 112.319 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -65.99 133.8 51.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.926 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 7.5 mtmt -66.04 168.91 7.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.446 ' C ' HD12 ' A' ' 277' ' ' ILE . 2.5 pp -105.16 160.69 5.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.149 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -122.29 148.09 45.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.858 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 53.0 p -73.07 151.58 90.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.543 0.687 . . . . 0.0 111.128 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 170.28 16.91 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.663 2.242 . . . . 0.0 112.35 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 9.9 m -68.61 125.89 27.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.77 87.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.107 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -38.78 -35.29 0.19 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.915 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.755 ' CD1' HG21 ' A' ' 332' ' ' VAL . 22.0 mt -86.72 -56.99 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.113 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 91.9 t -40.84 -36.1 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.139 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -64.65 -41.98 95.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.916 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 284' ' ' ILE . 55.1 t80 -74.26 -31.44 62.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.954 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.62 HG23 HD11 ' A' ' 325' ' ' LEU . 22.8 m -60.34 -20.98 61.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 293' ' ' MET . 21.4 mttt -77.98 -43.79 28.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 2.4 mp -58.88 -27.2 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.484 HG13 HG22 ' A' ' 321' ' ' THR . 5.5 pt -98.1 -51.13 10.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.476 ' N ' ' CG1' ' A' ' 291' ' ' ILE . . . -61.92 -46.28 90.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.094 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.519 ' HE2' ' HB2' ' A' ' 293' ' ' MET . 8.0 ttm -52.19 -63.46 1.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.922 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 293' ' ' MET . 14.9 mt-10 -37.53 -73.12 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.859 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 296' ' ' LEU . 1.1 mptm? -46.59 -64.14 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.606 HD12 HG21 ' A' ' 348' ' ' VAL . 51.1 mt -36.04 -55.92 0.75 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.587 ' CE1' HG12 ' A' ' 352' ' ' ILE . 11.5 m-85 -60.82 -41.95 96.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.935 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.405 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -58.83 -52.75 64.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.083 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 296' ' ' LEU . 27.7 m -65.44 -25.31 36.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.652 ' CD2' HG21 ' A' ' 352' ' ' ILE . 16.0 t80 -69.64 -62.37 1.41 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.853 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 14.6 t -58.09 -18.15 22.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.133 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -86.06 -65.09 1.05 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -89.39 48.6 1.63 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 305' ' ' HIS . 10.0 tp10 -64.67 -48.74 73.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.894 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.428 ' C ' ' O ' ' A' ' 304' ' ' GLU . 34.9 t60 -35.9 -45.25 0.4 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.851 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -167.43 130.64 1.73 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.832 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -59.78 -53.35 58.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.859 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 2.7 m -41.41 -33.38 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.137 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 7.5 t -53.22 111.57 0.71 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 46.96 42.0 11.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 313' ' ' ALA . 1.0 OUTLIER -43.15 -25.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.834 -179.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.469 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 7.8 pt-20 -39.29 -29.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.429 ' N ' ' O ' ' A' ' 311' ' ' ASP . . . -62.0 -53.71 51.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 96.0 t -61.15 -66.79 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.11 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.9 t30 -43.25 -49.65 6.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.919 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.469 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 20.5 mmtt -37.8 -55.64 1.16 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 320' ' ' ASP . 54.2 mt -43.08 -62.81 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.071 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.438 ' C ' ' O ' ' A' ' 317' ' ' ILE . 4.4 tmt_? -34.41 -38.41 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.842 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 8.4 mt -79.82 -43.09 23.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 317' ' ' ILE . 1.5 t70 -61.32 -65.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.484 HG22 HG13 ' A' ' 291' ' ' ILE . 71.7 p -50.79 -46.46 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.182 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.424 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 0.3 OUTLIER -48.08 -35.64 11.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.887 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -93.18 -20.22 20.68 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.859 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . . . . . . . . . 68.9 t60 -81.29 -21.6 39.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.877 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.62 HD11 HG23 ' A' ' 288' ' ' THR . 22.8 mt -94.22 -65.17 1.0 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.932 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -39.93 -29.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.918 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 328' ' ' LYS . 4.9 pt-20 -75.08 -43.01 55.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.538 ' HE3' ' CZ ' ' A' ' 329' ' ' PHE . 45.3 tttp -53.54 -45.52 69.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.883 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.986 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.1 OUTLIER -123.1 107.94 32.59 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.642 0.734 . . . . 0.0 110.926 179.941 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -22.5 32.13 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.657 2.238 . . . . 0.0 112.352 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -72.3 -39.45 68.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.918 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.986 HG12 ' O ' ' A' ' 329' ' ' PHE . 7.3 p -57.03 147.98 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.15 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . 0.688 ' O ' HD12 ' A' ' 337' ' ' ILE . 1.5 t70 -96.56 154.33 17.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -61.81 -21.67 64.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.593 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.5 t80 -76.44 -9.67 58.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.899 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -96.31 -46.87 6.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.688 HD12 ' O ' ' A' ' 333' ' ' ASP . 5.4 mp -62.15 -37.69 79.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.139 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 48.4 mt -71.18 -59.35 3.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.12 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -62.32 -12.29 20.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.92 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 341' ' ' PHE . 3.5 m -80.19 -68.62 0.66 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.821 -179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.44 ' C ' ' O ' ' A' ' 340' ' ' SER . 40.0 t80 -34.82 -44.49 0.22 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.9 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 19.9 m-20 -42.61 -49.99 5.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.429 ' H ' HD12 ' A' ' 343' ' ' ILE . 4.1 mp -63.42 -47.51 91.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.131 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 345' ' ' ALA . 53.9 t -48.89 -67.99 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.129 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.18 -66.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.133 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -38.45 -44.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.887 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' ' 348' ' ' VAL . 15.6 tt0 -62.37 -68.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.606 HG21 HD12 ' A' ' 296' ' ' LEU . 96.1 t -35.18 -68.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.145 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 352' ' ' ILE . 9.5 m-85 -34.72 -68.86 0.11 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.436 ' C ' ' O ' ' A' ' 349' ' ' PHE . 17.2 ttt180 -34.24 -50.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 3.5 m -67.07 -40.38 87.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.875 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.652 HG21 ' CD2' ' A' ' 300' ' ' PHE . 70.7 mt -59.71 -21.42 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.165 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.621 HG23 ' HB2' ' A' ' 357' ' ' TYR . 23.5 mm -68.82 -24.78 29.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.149 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -57.31 -16.9 9.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.947 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 66.5 m-80 -84.77 58.17 4.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . 0.417 ' O ' ' C ' ' A' ' 357' ' ' TYR . 23.5 mt-10 41.38 51.17 3.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.87 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.621 ' HB2' HG23 ' A' ' 353' ' ' ILE . 32.9 t80 -37.17 142.24 0.12 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 357' ' ' TYR . 1.1 pptp? -38.17 149.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.914 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 67.68 46.17 1.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 8.2 t -108.73 166.08 11.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -138.99 171.44 14.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 105.57 69.49 0.75 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.515 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -84.92 41.71 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.806 0.336 . . . . 0.0 110.878 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -131.82 113.98 14.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.876 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 17.0 m -132.25 123.17 26.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.823 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 88.43 146.6 12.55 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.481 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . 0.446 ' O ' ' C ' ' A' ' 368' ' ' SER . 54.0 Cg_endo -69.74 2.73 3.26 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.698 2.266 . . . . 0.0 112.35 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . 0.446 ' C ' ' O ' ' A' ' 367' ' ' PRO . 22.9 t -34.63 124.86 0.53 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 368' ' ' SER . 75.4 m -37.63 144.8 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.848 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.455 179.979 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 3.0 m 50.06 42.43 24.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 0.0 110.897 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 39.7 m -59.47 120.13 8.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.852 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 129.98 78.29 0.19 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.495 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 3.3 m -68.78 124.74 24.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.909 0.385 . . . . 0.0 110.825 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 56.2 p -73.99 -41.16 62.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.84 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -127.77 -174.03 13.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.486 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 106.91 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.736 2.291 . . . . 0.0 112.361 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 53.8 mm-40 -67.34 157.27 34.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.924 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.41 155.19 36.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.916 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . 0.417 ' C ' HD12 ' A' ' 277' ' ' ILE . 2.7 pp -96.01 148.33 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.12 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -132.15 137.74 47.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.901 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 17.0 p -95.79 153.59 39.29 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.591 0.71 . . . . 0.0 111.104 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . 0.425 ' HA ' ' OE1' ' A' ' 336' ' ' GLU . 53.9 Cg_endo -69.81 167.14 25.36 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.705 2.27 . . . . 0.0 112.322 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . 0.471 ' O ' HG23 ' A' ' 285' ' ' VAL . 1.4 p -72.95 122.88 22.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.537 ' HB1' ' HE2' ' A' ' 286' ' ' LYS . . . -62.04 -49.14 77.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.077 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -44.53 -42.79 7.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.737 HD12 HG21 ' A' ' 332' ' ' VAL . 8.8 mt -77.16 -44.21 31.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.094 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 281' ' ' SER . 40.5 t -52.13 -43.75 38.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.109 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . 0.537 ' HE2' ' HB1' ' A' ' 282' ' ' ALA . 0.0 OUTLIER -61.25 -30.52 70.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.58 ' CE2' ' HD2' ' A' ' 328' ' ' LYS . 47.6 t80 -84.47 -22.94 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.933 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.536 ' CG2' HG21 ' A' ' 344' ' ' VAL . 30.0 m -66.31 -22.96 66.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.143 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 293' ' ' MET . 2.1 mptm? -75.75 -44.1 43.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 287' ' ' TYR . 2.9 mp -53.64 -30.87 19.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.108 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.669 HG21 ' CD2' ' A' ' 324' ' ' HIS . 5.4 pt -98.37 -51.99 9.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.109 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.455 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -61.49 -48.61 80.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.096 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 15.4 ttm -55.11 -62.28 1.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -47.72 -64.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 298' ' ' ALA . 85.0 mttt -51.34 -63.7 1.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.929 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.463 HD12 HG21 ' A' ' 348' ' ' VAL . 51.3 mt -40.59 -57.43 1.85 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.926 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . 0.505 ' CE1' ' CG1' ' A' ' 352' ' ' ILE . 9.2 m-85 -55.58 -34.53 64.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 295' ' ' LYS . . . -66.64 -53.07 37.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.058 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.524 HG11 ' HB1' ' A' ' 313' ' ' ALA . 35.9 m -68.42 -25.82 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -50.57 -56.46 11.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.876 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 69.0 p -73.13 -11.53 60.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.14 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -77.46 -55.68 5.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.899 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -100.25 13.18 35.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -37.36 -34.72 0.1 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.909 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -41.77 -55.76 2.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.857 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -163.09 171.26 16.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.867 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.2 -62.25 1.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 38.4 t -48.25 -35.32 5.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.119 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 10.3 m -55.22 120.97 7.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.81 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 42.93 35.95 0.81 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.886 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -50.83 -20.76 1.39 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.843 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . 0.472 ' O ' ' CG ' ' A' ' 316' ' ' LYS . 6.7 pt-20 -57.56 -19.9 28.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.888 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.524 ' HB1' HG11 ' A' ' 299' ' ' VAL . . . -67.91 -58.9 3.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.125 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 78.2 t -54.65 -45.77 72.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.135 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 316' ' ' LYS . 1.7 t30 -67.81 -51.02 53.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.937 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.472 ' CG ' ' O ' ' A' ' 312' ' ' GLU . 18.4 mmtt -36.61 -59.14 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.899 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.402 ' O ' ' C ' ' A' ' 318' ' ' ARG . 92.8 mt -42.17 -54.02 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.157 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.402 ' C ' ' O ' ' A' ' 317' ' ' ILE . 76.4 mtt-85 -38.09 -35.84 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.914 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.7 mt -83.87 -43.95 14.79 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -56.91 -69.24 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.567 HG22 HG13 ' A' ' 291' ' ' ILE . 68.3 p -49.15 -46.79 45.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.096 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.48 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 7.3 tm-20 -46.76 -43.67 18.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.87 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -87.59 -10.14 52.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.923 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . 0.669 ' CD2' HG21 ' A' ' 291' ' ' ILE . 44.8 t60 -89.34 -26.18 21.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.87 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.742 HD12 HG23 ' A' ' 337' ' ' ILE . 19.5 mt -93.59 -53.32 4.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -50.62 -27.93 7.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.89 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 -84.5 -27.71 27.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.918 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.58 ' HD2' ' CE2' ' A' ' 287' ' ' TYR . 42.0 tttp -62.26 -55.19 30.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.848 ' O ' HG12 ' A' ' 332' ' ' VAL . 0.1 OUTLIER -123.31 108.39 31.82 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.642 0.734 . . . . 0.0 110.86 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 329' ' ' PHE . 53.9 Cg_endo -69.75 -21.08 34.02 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.691 2.261 . . . . 0.0 112.328 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.43 -35.5 75.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.848 HG12 ' O ' ' A' ' 329' ' ' PHE . 9.9 p -71.7 153.47 8.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.173 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . 0.497 ' O ' HD12 ' A' ' 337' ' ' ILE . 6.3 t0 -93.47 161.42 14.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.875 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -61.97 -47.04 86.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . 0.597 ' O ' ' CD1' ' A' ' 335' ' ' PHE . 3.4 t80 -51.41 -16.99 0.65 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.873 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.46 ' HB2' HG22 ' A' ' 332' ' ' VAL . 22.2 mm-40 -89.09 -34.54 16.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.915 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.742 HG23 HD12 ' A' ' 325' ' ' LEU . 2.8 mp -73.81 -30.33 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 28.1 mt -77.84 -61.83 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.151 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.62 ' O ' HD12 ' A' ' 343' ' ' ILE . 6.9 tp10 -52.67 -35.7 55.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . 0.407 ' O ' HG23 ' A' ' 344' ' ' VAL . 4.4 p -57.02 -47.79 80.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.834 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -56.85 -50.47 72.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -40.42 -51.48 2.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.62 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.9 mp -65.1 -38.07 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.169 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.536 HG21 ' CG2' ' A' ' 288' ' ' THR . 77.8 t -60.85 -63.64 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.137 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . . . . . . . . . . . -37.69 -51.99 1.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.079 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -54.84 -42.73 72.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 344' ' ' VAL . 20.0 tp10 -60.31 -54.74 42.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.947 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.463 HG21 HD12 ' A' ' 296' ' ' LEU . 49.2 t -57.56 -69.31 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.116 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.461 ' O ' ' N ' ' A' ' 352' ' ' ILE . 13.0 m-85 -35.32 -55.6 0.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 349' ' ' PHE . 15.4 tpt180 -36.85 -57.79 0.79 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . 0.625 ' O ' HD22 ' A' ' 354' ' ' LEU . 47.3 t -65.31 -31.25 72.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.885 -179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . 0.505 ' CG1' ' CE1' ' A' ' 297' ' ' TYR . 51.0 mt -76.39 -11.2 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.113 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.419 HG22 ' O ' ' A' ' 353' ' ' ILE . 12.0 mm -69.87 -15.88 19.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . 0.625 HD22 ' O ' ' A' ' 351' ' ' SER . 1.6 pt? -53.44 -27.39 24.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -95.3 -63.5 1.16 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -63.77 80.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.9 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -97.17 56.77 1.4 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.913 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp 50.89 45.0 28.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -106.0 36.45 2.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 31.4 p -39.63 154.79 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -86.23 -47.56 9.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.855 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 100.99 -125.37 8.56 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.48 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -105.1 153.5 21.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.814 0.34 . . . . 0.0 110.87 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -154.61 173.15 16.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.828 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 29.8 t -75.95 158.91 31.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.856 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 139.1 146.4 4.93 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.505 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -24.82 29.22 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.649 2.232 . . . . 0.0 112.368 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 4.1 t -54.34 127.75 28.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 3.6 t -163.78 159.75 21.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.866 -179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.291 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.5 179.985 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . . . . . . . . . 31.4 t -96.93 87.58 4.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.863 0.363 . . . . 0.0 110.873 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 6.0 m 51.53 42.13 29.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . -96.05 174.2 31.15 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.485 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' SER . . . . . . . . . . . . . 10.0 t -93.35 155.21 17.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.83 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 60.5 p -87.26 145.62 26.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.817 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 126.5 -72.78 0.45 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 156.97 61.94 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.704 2.269 . . . . 0.0 112.326 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -98.61 131.58 44.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.56 120.29 36.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.891 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ILE . . . . . . . . . . . . . 24.5 mm -94.37 142.36 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.108 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -108.4 143.04 37.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' THR . . . . . . . . . . . . . 40.1 p -82.61 152.49 66.8 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.567 0.699 . . . . 0.0 111.11 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 178.85 4.18 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.678 2.252 . . . . 0.0 112.308 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.57 121.28 26.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.844 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 283' ' ' GLU . . . -53.24 -57.46 10.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.066 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 282' ' ' ALA . 4.5 pt-20 -38.1 -44.46 0.83 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.879 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' ILE . . . . . 0.744 HD11 HG21 ' A' ' 332' ' ' VAL . 74.6 mt -69.82 -55.98 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.104 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' VAL . . . . . . . . . . . . . 88.0 t -37.81 -46.1 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.162 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -58.1 -55.94 28.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' TYR . . . . . 0.449 ' HA ' HD13 ' A' ' 290' ' ' ILE . 40.9 t80 -60.23 -26.72 66.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.931 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' THR . . . . . 0.41 ' O ' ' CB ' ' A' ' 292' ' ' ALA . 16.9 m -69.31 -20.17 63.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' LYS . . . . . 0.446 ' O ' ' CB ' ' A' ' 293' ' ' MET . 25.6 mttt -80.69 -38.26 29.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . 0.449 HD13 ' HA ' ' A' ' 287' ' ' TYR . 3.1 mp -60.23 -32.31 50.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ILE . . . . . 0.7 ' CD1' HG22 ' A' ' 321' ' ' THR . 16.9 pt -95.37 -46.84 13.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.126 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . 0.481 ' N ' HG13 ' A' ' 291' ' ' ILE . . . -62.79 -47.68 82.43 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.096 179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' MET . . . . . 0.446 ' CB ' ' O ' ' A' ' 289' ' ' LYS . 10.5 ttm -57.04 -60.97 2.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.861 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -48.77 -60.89 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.911 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 298' ' ' ALA . 27.0 mtmt -55.41 -62.94 1.34 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 67.0 mt -41.71 -49.05 4.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.867 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -67.59 -28.78 68.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 295' ' ' LYS . . . -70.59 -40.4 73.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.078 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . 0.566 ' CG1' ' HB1' ' A' ' 313' ' ' ALA . 30.6 m -78.79 -46.64 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.15 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' PHE . . . . . 0.515 ' N ' HG23 ' A' ' 299' ' ' VAL . 12.1 m-85 -63.54 -56.69 13.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.839 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 89.7 m -48.17 -48.48 34.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.13 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -69.15 -45.27 70.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.886 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' TYR . . . . . 0.53 ' CD2' ' O ' ' A' ' 299' ' ' VAL . 15.9 m-85 -97.82 76.62 2.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.446 ' O ' ' C ' ' A' ' 305' ' ' HIS . 11.6 pt-20 -95.05 -41.35 9.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.902 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' HIS . . . . . 0.446 ' C ' ' O ' ' A' ' 304' ' ' GLU . 52.3 m80 -34.96 -58.15 0.53 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -152.45 154.78 36.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 42.1 mttt -69.93 -48.07 59.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.931 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' VAL . . . . . . . . . . . . . 19.3 m -52.24 -22.52 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.12 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 23.5 t -69.22 103.67 2.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.815 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 62.49 37.66 13.21 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -50.02 -42.44 49.4 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -45.09 -36.54 3.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.874 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . 0.566 ' HB1' ' CG1' ' A' ' 299' ' ' VAL . . . -51.28 -37.89 49.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.047 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' VAL . . . . . . . . . . . . . 99.4 t -77.44 -54.8 12.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.141 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . 0.443 ' O ' ' C ' ' A' ' 316' ' ' LYS . 0.7 OUTLIER -51.54 -53.04 42.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 315' ' ' ASN . 15.9 mmmt -34.58 -51.66 0.48 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.861 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.507 HG22 ' CE1' ' A' ' 341' ' ' PHE . 82.5 mt -41.69 -58.85 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.126 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ARG . . . . . 0.419 ' C ' ' O ' ' A' ' 317' ' ' ILE . 25.5 mtp180 -37.11 -43.37 0.49 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' LEU . . . . . . . . . . . . . 4.2 mt -80.5 -44.26 19.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.907 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -56.57 -62.02 2.02 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.883 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.7 HG22 ' CD1' ' A' ' 291' ' ' ILE . 25.3 p -54.51 -57.51 11.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.123 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.43 ' HA ' ' CG2' ' A' ' 337' ' ' ILE . 17.0 tt0 -40.77 -34.92 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.89 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -87.84 -28.58 21.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' HIS . . . . . 0.676 ' CD2' HG21 ' A' ' 291' ' ' ILE . 71.4 t60 -75.0 -21.26 59.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.832 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.632 HD12 HG23 ' A' ' 337' ' ' ILE . 14.8 mt -93.2 -63.03 1.26 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.952 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 325' ' ' LEU . 8.4 tmtt? -35.98 -52.67 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -53.71 -44.85 70.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.869 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 325' ' ' LEU . 33.7 tttp -59.53 -44.08 93.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' PHE . . . . . 0.565 ' CE1' HG12 ' A' ' 284' ' ' ILE . 0.3 OUTLIER -115.97 89.19 23.81 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.676 0.751 . . . . 0.0 110.918 179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -26.64 27.29 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.696 2.264 . . . . 0.0 112.308 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.89 -29.03 55.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.911 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' VAL . . . . . 0.744 HG21 HD11 ' A' ' 284' ' ' ILE . 39.8 t -70.72 153.28 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.15 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . 0.41 ' N ' ' CG1' ' A' ' 332' ' ' VAL . 7.9 t0 -88.45 154.25 20.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.923 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -57.61 -47.97 80.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.953 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.67 -23.83 4.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.9 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' GLU . . . . . 0.483 ' HB2' ' CG1' ' A' ' 332' ' ' VAL . 7.7 mt-10 -79.83 -29.05 40.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' ILE . . . . . 0.632 HG23 HD12 ' A' ' 325' ' ' LEU . 1.5 mp -89.23 -23.73 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.093 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' ILE . . . . . . . . . . . . . 64.6 mt -74.15 -53.94 16.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.112 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.534 ' O ' HD12 ' A' ' 343' ' ' ILE . 19.6 mm-40 -64.06 -45.97 86.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.86 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' SER . . . . . . . . . . . . . 90.8 p -39.77 -50.73 2.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.879 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' PHE . . . . . 0.507 ' CE1' HG22 ' A' ' 317' ' ' ILE . 51.4 t80 -59.09 -56.56 20.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ASN . . . . . . . . . . . . . 17.9 m-20 -38.24 -44.95 0.92 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' ILE . . . . . 0.534 HD12 ' O ' ' A' ' 339' ' ' GLU . 4.2 mp -69.45 -42.4 80.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.169 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 345' ' ' ALA . 53.7 t -58.94 -63.32 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.113 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 344' ' ' VAL . . . -34.34 -55.59 0.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.088 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' LYS . . . . . . . . . . . . . 28.5 mtpt -47.92 -53.8 14.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.894 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -48.65 -61.37 2.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.866 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 349' ' ' PHE . 41.1 t -55.46 -62.03 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.201 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' PHE . . . . . 0.485 ' O ' HD12 ' A' ' 353' ' ' ILE . 6.6 m-85 -34.68 -63.44 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -39.29 -62.15 0.69 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.896 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' SER . . . . . . . . . . . . . 42.5 t -46.11 -45.26 16.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.798 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' ILE . . . . . . . . . . . . . 77.9 mt -56.79 -47.75 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.172 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 349' ' ' PHE . 3.2 mp -61.95 -36.42 73.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.107 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' LEU . . . . . . . . . . . . . 9.8 mp -67.69 -31.49 71.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 357' ' ' TYR . 35.1 m-20 -70.37 85.23 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 355' ' ' ASN . 58.3 mt-10 -32.58 92.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' TYR . . . . . 0.527 ' N ' ' O ' ' A' ' 355' ' ' ASN . 73.7 m-85 -38.22 151.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.918 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' LYS . . . . . 0.419 ' C ' ' O ' ' A' ' 357' ' ' TYR . 0.6 OUTLIER -34.97 -64.33 0.27 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -91.71 98.92 11.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.865 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' CYS . . . . . . . . . . . . . 4.1 t -87.14 168.89 12.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.881 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -133.63 42.47 2.97 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' GLY . . . . . . . . . . . . . . . 140.15 104.16 0.57 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.497 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -88.82 175.64 7.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.896 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -146.31 118.22 8.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' SER . . . . . . . . . . . . . 83.7 p 42.28 44.27 3.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.879 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' GLY . . . . . . . . . . . . . . . 58.64 -156.82 21.83 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.482 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 145.28 56.35 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.661 2.24 . . . . 0.0 112.343 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' SER . . . . . . . . . . . . . 8.4 t -173.53 156.03 2.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' SER . . . . . . . . . . . . . 31.4 t -131.34 140.02 49.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.908 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.483 -179.979 . . . . . . . . 0 0 . 1 stop_ save_